<?xml version="1.0" encoding="utf-8"?>


<DOCUMENT xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:noNamespaceSchemaLocation="dart3.xsd">

<DOCUMENT-HEADER AEXT-CLASS="Y">
<DOCUMENT-NAME ACODE="11011">사업보고서</DOCUMENT-NAME>
<FORMULA-VERSION SUBVER="3" ADATE="20210122">4.2</FORMULA-VERSION>
<COMPANY-NAME AREGCIK="01179927">(주)리독스바이오</COMPANY-NAME>

<SUMMARY>
<EXTRACTION ACODE="LINK_FLAG" AFEATURE="BOTH">N</EXTRACTION>
<EXTRACTION ACODE="FIN_TYPE" AFEATURE="BOTH">A</EXTRACTION>
<EXTRACTION ACODE="CRP_RGS_NO_TEMP" AFEATURE="BOTH">110111-4421436</EXTRACTION>
</SUMMARY>
</DOCUMENT-HEADER>

<BODY>

<INSERTION ABASISNUMBER="SE1" AFREQUENCY="0" ADUPLICATION="N">
<COMMENT>◆click◆ 정정문서 작성시 『정오표』 삽입</COMMENT>
<LIBRARYLIST>정정신고(보고)-대표이사등의확인.LCommon</LIBRARYLIST>
</INSERTION>

<COVER>
<P></P>
<COVER-TITLE ATOC="Y" AASSOCNOTE="COVER">사 업 보 고 서</COVER-TITLE>
<P>&cr;&cr;&cr;</P>
<P USERMARK="F-16">                                    (제 11기)</P>

<TABLE-GROUP ACLASS="COVER" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="Y" WIDTH="600" BORDER="0">

<COLGROUP>
<COL WIDTH="209"></COL>
<COL WIDTH="153"></COL>
<COL WIDTH="211"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD CLASS="NORMAL" ROWSPAN="2" ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="218" HEIGHT="60" AUPDATECONT="N">사업연도</TD>
<TU CLASS="NORMAL" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="162" HEIGHT="30" AUNIT="PERIODFROM" AUNITVALUE="20200101">2020년 01월 01일</TU>
<TD CLASS="NORMAL" VALIGN="MIDDLE" WIDTH="220" HEIGHT="30" AUPDATECONT="N"> 부터</TD>
</TR>

<TR ACOPY="N" ADELETE="N">
<TU CLASS="NORMAL" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="162" HEIGHT="30" AUNIT="PERIODTO" AUNITVALUE="20201231">2020년 12월 31일</TU>
<TD CLASS="NORMAL" VALIGN="MIDDLE" WIDTH="220" HEIGHT="30" AUPDATECONT="N"> 까지</TD>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
<P></P>

<TABLE AFIXTABLE="N" BORDER="0" WIDTH="600" ACLASS="NORMAL">

<COLGROUP>
<COL WIDTH="191"></COL>
<COL WIDTH="391"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="200" HEIGHT="30">금융위원회</TD>
<TD WIDTH="400" HEIGHT="30" ALIGN="RIGHT"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="200" HEIGHT="30">한국거래소 귀중</TD>
<TD WIDTH="400" HEIGHT="30" ALIGN="RIGHT">2021년      03월     18일</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="200" HEIGHT="30"></TD>
<TD WIDTH="400" HEIGHT="30"></TD>
</TR>
</TBODY>
</TABLE>

<TABLE-GROUP ACLASS="PB_VAL" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="600" BORDER="0">

<COLGROUP>
<COL WIDTH="191"></COL>
<COL WIDTH="391"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="200" HEIGHT="30" AUPDATECONT="N">제출대상법인 유형 :</TD>
<TU WIDTH="400" HEIGHT="30" AUNIT="PB_TYPE" AUNITVALUE="3">증권 모집ㆍ매출법인</TU>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="200" HEIGHT="30" AUPDATECONT="N"></TD>
<TD WIDTH="400" HEIGHT="30"></TD>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="200" HEIGHT="30" AUPDATECONT="N">면제사유발생 :</TD>
<TU WIDTH="400" HEIGHT="30" AUNIT="PB_CAMNT" AUNITVALUE="-">해당사항 없음</TU>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>

<TABLE AFIXTABLE="N" BORDER="0" WIDTH="600" ACLASS="NORMAL">

<COLGROUP>
<COL WIDTH="191"></COL>
<COL WIDTH="391"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="200" HEIGHT="30"></TD>
<TD WIDTH="400" HEIGHT="30"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="200" HEIGHT="30">회      사      명 :</TD>
<TD WIDTH="400" HEIGHT="30">주식회사 리독스바이오</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="200" HEIGHT="30"></TD>
<TD WIDTH="400" HEIGHT="30"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="200" HEIGHT="30">대   표    이   사 :</TD>
<TD WIDTH="400" HEIGHT="30">이한구, 한권석</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="200" HEIGHT="30"></TD>
<TD WIDTH="400" HEIGHT="30"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="200" HEIGHT="30">본  점  소  재  지 :</TD>
<TD WIDTH="400" HEIGHT="30">경기도 화성시 향남읍 제약공단 3길 83</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="200" HEIGHT="30"></TD>
<TD WIDTH="400" HEIGHT="30">(전  화) 031-353-6451</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="200" HEIGHT="30"></TD>
<TD WIDTH="400" HEIGHT="30">(홈페이지) http://www.redoxbio.co.kr</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="200" HEIGHT="30"></TD>
<TD WIDTH="400" HEIGHT="30"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="200" HEIGHT="30">작  성  책  임  자 :</TD>
<TD WIDTH="400" HEIGHT="30">(직  책) 신고업무담당이사      (성  명) 한권석</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="200" HEIGHT="30"></TD>
<TD WIDTH="400" HEIGHT="30">(전  화) 031-353-6451</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="200" HEIGHT="30"></TD>
<TD WIDTH="400" HEIGHT="30"></TD>
</TR>
</TBODY>
</TABLE>
<PGBRK></PGBRK>
</COVER>

<TOC>
<TITLE ATOC="N">목     차</TITLE>
<P></P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="600">

<COLGROUP>
<COL WIDTH="341"></COL>
<COL WIDTH="191"></COL>
<COL WIDTH="41"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="350" HEIGHT="32" VALIGN="MIDDLE">사업보고서</TD>
<TD WIDTH="200" HEIGHT="32" ALIGN="CENTER" VALIGN="MIDDLE">-----------------------</TD>
<TD WIDTH="50" HEIGHT="32" ALIGN="RIGHT" VALIGN="MIDDLE">1</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="350" HEIGHT="32" VALIGN="MIDDLE">【 대표이사 등의 확인 】</TD>
<TD WIDTH="200" HEIGHT="32" ALIGN="CENTER" VALIGN="MIDDLE">-----------------------</TD>
<TD WIDTH="50" HEIGHT="32" ALIGN="RIGHT" VALIGN="MIDDLE">1</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="350" HEIGHT="32" VALIGN="MIDDLE">I. 회사의 개요</TD>
<TD WIDTH="200" HEIGHT="32" ALIGN="CENTER" VALIGN="MIDDLE">-----------------------</TD>
<TD WIDTH="50" HEIGHT="32" ALIGN="RIGHT" VALIGN="MIDDLE">2</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="350" HEIGHT="32" VALIGN="MIDDLE">   1. 회사의 개요</TD>
<TD WIDTH="200" HEIGHT="32" ALIGN="CENTER" VALIGN="MIDDLE">-----------------------</TD>
<TD WIDTH="50" HEIGHT="32" ALIGN="RIGHT" VALIGN="MIDDLE">2</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="350" HEIGHT="32" VALIGN="MIDDLE">   2. 회사의 연혁</TD>
<TD WIDTH="200" HEIGHT="32" ALIGN="CENTER" VALIGN="MIDDLE">-----------------------</TD>
<TD WIDTH="50" HEIGHT="32" ALIGN="RIGHT" VALIGN="MIDDLE">4</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="350" HEIGHT="32" VALIGN="MIDDLE">   3. 자본금 변동사항</TD>
<TD WIDTH="200" HEIGHT="32" ALIGN="CENTER" VALIGN="MIDDLE">-----------------------</TD>
<TD WIDTH="50" HEIGHT="32" ALIGN="RIGHT" VALIGN="MIDDLE">7</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="350" HEIGHT="32" VALIGN="MIDDLE">   4. 주식의 총수 등</TD>
<TD WIDTH="200" HEIGHT="32" ALIGN="CENTER" VALIGN="MIDDLE">-----------------------</TD>
<TD WIDTH="50" HEIGHT="32" ALIGN="RIGHT" VALIGN="MIDDLE">7</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="350" HEIGHT="32" VALIGN="MIDDLE">   5. 의결권 현황</TD>
<TD WIDTH="200" HEIGHT="32" ALIGN="CENTER" VALIGN="MIDDLE">-----------------------</TD>
<TD WIDTH="50" HEIGHT="32" ALIGN="RIGHT" VALIGN="MIDDLE">8</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="350" HEIGHT="32" VALIGN="MIDDLE">   6. 배당에 관한 사항 등</TD>
<TD WIDTH="200" HEIGHT="32" ALIGN="CENTER" VALIGN="MIDDLE">-----------------------</TD>
<TD WIDTH="50" HEIGHT="32" ALIGN="RIGHT" VALIGN="MIDDLE">9</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="350" HEIGHT="32" VALIGN="MIDDLE">   7. 정관에 관한 사항</TD>
<TD WIDTH="200" HEIGHT="32" ALIGN="CENTER" VALIGN="MIDDLE">-----------------------</TD>
<TD WIDTH="50" HEIGHT="32" ALIGN="RIGHT" VALIGN="MIDDLE">10</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="350" HEIGHT="32" VALIGN="MIDDLE">II. 사업의 내용</TD>
<TD WIDTH="200" HEIGHT="32" ALIGN="CENTER" VALIGN="MIDDLE">-----------------------</TD>
<TD WIDTH="50" HEIGHT="32" ALIGN="RIGHT" VALIGN="MIDDLE">11</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="350" HEIGHT="32" VALIGN="MIDDLE">III. 재무에 관한 사항</TD>
<TD WIDTH="200" HEIGHT="32" ALIGN="CENTER" VALIGN="MIDDLE">-----------------------</TD>
<TD WIDTH="50" HEIGHT="32" ALIGN="RIGHT" VALIGN="MIDDLE">40</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="350" HEIGHT="32" VALIGN="MIDDLE">   1. 요약재무정보</TD>
<TD WIDTH="200" HEIGHT="32" ALIGN="CENTER" VALIGN="MIDDLE">-----------------------</TD>
<TD WIDTH="50" HEIGHT="32" ALIGN="RIGHT" VALIGN="MIDDLE">40</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="350" HEIGHT="32" VALIGN="MIDDLE">   2. 연결재무제표</TD>
<TD WIDTH="200" HEIGHT="32" ALIGN="CENTER" VALIGN="MIDDLE">-----------------------</TD>
<TD WIDTH="50" HEIGHT="32" ALIGN="RIGHT" VALIGN="MIDDLE">41</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="350" HEIGHT="32" VALIGN="MIDDLE">   3. 연결재무제표 주석</TD>
<TD WIDTH="200" HEIGHT="32" ALIGN="CENTER" VALIGN="MIDDLE">-----------------------</TD>
<TD WIDTH="50" HEIGHT="32" ALIGN="RIGHT" VALIGN="MIDDLE">41</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="350" HEIGHT="32" VALIGN="MIDDLE">   4. 재무제표</TD>
<TD WIDTH="200" HEIGHT="32" ALIGN="CENTER" VALIGN="MIDDLE">-----------------------</TD>
<TD WIDTH="50" HEIGHT="32" ALIGN="RIGHT" VALIGN="MIDDLE">41</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="350" HEIGHT="32" VALIGN="MIDDLE">   5. 재무제표 주석</TD>
<TD WIDTH="200" HEIGHT="32" ALIGN="CENTER" VALIGN="MIDDLE">-----------------------</TD>
<TD WIDTH="50" HEIGHT="32" ALIGN="RIGHT" VALIGN="MIDDLE">47</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="350" HEIGHT="32" VALIGN="MIDDLE">   6. 기타 재무에 관한 사항</TD>
<TD WIDTH="200" HEIGHT="32" ALIGN="CENTER" VALIGN="MIDDLE">-----------------------</TD>
<TD WIDTH="50" HEIGHT="32" ALIGN="RIGHT" VALIGN="MIDDLE">67</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="350" HEIGHT="32" VALIGN="MIDDLE">IV. 이사의 경영진단 및 분석의견</TD>
<TD WIDTH="200" HEIGHT="32" ALIGN="CENTER" VALIGN="MIDDLE">-----------------------</TD>
<TD WIDTH="50" HEIGHT="32" ALIGN="RIGHT" VALIGN="MIDDLE">71</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="350" HEIGHT="30" VALIGN="MIDDLE">V. 감사인의 감사의견 등</TD>
<TD WIDTH="200" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">-----------------------</TD>
<TD WIDTH="50" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">75</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="350" HEIGHT="32" VALIGN="MIDDLE">VI. 이사회 등 회사의 기관에 관한 사항</TD>
<TD WIDTH="200" HEIGHT="32" ALIGN="CENTER" VALIGN="MIDDLE">-----------------------</TD>
<TD WIDTH="50" HEIGHT="32" ALIGN="RIGHT" VALIGN="MIDDLE">77</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="350" HEIGHT="32" VALIGN="MIDDLE">   1. 이사회에 관한 사항</TD>
<TD WIDTH="200" HEIGHT="32" ALIGN="CENTER" VALIGN="MIDDLE">-----------------------</TD>
<TD WIDTH="50" HEIGHT="32" ALIGN="RIGHT" VALIGN="MIDDLE">77</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="350" HEIGHT="32" VALIGN="MIDDLE">   2. 감사제도에 관한 사항</TD>
<TD WIDTH="200" HEIGHT="32" ALIGN="CENTER" VALIGN="MIDDLE">-----------------------</TD>
<TD WIDTH="50" HEIGHT="32" ALIGN="RIGHT" VALIGN="MIDDLE">80</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="350" HEIGHT="32" VALIGN="MIDDLE">   3. 주주의 의결권 행사에 관한 사항</TD>
<TD WIDTH="200" HEIGHT="32" ALIGN="CENTER" VALIGN="MIDDLE">-----------------------</TD>
<TD WIDTH="50" HEIGHT="32" ALIGN="RIGHT" VALIGN="MIDDLE">83</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="350" HEIGHT="32" VALIGN="MIDDLE">VII. 주주에 관한 사항</TD>
<TD WIDTH="200" HEIGHT="32" ALIGN="CENTER" VALIGN="MIDDLE">-----------------------</TD>
<TD WIDTH="50" HEIGHT="32" ALIGN="RIGHT" VALIGN="MIDDLE">84</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="350" HEIGHT="32" VALIGN="MIDDLE">VIII. 임원 및 직원 등에 관한 사항</TD>
<TD WIDTH="200" HEIGHT="32" ALIGN="CENTER" VALIGN="MIDDLE">-----------------------</TD>
<TD WIDTH="50" HEIGHT="32" ALIGN="RIGHT" VALIGN="MIDDLE">90</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="350" HEIGHT="32" VALIGN="MIDDLE">   1. 임원 및 직원 등의 현황</TD>
<TD WIDTH="200" HEIGHT="32" ALIGN="CENTER" VALIGN="MIDDLE">-----------------------</TD>
<TD WIDTH="50" HEIGHT="32" ALIGN="RIGHT" VALIGN="MIDDLE">90</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="350" HEIGHT="32" VALIGN="MIDDLE">   2. 임원의 보수 등</TD>
<TD WIDTH="200" HEIGHT="32" ALIGN="CENTER" VALIGN="MIDDLE">-----------------------</TD>
<TD WIDTH="50" HEIGHT="32" ALIGN="RIGHT" VALIGN="MIDDLE">92</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="350" HEIGHT="32" VALIGN="MIDDLE">IX. 계열회사 등에 관한 사항</TD>
<TD WIDTH="200" HEIGHT="32" ALIGN="CENTER" VALIGN="MIDDLE">-----------------------</TD>
<TD WIDTH="50" HEIGHT="32" ALIGN="RIGHT" VALIGN="MIDDLE">95</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="350" HEIGHT="32" VALIGN="MIDDLE">X. 이해관계자와의 거래내용</TD>
<TD WIDTH="200" HEIGHT="32" ALIGN="CENTER" VALIGN="MIDDLE">-----------------------</TD>
<TD WIDTH="50" HEIGHT="32" ALIGN="RIGHT" VALIGN="MIDDLE">97</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="350" HEIGHT="32" VALIGN="MIDDLE">XI. 그 밖에 투자자 보호를 위하여 필요한 사항</TD>
<TD WIDTH="200" HEIGHT="32" ALIGN="CENTER" VALIGN="MIDDLE">-----------------------</TD>
<TD WIDTH="50" HEIGHT="32" ALIGN="RIGHT" VALIGN="MIDDLE">99</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="350" HEIGHT="32" VALIGN="MIDDLE">【 전문가의 확인 】</TD>
<TD WIDTH="200" HEIGHT="32" ALIGN="CENTER" VALIGN="MIDDLE">-----------------------</TD>
<TD WIDTH="50" HEIGHT="32" ALIGN="RIGHT" VALIGN="MIDDLE">105</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="350" HEIGHT="32" VALIGN="MIDDLE">   1. 전문가의 확인</TD>
<TD WIDTH="200" HEIGHT="32" ALIGN="CENTER" VALIGN="MIDDLE">-----------------------</TD>
<TD WIDTH="50" HEIGHT="32" ALIGN="RIGHT" VALIGN="MIDDLE">105</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="350" HEIGHT="32" VALIGN="MIDDLE">   2. 전문가와의 이해관계</TD>
<TD WIDTH="200" HEIGHT="32" ALIGN="CENTER" VALIGN="MIDDLE">-----------------------</TD>
<TD WIDTH="50" HEIGHT="32" ALIGN="RIGHT" VALIGN="MIDDLE">105</TD>
</TR>
</TBODY>
</TABLE>
<PGBRK></PGBRK>
</TOC>

<SECTION-1 AID="CEO-CERT" ACLASS="MANDATORY" APARTSOURCE="SOURCE">
<TITLE ATOC="Y" AASSOCNOTE="TTL_CEO_CERT">【 대표이사 등의 확인 】</TITLE>

<APPENDIX ATYPE="IMAGE">
<COMMENT>◆click◆ 대표이사 등이 서명한 『확인서』 그림파일 삽입</COMMENT>
</APPENDIX>

<IMAGE>
<IMG WIDTH="530" HEIGHT="627" ALIGN="CENTER" HSPACE="0">대표이사등의 확인.jpg</IMG>
<IMG-CAPTION ATOC="N">대표이사등의 확인</IMG-CAPTION>
</IMAGE>
<P></P>
<PGBRK></PGBRK>
</SECTION-1>

<SECTION-1 ACLASS="MANDATORY" APARTSOURCE="SOURCE">
<TITLE ATOC="Y">I. 회사의 개요</TITLE>

<SECTION-2 ACLASS="MANDATORY">
<TITLE ATOC="Y" AASSOCNOTE="D-0-1-1-0">1. 회사의 개요</TITLE>

<INSERTION ABASISNUMBER="SE1" AFREQUENCY="0" ADUPLICATION="N">
<COMMENT>◆click◆『연결재무제표를작성하는주권상장법인』 삽입</COMMENT>
<LIBRARYLIST>11011#*연결재무제표를작성하는주권상장법인.dsl</LIBRARYLIST>
</INSERTION>
<P></P>

<P>
<SPAN USERMARK="F-GL11 B">가. 회사의 법적ㆍ상업적 명칭.&cr;</SPAN>
<SPAN USERMARK="F-GL11 B"></SPAN>
<SPAN USERMARK="F-GL11">당사의 명칭은 '주식회사 리독스바이오' 라고 칭하고, 영문으로는 'Redoxbio Co., Ltd.'라 표기합니다.&cr;</SPAN>
</P>

<P>
<SPAN USERMARK="F-GL11"></SPAN>
<SPAN USERMARK="F-GL11 B">나. 설립일자 및 존속기간&cr;</SPAN>
<SPAN USERMARK="F-GL11">당사는 2010년 8월 26일 설립되었으며, 원료의약품 제조 및 판매 등을 주요사업으로 영위하고 있습니다.&cr;</SPAN>
</P>

<P>
<SPAN USERMARK="F-GL11 B">다. 본사의 주소, 전화번호, 홈페이지 주소</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="627">

<COLGROUP>
<COL WIDTH="197"></COL>
<COL WIDTH="412"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="206" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구  분</TH>
<TH WIDTH="421" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">내  용</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="206" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">본사 주소</TD>
<TD WIDTH="421" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">경기도 화성시 향남읍 제약공단3길 83</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="206" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">전화번호</TD>
<TD WIDTH="421" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">031-831-3910</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="206" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">홈페이지 주소</TD>
<TD WIDTH="421" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">http://www.redoxbio.co,kr</TD>
</TR>
</TBODY>
</TABLE>

<P>&cr;
<SPAN USERMARK="F-11"></SPAN>
<SPAN USERMARK="F-11 B"></SPAN>
<SPAN USERMARK="F-GL11 B"></SPAN>
<SPAN USERMARK="F-GL11 B">라. 중소기업 해당 여부&cr;</SPAN>
<SPAN USERMARK="F-GL11">당사는 본 보고서 제출이 현재 중소기업기본법 제2조 및 기본법 시행령 제3조</SPAN>
<SPAN USERMARK="F-GL11 B"></SPAN>
<SPAN USERMARK="F-GL11">에</SPAN>
<SPAN USERMARK="F-GL11"> 의한 중소기업에 해당하지 않습니다.&cr;</SPAN>
<SPAN USERMARK="F-11">&cr;</SPAN>
<SPAN USERMARK="F-11 B"></SPAN>
<SPAN USERMARK="F-GL11 B">마</SPAN>
<SPAN USERMARK="F-GL11 B"></SPAN>
<SPAN USERMARK="F-GL11 B"></SPAN>
<SPAN USERMARK="F-GL11 B"></SPAN>
<SPAN USERMARK="F-GL11 B">. 주요 사업의 내용&cr;</SPAN>
<SPAN USERMARK="F-GL11">당사는 </SPAN>
<SPAN USERMARK="F-GL11"> </SPAN>
<SPAN USERMARK="F-GL11"></SPAN>
<SPAN USERMARK="F-GL11"></SPAN>
<SPAN USERMARK="F-GL11">원료의약품 제조 및 판매를 주 영업 목적</SPAN>
<SPAN USERMARK="F-GL11"></SPAN>
<SPAN USERMARK="F-GL11"></SPAN>
<SPAN USERMARK="F-GL11"></SPAN>
<SPAN USERMARK="F-GL11"></SPAN>
<SPAN USERMARK="F-GL11"></SPAN>
<SPAN USERMARK="F-GL11">으로 영위하고 있으며, 보고서 제출일 현재 기타 신규 사업의 계획 및 추진 중인 사항은 없습니다. 자세한 내용은 </SPAN>
<SPAN USERMARK="F-GL11 U">Ⅱ. 사업의 내용</SPAN>
<SPAN USERMARK="F-GL11">을</SPAN>
<SPAN USERMARK="F-GL11"> 참조하시기 바랍니다.&cr;</SPAN>&cr;
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="680">

<COLGROUP>
<COL WIDTH="307"></COL>
<COL WIDTH="355"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="680" HEIGHT="30" COLSPAN="2" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">회사가 영위하는 목적사업</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="316" HEIGHT="30">1. 의약품 및 의료기기 개발, 생산 및 판매</TD>
<TD WIDTH="364" HEIGHT="30">11. 통신판매업</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="316" HEIGHT="30">2. 신기능 고기능성 생물소재 탐색 및 개발업</TD>
<TD WIDTH="364" HEIGHT="30">12. 화장품 도소매업</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="316" HEIGHT="30">3. 오염환경의 생물학적 처리업</TD>
<TD WIDTH="364" HEIGHT="30">13. 의료기기 관련 수출입업</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="316" HEIGHT="30">4. 동물의약품 연구개발 생산 및 판매</TD>
<TD WIDTH="364" HEIGHT="30">14. 연구용역업</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="316" HEIGHT="30">5. 유용 생물 자원 이용 관련업</TD>
<TD WIDTH="364" HEIGHT="30">15. 원료의약품 제조 및 판매</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="316" HEIGHT="30">6. 생물학적 제제 생산 및 판매</TD>
<TD WIDTH="364" HEIGHT="30">16. 원료의약품 관련기술의 연구, 개발, 기술 판매업</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="316" HEIGHT="30">7. 생물소재탐색, 개발기술, 생물환경 관련업</TD>
<TD WIDTH="364" HEIGHT="30">17. 화장품 제조 판매업</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="316" HEIGHT="30">8. 생물신소재 연구개발, 생산 및 판매</TD>
<TD WIDTH="364" HEIGHT="30">18. 부동산임대업</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="316" HEIGHT="30">9. 종묘 생산업</TD>
<TD WIDTH="364" HEIGHT="30">19. 각호와 관련된 부대사업 일체</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="316" HEIGHT="30">10. 기구개발 생산업</TD>
<TD WIDTH="364" HEIGHT="30"></TD>
</TR>
</TBODY>
</TABLE>

<P>&cr;
<SPAN USERMARK="F-GL11 B">바, 계열회사에</SPAN>
<SPAN USERMARK="F-GL11 B"> 관한 사항&cr;</SPAN>
<SPAN USERMARK="F-GL11">보고서 작성 기준일 현재 당사를 제외하고 1개의 상장회사(코스닥), 4개의 비상장 계열회사를 두고 있습니다.&cr;&cr;</SPAN>
<SPAN USERMARK="F-GL11 B">대화제약(주)</SPAN>
<SPAN USERMARK="F-GL11"> : 1984년 1월 19일에 의약품 및 의약부외품 외 제조 및 판매업을 주 영업목적으로 설립되었으며, 2003년 2월 12일에 코스닥시장 상장을 승인받아 회사의 발행주식이 2003년 2월 14일 자로 코스닥증권시장에 상장되었으며, </SPAN>
<SPAN USERMARK="F-GL11">당사의 지분 </SPAN>
<SPAN USERMARK="F-GL11">60.18%</SPAN>
<SPAN USERMARK="F-GL11">를 보유하고 있습니다.</SPAN>
<SPAN USERMARK="F-GL11">&cr;&cr;</SPAN>
<SPAN USERMARK="F-GL11 B"></SPAN>
<SPAN USERMARK="F-GL11 0X1814FF B"></SPAN>
<SPAN USERMARK="F-GL11 B">디에이치호림(주)</SPAN>
<SPAN USERMARK="F-GL11"> : 2007년 5월 17일 완제 의약품, 원료의약품 도ㆍ소매 강화를 위하여 신규법인설립 출자를 통해 대화제약의 계열회사로 추가하였습니다. 2010년 6월 23일 데아체파르마(주) 에서 디에이치호림(주)로 상호 변경되었습니다.&cr;&cr;</SPAN>
<SPAN USERMARK="F-GL11 B">(주)스페셜라이즈드메드</SPAN>
<SPAN USERMARK="F-GL11"> : 2007년 7월 6일 병원, 약국 등 의료정보시스템 콘텐츠 서비스업을 주업으로 하고 있으며 지분 참여를 통하여 대화제약의 계열회사로 추가하였습니다. &cr;&cr;</SPAN>
<SPAN USERMARK="F-GL11 B">S&V Technologies GmbH </SPAN>
<SPAN USERMARK="F-GL11">: 2017년 09월 18일 독일 필러생산법인 인수를 통한 안정적인 제품공급과 제품경쟁력을 확보하고 화장품 및 의료기기 제조의 사업영역을 넓히기 위해 지분 매입을 통해 계열회사로 추가하였습니다. 현재 당사가 보유한 지분은 40% (연결지분율 100%) 입니다.&cr;&cr;</SPAN>
<SPAN USERMARK="F-GL11 B">BSC Medical Devices GmbH</SPAN>
<SPAN USERMARK="F-GL11"> : 2017년 09월 18일 독일 의료기기 제조 및 판매에 대한 사업확대를 위하여 지분 매입을 통하여 독일 현지 법인을 계열회사로 추가하였습니다. 현재 당사가 보유한 지분은 40% (연결지분율 100%) 입니다.&cr;</SPAN>&cr;
<SPAN USERMARK="F-GL11"></SPAN>
<SPAN USERMARK="F-GL11"></SPAN>
<SPAN USERMARK="F-11"></SPAN>
<SPAN USERMARK="F-GL11 B">사. 신용평가에 관한 사항&cr;</SPAN>
<SPAN USERMARK="F-GL11">보고서 제출일 현재 해당사항이 없습니다.&cr;</SPAN>
</P>
<P USERMARK="F-GL11 B">아. 회사의 주권상장(또는 등록ㆍ지정)여부 및 특례상장에 관한 사항</P>

<TABLE-GROUP ACLASS="SPC_CRT" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="602" BORDER="1">

<COLGROUP>
<COL WIDTH="165"></COL>
<COL WIDTH="165"></COL>
<COL WIDTH="104"></COL>
<COL WIDTH="132"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="N" ADELETE="N">
<TH WIDTH="174" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53">주권상장&cr;(또는 등록ㆍ지정)여부</TH>
<TH WIDTH="174" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53">주권상장&cr;(또는 등록ㆍ지정)일자</TH>
<TH WIDTH="113" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53">특례상장 등&cr;여부</TH>
<TH WIDTH="141" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53">특례상장 등&cr;적용법규</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TE WIDTH="174" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="SPC_CHK">K-OTC</TE>
<TU WIDTH="174" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUNIT="SPC_DATE" AUNITVALUE="20190625">2019년 06월 25일</TU>
<TE WIDTH="113" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="SPC_CHP">해당없음</TE>
<TE WIDTH="141" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="SPC_LAW">해당없음</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
<P></P>
</SECTION-2>

<SECTION-2 ACLASS="MANDATORY">
<TITLE ATOC="Y" AASSOCNOTE="D-0-1-2-0">2. 회사의 연혁</TITLE>
<P></P>

<P>
<SPAN USERMARK="F-GL11 B">가. 회사의 연혁&cr;&cr;</SPAN>
<SPAN USERMARK="F-GL11">공시대상기간</SPAN>
<SPAN USERMARK="F-GL11 B">(</SPAN>
<SPAN USERMARK="F-GL11 B">최근5사업연도</SPAN>
<SPAN USERMARK="F-GL11 B">) </SPAN>
<SPAN USERMARK="F-GL11">중 회사의 주된 변동내용은 아래와 같습니다.</SPAN>
<SPAN USERMARK="F-GL11 B"></SPAN>
</P>

<TABLE ACLASS="NORMAL" WIDTH="627" BORDER="1" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="99"></COL>
<COL WIDTH="510"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH ALIGN="CENTER" WIDTH="108" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">년  월</TH>
<TH ALIGN="CENTER" WIDTH="519" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">내          용</TH>
</TR>
</THEAD>

<TBODY ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" WIDTH="108" HEIGHT="30">2010년 08월</TD>
<TD WIDTH="519" HEIGHT="30"> (주)와이언트 회사설립</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" WIDTH="108" HEIGHT="30">2011년 07월</TD>
<TD WIDTH="519" HEIGHT="30"> 산학연 협력 기업부설연구소 지원사업(4억5천만원)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" WIDTH="108" HEIGHT="30">2011년 10월</TD>
<TD WIDTH="519" HEIGHT="30"> (주)리독스바이오로 상호변경</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" WIDTH="108" HEIGHT="30">2011년 12월</TD>
<TD WIDTH="519" HEIGHT="30"> 벤처기업 인증</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="108" HEIGHT="30">2011년 12월</TD>
<TD WIDTH="519" HEIGHT="30"> 기업부설연구소 인증</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="108" HEIGHT="30">2011년 12월</TD>
<TD WIDTH="519" HEIGHT="30"> HA Dermal Filler 독일수입제품“Noblisse”식약청 허가</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" WIDTH="108" HEIGHT="30">2012년 06월</TD>
<TD WIDTH="519" HEIGHT="30"> HA원료 독일공급계약</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" WIDTH="108" HEIGHT="30">2013년 08월</TD>
<TD WIDTH="519" HEIGHT="30"> 대화제약(주) 자회사로 편입</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" WIDTH="108" HEIGHT="30">2014년 11월</TD>
<TD WIDTH="519" HEIGHT="30"> 히알루론산 생산제조공장 준공(경기 화성 향남 제약공단내)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" WIDTH="108" HEIGHT="30">2015년 05월</TD>
<TD WIDTH="519" HEIGHT="30"> EU-GMP 인증획득</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" WIDTH="108" HEIGHT="30">2016년 08월</TD>
<TD WIDTH="519" HEIGHT="30"> 대화제약으로부터 합성원료사업부문 현물출자 받아 증자</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="108" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">2016년 12월</TD>
<TD WIDTH="519" HEIGHT="30"> 3자배정 유상증자 약 9,946백만원(주당 1,000원, 9,946천주)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="108" HEIGHT="53" VALIGN="MIDDLE" ALIGN="CENTER">2017년 09월 </TD>
<TD WIDTH="519" HEIGHT="53"> 대화제약(주)와 공동으로 BSC Medocal Devices 인수계약&cr; 대화제약(주)와 공동으로 S&V Technologies 인수계약</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="108" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">2018년 08월</TD>
<TD WIDTH="519" HEIGHT="30"> GMP API(합성)공장 증축공사 계약 및 착공</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="108" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">2019년 05월</TD>
<TD WIDTH="519" HEIGHT="30"> GMP API(합성)공장 건축물 사용승인 및 준공</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="108" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">2019년 06월</TD>
<TD WIDTH="519" HEIGHT="30"> 금융투자협회 K-OCT시장 신규지정, 27일 거래시작</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="108" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">2020년 03월</TD>
<TD WIDTH="519" HEIGHT="30"> 관리동 증축공사 계약 및 착공</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="108" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">2020년 08월</TD>
<TD WIDTH="519" HEIGHT="30"> 관리동 준공</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK="F-GL11 B">&cr;</SPAN>
<SPAN USERMARK="F-GL11 B"></SPAN>
<SPAN USERMARK="F-GL11 B">나. 회사의 본점소재지 및 그 변경&cr;</SPAN>
<SPAN USERMARK="F-GL11 B"></SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="588">

<COLGROUP>
<COL WIDTH="83"></COL>
<COL WIDTH="487"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="92" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">변경일자</TH>
<TH WIDTH="496" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">주소</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="92" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">2011.08.29</TD>
<TD WIDTH="496" HEIGHT="30" VALIGN="MIDDLE">서울특별시 금천구 가산동 233-5 한국세라믹기술원 벤처관 303호</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="92" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">2013.09.04</TD>
<TD WIDTH="496" HEIGHT="30" VALIGN="MIDDLE">경기도 화성시 향남읍 제약공단3길 83</TD>
</TR>
</TBODY>
</TABLE>
<P></P>

<P>
<SPAN USERMARK="F-GL11 B">다. 경영진의 주요한 변동&cr;</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="1376">

<COLGROUP>
<COL WIDTH="83"></COL>
<COL WIDTH="439"></COL>
<COL WIDTH="439"></COL>
<COL WIDTH="379"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="92" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">변경일자</TH>
<TH WIDTH="448" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">변경전</TH>
<TH WIDTH="448" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">변경후</TH>
<TH WIDTH="388" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">비   고</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="92" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">2012.06.20</TD>
<TD WIDTH="448" HEIGHT="30" VALIGN="MIDDLE">이광진, 김성호</TD>
<TD WIDTH="448" HEIGHT="30" VALIGN="MIDDLE">김성호</TD>
<TD WIDTH="388" HEIGHT="30" VALIGN="MIDDLE">이광진 대표이사 사임</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="92" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">2012.10.08</TD>
<TD WIDTH="448" HEIGHT="30" VALIGN="MIDDLE">김성호</TD>
<TD WIDTH="448" HEIGHT="30" VALIGN="MIDDLE">김성욱</TD>
<TD WIDTH="388" HEIGHT="30" VALIGN="MIDDLE">김성호 사내이사 사임, 김성욱 단독대표로 변경</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="92" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">2013.09.04</TD>
<TD WIDTH="448" HEIGHT="30" VALIGN="MIDDLE">김성욱</TD>
<TD WIDTH="448" HEIGHT="30" VALIGN="MIDDLE">김성욱, 노병태, 이상태</TD>
<TD WIDTH="388" HEIGHT="30" VALIGN="MIDDLE">노병태, 이상태 사내이사 취임</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="92" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">2016.09.26</TD>
<TD WIDTH="448" HEIGHT="30" VALIGN="MIDDLE">김성욱, 노병태, 이상태</TD>
<TD WIDTH="448" HEIGHT="30" VALIGN="MIDDLE">김수지, 김성욱, 김은석, 노병태, 이상태, 박영택</TD>
<TD WIDTH="388" HEIGHT="30" VALIGN="MIDDLE">김수지 단독대표로 변경, 김은석, 박영택 사내이사 취임</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="92" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">2017.11.24</TD>
<TD WIDTH="448" HEIGHT="30" VALIGN="MIDDLE">김수지, 김성욱, 김은석, 노병태, 이상태, 박영택</TD>
<TD WIDTH="448" HEIGHT="30" VALIGN="MIDDLE">이한구, 한권석, 김수지, 김성욱, 김은석, 노병태, 이상태, 박영택</TD>
<TD WIDTH="388" HEIGHT="30" VALIGN="MIDDLE">이한구,한권석 각자대표로 변경</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="92" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">2018.01.31</TD>
<TD WIDTH="448" HEIGHT="30" VALIGN="MIDDLE">이한구, 한권석, 김수지, 김성욱, 김은석, 노병태, 이상태, 박영택</TD>
<TD WIDTH="448" HEIGHT="30" VALIGN="MIDDLE">이한구, 한권석, 김수지,  김은석, 노병태, 이상태, 박영택</TD>
<TD WIDTH="388" HEIGHT="30" VALIGN="MIDDLE">김성욱 사내이사 사임</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="92" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">2018.03.15</TD>
<TD WIDTH="448" HEIGHT="30" VALIGN="MIDDLE">이한구, 한권석, 김수지,  김은석, 노병태, 이상태, 박영택</TD>
<TD WIDTH="448" HEIGHT="30" VALIGN="MIDDLE">이한구, 한권석, 김수지,  김은석, 노병태, 박영택</TD>
<TD WIDTH="388" HEIGHT="30" VALIGN="MIDDLE">이상태 사내이사 사임</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="92" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">2021.11.24</TD>
<TD WIDTH="448" HEIGHT="30" VALIGN="MIDDLE">이한구, 한권석, 김수지,  김은석, 노병태, 박영택</TD>
<TD WIDTH="448" HEIGHT="30" VALIGN="MIDDLE">이한구, 한권석, 김수지,  김은석</TD>
<TD WIDTH="388" HEIGHT="30" VALIGN="MIDDLE">노병태, 박영택 사내이사 사임</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK="F-GL11">&cr;</SPAN>
<SPAN USERMARK="F-GL11 B">라. 최대주주의 변동&cr;</SPAN>
<SPAN USERMARK="F-GL11">&cr;</SPAN>
<SPAN USERMARK="F-GL11">설립이후의 최대주주 변동내역은 다음과 같습니다.</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" WIDTH="634" BORDER="1">

<COLGROUP>
<COL WIDTH="136"></COL>
<COL WIDTH="113"></COL>
<COL WIDTH="105"></COL>
<COL WIDTH="83"></COL>
<COL WIDTH="152"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="145" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">변동일</TH>
<TH WIDTH="122" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">최대주주명</TH>
<TH WIDTH="114" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">소유주식수</TH>
<TH WIDTH="92" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">지분율</TH>
<TH WIDTH="161" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">비 고</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="145" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2010.08.30</TD>
<TD WIDTH="122" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">이광진</TD>
<TD WIDTH="114" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">11,200 </TD>
<TD WIDTH="92" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">56.00% </TD>
<TD WIDTH="161" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">설립</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="145" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2010.11.06</TD>
<TD WIDTH="122" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">이광진</TD>
<TD WIDTH="114" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">14,600 </TD>
<TD WIDTH="92" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">62.39% </TD>
<TD WIDTH="161" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">유상증자</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="145" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2011.12.31</TD>
<TD WIDTH="122" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">김성호</TD>
<TD WIDTH="114" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">29,532 </TD>
<TD WIDTH="92" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">35.41% </TD>
<TD WIDTH="161" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">유상증자</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="145" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2012.06.21</TD>
<TD WIDTH="122" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">김성호</TD>
<TD WIDTH="114" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">30,732 </TD>
<TD WIDTH="92" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">32.83% </TD>
<TD WIDTH="161" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">유상증자</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="145" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2013.08.22</TD>
<TD WIDTH="122" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">대화제약㈜</TD>
<TD WIDTH="114" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">93,600 </TD>
<TD WIDTH="92" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">100.00% </TD>
<TD WIDTH="161" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">주식양수</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="145" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2014.12.23</TD>
<TD WIDTH="122" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">대화제약㈜</TD>
<TD WIDTH="114" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">300,000 </TD>
<TD WIDTH="92" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">100.00% </TD>
<TD WIDTH="161" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">유상증자</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="145" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2016.05.04</TD>
<TD WIDTH="122" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">대화제약㈜</TD>
<TD WIDTH="114" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">600,000 </TD>
<TD WIDTH="92" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">100.00% </TD>
<TD WIDTH="161" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">유상증자</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="145" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2016.08.29</TD>
<TD WIDTH="122" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">대화제약㈜</TD>
<TD WIDTH="114" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">14,665,370</TD>
<TD WIDTH="92" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">100.00% </TD>
<TD WIDTH="161" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">현물출자 및 주식분할</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="145" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2016.12.16</TD>
<TD WIDTH="122" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">대화제약㈜</TD>
<TD WIDTH="114" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">15,507,370</TD>
<TD WIDTH="92" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">63.01%</TD>
<TD WIDTH="161" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">유상증자</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="145" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2017.11.24</TD>
<TD WIDTH="122" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">대화제약㈜</TD>
<TD WIDTH="114" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">15,857,370</TD>
<TD WIDTH="92" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">64.44%</TD>
<TD WIDTH="161" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">특수관계인증가</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="145" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2018.08.01</TD>
<TD WIDTH="122" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">대화제약㈜</TD>
<TD WIDTH="114" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">15,897,370</TD>
<TD WIDTH="92" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">64.60%</TD>
<TD WIDTH="161" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">최대주주인증가</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="145" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2019.12.31</TD>
<TD WIDTH="122" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">대화제약㈜</TD>
<TD WIDTH="114" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">15,932,870</TD>
<TD WIDTH="92" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">64.74%</TD>
<TD WIDTH="161" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">최대주주인증가</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="145" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2020.03.31</TD>
<TD WIDTH="122" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">대화제약㈜</TD>
<TD WIDTH="114" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">15,958,290</TD>
<TD WIDTH="92" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">64.84%</TD>
<TD WIDTH="161" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">최대주주인증가</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="145" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2020.06.30</TD>
<TD WIDTH="122" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">대화제약㈜</TD>
<TD WIDTH="114" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">15,962,010</TD>
<TD WIDTH="92" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">64.85%</TD>
<TD WIDTH="161" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">최대주주인증가</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="145" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2020.09.30</TD>
<TD WIDTH="122" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">대화제약㈜</TD>
<TD WIDTH="114" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">15,981,830</TD>
<TD WIDTH="92" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">64.94%</TD>
<TD WIDTH="161" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">최대주주인증가</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="145" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2020.12.31</TD>
<TD WIDTH="122" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">대화제약㈜</TD>
<TD WIDTH="114" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">16,012,180</TD>
<TD WIDTH="92" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">65.06%</TD>
<TD WIDTH="161" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">최대주주인증가</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK="F-GL11">■ 2016년 08월 29일 지배회사인 대화제약(주)의 현물투자로 866,537주가 증가하였으며 주식 분할(액면가 5,000원 -> 500원)하여 14,665,370주로 변경됨.&cr;■ 2016년 12월 16일 제3자배정 유상증자를 통하여 지분율이 63.01% 변경됨.&cr;</SPAN>
<SPAN USERMARK="F-GL11">■</SPAN>
<SPAN USERMARK="F-GL11"> </SPAN>
<SPAN USERMARK="F-GL11">리독스바이오의 발행 주식 총수는 24,611,870주임.</SPAN>
<SPAN USERMARK="F-GL11">&cr;</SPAN>
<SPAN USERMARK="F-GL11">■ 2017년 11월 24일 특수관계인증가를 통하여 지분율이 64.44% 변경됨</SPAN>
<SPAN USERMARK="F-GL11">.(</SPAN>
<SPAN USERMARK="F-GL11 U">최대주주인 대화제약(주)의 지분 14,665,370주, 59.59%와 특수관계인의 지분 </SPAN>
<SPAN USERMARK="F-GL11 U">1,192,000주, 4.85%</SPAN>
<SPAN USERMARK="F-GL11 U"> 포함</SPAN>
<SPAN USERMARK="F-GL11">)</SPAN>
<SPAN USERMARK="F-GL11">■ 2018년 08월 01일 최대주주인지분증가를 통하여 지분율이 64.6% 변경됨</SPAN>
<SPAN USERMARK="F-GL11">.(</SPAN>
<SPAN USERMARK="F-GL11 U">최대주주인 대화제약(주)의 지분 14,715,370주, 59.79%와 특수관계인의 지분 </SPAN>
<SPAN USERMARK="F-GL11 U">1,182,000주, 4.81%</SPAN>
<SPAN USERMARK="F-GL11 U"> 포함</SPAN>
<SPAN USERMARK="F-GL11">)&cr;</SPAN>
<SPAN USERMARK="F-GL11"></SPAN>
<SPAN USERMARK="F-GL11"></SPAN>
<SPAN USERMARK="F-GL11"></SPAN>
<SPAN USERMARK="F-GL11">■ 2019년 12월 31일 최대주주인지분증가를 통하여 지분율이 64.74% 변경됨</SPAN>
<SPAN USERMARK="F-GL11"></SPAN>
<SPAN USERMARK="F-GL11">.(</SPAN>
<SPAN USERMARK="F-GL11 U">최대주주인 대화제약(주)의 지분 14,721,830주, 59.82%와 특수관계인의 지분 </SPAN>
<SPAN USERMARK="F-GL11 U">1,211,040주, 4.92%</SPAN>
<SPAN USERMARK="F-GL11 U"> 포함</SPAN>
<SPAN USERMARK="F-GL11">)</SPAN>
</P>

<P>
<SPAN USERMARK="F-GL11 B"></SPAN>
<SPAN USERMARK="F-GL11"></SPAN>
<SPAN USERMARK="F-GL11">■ 2020년 12월 31일 최대주주인지분증가를 통하여 지분율이 65.06% 변경됨</SPAN>
<SPAN USERMARK="F-GL11"></SPAN>
<SPAN USERMARK="F-GL11">.(</SPAN>
<SPAN USERMARK="F-GL11 U">최대주주인 대화제약(주)의 지분 14,810,770, 60.18%와 특수관계인의 지분 </SPAN>
<SPAN USERMARK="F-GL11 U">1,201.410주, 4.88%</SPAN>
<SPAN USERMARK="F-GL11 U"> 포함</SPAN>
<SPAN USERMARK="F-GL11">)</SPAN>
<SPAN USERMARK="F-GL11"></SPAN>
<SPAN USERMARK="F-GL11">&cr;</SPAN>
<SPAN USERMARK="F-GL11">&cr;</SPAN>
<SPAN USERMARK="F-GL11"></SPAN>
<SPAN USERMARK="F-GL11 B">마. 상</SPAN>
<SPAN USERMARK="F-GL11 B"></SPAN>
<SPAN USERMARK="F-GL11 B">호의 변경</SPAN>
<SPAN USERMARK="F-GL11">&cr;&cr;당사는 '주식회사 와이언트'로 설립되어 2011년 10월 25일 회사명을 '주식회사 리독스바이오'로 변경하였습니다.&cr;</SPAN>
</P>
<P></P>
</SECTION-2>

<SECTION-2 ACLASS="MANDATORY">
<TITLE ATOC="Y" AASSOCNOTE="D-0-1-3-0">3. 자본금 변동사항</TITLE>
<P></P>

<P>
<SPAN USERMARK="F-GL11 B"></SPAN>
<SPAN USERMARK="F-GL11 B"></SPAN>
<SPAN USERMARK="F-GL11 B">가. 증</SPAN>
<SPAN USERMARK="F-GL11 B">자(감자)현황&cr;</SPAN>
</P>

<TABLE-GROUP ACLASS="INC_STAT" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="Y" WIDTH="768" BORDER="0">

<COLGROUP>
<COL WIDTH="70"></COL>
<COL WIDTH="142"></COL>
<COL WIDTH="58"></COL>
<COL WIDTH="462"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD VALIGN="BOTTOM" WIDTH="79" HEIGHT="30" AUPDATECONT="N">(기준일 : </TD>
<TU ALIGN="CENTER" VALIGN="BOTTOM" WIDTH="151" HEIGHT="30" AUNIT="BASE_DT" AUNITVALUE="20201231">2020년 12월 31일</TU>
<TD VALIGN="BOTTOM" WIDTH="67" HEIGHT="30" AUPDATECONT="N">)</TD>
<TU ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="471" HEIGHT="30" AUNIT="WONSTOCK" AUNITVALUE="1">(단위 : 원, 주)</TU>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="769" BORDER="1">

<COLGROUP>
<COL WIDTH="128"></COL>
<COL WIDTH="149"></COL>
<COL WIDTH="99"></COL>
<COL WIDTH="83"></COL>
<COL WIDTH="69"></COL>
<COL WIDTH="81"></COL>
<COL WIDTH="97"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="N" ADELETE="N">
<TH ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="137" HEIGHT="83" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">주식발행&cr;(감소)일자</TH>
<TH ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="158" HEIGHT="83" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">발행(감소)&cr;형태</TH>
<TH COLSPAN="5" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="474" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">발행(감소)한 주식의 내용</TH>
</TR>

<TR ACOPY="N" ADELETE="N">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="108" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">주식의 종류</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="92" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">수량</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="78" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">주당&cr;액면가액</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="90" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">주당발행&cr;(감소)가액</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="106" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">비고</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="N">
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="137" HEIGHT="30" AUNIT="INC_DT" AUNITVALUE="20100826">2010년 08월 26일</TU>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="158" HEIGHT="30" AUNIT="INC_DR_KND" AUNITVALUE="-">-</TU>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="108" HEIGHT="30" ACODE="INC_STK_KND">기명식보통주</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="92" HEIGHT="30" ACODE="INC_CNT">20,000</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="78" HEIGHT="30" ACODE="INC_PAR_AMT">5,000</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="90" HEIGHT="30" ACODE="INC_SL_AMT">5,000</TE>
<TD VALIGN="MIDDLE" WIDTH="106" HEIGHT="30">설립자본금</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="137" HEIGHT="30" AUNIT="INC_DT" AUNITVALUE="20101106">2010년 11월 06일</TU>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="158" HEIGHT="30" AUNIT="INC_DR_KND" AUNITVALUE="02">유상증자(주주배정)</TU>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="108" HEIGHT="30" ACODE="INC_STK_KND">기명식보통주</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="92" HEIGHT="30" ACODE="INC_CNT">3,400</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="78" HEIGHT="30" ACODE="INC_PAR_AMT">5,000</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="90" HEIGHT="30" ACODE="INC_SL_AMT">5,000</TE>
<TD VALIGN="MIDDLE" WIDTH="106" HEIGHT="30">1차 유상증자</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="137" HEIGHT="30" AUNIT="INC_DT" AUNITVALUE="20111028">2011년 10월 28일</TU>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="158" HEIGHT="30" AUNIT="INC_DR_KND" AUNITVALUE="02">유상증자(주주배정)</TU>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="108" HEIGHT="30" ACODE="INC_STK_KND">기명식보통주</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="92" HEIGHT="30" ACODE="INC_CNT">10,000</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="78" HEIGHT="30" ACODE="INC_PAR_AMT">5,000</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="90" HEIGHT="30" ACODE="INC_SL_AMT">5,000</TE>
<TD VALIGN="MIDDLE" WIDTH="106" HEIGHT="30">2차 유상증자</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="137" HEIGHT="30" AUNIT="INC_DT" AUNITVALUE="20111104">2011년 11월 04일</TU>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="158" HEIGHT="30" AUNIT="INC_DR_KND" AUNITVALUE="02">유상증자(주주배정)</TU>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="108" HEIGHT="30" ACODE="INC_STK_KND">기명식보통주</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="92" HEIGHT="30" ACODE="INC_CNT">10,000</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="78" HEIGHT="30" ACODE="INC_PAR_AMT">5,000</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="90" HEIGHT="30" ACODE="INC_SL_AMT">5,000</TE>
<TD VALIGN="MIDDLE" WIDTH="106" HEIGHT="30">3차 유상증자</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="137" HEIGHT="30" AUNIT="INC_DT" AUNITVALUE="20111227">2011년 12월 27일</TU>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="158" HEIGHT="30" AUNIT="INC_DR_KND" AUNITVALUE="02">유상증자(주주배정)</TU>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="108" HEIGHT="30" ACODE="INC_STK_KND">기명식보통주</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="92" HEIGHT="30" ACODE="INC_CNT">40,000</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="78" HEIGHT="30" ACODE="INC_PAR_AMT">5,000</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="90" HEIGHT="30" ACODE="INC_SL_AMT">5,000</TE>
<TD VALIGN="MIDDLE" WIDTH="106" HEIGHT="30">4차 유상증자</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="137" HEIGHT="30" AUNIT="INC_DT" AUNITVALUE="20120622">2012년 06월 22일</TU>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="158" HEIGHT="30" AUNIT="INC_DR_KND" AUNITVALUE="02">유상증자(주주배정)</TU>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="108" HEIGHT="30" ACODE="INC_STK_KND">기명식보통주</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="92" HEIGHT="30" ACODE="INC_CNT">10,200</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="78" HEIGHT="30" ACODE="INC_PAR_AMT">5,000</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="90" HEIGHT="30" ACODE="INC_SL_AMT">5,000</TE>
<TD VALIGN="MIDDLE" WIDTH="106" HEIGHT="30">5차 유상증자</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="137" HEIGHT="30" AUNIT="INC_DT" AUNITVALUE="20141223">2014년 12월 23일</TU>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="158" HEIGHT="30" AUNIT="INC_DR_KND" AUNITVALUE="02">유상증자(주주배정)</TU>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="108" HEIGHT="30" ACODE="INC_STK_KND">기명식보통주</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="92" HEIGHT="30" ACODE="INC_CNT">206,400</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="78" HEIGHT="30" ACODE="INC_PAR_AMT">5,000</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="90" HEIGHT="30" ACODE="INC_SL_AMT">5,000</TE>
<TD VALIGN="MIDDLE" WIDTH="106" HEIGHT="30">6차 유상증자</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="137" HEIGHT="30" AUNIT="INC_DT" AUNITVALUE="20160504">2016년 05월 04일</TU>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="158" HEIGHT="30" AUNIT="INC_DR_KND" AUNITVALUE="02">유상증자(주주배정)</TU>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="108" HEIGHT="30" ACODE="INC_STK_KND">기명식보통주</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="92" HEIGHT="30" ACODE="INC_CNT">300,000</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="78" HEIGHT="30" ACODE="INC_PAR_AMT">5,000</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="90" HEIGHT="30" ACODE="INC_SL_AMT">5,000</TE>
<TD VALIGN="MIDDLE" WIDTH="106" HEIGHT="30">7차 유상증자</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="137" HEIGHT="30" AUNIT="INC_DT" AUNITVALUE="20160829">2016년 08월 29일</TU>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="158" HEIGHT="30" AUNIT="INC_DR_KND" AUNITVALUE="08">현물출자</TU>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="108" HEIGHT="30" ACODE="INC_STK_KND">기명식보통주</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="92" HEIGHT="30" ACODE="INC_CNT">866,537</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="78" HEIGHT="30" ACODE="INC_PAR_AMT">5,000</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="90" HEIGHT="30" ACODE="INC_SL_AMT">5,000</TE>
<TD VALIGN="MIDDLE" WIDTH="106" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="137" HEIGHT="30" AUNIT="INC_DT" AUNITVALUE="20160829">2016년 08월 29일</TU>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="158" HEIGHT="30" AUNIT="INC_DR_KND" AUNITVALUE="12">주식분할</TU>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="108" HEIGHT="30" ACODE="INC_STK_KND">기명식보통주</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="92" HEIGHT="30" ACODE="INC_CNT">14,665,370</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="78" HEIGHT="30" ACODE="INC_PAR_AMT">500</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="90" HEIGHT="30" ACODE="INC_SL_AMT">-</TE>
<TD VALIGN="MIDDLE" WIDTH="106" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="137" HEIGHT="30" AUNIT="INC_DT" AUNITVALUE="20161216">2016년 12월 16일</TU>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="158" HEIGHT="30" AUNIT="INC_DR_KND" AUNITVALUE="04">유상증자(제3자배정)</TU>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="108" HEIGHT="30" ACODE="INC_STK_KND">기명식보통주</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="92" HEIGHT="30" ACODE="INC_CNT">9,946,500</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="78" HEIGHT="30" ACODE="INC_PAR_AMT">500</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="90" HEIGHT="30" ACODE="INC_SL_AMT">1,000</TE>
<TD VALIGN="MIDDLE" WIDTH="106" HEIGHT="30">8차 유상증자</TD>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>

<P>
<SPAN USERMARK="F-GL11">보고서 기준일 현재 발행주식의 총수 24,611,870주 자본금은</SPAN>
<SPAN USERMARK="F-GL11"> </SPAN>
<SPAN USERMARK="F-GL11">12.305,935,000</SPAN>
<SPAN USERMARK="F-GL11">원 입</SPAN>
<SPAN USERMARK="F-GL11">니다</SPAN>
</P>

<INSERTION ABASISNUMBER="SE1" AFREQUENCY="0" ADUPLICATION="N">
<COMMENT>◆click◆ 『미상환 전환사채 발행현황』 삽입</COMMENT>
<LIBRARYLIST>11011#*미상환전환사채발행현황.dsl</LIBRARYLIST>
</INSERTION>

<INSERTION ABASISNUMBER="SE1" AFREQUENCY="0" ADUPLICATION="N">
<COMMENT>◆click◆ 『미상환 신주인수권부사채 등 발행현황』 삽입</COMMENT>
<LIBRARYLIST>11011#*미상환신주인수권부사채등발행현황.dsl</LIBRARYLIST>
</INSERTION>

<INSERTION ABASISNUMBER="SE1" AFREQUENCY="0" ADUPLICATION="N">
<COMMENT>◆click◆ 『미상환 전환형 조건부자본증권 등 발행현황』 삽입</COMMENT>
<LIBRARYLIST>11011#*미상환전환형조건부자본증권등발행현황.dsl</LIBRARYLIST>
</INSERTION>
<P></P>
</SECTION-2>

<SECTION-2 ACLASS="MANDATORY">
<TITLE ATOC="Y" AASSOCNOTE="D-0-1-4-0">4. 주식의 총수 등</TITLE>
<P></P>
<P USERMARK="F-GL11 B">가. 주식의 총수 현황&cr;</P>

<TABLE-GROUP ACLASS="TOT_STK" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="Y" WIDTH="663" BORDER="0">

<COLGROUP>
<COL WIDTH="71"></COL>
<COL WIDTH="143"></COL>
<COL WIDTH="97"></COL>
<COL WIDTH="316"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD VALIGN="BOTTOM" WIDTH="80" HEIGHT="30" AUPDATECONT="N">(기준일 : </TD>
<TU ALIGN="CENTER" VALIGN="BOTTOM" WIDTH="152" HEIGHT="30" AUNIT="BASE_DT" AUNITVALUE="20201231">2020년 12월 31일</TU>
<TD VALIGN="BOTTOM" WIDTH="106" HEIGHT="30" AUPDATECONT="N">)</TD>
<TU ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="325" HEIGHT="30" AUNIT="STOCK" AUNITVALUE="1">(단위 : 주)</TU>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="665" BORDER="1">

<COLGROUP>
<COL WIDTH="25"></COL>
<COL WIDTH="204"></COL>
<COL WIDTH="96"></COL>
<COL WIDTH="96"></COL>
<COL WIDTH="95"></COL>
<COL WIDTH="95"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="N" ADELETE="N">
<TH ROWSPAN="2" COLSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="247" HEIGHT="60" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">구  분</TH>
<TH COLSPAN="3" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="314" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" AUPDATECONT="N">주식의 종류</TH>
<TH ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="104" HEIGHT="60" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">비고</TH>
</TR>

<TR ACOPY="N" ADELETE="N">
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="105" HEIGHT="30" ACOPYCOL="N" ACODE="STK_KND_TOT" ADELETECOL="N" AMOVECOL="N">보통주</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="105" HEIGHT="30" ACOPYCOL="Y" ACODE="STK_KND_TOT" ADELETECOL="Y" AMOVECOL="N">-</TE>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="104" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">합계</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD COLSPAN="2" VALIGN="MIDDLE" WIDTH="247" HEIGHT="30" AUPDATECONT="N"> Ⅰ. 발행할 주식의 총수</TD>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="105" HEIGHT="30" ACODE="ISU_STK1">50,000,000</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="105" HEIGHT="30" ACODE="ISU_STK1">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="104" HEIGHT="30" ACODE="SUM_ISU_STK1">50,000,000</TE>
<TE VALIGN="MIDDLE" WIDTH="104" HEIGHT="30" ALIGN="CENTER" ACODE="NOTE">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD COLSPAN="2" VALIGN="MIDDLE" WIDTH="247" HEIGHT="30" AUPDATECONT="N"> Ⅱ. 현재까지 발행한 주식의 총수</TD>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="105" HEIGHT="30" ACODE="ISU_STK2">24,611,870</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="105" HEIGHT="30" ACODE="ISU_STK2">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="104" HEIGHT="30" ACODE="SUM_ISU_STK2">24,611,870</TE>
<TE VALIGN="MIDDLE" WIDTH="104" HEIGHT="30" ALIGN="CENTER" ACODE="NOTE1">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD COLSPAN="2" VALIGN="MIDDLE" WIDTH="247" HEIGHT="30" AUPDATECONT="N"> Ⅲ. 현재까지 감소한 주식의 총수</TD>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="105" HEIGHT="30" ACODE="TOT_RST">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="105" HEIGHT="30" ACODE="TOT_RST">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="104" HEIGHT="30" ACODE="SUM_RST">-</TE>
<TE VALIGN="MIDDLE" WIDTH="104" HEIGHT="30" ALIGN="CENTER" ACODE="NOTE2">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD ROWSPAN="4" VALIGN="MIDDLE" WIDTH="34" HEIGHT="120" AUPDATECONT="N"></TD>
<TD VALIGN="MIDDLE" WIDTH="213" HEIGHT="30" AUPDATECONT="N"> 1. 감자</TD>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="105" HEIGHT="30" ACODE="RDC_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="105" HEIGHT="30" ACODE="RDC_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="104" HEIGHT="30" ACODE="SUM_RDC_CNT">-</TE>
<TE VALIGN="MIDDLE" WIDTH="104" HEIGHT="30" ALIGN="CENTER" ACODE="NOTE3">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD VALIGN="MIDDLE" WIDTH="213" HEIGHT="30" AUPDATECONT="N"> 2. 이익소각</TD>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="105" HEIGHT="30" ACODE="DST_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="105" HEIGHT="30" ACODE="DST_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="104" HEIGHT="30" ACODE="SUM_DST_CNT">-</TE>
<TE VALIGN="MIDDLE" WIDTH="104" HEIGHT="30" ALIGN="CENTER" ACODE="NOTE4">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD VALIGN="MIDDLE" WIDTH="213" HEIGHT="30" AUPDATECONT="N"> 3. 상환주식의 상환</TD>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="105" HEIGHT="30" ACODE="RFD_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="105" HEIGHT="30" ACODE="RFD_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="104" HEIGHT="30" ACODE="SUM_RFD_CNT">-</TE>
<TE VALIGN="MIDDLE" WIDTH="104" HEIGHT="30" ALIGN="CENTER" ACODE="NOTE5">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD VALIGN="MIDDLE" WIDTH="213" HEIGHT="30" AUPDATECONT="N"> 4. 기타</TD>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="105" HEIGHT="30" ACODE="ETC_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="105" HEIGHT="30" ACODE="ETC_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="104" HEIGHT="30" ACODE="SUM_ETC_CNT">-</TE>
<TE VALIGN="MIDDLE" WIDTH="104" HEIGHT="30" ALIGN="CENTER" ACODE="NOTE6">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD COLSPAN="2" VALIGN="MIDDLE" WIDTH="247" HEIGHT="30" AUPDATECONT="N"> Ⅳ. 발행주식의 총수 (Ⅱ-Ⅲ)</TD>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="105" HEIGHT="30" ACODE="ISU_STK3">24,611,870</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="105" HEIGHT="30" ACODE="ISU_STK3">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="104" HEIGHT="30" ACODE="SUM_ISU_STK3">24,611,870</TE>
<TE VALIGN="MIDDLE" WIDTH="104" HEIGHT="30" ALIGN="CENTER" ACODE="NOTE7">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD COLSPAN="2" VALIGN="MIDDLE" WIDTH="247" HEIGHT="30" AUPDATECONT="N"> Ⅴ. 자기주식수</TD>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="105" HEIGHT="30" ACODE="TRS_STK">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="105" HEIGHT="30" ACODE="TRS_STK">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="104" HEIGHT="30" ACODE="SUM_TRS_STK">-</TE>
<TE VALIGN="MIDDLE" WIDTH="104" HEIGHT="30" ALIGN="CENTER" ACODE="NOTE8">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD COLSPAN="2" VALIGN="MIDDLE" WIDTH="247" HEIGHT="30" AUPDATECONT="N"> Ⅵ. 유통주식수 (Ⅳ-Ⅴ)</TD>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="105" HEIGHT="30" ACODE="FLT_STK">24,611,870</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="105" HEIGHT="30" ACODE="FLT_STK">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="104" HEIGHT="30" ACODE="SUM_FLT_STK">24,611,870</TE>
<TE VALIGN="MIDDLE" WIDTH="104" HEIGHT="30" ALIGN="CENTER" ACODE="NOTE9">-</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>

<INSERTION ABASISNUMBER="SE1" AFREQUENCY="0" ADUPLICATION="N">
<COMMENT>◆click◆ 『자기주식 취득 및 처분 현황』 삽입</COMMENT>
<LIBRARYLIST>11011#*자기주식취득및처분현황.dsl</LIBRARYLIST>
</INSERTION>

<INSERTION ABASISNUMBER="LE0" AFREQUENCY="0" ADUPLICATION="Y">
<COMMENT>◆click◆ 『종류주식(명칭) 발행현황』 삽입</COMMENT>
<LIBRARYLIST>11011#*종류주식발행현황.dsl</LIBRARYLIST>
</INSERTION>
<P></P>
</SECTION-2>

<SECTION-2 ACLASS="MANDATORY">
<TITLE ATOC="Y" AASSOCNOTE="D-0-1-5-0">5. 의결권 현황</TITLE>
<P></P>

<TABLE-GROUP ACLASS="VOT_STK" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="Y" WIDTH="600" BORDER="0">

<COLGROUP>
<COL WIDTH="70"></COL>
<COL WIDTH="142"></COL>
<COL WIDTH="58"></COL>
<COL WIDTH="294"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD VALIGN="BOTTOM" WIDTH="79" HEIGHT="30" AUPDATECONT="N">(기준일 : </TD>
<TU ALIGN="CENTER" VALIGN="BOTTOM" WIDTH="151" HEIGHT="30" AUNIT="BASE_DT" AUNITVALUE="20201231">2020년 12월 31일</TU>
<TD VALIGN="BOTTOM" WIDTH="67" HEIGHT="30" AUPDATECONT="N">)</TD>
<TU ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="303" HEIGHT="30" AUNIT="STOCK" AUNITVALUE="1">(단위 : 주)</TU>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="600" BORDER="1">

<COLGROUP>
<COL WIDTH="229"></COL>
<COL WIDTH="84"></COL>
<COL WIDTH="136"></COL>
<COL WIDTH="115"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="N" ADELETE="N">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="238" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">구     분</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="93" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">주식의 종류</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="145" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">주식수</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="124" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">비고</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="238" HEIGHT="60" AUPDATECONT="N">발행주식총수(A)</TD>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="93" HEIGHT="30" ACODE="ISU_STK_KND">보통주</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="145" HEIGHT="30" ACODE="ISU_STK">24,611,870</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="124" HEIGHT="30" ACODE="VOT_NOTE">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="N">
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="93" HEIGHT="30" ACODE="ISU_STK_KND">-</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="145" HEIGHT="30" ACODE="ISU_STK">-</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="124" HEIGHT="30" ACODE="VOT_NOTE">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="238" HEIGHT="60" AUPDATECONT="N">의결권없는 주식수(B)</TD>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="93" HEIGHT="30" ACODE="ISN_STK_KND">보통주</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="145" HEIGHT="30" ACODE="ISN_STK">-</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="124" HEIGHT="30" ACODE="VOT_NOTE1">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="N">
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="93" HEIGHT="30" ACODE="ISN_STK_KND">-</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="145" HEIGHT="30" ACODE="ISN_STK">-</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="124" HEIGHT="30" ACODE="VOT_NOTE1">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="238" HEIGHT="60" AUPDATECONT="N">정관에 의하여 의결권 행사가 배제된 주식수(C)</TD>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="93" HEIGHT="30" ACODE="ISQ_STK_KND">보통주</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="145" HEIGHT="30" ACODE="ISQ_STK">-</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="124" HEIGHT="30" ACODE="VOT_NOTE2">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="N">
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="93" HEIGHT="30" ACODE="ISQ_STK_KND">-</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="145" HEIGHT="30" ACODE="ISQ_STK">-</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="124" HEIGHT="30" ACODE="VOT_NOTE2">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="238" HEIGHT="60" AUPDATECONT="N">기타 법률에 의하여&cr;의결권 행사가 제한된 주식수(D)</TD>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="93" HEIGHT="30" ACODE="ISJ_STK_KND">보통주</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="145" HEIGHT="30" ACODE="ISJ_STK">-</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="124" HEIGHT="30" ACODE="VOT_NOTE3">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="N">
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="93" HEIGHT="30" ACODE="ISJ_STK_KND">-</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="145" HEIGHT="30" ACODE="ISJ_STK">-</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="124" HEIGHT="30" ACODE="VOT_NOTE3">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="238" HEIGHT="60" AUPDATECONT="N">의결권이 부활된 주식수(E)</TD>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="93" HEIGHT="30" ACODE="ISB_STK_KND">보통주</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="145" HEIGHT="30" ACODE="ISB_STK">-</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="124" HEIGHT="30" ACODE="VOT_NOTE4">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="N">
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="93" HEIGHT="30" ACODE="ISB_STK_KND">-</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="145" HEIGHT="30" ACODE="ISB_STK">-</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="124" HEIGHT="30" ACODE="VOT_NOTE4">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="238" HEIGHT="60" AUPDATECONT="N">의결권을 행사할 수 있는 주식수&cr;(F = A - B - C - D + E)</TD>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="93" HEIGHT="30" ACODE="ISH_STK_KND">보통주</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="145" HEIGHT="30" ACODE="ISH_STK">24,611,870</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="124" HEIGHT="30" ACODE="VOT_NOTE5">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="N">
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="93" HEIGHT="30" ACODE="ISH_STK_KND">-</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="145" HEIGHT="30" ACODE="ISH_STK">-</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="124" HEIGHT="30" ACODE="VOT_NOTE5">-</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
<P></P>
<P></P>
</SECTION-2>

<SECTION-2 ACLASS="MANDATORY">
<TITLE ATOC="Y" AASSOCNOTE="D-0-1-6-0">6. 배당에 관한 사항 등</TITLE>
<P></P>

<P>
<SPAN USERMARK="F-GL11 B">가. 배당에 관한 회사 정책&cr;</SPAN>
</P>

<P>
<SPAN USERMARK="F-GL11">◎당사의 정관내역</SPAN>
<SPAN USERMARK="F-GL11 B"></SPAN>
</P>

<TABLE ACLASS="NORMAL" WIDTH="600" BORDER="1" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="591"></COL>
</COLGROUP>

<TBODY ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="600" HEIGHT="444">제45조(이익금 및 결손금의 처분)&cr;  당 회사는 매 사업년도의 처분전 이익잉여금을 다음과 같이 처분한다.&cr;    1) 이익준비금&cr;    2) 기타의 법정적립금&cr;    3) 배당금&cr;    4) 임의 적립금&cr;    5) 기타의 이익잉여금처분액&cr;　&cr;제46조(이익배당)&cr;  1) 이익의 배당은 금전 또는 금전 외의 재산으로 할수 있다.&cr;  2) 제1항의 배당은 매 결산기 말 현재의 주주명부에 기재된 주주 또는 등록된 질권자에      게 지급한다.&cr;  3) 이익의 배당을 주식으로 하는 경우 회사가 수종의 주식을 발행한 때에는 주주총회의      결의로 그와 다른 종류의 주식으로 할 수 있다.&cr;  4) 이익배당은 주주총회의 결의로 정한다. 다만, 제44조 제5항에 따라 재무제표를 이사      회가 승인하는 경우 이사회의 결의로 이익배당을 정한다.&cr;　&cr;제47조(배당금지급청구권의 소멸시효)&cr;  배당금의 지급청구권은 5년간 이를 행사하지 아니하며 소멸시효가 완성된다.</TD>
</TR>
</TBODY>
</TABLE>
<P></P>

<P>
<SPAN USERMARK="F-GL11 B">나. 주요배당지표</SPAN>
</P>

<TABLE-GROUP ACLASS="DIVIDEND" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="607" BORDER="1" FRAME="BORDER" RULES="ALL">

<COLGROUP>
<COL WIDTH="152"></COL>
<COL WIDTH="104"></COL>
<COL WIDTH="102"></COL>
<COL WIDTH="102"></COL>
<COL WIDTH="102"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="N" ADELETE="N">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="161" HEIGHT="60" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ROWSPAN="2">구   분</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="113" HEIGHT="60" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ROWSPAN="2">주식의 종류</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="111" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">당기</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="111" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">전기</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="111" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">전전기</TH>
</TR>

<TR ACOPY="N" ADELETE="N">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="111" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">제11기</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="111" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">제10기</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="111" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">제9기</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD COLSPAN="2" VALIGN="MIDDLE" WIDTH="274" HEIGHT="30" AUPDATECONT="N" ALIGN="CENTER">주당액면가액(원)</TD>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="30" ACODE="X23" ADELIM="1" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="30" ACODE="X23" ADELIM="2" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="30" ACODE="X23" ADELIM="3" VALIGN="MIDDLE">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD COLSPAN="2" VALIGN="MIDDLE" WIDTH="274" HEIGHT="30" AUPDATECONT="N" ALIGN="CENTER">(연결)당기순이익(백만원)</TD>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="30" ACODE="X01" ADELIM="1" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="30" ACODE="X01" ADELIM="2" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="30" ACODE="X01" ADELIM="3" VALIGN="MIDDLE">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD COLSPAN="2" VALIGN="MIDDLE" WIDTH="274" HEIGHT="30" AUPDATECONT="N" ALIGN="CENTER">(별도)당기순이익(백만원)</TD>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="30" ACODE="X35" ADELIM="1" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="30" ACODE="X35" ADELIM="2" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="30" ACODE="X35" ADELIM="3" VALIGN="MIDDLE">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD COLSPAN="2" VALIGN="MIDDLE" WIDTH="274" HEIGHT="30" AUPDATECONT="N" ALIGN="CENTER">(연결)주당순이익(원)</TD>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="30" ACODE="X02" ADELIM="1" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="30" ACODE="X02" ADELIM="2" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="30" ACODE="X02" ADELIM="3" VALIGN="MIDDLE">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD COLSPAN="2" VALIGN="MIDDLE" WIDTH="274" HEIGHT="30" AUPDATECONT="N" ALIGN="CENTER">현금배당금총액(백만원)</TD>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="30" ACODE="X24" ADELIM="1" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="30" ACODE="X24" ADELIM="2" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="30" ACODE="X24" ADELIM="3" VALIGN="MIDDLE">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD COLSPAN="2" VALIGN="MIDDLE" WIDTH="274" HEIGHT="30" AUPDATECONT="N" ALIGN="CENTER">주식배당금총액(백만원)</TD>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="30" ACODE="X25" ADELIM="1" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="30" ACODE="X25" ADELIM="2" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="30" ACODE="X25" ADELIM="3" VALIGN="MIDDLE">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD COLSPAN="2" VALIGN="MIDDLE" WIDTH="274" HEIGHT="30" AUPDATECONT="N" ALIGN="CENTER">(연결)현금배당성향(%)</TD>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="30" ACODE="X05" ADELIM="1" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="30" ACODE="X05" ADELIM="2" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="30" ACODE="X05" ADELIM="3" VALIGN="MIDDLE">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD ROWSPAN="2" VALIGN="MIDDLE" WIDTH="161" HEIGHT="60" AUPDATECONT="N" ALIGN="CENTER">현금배당수익률(%)</TD>
<TE ALIGN="CENTER" WIDTH="113" HEIGHT="30" ACODE="XQ1" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="30" ACODE="X31" ADELIM="1" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="30" ACODE="X31" ADELIM="2" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="30" ACODE="X31" ADELIM="3" VALIGN="MIDDLE">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="N">
<TE ALIGN="CENTER" WIDTH="113" HEIGHT="30" ACODE="XQ1" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="30" ACODE="X31" ADELIM="1" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="30" ACODE="X31" ADELIM="2" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="30" ACODE="X31" ADELIM="3" VALIGN="MIDDLE">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD ROWSPAN="2" VALIGN="MIDDLE" WIDTH="161" HEIGHT="60" AUPDATECONT="N" ALIGN="CENTER">주식배당수익률(%)</TD>
<TE ALIGN="CENTER" WIDTH="113" HEIGHT="30" ACODE="XQ2" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="30" ACODE="X32" ADELIM="1" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="30" ACODE="X32" ADELIM="2" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="30" ACODE="X32" ADELIM="3" VALIGN="MIDDLE">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="N">
<TE ALIGN="CENTER" WIDTH="113" HEIGHT="30" ACODE="XQ2" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="30" ACODE="X32" ADELIM="1" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="30" ACODE="X32" ADELIM="2" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="30" ACODE="X32" ADELIM="3" VALIGN="MIDDLE">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD ROWSPAN="2" VALIGN="MIDDLE" WIDTH="161" HEIGHT="60" AUPDATECONT="N" ALIGN="CENTER">주당 현금배당금(원)</TD>
<TE ALIGN="CENTER" WIDTH="113" HEIGHT="30" ACODE="XQ3" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="30" ACODE="X33" ADELIM="1" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="30" ACODE="X33" ADELIM="2" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="30" ACODE="X33" ADELIM="3" VALIGN="MIDDLE">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="N">
<TE ALIGN="CENTER" WIDTH="113" HEIGHT="30" ACODE="XQ3" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="30" ACODE="X33" ADELIM="1" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="30" ACODE="X33" ADELIM="2" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="30" ACODE="X33" ADELIM="3" VALIGN="MIDDLE">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD ROWSPAN="2" VALIGN="MIDDLE" WIDTH="161" HEIGHT="60" AUPDATECONT="N" ALIGN="CENTER">주당 주식배당(주)</TD>
<TE ALIGN="CENTER" WIDTH="113" HEIGHT="30" ACODE="XQ4" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="30" ACODE="X34" ADELIM="1" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="30" ACODE="X34" ADELIM="2" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="30" ACODE="X34" ADELIM="3" VALIGN="MIDDLE">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="N">
<TE ALIGN="CENTER" WIDTH="113" HEIGHT="30" ACODE="XQ4" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="30" ACODE="X34" ADELIM="1" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="30" ACODE="X34" ADELIM="2" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="30" ACODE="X34" ADELIM="3" VALIGN="MIDDLE">-</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>

<INSERTION ABASISNUMBER="SE1" AFREQUENCY="0" ADUPLICATION="N">
<COMMENT>◆click◆ 『과거배당이력』 삽입</COMMENT>
<LIBRARYLIST>11011#*과거배당이력.dsl</LIBRARYLIST>
</INSERTION>
<P></P>
</SECTION-2>

<SECTION-2 ACLASS="MANDATORY">
<TITLE ATOC="Y" AASSOCNOTE="D-0-1-7-0">7. 정관에 관한 사항</TITLE>
<P></P>
<P></P>

<INSERTION ABASISNUMBER="SE1" AFREQUENCY="1" ADUPLICATION="N">
<COMMENT>◆click◆ 『정관변경이력』 삽입</COMMENT>
<LIBRARYLIST>11011#*정관변경이력.dsl</LIBRARYLIST>

<LIBRARY>
<FILENAME ATYPE="dsl">49_정관변경이력</FILENAME>

<P>
<SPAN USERMARK="F-GL11 B">가. 정관 변경 이력&cr;</SPAN>
</P>

<TABLE-GROUP ACLASS="ART_BCK" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="1168" BORDER="1">

<COLGROUP>
<COL WIDTH="128"></COL>
<COL WIDTH="142"></COL>
<COL WIDTH="713"></COL>
<COL WIDTH="149"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="N" ADELETE="N">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="137" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">정관변경일</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="151" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">해당주총명</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="722" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">주요변경사항</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="158" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">변경이유</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="N">
<TU ALIGN="CENTER" WIDTH="137" HEIGHT="99" AUNIT="ART_DATE" AUNITVALUE="20190322" VALIGN="MIDDLE">2019년 03월 22일</TU>
<TE ALIGN="CENTER" WIDTH="151" HEIGHT="99" ACODE="ART_NAME" VALIGN="MIDDLE">제9기 정기주주총회</TE>
<TE WIDTH="722" HEIGHT="99" ACODE="ART_CHN" VALIGN="MIDDLE">1. 제12조(명의개서) : 명의개서 대리인 선임에 따라 수정 및 신설 4건(1항, 2항, 3항, 4항)&cr;2. 제13조(주주 등의 주소, 성명 및 인감 또는 서명 등 신고) : 명의개서 대리인 선임에 따라 수정 1건(1항)&cr;3. 제13조2(질권의 등록 및 신탁재산의 표시와 주권의 재발행) : 삭제&cr;4. 제20조(소집통지 및 공고) : 삭제 3건(2항, 3항, 4항)</TE>
<TE ALIGN="CENTER" WIDTH="158" HEIGHT="99" ACODE="ART_RSN" VALIGN="MIDDLE">명의개서대리인 선임</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
</LIBRARY>
</INSERTION>
<PGBRK></PGBRK>
</SECTION-2>
</SECTION-1>

<SECTION-1 ACLASS="MANDATORY" APARTSOURCE="SOURCE">
<TITLE ATOC="Y" AASSOCNOTE="D-0-2-0-0">II. 사업의 내용</TITLE>
<P></P>

<P>
<SPAN USERMARK="F-GL16 0XC01D00 B">1. 사업의 개요</SPAN>
<SPAN USERMARK="F-GL16 0XC01D00 B">&cr;</SPAN>
<SPAN USERMARK="F-GL16">&cr;</SPAN>
<SPAN USERMARK="F-GL11"></SPAN>
<SPAN USERMARK="F-GL11"></SPAN>
<SPAN USERMARK="F-GL11">당사는 2010년 8월 설립되어 원료의약품 제조 및 판매를 주 영업 목적으로하여 히알루론산(HA</SPAN>
<SPAN USERMARK="F-GL11">)</SPAN>
<SPAN USERMARK="F-GL11">,</SPAN>
<SPAN USERMARK="F-GL11"> 합성원료인 메칠올세팔렉신리지네이트 등을 판매하고 있</SPAN>
<SPAN USERMARK="F-GL11">습니다. 사업부문별로는히알루론산(HA) 제조 및 필러부문 인 HA사업부문과 기타합성의약원료를 제조하는 의</SPAN>
<SPAN USERMARK="F-GL11">약품케미칼부문으로 구분되며, 이 중 히알루론산(HA)제조와 필러사업부문이 주요 사업부문입니다. </SPAN>
</P>

<P>
<SPAN USERMARK="F-GL11">&cr;</SPAN>
<SPAN USERMARK="F-GL11 B"></SPAN>
<SPAN USERMARK="F-GL11 B"></SPAN>
<SPAN USERMARK="F-GL11 B"></SPAN>
<SPAN USERMARK="F-GL11 B">가. 히알루론산(HA) 제조 및 필러 부문&cr;</SPAN>
<SPAN USERMARK="F-GL11">&cr;</SPAN>
<SPAN USERMARK="F-GL11">필러(Hyaluronic Acid based dermal fillers)는 피부의 꺼진 부분을 볼륨감 있게 채워주는 주사제로, 볼륨이 부족한 피부 부위에 채워 넣어서 주름을 펴주는 보충제 역할을 합니다. 보툴리눔 독소를 이용한 주사제가 주름이나 표적을 만드는 근육의 일정기간 마비를 통해 다양한 분야에 적용되는 반면에, 필러는 특정 부위를 메우거나 도톰하게채워주는 용도로 활용되고 있습니다. 필러 제품의 원료로는 히알루론산(Hyaluronic Acid Derivatives), 자가이식 보형물(Autologous Dermal Implants), 동종이식 보형물(Allogenic Dermal Implants), 유전자 재조합 콜라겐(Recombinant Human Collangen), 합성물질 등이 사용되며 보톡스, 히알루론산 필러가 널리 사용되면서 콜라겐 제품의 감소하고 있는 추세입니다. &cr;</SPAN>
</P>
<P USERMARK="F-GL11">필러(fillers)의 일반적인 사전적 의미는 ‘채우는 것’ 또는 ‘보충제’라는 뜻으로 해석되어 있는데, 의학적 용어로는 아직 완전히 정의되어 있지 않습니다. 다만 ‘materials for soft tissue augmentation(연조직을 확대 해 주는 재료)’이라는 의미로 주로 합의(consensus)되어 있습니다. 이를 근거로 필러를 넓은 의미의 연조직 확대를 위한 재료로서 그 주요한 종류와 연혁별 변화는 아래와 같습니다.</P>

<P>
<SPAN USERMARK="F-GL11">&cr;[필러 연혁 - 시대별 주요 성분 변동]</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="808">

<COLGROUP>
<COL WIDTH="198"></COL>
<COL WIDTH="78"></COL>
<COL WIDTH="328"></COL>
<COL WIDTH="168"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="207" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">성분</TH>
<TH WIDTH="87" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">시기</TH>
<TH WIDTH="337" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">특징</TH>
<TH WIDTH="177" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">비고</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="207" VALIGN="MIDDLE" HEIGHT="99">지방(Fat)</TD>
<TD WIDTH="87" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="99">1893년</TD>
<TD WIDTH="337" VALIGN="MIDDLE" HEIGHT="99">-독일 의사 노이버(Dr. Neuber)에 의해 환자 팔의 지방조직을 얼굴결손 부위에 이식&cr;-1911년에 브루닝 박사(Dr. Bruning)가 최초로 주사기를 이용하여 지방주입(fat injection)을 시도</TD>
<TD WIDTH="177" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="99">연조직 확대로서 넓은 의미에서 필러로 해석</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="207" VALIGN="MIDDLE" HEIGHT="99">액상 실리콘&cr;(Liquid silicone)</TD>
<TD WIDTH="87" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="99">1940년대</TD>
<TD WIDTH="337" VALIGN="MIDDLE" HEIGHT="99">-인공 합성물질로 유방확대를 위해 사용&cr;-FDA에서 1994년과 1997년 Silikon? 1000과 AdatoSil? 5000이라는 실리콘 주사액을 안과 적응증으로만 허가</TD>
<TD WIDTH="177" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="99">1991년 FDA 금지 약물 규정</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="207" VALIGN="MIDDLE" HEIGHT="99">소 콜라겐&cr;(Bovine Collagen)</TD>
<TD WIDTH="87" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="99">1980년대</TD>
<TD WIDTH="337" VALIGN="MIDDLE" HEIGHT="99">-앨러간사에 합병된 이나메드(INAMED)사가 1980년대 Zyderm? I, II와 Zyplast? FDA 승인 받음&cr;-소콜라겐은 유지기간이 3~6개월로 짧고, 시술 전 피부테스트를 받아야 하는 불편함</TD>
<TD WIDTH="177" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="99">현재 주사형 필러의 인식을 갖게 해 준 필러</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="207" VALIGN="MIDDLE" HEIGHT="99">돼지 콜라겐&cr;(Porcine Collagen)</TD>
<TD WIDTH="87" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="99">1985년</TD>
<TD WIDTH="337" VALIGN="MIDDLE" HEIGHT="99">-Fibrel?이 1985년 FDA 승인: 복잡한 키트 형태&cr;-돼지 콜라겐으로 미용목적으로 최초의 일반 형태의 주사형 필러는 2004년 등장한 Evolence?로 2008년 FDA에 정식 허가</TD>
<TD WIDTH="177" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="99">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="207" VALIGN="MIDDLE" HEIGHT="122">인간 콜라겐&cr;(Human Collagen)</TD>
<TD WIDTH="87" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="122">1992년</TD>
<TD WIDTH="337" VALIGN="MIDDLE" HEIGHT="122">-매몰형 임플란트인 Alloderm?이 사용되기 시작&cr;-2003년 FDA 허가를 취득한 CosmoDerm? 1, CosmoDerm? 2, CostmoPlast?가 최초인데 이때 히알루론산 필러가 무르익기 시작한 시기여서 부각되지 못함</TD>
<TD WIDTH="177" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="122">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="207" VALIGN="MIDDLE" HEIGHT="76">PMMA&cr;(Polymethyl-methaacrylate)</TD>
<TD WIDTH="87" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">1992년</TD>
<TD WIDTH="337" VALIGN="MIDDLE" HEIGHT="76">-독일의 성형외과 의사인 렘퍼레 박사(Dr. Lemperle)가 개발한 Artecoll?은 PMMA와 소 콜라겐을 1대 3으로 섞어 만든 것</TD>
<TD WIDTH="177" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">시장에서 주목받지 못함</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="207" VALIGN="MIDDLE" HEIGHT="53">PAAG&cr;(Polyacrylamide gel)</TD>
<TD WIDTH="87" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">2001년</TD>
<TD WIDTH="337" VALIGN="MIDDLE" HEIGHT="53">-PMMA 외에 대표적 장기작용필러(long acting filler)가 유럽에서 출시된 Auamid?</TD>
<TD WIDTH="177" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">가슴사용금지</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="207" VALIGN="MIDDLE" HEIGHT="53">히알루론산&cr;(Hyaluronic acid)</TD>
<TD WIDTH="87" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">2003년</TD>
<TD WIDTH="337" VALIGN="MIDDLE" HEIGHT="53">-레스틸렌이 FDA 승인 받음&cr;-현재, 필러의 대표적 성분</TD>
<TD WIDTH="177" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">필러의 대중화</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="207" VALIGN="MIDDLE" HEIGHT="76">CaHA&cr;(CalciumHydroxylapatite)</TD>
<TD WIDTH="87" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">2006년</TD>
<TD WIDTH="337" VALIGN="MIDDLE" HEIGHT="76">-미용목적으로 FDA 승인&cr;-인체 유사물질을 이용한 필러중 가장 긴 유지기간</TD>
<TD WIDTH="177" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="207" VALIGN="MIDDLE" HEIGHT="53">PLLA&cr;(Polylactic acid)</TD>
<TD WIDTH="87" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">2009년</TD>
<TD WIDTH="337" VALIGN="MIDDLE" HEIGHT="53">- "스컬트라"가 FDA에 미용목적 승인(1999년 흉터치료, 2004년 지방위축증 적응증으로 승인)</TD>
<TD WIDTH="177" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">증류수에 녹여 사용</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK="F-GL11">(출처 : 2011' 보톡스와 필러의 정석, 한미의학)</SPAN>
<SPAN USERMARK="F-GL11">&cr;</SPAN>
</P>

<P>
<SPAN USERMARK="F-GL11"></SPAN>
<SPAN USERMARK="F-GL11"></SPAN>
<SPAN USERMARK="F-GL11"></SPAN>
<SPAN USERMARK="F-GL11"></SPAN>
<SPAN USERMARK="F-GL11">1) 산업의 특성 및 성장성&cr;</SPAN>
<SPAN USERMARK="F-GL11"></SPAN>
<SPAN USERMARK="F-GL11 0X1814FF"></SPAN>
<SPAN USERMARK="F-GL11">최근 의학의 대부분 분야에서는 최소침습 또는 비침습 시술(Minimally Invasive or Non invasive Procedures)이 주류를 형성하고 있습니다. 이러한 현상은 미용/성형 분야에서 더욱 두드러지고 있으며, 보툴리눔 톡신(Botulinum Toxin) 및 피부 보형물(Dermal Fillers)과 같은 주사제(Injectables)를 이용한 시술은 최소침습 또는 비침습 쁘띠 성형시술(Petit Surgery)로 명명되며 주름제거뿐 아니라 안면윤곽 성형 등 다양한분야에서 활용되고 있습니다.&cr;&cr;</SPAN>
<SPAN USERMARK="F-GL11">① 안면성형용 필러 세계 시장 규모&cr;</SPAN>
<SPAN USERMARK="F-GL11"></SPAN>
<SPAN USERMARK="F-GL11 0X1814FF"></SPAN>
<SPAN USERMARK="F-GL11">세계 시장은 히알루론산(HA) 필러에 대한 소비자들의 수요 증가와 더불어 시술가격의 하락의 영향으로 지속적인 성장세가 전망됩니다.&cr; &cr;</SPAN>
<SPAN USERMARK="F-GL11"></SPAN>
<SPAN USERMARK="F-GL11">[안면성형용 필러 세계 시장규모]</SPAN>
<SPAN USERMARK="F-GL11"></SPAN>
<SPAN USERMARK="F-GL11"></SPAN>
</P>

<TABLE ACLASS="NORMAL" WIDTH="715" BORDER="0" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="359"></COL>
<COL WIDTH="338"></COL>
</COLGROUP>

<TBODY ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="368" HEIGHT="30"></TD>
<TD ALIGN="RIGHT" WIDTH="347" HEIGHT="30">(단위 : 억 달러)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="715">

<COLGROUP>
<COL WIDTH="74"></COL>
<COL WIDTH="41"></COL>
<COL WIDTH="41"></COL>
<COL WIDTH="41"></COL>
<COL WIDTH="41"></COL>
<COL WIDTH="41"></COL>
<COL WIDTH="41"></COL>
<COL WIDTH="41"></COL>
<COL WIDTH="41"></COL>
<COL WIDTH="107"></COL>
<COL WIDTH="107"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="83" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구분</TH>
<TH WIDTH="50" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">2013</TH>
<TH WIDTH="50" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">2014</TH>
<TH WIDTH="50" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">2015</TH>
<TH WIDTH="50" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">2016</TH>
<TH WIDTH="50" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">2017</TH>
<TH WIDTH="50" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">2018</TH>
<TH WIDTH="50" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">2019</TH>
<TH WIDTH="50" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">2020</TH>
<TH WIDTH="116" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">과거 CAGR(%)</TH>
<TH WIDTH="116" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">예상 CAGR(%)</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="83" HEIGHT="30" ALIGN="CENTER">시장 규모</TD>
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="50" HEIGHT="30">12</TD>
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="50" HEIGHT="30">13</TD>
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="50" HEIGHT="30">15</TD>
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="50" HEIGHT="30">17</TD>
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="50" HEIGHT="30">19</TD>
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="50" HEIGHT="30">21</TD>
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="50" HEIGHT="30">24</TD>
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="50" HEIGHT="30">27</TD>
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="116" HEIGHT="30">12</TD>
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="116" HEIGHT="30">12</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK="F-GL11">(자료: GBI Research, 2014)&cr;</SPAN>
<SPAN USERMARK="F-GL11">- 2013년 시장규모가 12억 달러였던 안면성형용 필러 시장은 2020년까지 연평균 12%의 성장률을 기록하며 27억 달러의 규모로 성장할 것으로 예상됩니다.&cr;&cr;- 안면성형용 필러는 효과가 일시적이기 때문에 환자들이 치료 효과를 유지하기 위해선 여러 차례 반복적인 치료가 필요하므로, 지속적인 수익 창출로 이어질 것으로 사료되고 있습니다.&cr;</SPAN>
<SPAN USERMARK="F-GL11">&cr;②  성장성&cr;&cr;</SPAN>
<SPAN USERMARK="F-GL11 B"></SPAN>
<SPAN USERMARK="F-GL11 B"></SPAN>
<SPAN USERMARK="F-GL11 BU"></SPAN>
<SPAN USERMARK="F-GL11 U">안정성 및 경쟁력</SPAN>
<SPAN USERMARK="F-GL11 U">&cr;</SPAN>
<SPAN USERMARK="F-GL11">히</SPAN>
<SPAN USERMARK="F-GL11">알루론산(HA) 필러의 성분은 콜라겐 생성을 담당하는 인체구성 성분으로 중합체 필러와 달리 완벽하게 생분해되며 분작용을 유발하는 독성 단위체를 포함하지 안하 부작용및 불편함을 호소하는 환자들이 적어 높은 경쟁력을 보이고 있습니다. &cr;&cr;</SPAN>
<SPAN USERMARK="F-GL11 U">수요층의 다변화&cr;</SPAN>
<SPAN USERMARK="F-GL11">미용/성형 시술 시장은 과거 절대적으로 여성 중심의 시장에서, 남성까지 시술 수요층이 확대 중에 있습니다. 영화배우, 가수 등 연예인을 중심으로 최근에는 변호사, 사업가 중 외모 경쟁력을 갖추고자 하는 계층까지 확대되어 시술건수가 가파른 속도로 증가가 지속될 것으로 전망됩니다.&cr;&cr;[2016년에 시행된 미용/성형 시술건수에 대한 국제 연구 결과]</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="760">

<COLGROUP>
<COL WIDTH="453"></COL>
<COL WIDTH="289"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="462" HEIGHT="30" VALIGN="MIDDLE"></TD>
<TD WIDTH="298" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">(단위 : 건)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="761">

<COLGROUP>
<COL WIDTH="110"></COL>
<COL WIDTH="120"></COL>
<COL WIDTH="120"></COL>
<COL WIDTH="119"></COL>
<COL WIDTH="119"></COL>
<COL WIDTH="119"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="119" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="53">구 분</TH>
<TH WIDTH="129" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="53">Total Procedures</TH>
<TH WIDTH="129" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="53">Total Surgical &cr;Procedures</TH>
<TH WIDTH="128" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="53">Total Non-Surgical Procedures</TH>
<TH WIDTH="128" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="53">Botulinum Toxin</TH>
<TH WIDTH="128" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="53">Hyaluronic Acid</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="119" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">전세계</TD>
<TD WIDTH="129" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">23,626,909 </TD>
<TD WIDTH="129" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">10,417,370 </TD>
<TD WIDTH="128" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">13,209,539 </TD>
<TD WIDTH="128" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">4,931,577 </TD>
<TD WIDTH="128" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">3,372,445 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="119" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">USA</TD>
<TD WIDTH="129" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">4,217,862 </TD>
<TD WIDTH="129" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,480,314 </TD>
<TD WIDTH="128" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">2,737,548 </TD>
<TD WIDTH="128" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,118,370 </TD>
<TD WIDTH="128" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">650,232 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="119" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">Brazil</TD>
<TD WIDTH="129" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">2,524,115 </TD>
<TD WIDTH="129" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,450,020 </TD>
<TD WIDTH="128" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,074,095 </TD>
<TD WIDTH="128" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">472,615 </TD>
<TD WIDTH="128" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">279,785 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="119" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">Japan</TD>
<TD WIDTH="129" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,137,976 </TD>
<TD WIDTH="129" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">209,017 </TD>
<TD WIDTH="128" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">928,960 </TD>
<TD WIDTH="128" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">183,429 </TD>
<TD WIDTH="128" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">192,730 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="119" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">Italy</TD>
<TD WIDTH="129" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">957,814 </TD>
<TD WIDTH="129" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">324,989 </TD>
<TD WIDTH="128" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">632,825 </TD>
<TD WIDTH="128" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">234,294 </TD>
<TD WIDTH="128" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">250,648 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="119" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">Mexcico</TD>
<TD WIDTH="129" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">923,243 </TD>
<TD WIDTH="129" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">488,043 </TD>
<TD WIDTH="128" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">435,200 </TD>
<TD WIDTH="128" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">186,521 </TD>
<TD WIDTH="128" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">94,118 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="119" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">Russia</TD>
<TD WIDTH="129" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">896,629 </TD>
<TD WIDTH="129" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">579,535 </TD>
<TD WIDTH="128" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">317,094 </TD>
<TD WIDTH="128" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">125,542 </TD>
<TD WIDTH="128" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">77,900 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="119" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">India</TD>
<TD WIDTH="129" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">878,180 </TD>
<TD WIDTH="129" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">421,600 </TD>
<TD WIDTH="128" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">456,580 </TD>
<TD WIDTH="128" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">58,820 </TD>
<TD WIDTH="128" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">40,140 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="119" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">Turkey</TD>
<TD WIDTH="129" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">789,564 </TD>
<TD WIDTH="129" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">305,820 </TD>
<TD WIDTH="128" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">483,744 </TD>
<TD WIDTH="128" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">221,808 </TD>
<TD WIDTH="128" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">119,832 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="119" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">Germany</TD>
<TD WIDTH="129" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">730,437 </TD>
<TD WIDTH="129" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">336,396 </TD>
<TD WIDTH="128" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">394,042 </TD>
<TD WIDTH="128" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">187,004 </TD>
<TD WIDTH="128" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">139,692 </TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK="F-GL11">(출처 : ISAPS International Survey on Aesthetic/Cosmetic)&cr;</SPAN>
<SPAN USERMARK="F-GL11">&cr;</SPAN>
<SPAN USERMARK="F-GL11"></SPAN>
<SPAN USERMARK="F-GL11"></SPAN>
<SPAN USERMARK="F-GL11"></SPAN>
<SPAN USERMARK="F-GL11"></SPAN>
<SPAN USERMARK="F-GL11">2) 주요 기업 시장 점유율&cr;</SPAN>
<SPAN USERMARK="F-GL11">2013년 세계 안면성형용 필러 시장은 Allergan사가 38%, Valeant사가 그 뒤를 이어 22%점유율을 차지하며, 상위 3개 기업이 전체 시장의 80%를 차지하고 있습니다.&cr;&cr;</SPAN>
<SPAN USERMARK="F-GL11"></SPAN>
<SPAN USERMARK="F-GL11">3) 국내 시장 동향&cr;</SPAN>
<SPAN USERMARK="F-GL11">&cr;① 안면성형용 필러 국내 시장 규모&cr;2016년 국내 시장 규모는 생산 및 수출입 단가 기준 약 1,133억원으로 최근 5년간 연평균 18.9%로 성장하였습니다. 특히 2011년까지는 주로 수입 제품 위주였던 시장이 2012년 국내 제약사들이 개발한 제품들을 출시하며 시장규모가 2배 이상 확대되었습니다</SPAN>
<SPAN USERMARK="F-GL11">.</SPAN>
<SPAN USERMARK="F-GL11"> 2016년국내 성형용 필러의 총 시장규모는</SPAN>
<SPAN USERMARK="F-GL11"> 2016년 기준 약 1,343억 원이였으며 이때, 안면 성형용 목적의 필러 비중은 약 84%(1,133억원)를 차지하였습니다.</SPAN>
</P>

<TABLE ACLASS="NORMAL" WIDTH="618" BORDER="0" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="609"></COL>
</COLGROUP>

<TBODY ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="RIGHT" WIDTH="618" HEIGHT="30">(단위 : 백만원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="619">

<COLGROUP>
<COL WIDTH="104"></COL>
<COL WIDTH="59"></COL>
<COL WIDTH="59"></COL>
<COL WIDTH="59"></COL>
<COL WIDTH="59"></COL>
<COL WIDTH="58"></COL>
<COL WIDTH="158"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="113" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">구분 </TH>
<TH WIDTH="68" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">2012년</TH>
<TH WIDTH="68" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">2013년</TH>
<TH WIDTH="68" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">2014년</TH>
<TH WIDTH="68" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">2015년</TH>
<TH WIDTH="67" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">2016년</TH>
<TH WIDTH="167" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">연평균 성장률(CAGR) </TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="113" HEIGHT="30">시장 규모 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="68" HEIGHT="30">56.731 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="68" HEIGHT="30">74,350 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="68" HEIGHT="30">30,775 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="68" HEIGHT="30">93,964 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="67" HEIGHT="30">113,263</TD>
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="167" HEIGHT="30">18.9%</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK="F-GL11">(출처 : 의료기기 생산, 수출, 수입 실적 보고자료(2012∼2016), 식품의약품안전처)&cr;</SPAN>
<SPAN USERMARK="F-GL11">&cr;</SPAN>
<SPAN USERMARK="F-GL11">② 국내 안면성형용 필러 생산 및 수출 수입 현황&cr;</SPAN>
<SPAN USERMARK="F-GL11">국내 안면 성형용 필러 제조업체 증가 및 제약사들이 개발한 제춤출시 확대로 인해 2012년부터 생산액 및 수출액은 지속적으로 증가하는 추세에 있으며, </SPAN>
<SPAN USERMARK="F-GL11">2018년 의료기기 생산액은 6.51조원으로 전년대비 9.05%, 수출액은 3.97조원으로 전년대비 10.00%, 수입액은 4.28조원으로 전년대비 8.31%증가하였다.&cr;(시장규모 6.82조원, 최근 5년 연평균 성장률: 8.20%)&cr;</SPAN>
</P>

<IMAGE>
<IMG WIDTH="600" HEIGHT="534" ALIGN="CENTER" HSPACE="0">의료기기 산업 현황.jpg</IMG>
<IMG-CAPTION ATOC="N">의료기기 산업 현황</IMG-CAPTION>
</IMAGE>

<P>
<SPAN USERMARK="F-GL11">(자료 : 식</SPAN>
<SPAN USERMARK="F-GL11">품의약품통계연보, 2019년)&cr;</SPAN>
<SPAN USERMARK="F-GL11">&cr;</SPAN>
<SPAN USERMARK="F-GL11"></SPAN>
<SPAN USERMARK="F-GL11"></SPAN>
<SPAN USERMARK="F-GL11"></SPAN>
<SPAN USERMARK="F-GL11">③국내 시장 경쟁 상황</SPAN>
<SPAN USERMARK="F-GL11"> 등&cr;&cr;국내 필러 시장은 고성장하면서 신규 업체들의 시장 진입이 눈에 띄고 있습니다. </SPAN>
<SPAN USERMARK="F-GL11">의료기기로 분류되는 특성상 진입장벽이 상대적으로 높지 않아 업체 수가 빠르게 증가한 것으로 분석되고 있습니다.</SPAN>
<SPAN USERMARK="F-GL11"> 실제로 국내 필러 제조업체 수는 2011년 12개에서 2014년 27개로 2배 이상 늘어났습니다.&cr;&cr;하지만 2014년말 현재 상위 6개 업체가 시장의 90% 이상을 점유하고 있고, 이 같은 과점 구도가 무너지고 국내 신규 저가 업체들이 상위 업체들의 시장을 잠식하기는 쉽지 않은 상황입니다. 2014년말 국내 필러시장 점유율은 하기와 같습니다.&cr;&cr;[국내필러시장 점유율]</SPAN>
</P>

<IMAGE>
<IMG WIDTH="600" HEIGHT="285" ALIGN="CENTER" HSPACE="0">kakaotalk_20161128_103919377.jpg</IMG>
<IMG-CAPTION ATOC="N">국내필러시장 점유율</IMG-CAPTION>
</IMAGE>

<P>
<SPAN USERMARK="F-GL11 0X0000FF"></SPAN>
<SPAN USERMARK="F-GL11"></SPAN>
</P>
<P USERMARK="F-GL11">4) 관련 법령 또는 정부의 규제 등&cr;의약품 및 의료기기는 국민의 건강과 직결되고 인체에 직접 사용되는 제품인만큼 제조에서 판매 이후 관리까지 법적 규제와 규제당국의 관리감독을 받는 산업입니다. 약사법과 의료기기법 등의 법령과 대통령령, 복지부장관령 및 다수의 식약처장 고시를 비롯한 많은 규정에 의하여 관리되고 있습니다. 또한 의약품 및 의료기기를 제조하기위해서는 식품의약품안전처로부터 제조업 허가및 우수한 제품의 생산 및 품질관리시스템을 사전 점검받아 GMP(Good Manufacturing Practice) 인정을 받아야 가능하 며, 또한 개별 품목에 대해서 그 안전성과 유효성을 입증할 수 있는 자료를 검토 받아개별 허가를 취득해야 합니다. GMP는 한번 인정으로 끝나는 것이 아니라, 정기적인 실사를 통해 계속 유지여부를 감시를 받고 있으며, 허가 받은 대로 의약품을 제조하는지부터 시작해서 관리 및 유통까지 전체의 과정이 관리감독의 대상입니다. 국외에서는 유럽의 경우 CE 인증이나 미국 식품의약품안전국(FDA)의 허가 승인을 비롯한 각 국가별로 엄격하게 관리 감독되고 있으며, 미국과 유럽은 의약품의 효능을 의약품가치 평가 기준으로 도입하면서 신약 승인 절차가 더욱 까다로워지고 있습니다.</P>

<P USERMARK="F-GL11">
<SPAN> </SPAN>
<SPAN>&cr;</SPAN>
<SPAN></SPAN>
<SPAN>4) 기타 사업 특성&cr;</SPAN>
<SPAN USERMARK=" B"></SPAN>
<SPAN USERMARK=" B"></SPAN>
<SPAN USERMARK=" B"></SPAN>
</P>

<P USERMARK="F-GL11 0X1814FF">
<SPAN USERMARK=" 0X000000">히알루론산(HA)의 원료는 계절성이나 경기 변동성이 없으나, 최종 제품인 필러나 화장품의 경우 가을이나 겨울 특히, 방학철이 가장 수요가 많습니다. 필러 시술의 특성상 온도가 낮은 가을 겨울이 부작용이 적은 점 또한 수요의 계절성이 나타나는 주요 원인으로 작용합니다. &cr;</SPAN>
<SPAN>&cr;</SPAN>
<SPAN USERMARK=" 0X000000">5) 회사의 경쟁상 강점</SPAN>
<SPAN USERMARK=" 0X000000"></SPAN>
<SPAN USERMARK=" 0X000000 B"></SPAN>
<SPAN USERMARK=" 0X000000"></SPAN>
<SPAN USERMARK=" 0X000000">&cr;&cr;</SPAN>
<SPAN USERMARK=" 0X000000 U">원가의 경쟁력 및 품질유지</SPAN>
</P>
<P USERMARK="F-GL11">무엇보다 제품 생산 단가 및 시설 관리 비용 등이 타사에 비해 적음으로 인한 원가 경쟁력이 있으며, 추가적으로는 고분자나 저분자 제품 모두 동일한 기술로 생산 가능한유일한 기술을 갖고 있어 발효 원료의 변화에도 품질을 유지할 수 있는 장점이 있습니다.</P>

<P>
<SPAN USERMARK="F-GL11">&cr;</SPAN>
<SPAN USERMARK="F-GL11 U">품질보증 프로세스로 품질관리</SPAN>
</P>
<P USERMARK="F-GL11">당사는 생산 제품이 정해진 스펙 (식품의약품안전처 허가, 공정서 기준)에 적합한지를 확인하고 원재료 구매부터 생산단계, 판매단계까지 각 단계의 정보를 기록·관리하여 제품의 안전성 등에 문제가 발생할 경우 해당 제품을 추적하여 원인규명 및 필요한 조치를 할 수 있도록 관리하고 있습니다. 품질보증프로세스로 품질(보증)관리 자, 제조관리자, 연구관리자가 선정되어 있으며, 다음과 같은 세부 프로세스로 품질보증을 수행하고 있습니다.&cr;</P>
<P USERMARK="F-GL11">① 공정서, Validation을 통한 기준에 준한 품질계획수립</P>
<P USERMARK="F-GL11">② 생산 공정의 validation.</P>
<P USERMARK="F-GL11">③ 생산 각 단계별 인스펙션, 시험을 통한 품질점검 (품질시험서 작성)</P>
<P USERMARK="F-GL11">④ 품질 평가(일탈, 부적합 여부평가, 품질평가보고서 작성)</P>
<P USERMARK="F-GL11">⑤ 품질결과보고를 통한 품질 평가 및 연간품질 평가</P>
<P USERMARK="F-GL11">⑥ 품질관리책임자의 승인을 통한 제품 출하를 진행하는 프로세스로 운영하고 있다.</P>
<P USERMARK="F-GL11">  </P>
<P USERMARK="F-GL11">한편 주요 품질관리 및 보증업무는 하기와 같습니다.&cr;</P>
<P USERMARK="F-GL11">① 원자재 공급업자 평가시스템으로 평가 후 선정 및 선별하여 원자재 입고</P>
<P USERMARK="F-GL11">② 원자재, 반제품(공정검사) 및 완제품 시험</P>
<P USERMARK="F-GL11">③ 제조공정, 제조지원설비 및 제조장비 세척에 대한 검증</P>
<P USERMARK="F-GL11">④ 일탈 및 변경관리 </P>
<P USERMARK="F-GL11">⑤ 부적합품, 반품 및 회수관리 </P>
<P USERMARK="F-GL11">⑥ 주기적으로 제품 품질평가 실시 </P>
<P USERMARK="F-GL11">⑦ 시정 및 예방조치 활동 및 평가 </P>
<P USERMARK="F-GL11">⑧ 위험성 평가</P>

<P>
<SPAN USERMARK="F-GL11 0X0000FF">&cr;</SPAN>
<SPAN USERMARK="F-GL11 B">나. 의약품  케미칼사업 부문</SPAN>
<SPAN USERMARK="F-GL11 B">&cr;</SPAN>
</P>
<P USERMARK="F-GL11">1) 산업의 특성&cr;&cr;원료의약품 산업은 완제의약품의 제품경쟁력과 직결됨으로 제조한 모든 과정에 대해관리가 이루워져야 지속적으로 우수한 균일된 품질의 API(원료의약품 : Active Pharmaceutical Ingredient)가 생산되는 산업으로 균일된 품질성과 안정성검증등 인허가 과정과 완제의약품생산업체와의 거래에서 특별한절차가 요구되는 산업이며 판매관리비의 비중이 낮아 완제의약품 제약사 대비 영업이익률이 높은 산업입니다.&cr;&cr;2) 산업의 성장성&cr;원료의약품 시장은 완제의약품시장의 전세계적으로 노령인구의 증가에 따른 노화 관련질환과 식습관 등의 변화로 인한 심혈관계 질환의 증가와 암의 발병률이 증가하면서 성장이 매년 약 6%이상 지속될것으로 예상된다고 합니다. 특히 정부의 약가인하 정책등으로 제네릭 원료의약품 부문이 지속적인 성장률을 보일것으로 예상합니다. &cr;</P>
<P USERMARK="F-GL11">3) 경기변동의 특성&cr;원료의약품제조업은 인간의 생명과 건강을 다루는 제약산업에 기반을 두고 있어  경기변동에 영향을 비교적 덜 받습니다.&cr;&cr;4) 국내시장여건&cr;원료의약품 국내시장은 정부의 국내원료의약품에 대한 우대정책 철회와 약가인하정책으로 가격이 저렴한 중국 또는 인도산등의 수입원료로 대체 함으로써 국내시장 여건은 우호적이지만은 않은것이 현실이기도 합니다. 이러한 국내시장 여건을 극복하기 위해 원료의약품 품목 특화와 생산시설확대와 시설의 국제인증을 통해 경쟁력을 확보하고 글로벌 시장진출을 통한 성장을 도모하고 있습니다.</P>

<IMAGE>
<IMG WIDTH="600" HEIGHT="349" ALIGN="CENTER" HSPACE="0">국내 원료의약품 생산액 및 비중 추이.jpg</IMG>
<IMG-CAPTION ATOC="N">국내 원료의약품 생산액 및 비중 추이</IMG-CAPTION>
</IMAGE>

<P>
<SPAN USERMARK="F-GL11">&cr;5) 관계법령&cr;의약품 및 의료기기는 국민의 건강과 직결되고 인체에 직접 사용되는 제품인만큼 제조에서 판매 이후 관리까지 법적 규제와 규제당국의 관리감독을 받는 산업입니다. 약사법과 의료기기법 등의 법령과 대통령령, 복지부장관령 및 다수의 식약처장 고시를 비롯한 많은 규정에 의하여 관리되고 있습니다. 또한 의약품 및 의료기기를 제조하기위해서는 식품의약품안전처로부터 제조업 허가및 우수한 제품의 생산 및 품질관리시스템을 사전 점검받아 GMP(Good Manufacturing Practice) 인정을 받아야 가능하며, 또한 개별 품목에 대해서 그안전성과 유효성을 입증할 수 있는 자료를 검토 받아 개별 허가를 취득해야 합니다. GMP는 한번 인정으로 끝나는 것이 아니라, 정기적인 실사를 통해 계속 유지여부를 감시를 받고 있으며, 허가 받은 대로 의약품을 제조하는지부터 시작해서 관리 및 유통까지 전체의 과정이 관리감독의 대상입니다. 국외에서는 유럽의 경우 CE 인증이나 미국 식품의약품안전국(FDA)의 허가 승인을 비롯한 각 국가별로 엄격하게 관리 감독되고 있으며, 미국과 유럽은 의약품의 효능을 의약품가치 평가 기준으로 도입하면서 신약 승인 절차가 더욱 까다로워지고 있습니다. </SPAN>
<SPAN USERMARK="F-GL11">약사법, 우수의약품 유통관리기준(KGSP), 우수의약품제조 및 품질관리기준(KGMP),</SPAN>
<SPAN USERMARK="F-GL11">우수의약품임상시험관리기준(KGCP), </SPAN>
<SPAN USERMARK="F-GL11">우수의약품안전성시험관리기준(KGLP) 등의 법령에 규제하고 있으며 의약품의 생산 및 판매를 위한 원료의약품 신고제도 (DMF : Drug Master File)의 등록 및 허가가 필수적입니다. </SPAN>
<SPAN USERMARK="F-GL">&cr;</SPAN>
<SPAN USERMARK="F-GL11">&cr;&cr;</SPAN>
<SPAN USERMARK="F-GL11"></SPAN>
<SPAN USERMARK="F-GL11"></SPAN>
<SPAN USERMARK="F-GL11">6) 회사의 현황&cr;</SPAN>
</P>

<P>
<SPAN USERMARK="F-GL11">① 영업 개황 및 주요 합성원료&cr;</SPAN>
<SPAN USERMARK="F-GL11 B"></SPAN>
<SPAN USERMARK="F-GL11">2016년 8월 대화제약으로 부터의 현물투자 이후 신제품 개발, 기존 제품의 판매촉진활동을 통하여 매출신장 및 2019년 하반기에 API공장 증축공사 준공하였으며 해외수출 계획으로 매출신장을 창출할 것입니다..&cr;한편, 당사가 생산하는 주요 합성원료는 다음과 같습니다.</SPAN>
</P>
<P USERMARK="F-GL11">록소프로펜나트륨 , 플로로글루시놀, 플로로글루시놀수화물, 툴로부테롤, 록사티딘아세테이트염산염, 보글리보스, 디클로페낙에폴아민, 메칠올세팔렉신리지네이트, 리바스티그민, 노닐산바닐아미드, 에스암로디핀베실산염, 디아세레인 등의 주요 합성원료를 생산하고 있습니다.</P>
<P USERMARK="F-GL11"> </P>
<P USERMARK="F-GL11">② 시장의 특성&cr;- 제네릭 의약품 시장성장과 고부가가치 원료의약품 수요증가&cr;- 국내 주요 원료의약품 생산 전문제약사 국내 산재&cr;- 유럽의 제약사에서 인도, 중국의 제약사로 시장 확대가 용이</P>
<P USERMARK="F-GL11">- 판매관리비 비중이 낮아 완제의약품 제약사 대비 영업이익률이 높음</P>
<P USERMARK="F-GL11"> </P>
<P USERMARK="F-GL11">7) 국내외 의약품산업 동향</P>
<P USERMARK="F-GL11"> &cr;① 국내외 의약품산업 동향 및 글로벌 시장 규모&cr;세계 의약품시장 규모는 2008년 기준 7,731억달러로 4.8%의 성장률을 나타내었으며 세계적인 인구고령화 추세에 따라 고혈압, 당뇨, 관절염 등 만성질환의 치료수요가 급증하고 있고, 치매, 중풍, 파킨슨병 등 노인성질환의 의약품 수요도 함께 빠르고늘어나고 있습니다. 세계보건기구(WHO)는 2020년에는 고혈압 및 당뇨병 등 만성질환이 전세계 질병의 70%를 차지하게 되어 현재의 의약품시장 대비 두 배에 달하는 1조 3천억 달러까지 시장규모가 확대될 것이라고 전망하고 있습니다.</P>

<P USERMARK="F-GL11">지역적으로 현재 북미와 유럽이 전세계 시장의2/3이상을 차지하고 있고, 북미지역  40%, 유럽32%, 아시아/아프리카 등12%, 일본10%, 남미6% 순으로 점유되고 있습니다.남미와 아시아/아프리카/호주 의약품 시장이 급성장 할 것으로 예상되는 가운데 북미와 유럽, 일본 시장은 정체가 예상되고 있어 향후 지역별 시장 점유율 판도 변화가 예상되고 있습니다.
<SPAN USERMARK=" 0X0000FF"></SPAN>
<SPAN>&cr;</SPAN>
<SPAN>② </SPAN>
<SPAN>시장점유율&cr;</SPAN>
<SPAN>식품의약품안전처 '2018 식품의약품통계연보'에 따르면 국내 원료의약품 생산 업체수는 2017년 231개 업체로 나타나고 있습니다. 영세한 원료의약품 업체들이 난립하고 있어 원료의약품상위 10대 생산업체의 별도 매출액으로 시장점유율을 기표합니다.</SPAN>
</P>

<TABLE ACLASS="NORMAL" WIDTH="754" BORDER="0" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="745"></COL>
</COLGROUP>

<TBODY ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="754" HEIGHT="30">(단위 : 백만원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="756">

<COLGROUP>
<COL WIDTH="154"></COL>
<COL WIDTH="110"></COL>
<COL WIDTH="110"></COL>
<COL WIDTH="110"></COL>
<COL WIDTH="109"></COL>
<COL WIDTH="109"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="163" HEIGHT="30" ALIGN="CENTER" VALIGN="BOTTOM" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">회 사 명</TH>
<TH WIDTH="119" HEIGHT="30" ALIGN="CENTER" VALIGN="BOTTOM" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">2019년도</TH>
<TH WIDTH="119" HEIGHT="30" ALIGN="CENTER" VALIGN="BOTTOM" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">2018년도</TH>
<TH WIDTH="119" HEIGHT="30" ALIGN="CENTER" VALIGN="BOTTOM" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">2017년도 </TH>
<TH WIDTH="118" HEIGHT="30" ALIGN="CENTER" VALIGN="BOTTOM" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">2016년도 </TH>
<TH WIDTH="118" HEIGHT="30" ALIGN="CENTER" VALIGN="BOTTOM" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">2015년도</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="163" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">대웅바이오</TD>
<TD WIDTH="119" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">     321,499 </TD>
<TD WIDTH="119" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">276,746</TD>
<TD WIDTH="119" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">246,701</TD>
<TD WIDTH="118" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">216,439</TD>
<TD WIDTH="118" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">168,271</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="163" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">경보제약</TD>
<TD WIDTH="119" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">     191,706 </TD>
<TD WIDTH="119" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">201,344</TD>
<TD WIDTH="119" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">191,661</TD>
<TD WIDTH="118" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">186,726</TD>
<TD WIDTH="118" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">178,033</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="163" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">유한화학공업</TD>
<TD WIDTH="119" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">     162,691 </TD>
<TD WIDTH="119" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">188,765</TD>
<TD WIDTH="119" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">190,209</TD>
<TD WIDTH="118" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">173,619</TD>
<TD WIDTH="118" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">140,863</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="163" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">코오롱생명과학</TD>
<TD WIDTH="119" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">     148,541 </TD>
<TD WIDTH="119" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">132,680</TD>
<TD WIDTH="119" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">118,102</TD>
<TD WIDTH="118" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">158,284</TD>
<TD WIDTH="118" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">121,175</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="163" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">종근당바이오</TD>
<TD WIDTH="119" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">     137,184 </TD>
<TD WIDTH="119" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">124,510</TD>
<TD WIDTH="119" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">118,187</TD>
<TD WIDTH="118" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">113,013</TD>
<TD WIDTH="118" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">106,691</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="163" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">한미정밀화확</TD>
<TD WIDTH="119" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT"> 111,338 </TD>
<TD WIDTH="119" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">85,311</TD>
<TD WIDTH="119" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">87,173</TD>
<TD WIDTH="118" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">93,062</TD>
<TD WIDTH="118" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">89,136</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="163" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">화일약품</TD>
<TD WIDTH="119" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">     108,744 </TD>
<TD WIDTH="119" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">102,073</TD>
<TD WIDTH="119" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">102,463</TD>
<TD WIDTH="118" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">111,519</TD>
<TD WIDTH="118" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">106,130</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="163" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">에스티팜</TD>
<TD WIDTH="119" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">      92,995 </TD>
<TD WIDTH="119" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">97,738</TD>
<TD WIDTH="119" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">202,623</TD>
<TD WIDTH="118" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">200,362</TD>
<TD WIDTH="118" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">138,052</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="163" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">하이텍팜</TD>
<TD WIDTH="119" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">      63,067 </TD>
<TD WIDTH="119" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">66,388</TD>
<TD WIDTH="119" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">66,049</TD>
<TD WIDTH="118" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">54,836</TD>
<TD WIDTH="118" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">48,092</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="163" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">에스텍파마</TD>
<TD WIDTH="119" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">      46,489 </TD>
<TD WIDTH="119" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">40,330</TD>
<TD WIDTH="119" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">38,174</TD>
<TD WIDTH="118" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">43,386</TD>
<TD WIDTH="118" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">45,066</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK="F-GL11">주)상기 매출액은 금융감독원에 공시된 자료중 별도기준 매출액를 표기하였습니다.&cr;</SPAN>
<SPAN USERMARK="F-GL11 B">&cr;</SPAN>
<SPAN USERMARK="F-GL11"></SPAN>
<SPAN USERMARK="F-GL11"></SPAN>
<SPAN USERMARK="F-GL11"></SPAN>
<SPAN USERMARK="F-GL11">8) 기타 사업 특성&cr;</SPAN>
<SPAN USERMARK="F-GL11 B"></SPAN>
<SPAN USERMARK="F-GL11"></SPAN>
<SPAN USERMARK="F-GL11">원료의약산업은 제약산업에 기반을 두고 있어  경기변동에 영향을 비교적 덜 받습니다.&cr;&cr;</SPAN>
<SPAN USERMARK="F-GL"></SPAN>
<SPAN USERMARK="F-GL"></SPAN>
<SPAN USERMARK="F-GL"></SPAN>
<SPAN USERMARK="F-GL11">9) 회사의 경쟁상 강점</SPAN>
<SPAN USERMARK="F-GL11">&cr;&cr;</SPAN>
<SPAN USERMARK="F-GL11 U">원천기술 보유&cr;</SPAN>
<SPAN USERMARK="F-GL11"></SPAN>
<SPAN USERMARK="F-GL11"></SPAN>
<SPAN USERMARK="F-GL11">당사의 케미칼 사업부문은 지배회사인 대화제약(주)로부터의 사업부이전 전부터 대화제약(주)에서 정상적으로 운영하던 사업부문으로 누적된 기술력을 통해 선진국으로의 수출에도 전혀 문제가 없을 정도의 불순물이 거의 없는 고품질의 원료의약품을 생산할 수 있는 기술력을 가지고 있습니다. 또한, 지속적인 연구개발활동을 통해 다수의 최초 개발 원료의약품을 보유하고 있어 타사대비 경쟁력을 보이고 </SPAN>
<SPAN USERMARK="F-GL11">있습니다.&cr;&cr;</SPAN>
<SPAN USERMARK="F-GL11 B"></SPAN>
<SPAN USERMARK="F-GL11 U">품질보증 프로세스로 품질관리</SPAN>
<SPAN USERMARK="F-GL11">&cr;당사는 생산 제품이 정해진 스펙 (식품의약품안전처 허가, 공정서 기준)에 적합한지를 확인하고 원재료 구매부터 생산단계, 판매단계까지 각 단계의 정보를 기록·관리하여 제품의 안전성 등에 문제가 발생할 경우 해당 제품을 추적하여 원인규명 및 필요한 조치를 할 수 있도록 관리하고 있습니다. 품질보증프로세스로 품질(보증)관리 자, 제조관리자, 연구관리자가 선정되어 있으며, 다음과 같은 세부 프로세스로 품질보증을 수행하고 있습니다.&cr;1) 공정서, Validation을 통한 기준에 준한 품질계획수립&cr;2) 생산 공정의 validation.&cr;3) 생산 각 단계별 인스펙션, 시험을 통한 품질점검 (품질시험서 작성)&cr;4) 품질 평가(일탈, 부적합 여부평가, 품질평가보고서 작성)&cr;5) 품질결과보고를 통한 품질 평가 및 연간품질 평가&cr;6) 품질관리책임자의 승인을 통한 제품 출하를 진행하는 프로세스로 운영&cr;</SPAN>
</P>
<P USERMARK="F-GL16 0XFF0016 B">2. 주요 제품 및 매출 현황</P>

<P USERMARK="F-16">
<SPAN USERMARK="F-GL12 B"></SPAN>
<SPAN USERMARK="F-GL12 B"></SPAN>
</P>

<TABLE ACLASS="NORMAL" WIDTH="603" BORDER="0" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="594"></COL>
</COLGROUP>

<TBODY ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="RIGHT" WIDTH="603" HEIGHT="30">(단위 : 천원, %)</TD>
</TR>
</TBODY>
</TABLE>
<P></P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="603">

<COLGROUP>
<COL WIDTH="39"></COL>
<COL WIDTH="207"></COL>
<COL WIDTH="96"></COL>
<COL WIDTH="61"></COL>
<COL WIDTH="84"></COL>
<COL WIDTH="62"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="48" HEIGHT="60" ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구분</TH>
<TH WIDTH="216" HEIGHT="60" ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">품목</TH>
<TH WIDTH="175" HEIGHT="30" COLSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">2020년 당기</TH>
<TH WIDTH="164" HEIGHT="30" COLSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">2019년 전기</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="105" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">금액</TH>
<TH WIDTH="70" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">비중</TH>
<TH WIDTH="93" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">금액</TH>
<TH WIDTH="71" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">비중</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="48" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">상품</TD>
<TD WIDTH="216" HEIGHT="30" VALIGN="MIDDLE">Amalian</TD>
<TD WIDTH="105" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">1,709,070</TD>
<TD WIDTH="70" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">22.89 </TD>
<TD WIDTH="93" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">2,460,874</TD>
<TD WIDTH="71" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">23.04</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="48" HEIGHT="420" ROWSPAN="14" ALIGN="CENTER" VALIGN="MIDDLE">제품</TD>

<TD WIDTH="216" HEIGHT="30" VALIGN="MIDDLE">
<P>Methylol Cephalexin Lysinate </P>
</TD>
<TD WIDTH="105" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">3,106,820</TD>
<TD WIDTH="70" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">41.61 </TD>
<TD WIDTH="93" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">6,144,335</TD>
<TD WIDTH="71" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">57.54</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="216" HEIGHT="30" VALIGN="MIDDLE">
<P>록소프로펜나트륨</P>
</TD>
<TD WIDTH="105" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">519,125</TD>
<TD WIDTH="70" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">6.95 </TD>
<TD WIDTH="93" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">98,669</TD>
<TD WIDTH="71" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">0.92</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="216" HEIGHT="30" VALIGN="MIDDLE">
<P>록사티딘아세테이트염산염</P>
</TD>
<TD WIDTH="105" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">409,069</TD>
<TD WIDTH="70" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">5.48 </TD>
<TD WIDTH="93" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">443,515</TD>
<TD WIDTH="71" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">4.15</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="216" HEIGHT="30" VALIGN="MIDDLE">
<P>클로피도그렐 황산염</P>
</TD>
<TD WIDTH="105" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">358,202</TD>
<TD WIDTH="70" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">4.80 </TD>
<TD WIDTH="93" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">540,282</TD>
<TD WIDTH="71" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">5.06</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="216" HEIGHT="30" VALIGN="MIDDLE">
<P>플로로글루시놀</P>
</TD>
<TD WIDTH="105" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">283,938</TD>
<TD WIDTH="70" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">3.80 </TD>
<TD WIDTH="93" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">304,552</TD>
<TD WIDTH="71" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">2.85</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="216" HEIGHT="30" VALIGN="MIDDLE">
<P>Sodium Hyaluronate</P>
</TD>
<TD WIDTH="105" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">288,804</TD>
<TD WIDTH="70" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">3.87 </TD>
<TD WIDTH="93" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">9,026</TD>
<TD WIDTH="71" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">0.08</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="216" HEIGHT="30" VALIGN="MIDDLE">
<P>에스암로디핀베실산염</P>
</TD>
<TD WIDTH="105" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">194,169</TD>
<TD WIDTH="70" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">2.60 </TD>
<TD WIDTH="93" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">84,436</TD>
<TD WIDTH="71" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">0.79</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="216" HEIGHT="30" VALIGN="MIDDLE">디아세레인</TD>
<TD WIDTH="105" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">155,724</TD>
<TD WIDTH="70" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">2.08 </TD>
<TD WIDTH="93" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">144,250</TD>
<TD WIDTH="71" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">1.35</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="216" HEIGHT="30" VALIGN="MIDDLE">플로로글루시놀수화물</TD>
<TD WIDTH="105" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">132,064</TD>
<TD WIDTH="70" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">1.77 </TD>
<TD WIDTH="93" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">161,206</TD>
<TD WIDTH="71" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">1.51</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="216" HEIGHT="30" VALIGN="MIDDLE">
<P>툴로부테롤</P>
</TD>
<TD WIDTH="105" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">104,600</TD>
<TD WIDTH="70" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">1.40 </TD>
<TD WIDTH="93" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">95,200</TD>
<TD WIDTH="71" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">0.89</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="216" HEIGHT="30" VALIGN="MIDDLE">리바스티그민</TD>
<TD WIDTH="105" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">73,386</TD>
<TD WIDTH="70" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">0.98 </TD>
<TD WIDTH="93" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="71" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="216" HEIGHT="30" VALIGN="MIDDLE">디클록페낙에폴아민</TD>
<TD WIDTH="105" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">72,652</TD>
<TD WIDTH="70" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">0.97 </TD>
<TD WIDTH="93" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="71" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="216" HEIGHT="30" VALIGN="MIDDLE">
<P>노닐산바닐릴아미드</P>
</TD>
<TD WIDTH="105" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">59,652</TD>
<TD WIDTH="70" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">0.80 </TD>
<TD WIDTH="93" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">56,396</TD>
<TD WIDTH="71" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">0.53</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="216" HEIGHT="30" VALIGN="MIDDLE">보글리보스</TD>
<TD WIDTH="105" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="70" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="93" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">136,320</TD>
<TD WIDTH="71" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">1.28</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="264" HEIGHT="30" COLSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE">합 계</TD>
<TD WIDTH="105" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">7,467,275</TD>
<TD WIDTH="70" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">100</TD>
<TD WIDTH="93" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">10,679,061</TD>
<TD WIDTH="71" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">100</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK="F-GL">&cr;</SPAN>
<SPAN USERMARK="F-GL"></SPAN>
<SPAN USERMARK="F-GL"></SPAN>
<SPAN USERMARK="F-GL B"></SPAN>
<SPAN USERMARK="F-GL B"></SPAN>
<SPAN USERMARK="F-GL B"></SPAN>
<SPAN USERMARK="F-GL B"></SPAN>
<SPAN USERMARK="F-GL 0XFF0016 B"></SPAN>
<SPAN USERMARK="F-GL16 0XFF0016 B">3. 주</SPAN>
<SPAN USERMARK="F-GL16 0XFF0016 B">요</SPAN>
<SPAN USERMARK="F-GL16 0XFF0016 B"> 원재료&cr;</SPAN>
<SPAN USERMARK="F-GL 0XFF0016 B">&cr;</SPAN>
<SPAN USERMARK="F-GL11 0XFF0016 B"></SPAN>
<SPAN USERMARK="F-GL11 B">가. 제품별 주원료&cr;</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="733">

<COLGROUP>
<COL WIDTH="150"></COL>
<COL WIDTH="199"></COL>
<COL WIDTH="219"></COL>
<COL WIDTH="129"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="159" HEIGHT="30" ALIGN="CENTER" VALIGN="BOTTOM" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">사업부문</TH>
<TH WIDTH="208" HEIGHT="30" ALIGN="CENTER" VALIGN="BOTTOM" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">품목</TH>
<TH WIDTH="228" HEIGHT="30" ALIGN="CENTER" VALIGN="BOTTOM" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N"> 주원료 </TH>
<TH WIDTH="138" HEIGHT="30" ALIGN="CENTER" VALIGN="BOTTOM" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N"> 비고 </TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="159" HEIGHT="60" ROWSPAN="2" VALIGN="MIDDLE" ALIGN="CENTER">히알루론산(HA) 부문</TD>
<TD WIDTH="208" HEIGHT="30" VALIGN="MIDDLE"> Sodium Hyaluronate_LM </TD>
<TD WIDTH="228" HEIGHT="30" VALIGN="MIDDLE"> Low molecular weight </TD>
<TD WIDTH="138" HEIGHT="30" ALIGN="CENTER" VALIGN="BOTTOM">　-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="208" HEIGHT="30" VALIGN="MIDDLE"> Sodium Hyaluronate_HM </TD>
<TD WIDTH="228" HEIGHT="30" VALIGN="MIDDLE"> High molecular weight </TD>
<TD WIDTH="138" HEIGHT="30" ALIGN="CENTER" VALIGN="BOTTOM">　-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="159" HEIGHT="120" ROWSPAN="4" VALIGN="MIDDLE" ALIGN="CENTER"> 케미칼 부문 </TD>
<TD WIDTH="208" HEIGHT="30" VALIGN="MIDDLE"> 록소프로펜나트륨</TD>
<TD WIDTH="228" HEIGHT="30" VALIGN="MIDDLE"> Loxoprofen acid</TD>
<TD WIDTH="138" HEIGHT="30" ALIGN="CENTER" VALIGN="BOTTOM">진통제</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="208" HEIGHT="30" VALIGN="MIDDLE"> 메치올세팔렉신리지네이트 </TD>
<TD WIDTH="228" HEIGHT="30" VALIGN="MIDDLE"> 세팔렉신 일수화물</TD>
<TD WIDTH="138" HEIGHT="30" ALIGN="CENTER" VALIGN="BOTTOM">항생제</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="208" HEIGHT="30" VALIGN="MIDDLE"> 플로로글루시놀무수물 </TD>
<TD WIDTH="228" HEIGHT="30" VALIGN="MIDDLE"> 플로로글루시놀</TD>
<TD WIDTH="138" HEIGHT="30" ALIGN="CENTER" VALIGN="BOTTOM">진정제</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="208" HEIGHT="30" VALIGN="MIDDLE"> 툴로부테롤 </TD>
<TD WIDTH="228" HEIGHT="30" VALIGN="MIDDLE"> 2′-클로로아세토페논</TD>
<TD WIDTH="138" HEIGHT="30" ALIGN="CENTER" VALIGN="BOTTOM">천식치료제</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK="F-GL11">&cr;</SPAN>
<SPAN USERMARK="F-GL11 B">나. 원료 공급업체 및 위험관리&cr;</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="1095">

<COLGROUP>
<COL WIDTH="112"></COL>
<COL WIDTH="181"></COL>
<COL WIDTH="175"></COL>
<COL WIDTH="267"></COL>
<COL WIDTH="315"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="121" HEIGHT="30" ALIGN="CENTER" VALIGN="BOTTOM" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">사업부문</TH>
<TH WIDTH="190" HEIGHT="30" ALIGN="CENTER" VALIGN="BOTTOM" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">원재료명</TH>
<TH WIDTH="184" HEIGHT="30" ALIGN="CENTER" VALIGN="BOTTOM" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">업체명(주2)</TH>
<TH WIDTH="276" HEIGHT="30" ALIGN="CENTER" VALIGN="BOTTOM" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">현황</TH>
<TH WIDTH="324" HEIGHT="30" ALIGN="CENTER" VALIGN="BOTTOM" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">위험관리</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="121" HEIGHT="260" VALIGN="MIDDLE" ALIGN="CENTER">
<P>히알루론산(HA) </P>
<P>부문</P>
</TD>
<TD WIDTH="190" HEIGHT="260" VALIGN="MIDDLE">Low/ high molecular weight</TD>
<TD WIDTH="184" HEIGHT="260" VALIGN="MIDDLE">(주)해피콜</TD>
<TD WIDTH="276" HEIGHT="260" VALIGN="MIDDLE">- 발주 후 30일이내 입고.&cr;- 수요와 공급의 변동에 따른 문제를 방   지하고자 안전재고 관리(2개월 생산     가동).</TD>
<TD WIDTH="324" HEIGHT="260" VALIGN="MIDDLE">- 이전까지 설비 및 생산안정을 위해 원료공급    업체에 따른 리스크 관리를 하지 못함.&cr;- 현재 공급업체의 문제로인한 리스크를 최소    화할 목적으로 대체업체 선정과정에 있으며,    여러 업체에 Sample요청하여 자체시험한 자    료를 바탕으로 Bloomage Freda Biopharm, '     Shaanxi Huatai Bio-fine Chemical, Qufu Lon    gercare Meditech Limited 등 검토중에 있음.&cr;- 주원료의 구입가격추이 확인결과(주1) 향후    구입가격 변동율은 1% 미만의 미미한 수준일   것으로 추정됨.</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="121" HEIGHT="603" ROWSPAN="4" VALIGN="MIDDLE" ALIGN="CENTER">케미칼 부문</TD>
<TD WIDTH="190" HEIGHT="122" VALIGN="MIDDLE">Loxoprofen acid</TD>
<TD WIDTH="184" HEIGHT="122" VALIGN="MIDDLE">1) 중국 Weihai Dijia&cr;2) Henan Huashang pharmaceutical 로 복수의 공급처가 확보되어 있는 상황임.</TD>
<TD WIDTH="276" HEIGHT="122" VALIGN="MIDDLE">Weihai Dijia  사는 수 년간 차질없이 공급해왔으며, 현재 및 지난 수년간 균일한 품질로 공급해왔으며, 폐사의 생산 일정에 지장을 초래한 경우 없었음.</TD>
<TD WIDTH="324" HEIGHT="122" VALIGN="MIDDLE">복수의 공급처 확보로 인하여 일정한 공급 가격(가격 변동폭 2 % 이내)으로 가격 변동으로 인한 원가 상승 요인은 희박할 뿐만 아니라 현재 가격 인하 협의 중에 있음.</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="190" HEIGHT="237" VALIGN="MIDDLE">세팔렉신 일수화물</TD>
<TD WIDTH="184" HEIGHT="237" VALIGN="MIDDLE">인도 루핀사(Lupin ltd., 1968년 설립, 현재 자국에만10여 개의 생산공장을 둔 대형 제약업체임.</TD>
<TD WIDTH="276" HEIGHT="237" VALIGN="MIDDLE">인도 제약사 중 매출 3위(2014 매출 : USD 20억6054만)인 회사로 안정적인 회사이며, 현재 및 지난 10여 년간 균일한 품질로 공급해왔으며, 폐사의 생산 일정에 지장을 초래한 경우 없었음.</TD>
<TD WIDTH="324" HEIGHT="237" VALIGN="MIDDLE">- 공급 가능 후보 업체(Sub-supplier)로 Global    Suppliers로써,&cr;   1. Shangyu Zhebang Pharmaceutical Co., Lt        d.(China, 제조사)&cr;   2. Taiyuan Pharmaceutical Works Ltd. (China       , 제조사) 등이 있음.&cr;- 현재 및 지난 10여 년간 일정한 공급 가격(가    격 변동폭 3 % 이내)으로 공급해왔으며, 환율   의 특별한 변동이 없는 한 원가상승에 따른      리스크는 없으리라 판단됨.</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="190" HEIGHT="99" VALIGN="MIDDLE">플로로글루시놀</TD>
<TD WIDTH="184" HEIGHT="99" VALIGN="MIDDLE">1) 중국 HENAN SUNNY    2) TAXING YINXIN CHEMICAL 로 공급처는 확보되어 있는 상황임.</TD>
<TD WIDTH="276" HEIGHT="99" VALIGN="MIDDLE">현재 및 지난 수년간 균일한 품질로 공급해왔으며, 폐사의 생산 일정에 지장을초래한 경우 없었음.</TD>
<TD WIDTH="324" HEIGHT="99" VALIGN="MIDDLE">복수의 공급처 확보로 인하여 일정한 공급 가격(가격 인하율 5 % /3년)으로 가격 변동으로 인한 원가 상승 요인은 희박할 뿐만 아니라 현재 가격 인하 협의 중에 있음.</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="190" HEIGHT="145" VALIGN="MIDDLE">2′-클로로아세토페논</TD>
<TD WIDTH="184" HEIGHT="145" VALIGN="MIDDLE">1) Alpha Hawk Chemicals 2) Zhenjiang star group사로 확보되어 있는 상황임.</TD>
<TD WIDTH="276" HEIGHT="145" VALIGN="MIDDLE">현재 및 지난 수년간 일정한 품질로 공급해왔으며, 폐사의 생산 일정에 지장을초래한 경우 없었음.</TD>
<TD WIDTH="324" HEIGHT="145" VALIGN="MIDDLE">복수의 공급처 확보로 인하여 일정한 공급 가격(가격 인하율 3 % /3년)으로 가격 변동으로 인한 원가 상승 요인은 희박하리라 판단되나, 원재료의 가격 상승요인이 발생할 경우 자체의 기술력으로 커버할 수 있는 수준(자체 공정 기술 확보)으로 특별한 리스크는 없으리라 판단됨.</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK="F-GL11">(주1)HA부문 주원료 구입원가 변동추이</SPAN>
</P>

<TABLE ACLASS="NORMAL" WIDTH="501" BORDER="0" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="492"></COL>
</COLGROUP>

<TBODY ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="501" HEIGHT="30">(단위: 천원/kg)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="501">

<COLGROUP>
<COL WIDTH="161"></COL>
<COL WIDTH="102"></COL>
<COL WIDTH="101"></COL>
<COL WIDTH="101"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="170" VALIGN="BOTTOM" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">원 료 명</TH>
<TH WIDTH="111" VALIGN="BOTTOM" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">2018년</TH>
<TH WIDTH="110" VALIGN="BOTTOM" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">2019년</TH>
<TH WIDTH="110" VALIGN="BOTTOM" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">2020년</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="170" HEIGHT="30"> Low molecular weight </TD>
<TD VALIGN="BOTTOM" ALIGN="RIGHT" WIDTH="111" HEIGHT="30">1,520 </TD>
<TD VALIGN="BOTTOM" ALIGN="RIGHT" WIDTH="110" HEIGHT="30">1,520</TD>
<TD VALIGN="BOTTOM" ALIGN="RIGHT" WIDTH="110" HEIGHT="30">330</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="170" HEIGHT="30"> High molecular weight </TD>
<TD VALIGN="BOTTOM" ALIGN="RIGHT" WIDTH="111" HEIGHT="30">1,700 </TD>
<TD VALIGN="BOTTOM" ALIGN="RIGHT" WIDTH="110" HEIGHT="30">1,700</TD>
<TD VALIGN="BOTTOM" ALIGN="RIGHT" WIDTH="110" HEIGHT="30">330</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK="F-GL11">(주2) 당사가 원재료를 구매하는 모든 업체와 당사간의 특수관계는 없습니다.&cr;&cr;</SPAN>
<SPAN USERMARK="F-GL11">1) 사업부문별 원재료 공급시장의 경쟁 상황은 하기와 같습니다.&cr;</SPAN>
<SPAN USERMARK="F-GL11">&cr;</SPAN>
<SPAN USERMARK="F-GL11"></SPAN>
<SPAN USERMARK="F-GL11">① 히알루론산(HA)사업부문&cr;</SPAN>
<SPAN USERMARK="F-GL11">사용되고 있는 원재료들은 다수의 공급업체가 존재하여 현재 상황으로는 독과점이 없다고할 수 있는 상황입니다. 당사의 원재료 주요 매입처인 (주)해피콜의 경우, 당사와 지난 2년간 원료에 대한 개발에 함께 참여하여 중국과 일본의 여러 경쟁 업체가 있음에도 불구하고저렴한 가격에 당사로 독점 공급하고 있습니다.&cr;&cr;② 케미칼 사업부문&cr;사용되고 있는 원재료들은 다수의 공급업체가 존재하여 현재 상황으로는 독과점이 없다고할 수 있는 상황입니다. 원활한 원재료 수급 및 원가상승을 억제하기 대책으로 당사 제품중의 하나인 Loxoprofen sodium인 경우, 원재료 공급업체인 중국 Weihai Dijia사가 당사의 지배회사인 '대화제약(주)'의 협력업체로 선정되어 있어 균일한품질로 원활하게 공급받고 있습니다.&cr;</SPAN>
<SPAN USERMARK="F-GL">&cr;</SPAN>
<SPAN USERMARK="F-GL"></SPAN>
<SPAN USERMARK="F-GL">&cr;</SPAN>
<SPAN USERMARK="F-GL 0XFF0016"></SPAN>
<SPAN USERMARK="F-GL16 0XFF0016"></SPAN>
<SPAN USERMARK="F-GL16 0XFF0016 B"></SPAN>
<SPAN USERMARK="F-GL16 0XFF0016 B"></SPAN>
<SPAN USERMARK="F-GL16 0XFF0016 B">4. 생산 및 설비&cr;</SPAN>
<SPAN USERMARK="F-GL">&cr;</SPAN>
<SPAN USERMARK="F-GL11"></SPAN>
<SPAN USERMARK="F-GL11 B"></SPAN>
<SPAN USERMARK="F-GL11 B">가. 사업장 현황&cr;</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="474">

<COLGROUP>
<COL WIDTH="184"></COL>
<COL WIDTH="272"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="193" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구 분</TH>
<TH WIDTH="281" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">소재지</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="193" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER"> 본사 및 생산공장</TD>
<TD WIDTH="281" HEIGHT="60" ROWSPAN="2" VALIGN="MIDDLE">경기도 화성시 향남읍 제약공단3길 83</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="193" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER"> 연구소</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK="F-GL11"></SPAN>
</P>
<P USERMARK="F-GL11 B">나. 생산설비에 관한 사항&cr;</P>

<P>
<SPAN USERMARK="F-GL11">1)</SPAN>
<SPAN USERMARK="F-GL11"> 생산능력 및 생산능력의 산출근거&cr;</SPAN>
<SPAN USERMARK="F-GL11">&cr;</SPAN>
<SPAN USERMARK="F-GL11"></SPAN>
<SPAN USERMARK="F-GL11">① 총생산능력 </SPAN>
<SPAN USERMARK="F-GL11"></SPAN>
</P>

<TABLE ACLASS="NORMAL" WIDTH="605" BORDER="0" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="596"></COL>
</COLGROUP>

<TBODY ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="605" HEIGHT="30">(단위 : kg, 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="606">

<COLGROUP>
<COL WIDTH="185"></COL>
<COL WIDTH="101"></COL>
<COL WIDTH="103"></COL>
<COL WIDTH="72"></COL>
<COL WIDTH="100"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH ROWSPAN="2" WIDTH="194" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">사업부문</TH>
<TH COLSPAN="2" WIDTH="222" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">2020년 당기</TH>
<TH COLSPAN="2" WIDTH="190" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">2019년 전기</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="110" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">수량</TH>
<TH WIDTH="112" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">금액</TH>
<TH WIDTH="81" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">수량</TH>
<TH WIDTH="109" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">금액</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="194" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">히알루론산(HA) 제조 부문</TD>
<TD WIDTH="110" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30">205</TD>
<TD WIDTH="112" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30">2,270,305</TD>
<TD WIDTH="81" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30">194</TD>
<TD VALIGN="BOTTOM" ALIGN="RIGHT" WIDTH="109" HEIGHT="30">9,720,345</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="194" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">케미칼 제조 부문</TD>
<TD WIDTH="110" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30">6,985</TD>
<TD WIDTH="112" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30">2,705,564</TD>
<TD WIDTH="81" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30">6,530</TD>
<TD VALIGN="BOTTOM" ALIGN="RIGHT" WIDTH="109" HEIGHT="30">2,720,923</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK="F-GL11">(주1) 생산실적 금액을 바탕으로 가동률에 근거하여 산출하였습니다.&cr;(주2) 케미칼 부문은 2016년 사업을 이전받아 영위하기 시작하였습니다.&cr;</SPAN>
<SPAN USERMARK="F-GL11"></SPAN>
<SPAN USERMARK="F-GL11"></SPAN>
<SPAN USERMARK="F-GL11">(주3)생산능력 산출 &cr;</SPAN>
<SPAN USERMARK="F-GL11">히알루론산 = 3.8kg * 1라인 * 1주 * 54주 = 205kg</SPAN>
<SPAN USERMARK="F-GL11">&cr;케미칼 = 8시간 * 292일 * 1라인 * 2.99kg = 6,985kg</SPAN>
<SPAN USERMARK="F-GL11"></SPAN>
<SPAN USERMARK="F-GL11"></SPAN>
<SPAN USERMARK="F-GL11"></SPAN>
<SPAN USERMARK="F-GL11"></SPAN>
<SPAN USERMARK="F-GL11"></SPAN>
<SPAN USERMARK="F-GL11"> </SPAN>
<SPAN USERMARK="F-GL11">&cr;</SPAN>
<SPAN USERMARK="F-GL11">☞생산능력(최대 생산가능량 및 금액)&cr;생산능력(수량) = 일일 표준작업시간×근무 일수×설비의 시간당 생산량&cr;</SPAN>
<SPAN USERMARK="F-GL11">생산능력(금액) =</SPAN>
<SPAN USERMARK="F-GL11 0X1814FF"> </SPAN>
<SPAN USERMARK="F-GL11">생산실적 금액 </SPAN>
<SPAN USERMARK="F-GL11">/ 생산실적 수량 </SPAN>
<SPAN USERMARK="F-GL11">×</SPAN>
<SPAN USERMARK="F-GL11">생산능력(수량)</SPAN>
<SPAN USERMARK="F-GL11 0X1814FF">&cr;&cr;</SPAN>
<SPAN USERMARK="F-GL11 0X1814FF"></SPAN>
<SPAN USERMARK="F-GL11 0X1814FF"></SPAN>
<SPAN USERMARK="F-GL11 0X1814FF"></SPAN>
<SPAN USERMARK="F-GL11 0X1814FF"></SPAN>
<SPAN USERMARK="F-GL11 0X1814FF"></SPAN>
<SPAN USERMARK="F-GL11">2) 생산실적 및 가동률&cr;</SPAN>
<SPAN USERMARK="F-GL11">&cr;</SPAN>
<SPAN USERMARK="F-GL11">① 생산실적</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="577">

<COLGROUP>
<COL WIDTH="568"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="577" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">(단위 : kg, 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="579">

<COLGROUP>
<COL WIDTH="185"></COL>
<COL WIDTH="83"></COL>
<COL WIDTH="80"></COL>
<COL WIDTH="83"></COL>
<COL WIDTH="103"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH ROWSPAN="2" WIDTH="194" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">사업부문</TH>

<TH COLSPAN="2" WIDTH="181" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>2020년 당기</P>
</TH>

<TH COLSPAN="2" WIDTH="204" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>2019년 전기</P>
</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TH WIDTH="92" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>수량</P>
</TH>

<TH WIDTH="89" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>금액</P>
</TH>

<TH WIDTH="92" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>수량</P>
</TH>

<TH WIDTH="112" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>금액</P>
</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="194" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">히알루론산(HA) 제조 부문</TD>
<TD WIDTH="92" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">42.37</TD>
<TD WIDTH="89" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">468,776</TD>
<TD WIDTH="92" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30">5.85</TD>
<TD VALIGN="BOTTOM" ALIGN="RIGHT" WIDTH="112" HEIGHT="30">293,416</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="194" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">케미칼 제조부문</TD>
<TD WIDTH="92" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">10,603.99</TD>
<TD WIDTH="89" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">4,107,552</TD>
<TD WIDTH="92" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30">6,099.01</TD>
<TD VALIGN="BOTTOM" ALIGN="RIGHT" WIDTH="112" HEIGHT="30">2,541,276</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK="F-GL11">(주1) 생산실적 금액은 제품제조원가명세서에 근거하여 작성하였습니다.&cr;</SPAN>
<SPAN USERMARK="F-GL11 0X1814FF">&cr;</SPAN>
<SPAN USERMARK="F-GL11">② 평균가동률</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="600">

<COLGROUP>
<COL WIDTH="591"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="600" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">(단위 : h)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="602">

<COLGROUP>
<COL WIDTH="198"></COL>
<COL WIDTH="120"></COL>
<COL WIDTH="122"></COL>
<COL WIDTH="126"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="207" VALIGN="BOTTOM" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">사업부문</TH>
<TH WIDTH="129" VALIGN="BOTTOM" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">가동가능시간</TH>
<TH WIDTH="131" VALIGN="BOTTOM" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">실제가동시간</TH>
<TH WIDTH="135" VALIGN="BOTTOM" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">평균가동률</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="207" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">히알루론산(HA) 제조 부문</TD>
<TD WIDTH="129" VALIGN="BOTTOM" ALIGN="CENTER" HEIGHT="30">2,592</TD>
<TD WIDTH="131" VALIGN="BOTTOM" ALIGN="CENTER" HEIGHT="30">379</TD>
<TD WIDTH="135" VALIGN="BOTTOM" ALIGN="CENTER" HEIGHT="30">14.5%</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="207" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">케미칼 제조 부문</TD>
<TD WIDTH="129" VALIGN="BOTTOM" ALIGN="CENTER" HEIGHT="30">2,400</TD>
<TD WIDTH="131" VALIGN="BOTTOM" ALIGN="CENTER" HEIGHT="30">2,304</TD>
<TD WIDTH="135" VALIGN="BOTTOM" ALIGN="CENTER" HEIGHT="30">96.0%</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK="F-GL11 0X1814FF"></SPAN>
<SPAN USERMARK="F-GL11">&cr;</SPAN>
<SPAN USERMARK="F-GL11 B">다. 생산설비 현황 등&cr;&cr;</SPAN>
<SPAN USERMARK="F-GL11">1) 당사의 당기 및 전기 현재 유형자산의 변동내역은 다음과 같습니다.</SPAN>
</P>

<P>
<SPAN USERMARK="F-GL11"></SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="861">

<COLGROUP>
<COL WIDTH="302"></COL>
<COL WIDTH="541"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="311" HEIGHT="30"><당기></TD>
<TD WIDTH="550" HEIGHT="30" ALIGN="RIGHT">(단위 : 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="864">

<COLGROUP>
<COL WIDTH="129"></COL>
<COL WIDTH="112"></COL>
<COL WIDTH="112"></COL>
<COL WIDTH="112"></COL>
<COL WIDTH="112"></COL>
<COL WIDTH="112"></COL>
<COL WIDTH="112"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="138" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구 분</TH>
<TH WIDTH="121" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">기초</TH>
<TH WIDTH="121" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">취득</TH>
<TH WIDTH="121" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">처분</TH>
<TH WIDTH="121" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">감가상각비</TH>
<TH WIDTH="121" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">대체</TH>
<TH WIDTH="121" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">기말</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="138" HEIGHT="30" VALIGN="MIDDLE">토지</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT">2,593,482</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT">2,593,482</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="138" HEIGHT="30" VALIGN="MIDDLE">건물</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT">8,899,201</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT">517,021</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT">(6,597)</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT">(236,812)</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT">6,000</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT">9,178,812</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="138" HEIGHT="30" VALIGN="MIDDLE">기계장치</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT">458,035</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT">126,693</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT">(533,271)</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT">4,660,000</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT">4,711,457</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="138" HEIGHT="30" VALIGN="MIDDLE">차량운반구</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT">192</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT">(86)</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT">105</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="138" HEIGHT="30" VALIGN="MIDDLE">비품</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT">108,724</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT">21,268</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT">(55,857)</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT">74,135</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="138" HEIGHT="30" VALIGN="MIDDLE">건설중인자산</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT">4,666,000</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT">(4,666,000)</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="138" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">합 계</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT">16,725,634</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT">664,982</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT">(6,597)</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT">(826,026)</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT">16,557,991</TD>
</TR>
</TBODY>
</TABLE>
<P></P>
<PGBRK></PGBRK>

<TABLE BORDER="0" WIDTH="865" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="335"></COL>
<COL WIDTH="512"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="344" HEIGHT="30"><전기></TD>
<TD WIDTH="521" HEIGHT="30" ALIGN="RIGHT">(단위 : 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="864">

<COLGROUP>
<COL WIDTH="129"></COL>
<COL WIDTH="112"></COL>
<COL WIDTH="112"></COL>
<COL WIDTH="112"></COL>
<COL WIDTH="112"></COL>
<COL WIDTH="112"></COL>
<COL WIDTH="112"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="138" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구 분</TH>
<TH WIDTH="121" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">기초</TH>
<TH WIDTH="121" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">취득</TH>
<TH WIDTH="121" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">처분</TH>
<TH WIDTH="121" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">감가상각비</TH>
<TH WIDTH="121" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">대체</TH>
<TH WIDTH="121" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">기말</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="138" HEIGHT="30" VALIGN="MIDDLE">토지</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT">2,593,482</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT">2,593,482</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="138" HEIGHT="30" VALIGN="MIDDLE">건물</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT">1,095,925</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT">(83,606)</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT">7,886,882</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT">8,899,201</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="138" HEIGHT="30" VALIGN="MIDDLE">기계장치</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT">614,602</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT">152,965</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT">(309,532)</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT">458,035</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="138" HEIGHT="30" VALIGN="MIDDLE">차량운반구</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT">5,512</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT">(4,193)</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT">(1,127)</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT">192</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="138" HEIGHT="30" VALIGN="MIDDLE">비품</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT">27,233</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT">109,463</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT">(27,972)</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT">108,724</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="138" HEIGHT="30" VALIGN="MIDDLE">건설중인자산</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT">2,745,500</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT">9,807,382</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT">(7,886,882)</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT">4,666,000</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="138" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">합 계</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT">7,082,254</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT">10,069,810</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT">(4,193)</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT">(422,237)</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT">16,725,634</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK="F-GL11">&cr;2) 당사가 보유중인 토지의 공시지가는 다음과 같습니다.</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="620">

<COLGROUP>
<COL WIDTH="335"></COL>
<COL WIDTH="267"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="344" HEIGHT="30"></TD>
<TD WIDTH="276" HEIGHT="30" ALIGN="RIGHT">(단위 : 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="614">

<COLGROUP>
<COL WIDTH="254"></COL>
<COL WIDTH="164"></COL>
<COL WIDTH="169"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">

<TH WIDTH="263" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>주소</P>
</TH>

<TH WIDTH="173" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>개별공시지가(㎡당)</P>
</TH>

<TH WIDTH="178" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>면적(㎡)</P>
</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="263" HEIGHT="30">
<P>경기 화성 향남읍 상신리 907</P>
</TD>
<TD WIDTH="173" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">2,029,189</TD>

<TD WIDTH="178" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">
<P>4,937.2 </P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="263" HEIGHT="30">
<P>경기 파주 적성면 장현리 253-1</P>
</TD>
<TD WIDTH="173" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">193,217</TD>

<TD WIDTH="178" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">
<P>1,643.0 </P>
</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK="F-GL">&cr;3) 당사의 현재 회사 유형자산이 담보로 제공되어 있는 내용은 다음과 같습니다.</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="620">

<COLGROUP>
<COL WIDTH="335"></COL>
<COL WIDTH="267"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="344" HEIGHT="30"></TD>
<TD WIDTH="276" HEIGHT="30" ALIGN="RIGHT">(단위 : 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="620">

<COLGROUP>
<COL WIDTH="163"></COL>
<COL WIDTH="141"></COL>
<COL WIDTH="140"></COL>
<COL WIDTH="140"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="172" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">담보제공내역</TH>
<TH WIDTH="150" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">장부금액</TH>
<TH WIDTH="149" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">채권최고액</TH>
<TH WIDTH="149" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">담보권자</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="172" HEIGHT="30">토지</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="150" HEIGHT="30">2,593,482</TD>
<TD ROWSPAN="4" VALIGN="MIDDLE" WIDTH="149" HEIGHT="120" ALIGN="RIGHT">9,252,000</TD>
<TD ROWSPAN="4" VALIGN="MIDDLE" WIDTH="149" HEIGHT="120" ALIGN="CENTER">기업은행</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="172" HEIGHT="30">건물</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="150" HEIGHT="30">9,178,812</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="172" HEIGHT="30">기계장치</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="150" HEIGHT="30">4,711,457</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="172" HEIGHT="30">합   계</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="150" HEIGHT="30">16,483,751</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK="F-GL"> &cr;</SPAN>
<SPAN USERMARK="F-GL B">라. 설비의 신설·매입계획 등 </SPAN>
<SPAN USERMARK="F-GL">&cr;</SPAN>&cr;
<SPAN USERMARK="F-GL">(1) API(합성)공장 증축 </SPAN>
</P>

<P USERMARK=" 0X0000FF">
<SPAN USERMARK="F-GL 0X000000">당사는 2018년 09월초 API GMP증축공사 착공하였으며, 신공장은 기존 원료합성설비공장의 스케일업 형태이며 API 공장입니다. 2019년도말에 완공된 공장은 기존보다 4배이상 생산규모가 늘어나며, 2022년까지 생산능력을 연매출 200억원 규모로 끌어올릴 계획입니다.&cr;</SPAN>
</P>

<P USERMARK="F-GL16 B">
<SPAN USERMARK=" 0XC01D00">5. 매출에 관한 사항&cr;</SPAN>
<SPAN>&cr;</SPAN>
<SPAN USERMARK="F-11">가. 매출실적&cr;&cr;</SPAN>
<SPAN USERMARK="F-11 0X0000FF"></SPAN>
<SPAN USERMARK="F-11 !B">당사의 </SPAN>
<SPAN USERMARK="F-11 !B">2020년 당기 </SPAN>
<SPAN USERMARK="F-11 !B">및 전기의 주요 제품별 매출 실적은 하기와 같습니다.</SPAN>
</P>

<TABLE ACLASS="NORMAL" WIDTH="641" BORDER="0" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="632"></COL>
</COLGROUP>

<TBODY ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="641" HEIGHT="30">(단위 : 천원,%)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="642">

<COLGROUP>
<COL WIDTH="39"></COL>
<COL WIDTH="126"></COL>
<COL WIDTH="66"></COL>
<COL WIDTH="103"></COL>
<COL WIDTH="68"></COL>
<COL WIDTH="103"></COL>
<COL WIDTH="74"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH ROWSPAN="2" WIDTH="48" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="60">구분</TH>
<TH COLSPAN="2" ROWSPAN="2" WIDTH="210" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="60">품목</TH>
<TH COLSPAN="2" WIDTH="189" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">2020년 당기</TH>
<TH COLSPAN="2" WIDTH="195" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">2019년 전기</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" WIDTH="112" HEIGHT="30">금액</TH>
<TH VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" WIDTH="77" HEIGHT="30">비중</TH>
<TH VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" WIDTH="112" HEIGHT="30">금액</TH>
<TH VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" WIDTH="83" HEIGHT="30">비중</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD ROWSPAN="2" VALIGN="MIDDLE" WIDTH="48" HEIGHT="60">상품</TD>
<TD ROWSPAN="2" VALIGN="MIDDLE" WIDTH="135" HEIGHT="60" ALIGN="CENTER">Amalian</TD>
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="75" HEIGHT="30">수출</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="112" HEIGHT="30">-</TD>
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="77" HEIGHT="30">-</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="112" HEIGHT="30">-</TD>
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="83" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="75" HEIGHT="30">내수</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="112" HEIGHT="30">1,709,070</TD>
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="77" HEIGHT="30">22.89</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="112" HEIGHT="30">2,460,874</TD>
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="83" HEIGHT="30">23.04</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD COLSPAN="2" ROWSPAN="3" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="183" HEIGHT="90">상품계</TD>
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="75" HEIGHT="30">수출</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="112" HEIGHT="30">-</TD>
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="77" HEIGHT="30">-</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="112" HEIGHT="30">-</TD>
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="83" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="75" HEIGHT="30">내수</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="112" HEIGHT="30">1,709,070</TD>
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="77" HEIGHT="30">22.89</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="112" HEIGHT="30">2,460,874</TD>
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="83" HEIGHT="30">23.04</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="75" HEIGHT="30">소계</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="112" HEIGHT="30">1,709,070</TD>
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="77" HEIGHT="30">22.89</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="112" HEIGHT="30">2,460,874</TD>
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="83" HEIGHT="30">23.04</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ROWSPAN="4" VALIGN="MIDDLE" WIDTH="48" HEIGHT="120">제품</TD>
<TD ROWSPAN="2" VALIGN="MIDDLE" WIDTH="135" HEIGHT="60" ALIGN="CENTER">HA</TD>
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="75" HEIGHT="30">수출</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="112" HEIGHT="30">18,804</TD>
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="77" HEIGHT="30">0.25</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="112" HEIGHT="30">5,571</TD>
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="83" HEIGHT="30">0.05</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="75" HEIGHT="30">내수</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="112" HEIGHT="30">270,000</TD>
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="77" HEIGHT="30">3.62</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="112" HEIGHT="30">3,454</TD>
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="83" HEIGHT="30">0.03</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ROWSPAN="2" VALIGN="MIDDLE" WIDTH="135" HEIGHT="60" ALIGN="CENTER">케미칼</TD>
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="75" HEIGHT="30">수출</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="112" HEIGHT="30">-</TD>
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="77" HEIGHT="30">-</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="112" HEIGHT="30">-</TD>
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="83" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="75" HEIGHT="30">내수</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="112" HEIGHT="30">5,469,401</TD>
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="77" HEIGHT="30">73.24</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="112" HEIGHT="30">8,209,161</TD>
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="83" HEIGHT="30">76.87</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD COLSPAN="2" ROWSPAN="3" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="183" HEIGHT="90">제품계</TD>
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="75" HEIGHT="30">수출</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="112" HEIGHT="30">18,804</TD>
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="77" HEIGHT="30">0.25</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="112" HEIGHT="30">5,571</TD>
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="83" HEIGHT="30">0.05</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="75" HEIGHT="30">내수</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="112" HEIGHT="30">5,739,401</TD>
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="77" HEIGHT="30">76.86</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="112" HEIGHT="30">8,212,615</TD>
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="83" HEIGHT="30">76.90</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="75" HEIGHT="30">소계</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="112" HEIGHT="30">5,758,205</TD>
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="77" HEIGHT="30">77.11</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="112" HEIGHT="30">8,218,186</TD>
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="83" HEIGHT="30">76.96</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD COLSPAN="2" ROWSPAN="3" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="183" HEIGHT="90">합  계</TD>
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="75" HEIGHT="30">수출</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="112" HEIGHT="30">18,804</TD>
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="77" HEIGHT="30">0.25</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="112" HEIGHT="30">5,571</TD>
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="83" HEIGHT="30">0.05</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="75" HEIGHT="30">내수</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="112" HEIGHT="30">7,448,471</TD>
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="77" HEIGHT="30">99.75</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="112" HEIGHT="30">10,673,489</TD>
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="83" HEIGHT="30">99.95</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="75" HEIGHT="30">소계</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="112" HEIGHT="30">7,467,275 </TD>
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="77" HEIGHT="30">100</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="112" HEIGHT="30">10,679,060</TD>
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="83" HEIGHT="30">100.00</TD>
</TR>
</TBODY>
</TABLE>

<P USERMARK="F-GL11">
<SPAN>&cr;</SPAN>
<SPAN USERMARK=" B"></SPAN>
<SPAN USERMARK=" B"></SPAN>
<SPAN USERMARK="F-12 B">나. 판매경로 등&cr;</SPAN>&cr;당사의 주요 매출처는 하기와 같습니다.
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="455">

<COLGROUP>
<COL WIDTH="153"></COL>
<COL WIDTH="174"></COL>
<COL WIDTH="101"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="162" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">구분</TH>
<TH WIDTH="183" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">매출처</TH>
<TH WIDTH="110" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">비중</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD ROWSPAN="3" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="162" HEIGHT="90">상 품</TD>
<TD VALIGN="MIDDLE" WIDTH="183" HEIGHT="30" ALIGN="CENTER">대화제약(주)</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="110" HEIGHT="30">100.0%</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="183" HEIGHT="30" ALIGN="CENTER">기타</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="110" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="183" HEIGHT="30" ALIGN="CENTER">소 계</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="110" HEIGHT="30">100.0%</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ROWSPAN="4" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="162" HEIGHT="120">제 품</TD>
<TD VALIGN="MIDDLE" WIDTH="183" HEIGHT="30" ALIGN="CENTER">대화제약(주)</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="110" HEIGHT="30">53.12%</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="183" HEIGHT="30" ALIGN="CENTER">한림제약(주)</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="110" HEIGHT="30">37.77%</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="183" HEIGHT="30" ALIGN="CENTER">기타</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="110" HEIGHT="30">9.11%</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="183" HEIGHT="30" ALIGN="CENTER">소 계</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="110" HEIGHT="30">100.0%</TD>
</TR>
</TBODY>
</TABLE>
<P></P>

<P>
<SPAN USERMARK="F-GL16 0XFF0016 B">6. 수주상황&cr;</SPAN>
<SPAN USERMARK="F-GL16 0XFF0016 B"></SPAN>
<SPAN USERMARK="F-GL11">해당사항 없습니다.</SPAN>
</P>
<P USERMARK="F-GL">  </P>
<P USERMARK="F-GL16 0XFF0016 B">7. 시장위험과 위험관리&cr;</P>
<P USERMARK="F-GL11 B">가. 위험관리정책&cr;</P>
<P USERMARK="F-GL11">당사는 여러 활동으로 인하여 시장위험(외환위험, 이자율위험 및 가격위험), 신용위험 및 유동성위험과 같은 다양한 금융 위험에 노출돼 있습니다. 회사의 전반적인 위험관리정책은 금융시장의 변동성에 초점을 맞추고 있으며 재무성과에 미치는 부정적 영향을 최소화하는데 중점을 두고 있습니다. 위험관리는 이사회에서 승인한 정책에 따라 이루어지고 있습니다. 이사회는 전반적인 위험관리에 대한 문서화된 정책, 외환위험, 이자율 위험, 신용 위험, 파생금융상품과 비파생금융상품의 이용 및 유동성을 초과하는 투자와 같은 특정 분야에 관한 문서화된 정책을 검토하고 승인합니다</P>
<P USERMARK="F-GL11"> </P>
<P USERMARK="F-GL11 B">나. 재무위험관리</P>
<P USERMARK="F-GL11"> </P>
<P USERMARK="F-GL11">1) 재무위험요소&cr;회사는 여러 활동으로 인하여 시장위험(외환위험, 이자율위험 및 가격위험), 신용위험 및 유동성위험과 같은 다양한 금융 위험에 노출돼 있습니다. 회사의 전반적인 위험관리정책은 금융시장의 변동성에 초점을 맞추고 있으며 재무성과에 미치는 부정적 영향을 최소화하는데 중점을 두고 있습니다.</P>
<P USERMARK="F-GL11"> </P>
<P USERMARK="F-GL11">2) 시장위험</P>
<P USERMARK="F-GL11"> </P>
<P USERMARK="F-GL11">① 외환위험 &cr;회사는 주로 해외에서 상품을 매입하여 국내에 판매하고 있으므로 외환위험에 노출돼 있으며, 특히 유로화의 환율변동위험에 노출돼 있습니다. 그러나, 당사는 채무에 대한 지급기일을 매우 짧게 가져가고 있어 환율변동에 따른 위험의 노출도가 크지 않습니다. 따라서 외화 채권,채무의 환율변동에 따른 민감도 분석을 생략합니다.</P>
<P USERMARK="F-GL11"> </P>

<P USERMARK="F-GL11">
<SPAN>② 이자율위험&cr;</SPAN>
<SPAN>이자율위험은 미래의 시장이자율 변동에 따라 예금 또는 차입금 등에서 발생하는 이자수익 및 이자비용이 변동될 위험으로서 이는 주로 변동금리부 조건의 예금과 차입금에서 발생하고 있습니다. 회사의 이자율위험관리의 목표는 이자율변동으로 인한 불확실성과 순이자비용의 최소화를 추구함으로써 기업의 가치를 극대화하는데 있습니다. 당기 및 전기 현재 이자율 위험에 노출된 차입금의 장부금액은 다음과 같습니다.</SPAN>
<SPAN></SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="554">

<COLGROUP>
<COL WIDTH="291"></COL>
<COL WIDTH="245"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="300" HEIGHT="30"></TD>
<TD WIDTH="254" HEIGHT="30" ALIGN="RIGHT">(단위 : 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="553">

<COLGROUP>
<COL WIDTH="173"></COL>
<COL WIDTH="177"></COL>
<COL WIDTH="176"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="182" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">구분</TH>
<TH WIDTH="186" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">당기</TH>
<TH WIDTH="185" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">전기</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="182" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">차입금</TD>
<TD WIDTH="186" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">8,050,000</TD>
<TD WIDTH="185" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">6,710,000 </TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK="F-11"></P>
<P USERMARK="F-GL11">&cr;③ 신용위험&cr;신용위험은 계약상대방이 계약상의 의무를 불이행하여 당사에 재무적 손실을 미칠 위험을의미합니다. 당사의 신용위험은 보유하고 있는 수취채권을 포함한 거래처에 대한 신용위험 뿐아니라, 금융기관예치금으로부터 발생하고 있습니다. 금융기관의 경우, 신용등급이 우수한 금융기관과 거래하고 있으므로 금융기관으로부터의 신용위험은 제한적입니다. 일반거래처의 경우 고객의 재무상태, 과거 경험 등 기타 요소들을 고려하여 신용을 평가하게 됩니다. 수취채권과의 신용위험 최대노출액은 장부금액과 유사합니다</P>
<P USERMARK="F-GL11"> </P>
<P USERMARK="F-GL11">④ 유동성위험&cr;회사는 영업 자금 수요를 충족시키기 위해 차입금 한도나 약정을 위반하는 일이 없도록 유동성에 대한 예측을 항시 모니터링하고 있습니다. 당사는 유동성위험을 관리하기 위하여 단기 및 중장기 자금관리계획을 수립하고 현금유출예산과 실제 현금유출액을 지속적으로 분석ㆍ검토하여 금융부채와 금융자산의 만기구조를 대응시키고 있습니다. 또한, 유동성을예측하는데 있어 회사의 자금조달 계획, 약정 준수, 회사 내부의 목표재무비율 및 통화에 대한 제한과 같은 외부 법규나 법률 요구사항도 고려하고 있습니다.</P>
<P USERMARK="F-GL11"> </P>
<P USERMARK="F-GL11">3) 자본위험관리</P>
<P USERMARK="F-GL11"> </P>

<P>
<SPAN USERMARK="F-GL11">회사의 자본관리는 계속기업으로서의 존속능력을 유지하는 것과 더불어 자본조달비용을 최소화하여 주주이익을 극대화하는 것을 그 목적으로 하고 있습니다. 회사의 경영진은 부채비율 및 순차입금비율 등의 재무비율을 주기적으로 검토하고 있습니다. 당기 및 전기 현재 자본조달비율은 다음과 같습니다.</SPAN>
<SPAN USERMARK="F-GL11"></SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="521">

<COLGROUP>
<COL WIDTH="291"></COL>
<COL WIDTH="212"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="300" HEIGHT="30"></TD>
<TD WIDTH="221" HEIGHT="30" ALIGN="RIGHT">(단위 : 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="520">

<COLGROUP>
<COL WIDTH="217"></COL>
<COL WIDTH="138"></COL>
<COL WIDTH="138"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="226" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">구분</TH>
<TH WIDTH="147" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">당기말</TH>
<TH WIDTH="147" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">전기말</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="226" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">총차입금(A)</TD>
<TD WIDTH="147" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">8,050,000</TD>
<TD WIDTH="147" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">6,710,000</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="226" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">차감: 현금및현금성자산(B)</TD>
<TD WIDTH="147" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">362,825</TD>
<TD WIDTH="147" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">414,545</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="226" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">순부채(C=A-B)</TD>
<TD WIDTH="147" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">7,687,175</TD>
<TD WIDTH="147" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">6,295,455</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="226" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">자본총계(D)</TD>
<TD WIDTH="147" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">14,388,576</TD>
<TD WIDTH="147" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">15,479,002</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="226" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">총자본(E=C+D)</TD>
<TD WIDTH="147" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">22,075,751</TD>
<TD WIDTH="147" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">21,774,457</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK="F-GL">&cr;</SPAN>
</P>
<P USERMARK="F-GL16 0XFF0016 B">8. 파생상품 및 풋백옵션 등 거래 현황</P>

<P USERMARK="F-GL">
<SPAN USERMARK="F-11">해당사항 없습니다.</SPAN>
</P>
<P USERMARK="F-GL"></P>
<P USERMARK="F-GL16 0XFF0016 B">9. 경영상의 주요계약 등</P>

<P>
<SPAN USERMARK="F-GL11 B">&cr;가. 경영권양수도 계약&cr;</SPAN>
<SPAN USERMARK="F-GL11 B"></SPAN>
</P>
<P USERMARK="F-GL11">[ S&V Technologies GmbH(독일)]&cr;&cr;당사는 안정적인 필러제품의 공급과 제품 경쟁력확보를 위하여 2017년 6월 7일   Dr. Christine F. Kreiner외 6명과 독일 S&V Technologies GmbH사의 지분 40%를 양수하는 지분양수도 계약을 체결하였습니다. 지분양수대금은 2017년 9월 13일 지급하여 9월 18일 인수 완료 하였습니다. 유한회사로 실수자본(납입자본금)에 대한지분을 보유하는 것으로 주식 취득수는 없습니다.&cr;</P>

<TABLE BORDER="1" WIDTH="760" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="188"></COL>
<COL WIDTH="137"></COL>
<COL WIDTH="118"></COL>
<COL WIDTH="135"></COL>
<COL WIDTH="137"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="197" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">계약상대방</TD>
<TD WIDTH="146" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">이사회 결의일</TD>
<TD WIDTH="127" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">취득주식수</TD>
<TD WIDTH="144" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">취득금액</TD>
<TD WIDTH="146" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">취득지분율</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="197" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53"> Dr. Christine F. Kreiner 외</TD>
<TD WIDTH="146" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">2017.06.07</TD>
<TD WIDTH="127" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">-</TD>
<TD WIDTH="144" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">EUR 2,470,000</TD>
<TD WIDTH="146" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">40%</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK="F-GL11 B">&cr;나. GMP API(합성)공장 증축공사 계약 등</SPAN>
<SPAN USERMARK="F-GL16 0XFF0016 B">&cr;&cr;</SPAN>
<SPAN USERMARK="F-GL11">당사는 다음과 같이 공사계약을 하였습니다. 동 계약은 GMP API(합성)공장 증축공사를 위하여 건축시공사인 (주)녹십자이엠과 계약 체결 및 설비부문인 (주)정현프랜트와 계약 체결하여 공사를 진행완료하였습니다.</SPAN>
<SPAN USERMARK="F-GL16 0XFF0016 B">&cr;</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="928">

<COLGROUP>
<COL WIDTH="919"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="928" HEIGHT="30" ALIGN="RIGHT">(단위 : 원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="929">

<COLGROUP>
<COL WIDTH="478"></COL>
<COL WIDTH="111"></COL>
<COL WIDTH="104"></COL>
<COL WIDTH="88"></COL>
<COL WIDTH="103"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="487" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">계약의 목적 및 내역</TH>
<TH WIDTH="120" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">계약업체</TH>
<TH WIDTH="113" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">계약금액</TH>
<TH WIDTH="97" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">계약일자</TH>
<TH WIDTH="112" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">비 고</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="487" HEIGHT="36" VALIGN="MIDDLE" ALIGN="CENTER">(주)리독스바이오 GMP API(합성)공장 증축공사</TD>
<TD WIDTH="120" HEIGHT="36" VALIGN="MIDDLE" ALIGN="CENTER">(주)녹십자이엠</TD>
<TD WIDTH="113" HEIGHT="36" ALIGN="CENTER" VALIGN="MIDDLE">7,470,000,000</TD>
<TD WIDTH="97" HEIGHT="36" ALIGN="CENTER" VALIGN="MIDDLE">2018.08.30.</TD>
<TD WIDTH="112" HEIGHT="36" ALIGN="CENTER" VALIGN="MIDDLE">계약금액변경</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="487" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">(주)리독스바이오 GMP API(합성)공장 증축공사 생산장비 제작 설치외</TD>
<TD WIDTH="120" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">(주)정현프랜트</TD>
<TD WIDTH="113" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">4,570,000,000</TD>
<TD WIDTH="97" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">2018.11.16.</TD>
<TD WIDTH="112" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">계약금액변경</TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK="F-GL16 0XFF0016 B">&cr;10. 연구개발활동</P>

<P USERMARK="F-GL">&cr;
<SPAN USERMARK=" B"></SPAN>
<SPAN USERMARK=" B">가. 연구개발활동의 개요&cr;&cr;</SPAN>
<SPAN USERMARK="F-11">당</SPAN>
<SPAN USERMARK="F-11">사</SPAN>
<SPAN USERMARK="F-11">는</SPAN>
<SPAN USERMARK="F-11"> 2016년 </SPAN>
<SPAN USERMARK="F-11">현물출자로 인하여 모회사의 연구인력이 당사(리독스바이오)로 흡수되면서 향후</SPAN>
<SPAN USERMARK="F-11"> 제제화 기술, 원료의약품 합성, 약물전달시스템 개발, 천연물 의약품 후보물질 스크리닝 및 제품 개발활동이 적극적 전개될 예정입니다. 이로 인해 당사 자체적 특성화된 기술을 보유하고 될 것이며, 수행과제의 내부적 관리·평가 시스템을 운영하여 효율적인 신약/개량신약 개발 프로세스를 진행할 수 있을 것이라 예상됩니다.&cr;</SPAN>
</P>
<P USERMARK="F-GL11">1) 원료의약품(API) 합성 연구(현물출자 이전 연구 내역 포함)</P>
<P USERMARK="F-GL11">   ① 리바스티그민(치매치료제) 개발</P>
<P USERMARK="F-GL11">   ② 툴로부테롤(천식치료제) 국내 최초 개발</P>
<P USERMARK="F-GL11">   ③ 플로로글루시놀 무수물(진경제) 국내 최초 개발</P>
<P USERMARK="F-GL11">   ④ 염산록사티딘아세테이트(항궤양제)</P>
<P USERMARK="F-GL11">   ⑤ 보글리보스(당뇨치료제)</P>
<P USERMARK="F-GL11">   ⑥ 메칠올세팔렉신리지네이트(항생제) 국내 최초 개발</P>
<P USERMARK="F-GL11">   ⑦ 에스암로디핀베실산(항고혈압)</P>
<P USERMARK="F-GL11">   ⑧ 노닐산바닐릴아마이드(진통제)</P>
<P USERMARK="F-GL11">   ⑨ 디아세레인(관절염 치료제) 국내 최초 개발</P>
<P USERMARK="F-GL11">   ⑩ 록소프로펜나트륨(진통제)</P>
<P USERMARK="F-GL11">   ⑪ 로수바스타틴칼슘(고지혈증치료제)&cr;   ⑫ 톨밥탄(다낭신장병치료제)&cr;   ⑬ 에스판토프라졸나트륨(위궤양 및 중(中)-중(重)증의 역류성 식도염치료제)</P>
<P USERMARK="F-GL11">&cr;2) 항체-약물 접합체(Antibody Drug Conjugate) LINKER 플랫폼 기술 연구 : 항암제를 암에 표적하여 효율적으로 전달하는 LINKER 개발</P>

<P USERMARK="F-GL11">  &cr;
<SPAN USERMARK="F-12 B">나. 연구개발 담당조직</SPAN>
</P>
<P USERMARK="F-GL11">&cr;1) 연구개발 조직 개요&cr;   당사는 연구개발 조직은 중앙연구소(향남소재) 2개팀으로 구성되어 있으며, 그 현황은 다음과 같습니다.&cr;&cr;<연구개발 조직 구성>&cr;</P>

<TABLE ACLASS="NORMAL" WIDTH="600" BORDER="1" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="191"></COL>
<COL WIDTH="131"></COL>
<COL WIDTH="251"></COL>
</COLGROUP>

<TBODY ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="200" HEIGHT="30" USERMARK=" BC0XBEBEBE">연구소</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="140" HEIGHT="30" USERMARK=" BC0XBEBEBE">팀</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="260" HEIGHT="30" USERMARK=" BC0XBEBEBE">주요업무</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="200" HEIGHT="60">중앙연구소</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="140" HEIGHT="30">바이오 사업팀</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="260" HEIGHT="30">생체 고분자 관련 연구</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="140" HEIGHT="30">의약품 합성팀</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="260" HEIGHT="30">원료의약품 개발 연구</TD>
</TR>
</TBODY>
</TABLE>
<P></P>

<IMAGE>
<IMG WIDTH="600" HEIGHT="337" ALIGN="CENTER" HSPACE="0">조직도.jpg</IMG>
<IMG-CAPTION ATOC="N">조직도</IMG-CAPTION>
</IMAGE>
<P USERMARK="F-GL11">&cr;2) 연구개발 인력 현황&cr;   공시서류 작성기준일 현재 당사는 박사급 1명, 석사급 3명 등 총 6명의 연구인력을 보유하고 있으며, 그 현황은 다음과 같습니다.&cr;                                                                                                           (단위:명)</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="600">

<COLGROUP>
<COL WIDTH="111"></COL>
<COL WIDTH="155"></COL>
<COL WIDTH="70"></COL>
<COL WIDTH="70"></COL>
<COL WIDTH="70"></COL>
<COL WIDTH="70"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" BC0XBEBEBE" WIDTH="284" HEIGHT="60" ALIGN="CENTER" VALIGN="MIDDLE" ROWSPAN="2" COLSPAN="2">연구소</TD>
<TD USERMARK=" BC0XBEBEBE" WIDTH="316" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" COLSPAN="4">인 원</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" BC0XBEBEBE" WIDTH="79" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">박 사</TD>
<TD USERMARK=" BC0XBEBEBE" WIDTH="79" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">석 사</TD>
<TD USERMARK=" BC0XBEBEBE" WIDTH="79" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">기 타</TD>
<TD USERMARK=" BC0XBEBEBE" WIDTH="79" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">합 계</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="120" HEIGHT="60" ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE">중앙연구소</TD>
<TD WIDTH="164" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">바이오 사업팀</TD>
<TD WIDTH="79" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">1</TD>
<TD WIDTH="79" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">0</TD>
<TD WIDTH="79" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">1</TD>
<TD WIDTH="79" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">2</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="164" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">의약품 합성팀</TD>
<TD WIDTH="79" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">0</TD>
<TD WIDTH="79" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">3</TD>
<TD WIDTH="79" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">1</TD>
<TD WIDTH="79" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">4</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="284" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" COLSPAN="2">합 계</TD>
<TD WIDTH="79" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">1</TD>
<TD WIDTH="79" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">3</TD>
<TD WIDTH="79" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">2</TD>
<TD WIDTH="79" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">6</TD>
</TR>
</TBODY>
</TABLE>

<P USERMARK="F-GL11">&cr;
<SPAN>3) 핵심 연구인력&cr;    당사의 핵심연구인력은 박영택 연구소장으로 바이오사업팀 겸임팀장, 의약품 합성팀 이한원 팀장으로, 연구소장인 박영택은 연구 및 사업화를 총괄하고 있으며, 생체 고분자 정제 및 생체 고분자를 이용한 담체 개발에 중점적인 연구 개발 및 사업화를 하고 있으며, 이한원 팀장은 제네릭 원료의약품 개발, 카이랄분리 기술을 이용한 개량신약개발 및 사업화를 진행하고 있음. </SPAN>
</P>
<P USERMARK="F-GL11">연구소장인 박영택은 발명자로 다수의 특허를 등록하였으며 대표적으로 </P>
<P USERMARK="F-GL11"> 1) 파클리탁셀의 가용화용 조성물 및 그의 제조 방법(Composition for solubilization of &cr;     paclitaxel and preparation method thereof)</P>
<P USERMARK="F-GL11"> 2) 플로로글루시놀을 유효성분으로 함유하는 신규 진경액제 (New antispasmodic solutio       n containing phloroglucinol as active ingredient) </P>
<P USERMARK="F-GL11"> 3) 리바스티그민의 간단한 경피흡수제 (A simple transdermal composition of rivastigmine)&cr; 4) 암로디핀 및 그 염을 함유한 필름코팅 제제 (A film-coated amlodipine preparation) </P>
<P USERMARK="F-GL11"> 5) 덱시부프로펜 알지닌염의 제조방법 (Manufacturing method of dexibuprofen arginate)&cr; 6) 디(뉴클레오시드5'-)폴리포스페이트의 제조 방법(Process for producing di(nucleosid      e5'-)polyphosphate) 이 있음.</P>
<P USERMARK="F-GL11">또한 연구소장인 박영택은 국가 과제 참여 실적으로</P>
<P USERMARK="F-GL11">  1) 산업자원부  '산업기반기술개발사업' &cr;    [총괄과제명: 고효율 항암제 전달체 개발(1999~2004)] </P>
<P USERMARK="F-GL11">     총괄관리기관: 한국화학연구원</P>
<P USERMARK="F-GL11">     세부주관기관: 대화제약㈜</P>
<P USERMARK="F-GL11">     세부총괄책임자: 박영택</P>
<P USERMARK="F-GL11">     세부과제명: Cubosome 등의 지질미세구조를 이용한 paclitaxel 복합제제 및 제형화기      술 개발</P>
<P USERMARK="F-GL11">   2) 보건복지부  '제품화기술개발지원 연구개발사업' &cr;    [총괄과제명: 고형암치료를 위한 파클리탁셀 제형 및 복합제제 개발(2002~2007)]</P>
<P USERMARK="F-GL11">     주관기관: 대화제약㈜ </P>
<P USERMARK="F-GL11">     주관연구책임자: 박영택</P>
<P USERMARK="F-GL11">   3) 산업자원부  '지역산업기술개발사업' &cr;     [과제명: 신규염을 이용한 속효성 dexibuprofen 제형 개발(2007~2008)] </P>
<P USERMARK="F-GL11">      주관기관: 대화제약㈜</P>
<P USERMARK="F-GL11">      총괄책임자: 박영택</P>
<P USERMARK="F-GL11">   4) 산업기술혁신사업  '전략적핵심소재기술개발사업'</P>
<P USERMARK="F-GL11">      [과제명: 발색·발광·검지 소자를 위한 테트라피롤계 소재개발 (2013~2016)] </P>
<P USERMARK="F-GL11">       참여기관: 대화제약㈜</P>
<P USERMARK="F-GL11">       연구책임자: 박영택&cr; 이한원 팀장은 발명자로 다수의 특허를 등록하였으며 대표적으로&cr;  1) 히알루론산 합성효소 변이 단백질 및 이를 이용한 히알루론산 생산 방법 (Mutant prot       ein of hyaluronic acid synthase and method of producing hyaluronic acid using the sy       stem)&cr;  2) 비병원성 세균을 이용하여 히알루론산 생산을 위한 발현 시스템 및 상기 발현 시스템       을 이용한 히알루론산 생산방법 (Expression system for production of hyaluronic acid       by using non-pathogenic bacteria and method of preparing hyaluronic acid using the s      ame)&cr; 이한원 팀장의 국가 과제 참여 실적으로&cr;  1) 산업통상자원부 '경제협력권산업육성사업'&cr;     [총괄과제명: 천연물 유래 기능성 물질 기반의 웰에이징 코스메슈티컬 제품 개발             (2018.04.01~2020.12.31)] &cr;      주관기관: 대화제약(주)</P>

<P USERMARK="F-GL11">      총괄책임자: 이정식&cr;      참여기관: (주)리독스바이오&cr;      참여기관책임자: 이한원&cr;                                          
<SPAN><핵심 연구인력 현황></SPAN>
</P>

<TABLE BORDER="1" WIDTH="1273" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="66"></COL>
<COL WIDTH="66"></COL>
<COL WIDTH="133"></COL>
<COL WIDTH="420"></COL>
<COL WIDTH="543"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="75" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" USERMARK=" BC0XBEBEBE">
<P USERMARK=" BC0XBEBEBE">직위</P>
</TD>

<TD WIDTH="75" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" USERMARK=" BC0XBEBEBE">
<P USERMARK=" BC0XBEBEBE">성명</P>
</TD>

<TD WIDTH="142" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" USERMARK=" BC0XBEBEBE">
<P USERMARK=" BC0XBEBEBE">담당업무</P>
</TD>

<TD WIDTH="429" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" USERMARK=" BC0XBEBEBE">
<P USERMARK=" BC0XBEBEBE">주요경력</P>
</TD>

<TD WIDTH="552" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" USERMARK=" BC0XBEBEBE">
<P USERMARK=" BC0XBEBEBE">주요 연구실적</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="75" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="102">
<P>연구소장 (전무)</P>
</TD>

<TD WIDTH="75" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="102">
<P>박영택</P>
</TD>

<TD WIDTH="142" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="102">
<P>연구총괄,&cr;생체 고분자 정제 및 생체 고분자를 이용한 담체 개발</P>
</TD>

<TD WIDTH="429" VALIGN="MIDDLE" HEIGHT="102">
<P>고려대학교 화학과 박사('91)</P>
<P>대화제약㈜ 연구소장('04~'08)</P>
<P>대화제약㈜ 향남공장공장장('12~'16)</P>
</TD>

<TD WIDTH="552" HEIGHT="102">
<P>1.Stable paclitaxel formulations in oily contrast medium, </P>
<P>Journal of Controlled Release 102 (2005) 415?425</P>
<P>2.Efficacy and tissue distribution of DHP107, an oral paclitaxel formulation, Mol Cancer Ther 2007;6(12). December 2007</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="75" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="214">
<P>의약품 </P>
<P>합성팀</P>
<P>(이사)</P>
</TD>

<TD WIDTH="75" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="214">
<P>이한원</P>
</TD>

<TD WIDTH="142" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="214">
<P>제네릭 원료의약품, 개량신약 개발</P>
</TD>

<TD WIDTH="429" VALIGN="MIDDLE" HEIGHT="214">
<P>한양대학교 화학과 유기화학 석사('93)</P>
<P>CJ제일제당 바이오기술연구소 바이오화학센터 팀장('11~'13)</P>
<P>동국제약 중앙연구소 합성연구팀 팀장('07-'08)</P>
<P>대상그룹 중앙연구소 유기합성연구소, 선임연구원</P>
</TD>

<TD WIDTH="552" HEIGHT="214">
<P>1. 바이오 화학산업과 CJ, BT NEWS 18(2), 2011.09</P>
<P>2. 전립선암 치료용 장기서방출성 펩타이드 호르몬 제제 개발, ATC 과제, 2005</P>
<P>3.Sodium Iodide as a novel, neutral and facile deprotecting reagent of &cr; N-tert-butyloxylcarbonyl groups in peptide chemistry, Protein and Peptide Letters 1998, 5(5):257-258</P>
<P>4. Sodium Iodide as a deprotection reagent in peptide synthesis, 80회 대한화학회 추계총회 논문초록, 1997, p352</P>
<P>5. 電氣化學的 方法에 의한 Epoxide Ring Opening Reaction과 Aldehyde와 Ketone의 合成, 대한화학회, 1992</P>
</TD>
</TR>
</TBODY>
</TABLE>

<P USERMARK="F-GL11">&cr;
<SPAN USERMARK="F-12 B">다. 연구개발비용 </SPAN>&cr;   당사의 최근 12개월간 연구개발비용은 다음과 같습니다.   &cr;                                                                                                   (단위: 천원,%)
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="837">

<COLGROUP>
<COL WIDTH="139"></COL>
<COL WIDTH="144"></COL>
<COL WIDTH="125"></COL>
<COL WIDTH="125"></COL>
<COL WIDTH="125"></COL>
<COL WIDTH="125"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD COLSPAN="2" WIDTH="301" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XBEBEBE">구          분</TD>
<TD WIDTH="134" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XBEBEBE">제11기</TD>
<TD WIDTH="134" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XBEBEBE">제10기</TD>
<TD WIDTH="134" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XBEBEBE">제9기</TD>
<TD WIDTH="134" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XBEBEBE">비 고</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ROWSPAN="6" VALIGN="MIDDLE" WIDTH="148" HEIGHT="180">비용의 성격별 분류</TD>
<TD VALIGN="MIDDLE" WIDTH="153" HEIGHT="30"> 원재료비 </TD>
<TD VALIGN="MIDDLE" WIDTH="134" HEIGHT="30" ALIGN="RIGHT">35,043</TD>
<TD VALIGN="MIDDLE" WIDTH="134" HEIGHT="30" ALIGN="RIGHT">4,037</TD>
<TD VALIGN="MIDDLE" WIDTH="134" HEIGHT="30" ALIGN="RIGHT">         1,160 </TD>
<TD VALIGN="MIDDLE" WIDTH="134" HEIGHT="30" ALIGN="CENTER">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="153" HEIGHT="30"> 인건비 </TD>
<TD VALIGN="MIDDLE" WIDTH="134" HEIGHT="30" ALIGN="RIGHT">375,134</TD>
<TD VALIGN="MIDDLE" WIDTH="134" HEIGHT="30" ALIGN="RIGHT">396,135</TD>

<TD VALIGN="MIDDLE" WIDTH="134" HEIGHT="30" ALIGN="RIGHT">
<SPAN>  </SPAN>
<SPAN>   473,801</SPAN>
</TD>
<TD VALIGN="MIDDLE" WIDTH="134" HEIGHT="30" ALIGN="CENTER">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="153" HEIGHT="30"> 감가상각비 </TD>
<TD VALIGN="MIDDLE" WIDTH="134" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD VALIGN="MIDDLE" WIDTH="134" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD VALIGN="MIDDLE" WIDTH="134" HEIGHT="30" ALIGN="RIGHT">                    - </TD>
<TD VALIGN="MIDDLE" WIDTH="134" HEIGHT="30" ALIGN="CENTER">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="153" HEIGHT="30"> 위탁용역비 </TD>
<TD VALIGN="MIDDLE" WIDTH="134" HEIGHT="30" ALIGN="RIGHT">420</TD>
<TD VALIGN="MIDDLE" WIDTH="134" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD VALIGN="MIDDLE" WIDTH="134" HEIGHT="30" ALIGN="RIGHT">         5,460 </TD>
<TD VALIGN="MIDDLE" WIDTH="134" HEIGHT="30" ALIGN="CENTER">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="153" HEIGHT="30"> 기타 </TD>
<TD VALIGN="MIDDLE" WIDTH="134" HEIGHT="30" ALIGN="RIGHT">117,621</TD>
<TD VALIGN="MIDDLE" WIDTH="134" HEIGHT="30" ALIGN="RIGHT">131,320</TD>
<TD VALIGN="MIDDLE" WIDTH="134" HEIGHT="30" ALIGN="RIGHT">       97,879 </TD>
<TD VALIGN="MIDDLE" WIDTH="134" HEIGHT="30" ALIGN="CENTER">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="153" HEIGHT="30"> 연구개발비용 합계 </TD>
<TD VALIGN="MIDDLE" WIDTH="134" HEIGHT="30" ALIGN="RIGHT">528,218</TD>
<TD VALIGN="MIDDLE" WIDTH="134" HEIGHT="30" ALIGN="RIGHT">531,492</TD>
<TD VALIGN="MIDDLE" WIDTH="134" HEIGHT="30" ALIGN="RIGHT">     578,300 </TD>
<TD VALIGN="MIDDLE" WIDTH="134" HEIGHT="30" ALIGN="CENTER">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ROWSPAN="6" VALIGN="MIDDLE" WIDTH="148" HEIGHT="180">회계처리내역</TD>
<TD VALIGN="MIDDLE" WIDTH="153" HEIGHT="30"> 판매비와관리비 </TD>
<TD VALIGN="MIDDLE" WIDTH="134" HEIGHT="30" ALIGN="RIGHT">548,722</TD>
<TD VALIGN="MIDDLE" WIDTH="134" HEIGHT="30" ALIGN="RIGHT">484,800</TD>
<TD VALIGN="MIDDLE" WIDTH="134" HEIGHT="30" ALIGN="RIGHT">    616,190 </TD>
<TD VALIGN="MIDDLE" WIDTH="134" HEIGHT="30" ALIGN="CENTER">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="153" HEIGHT="30"> 제조경비 </TD>
<TD VALIGN="MIDDLE" WIDTH="134" HEIGHT="30" ALIGN="RIGHT">44,851</TD>
<TD VALIGN="MIDDLE" WIDTH="134" HEIGHT="30" ALIGN="RIGHT">46,692</TD>
<TD VALIGN="MIDDLE" WIDTH="134" HEIGHT="30" ALIGN="RIGHT">       30,166 </TD>
<TD VALIGN="MIDDLE" WIDTH="134" HEIGHT="30" ALIGN="CENTER">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="153" HEIGHT="30"> 개발비(무형자산) </TD>
<TD VALIGN="MIDDLE" WIDTH="134" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD VALIGN="MIDDLE" WIDTH="134" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD VALIGN="MIDDLE" WIDTH="134" HEIGHT="30" ALIGN="RIGHT">                    - </TD>
<TD VALIGN="MIDDLE" WIDTH="134" HEIGHT="30" ALIGN="CENTER">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="153" HEIGHT="30"> 회계처리금액 계 </TD>
<TD VALIGN="MIDDLE" WIDTH="134" HEIGHT="30" ALIGN="RIGHT">593,573</TD>
<TD VALIGN="MIDDLE" WIDTH="134" HEIGHT="30" ALIGN="RIGHT">531,492</TD>
<TD VALIGN="MIDDLE" WIDTH="134" HEIGHT="30" ALIGN="RIGHT">     646,356 </TD>
<TD VALIGN="MIDDLE" WIDTH="134" HEIGHT="30" ALIGN="CENTER">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="153" HEIGHT="30"> 정부보조금 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="134" HEIGHT="30">(65,355)</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="134" HEIGHT="30">(77,328)</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="134" HEIGHT="30">(68,056) </TD>
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="134" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="153" HEIGHT="30"> 연구개발비용 합계 </TD>
<TD VALIGN="MIDDLE" WIDTH="134" HEIGHT="30" ALIGN="RIGHT">528,218</TD>
<TD VALIGN="MIDDLE" WIDTH="134" HEIGHT="30" ALIGN="RIGHT">454,164</TD>
<TD VALIGN="MIDDLE" WIDTH="134" HEIGHT="30" ALIGN="RIGHT">     578,300 </TD>
<TD VALIGN="MIDDLE" WIDTH="134" HEIGHT="30" ALIGN="CENTER">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD COLSPAN="2" WIDTH="301" VALIGN="MIDDLE" HEIGHT="53">연구개발비/매출액비율&cr; [연구개발비용합계 / 당기매출액*100]</TD>
<TD VALIGN="MIDDLE" WIDTH="134" HEIGHT="53" ALIGN="RIGHT">7.07</TD>
<TD VALIGN="MIDDLE" WIDTH="134" HEIGHT="53" ALIGN="RIGHT">4.25</TD>

<TD VALIGN="MIDDLE" WIDTH="134" HEIGHT="53" ALIGN="RIGHT">
<SPAN>               </SPAN>
<SPAN> 5.57</SPAN>
<SPAN> </SPAN>
</TD>
<TD VALIGN="MIDDLE" WIDTH="134" HEIGHT="53" ALIGN="CENTER">-</TD>
</TR>
</TBODY>
</TABLE>

<P USERMARK="F-GL11"> &cr;
<SPAN USERMARK="F-12 B">라. 연구개발실</SPAN>
<SPAN USERMARK=" B">적&cr;</SPAN>1) 연구개발 진행 현황 및 향후계획&cr;   공시서류 작성기준일 현재 당사가 연구개발 진행 중인 신약 [개량신약, 복제약(시밀러)등 포함]의 현황은 다음과 같습니다.&cr;
</P>

<TABLE ACLASS="NORMAL" WIDTH="753" BORDER="1" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="54"></COL>
<COL WIDTH="194"></COL>
<COL WIDTH="139"></COL>
<COL WIDTH="84"></COL>
<COL WIDTH="81"></COL>
<COL WIDTH="54"></COL>
<COL WIDTH="84"></COL>
</COLGROUP>

<TBODY ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TD ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="60" USERMARK=" BC0XBEBEBE">구 분</TD>
<TD ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="203" HEIGHT="60" USERMARK=" BC0XBEBEBE">품 목</TD>
<TD ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="148" HEIGHT="60" USERMARK=" BC0XBEBEBE">적응증</TD>
<TD ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="93" HEIGHT="60" USERMARK=" BC0XBEBEBE">연구시작일</TD>
<TD COLSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="153" HEIGHT="30" USERMARK=" BC0XBEBEBE">현재 진행단계</TD>
<TD ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="93" HEIGHT="60" USERMARK=" BC0XBEBEBE">비 고</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="90" HEIGHT="30" USERMARK=" BC0XBEBEBE">단계(국가)</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" USERMARK=" BC0XBEBEBE">승인일</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="43">바이오</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="203" HEIGHT="43">웰에이징 코스메슈티컬제품</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="148" HEIGHT="43">주름개선, 탈모완화</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="93" HEIGHT="43">2018년</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="90" HEIGHT="43">-</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="43">-</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="93" HEIGHT="43">정보보조금</TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK="F-GL11">&cr; (가) 품목: 천연물 유래 기능성 물질 기반의 웰에이징 코스메슈티컬 제품 개발</P>

<TABLE ACLASS="NORMAL" WIDTH="757" BORDER="1" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="126"></COL>
<COL WIDTH="613"></COL>
</COLGROUP>

<TBODY ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="135" HEIGHT="30" USERMARK=" BC0XBEBEBE">1. 구분</TD>
<TD WIDTH="622" HEIGHT="30">바이오</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="135" HEIGHT="53" USERMARK=" BC0XBEBEBE">2. 적응증</TD>

<TD WIDTH="622" HEIGHT="53">
<P>1) 주름개선, 탈모완화 및 아토피 피부염 증상 완화 </P>
<P>2) 서방출이 제어가능한 생체고분자의 서방형 소재 </P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="135" HEIGHT="76" USERMARK=" BC0XBEBEBE">3. 작용기전</TD>
<TD WIDTH="622" HEIGHT="76">주름개선, 탈모완화 및 아토피 피부염 증상 완화를 시킬 수 있는 천연물 유효성분의 서방출을 조절하기 위해 분자량 차이, 나노/마이크로 입자 혹은 고분자마이셀 등과 같은 유효성분저장고를 이용하여 유효성분이 장기간 피부 속에서 방출되도록 하는 작용기전임.</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="135" HEIGHT="122" USERMARK=" BC0XBEBEBE">4. 제품의 특성</TD>

<TD WIDTH="622" HEIGHT="122">
<P>1) 생체고분자 서방형 소재인 히알루론산 나트륨에 존재할 수 있는 미생물 내독소(엔도톡     신)가 국제 기준에 적합함.</P>
<P>2) 생체고분자인 히알루론산 나트륨의 분자량에 따른 유효성분의 서방출이 제어가능한 소    재 platform을 적용 가능함.</P>
<P>3) 자연친화적이며, 안전한 천연물 추출물을 융합할 수 있는 생체 유래 기능성 소재임.</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="135" HEIGHT="145" USERMARK=" BC0XBEBEBE">5. 진행경과</TD>

<TD WIDTH="622" HEIGHT="145">
<P>1) 현재, 생체고분자 소재 개발을 위해 '산업통상자원부 경제협력권산업육성사업' &cr;   (협력프로젝트명: 웰라이프 바이오 헬스케어 특화 기능성 소재 및 융합형 의료기기 기술    개발, 총수행기간: 2018. 04. 01 ~ 2020. 12. 31)을 진행하고 있음. </P>
<P>2) 우선 일차적으로, 생체고분자인 히알루론산 나트륨에 존재할 수 있는 미생물 내독소(       엔도톡신, endotoxin)를 국제 기준에 맞게 제거하는 기술을 확립하여 소재에 대한 안전성    을 확보하였음.  </P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="135" HEIGHT="191" USERMARK=" BC0XBEBEBE">6. 향후계획</TD>

<TD WIDTH="622" HEIGHT="191">
<P>1) 현재, 진행중인 '산업통상자원부 경제협력권산업육성사업'을 통해 천연물 유래 기능성      물질 기반의 웰에이징 코스메슈티컬 제품 개발에 필요한 소재를 제공하기 위해 생체고분    자의 분자량에 따른 소재 platform 개발을 진행할 계획이며,</P>
<P>2) 주관기관인 대화제약㈜, 참여기업인 ㈜알엔에스가 제형 시제품 개발 및 주름 개선 및 탈    모개선의 임상 효과를 확인하기 위한 인체적용시험에 필요한 소재를 제공할 계획에 있고,   향후, 제품화에 참여할 계획임. </P>
<P>3) 생체유래 천연고분자의 자체 생산을 위한 발효연구 및 발효 생산성을 높이기 위한 미생     물 균주의 스크리닝 및 유전자 조작에 의한 우수 균주의 개발을 진행할 계획에 있음.</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="135" HEIGHT="191" USERMARK=" BC0XBEBEBE">7. 경쟁제품</TD>

<TD WIDTH="622" HEIGHT="191">
<P>1) 주름 개선 소재: 현재, 주름개선 기능성화장품의 고시 원료들에는 레티놀, 레티닐팔미       테이트, 아데노신 및 폴리에톡실레이티드레틴아마이드와 같이 4 종류로 한정되어 있으       며, 아직까지 서방출이 제어가능한 제품은 없음.</P>
<P>2) 탈모 지연 약물: 염화카프로니움, 미녹시딜 및 혈관 확장제 및 호르몬 (에스트로겐, 에스    트라디올) 등이 있으나, 이들 약물들은 그 부작용으로 인해 사용상 주의가 필요함</P>
<P>3) 아토피 피부염의 약물치료제 : 국소 및 전신 스테로이드제, 항히스타민제, 국소 및 전신     항생제 등이 사용되고 있으나, 각 치료제에 따른 부작용이 존재하며, 아직까지 서방출이     제어가능한 제품은 없음. </P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="135" HEIGHT="30" USERMARK=" BC0XBEBEBE">8. 관련논문 등</TD>
<TD WIDTH="622" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="135" HEIGHT="168" USERMARK=" BC0XBEBEBE">9. 시장규모</TD>

<TD WIDTH="622" HEIGHT="168">
<P>1) 탈모관련 헤어케어 화장품 등의 의약외품 및 탈모치료제 국내 시장은 2015년 상반기를      기준으로 1조원에 육박하며, 최근 탈모인구가 2013년 21만명에서 2015년에는 223만명을    초과하는 등 향후 탈모 관련 분야의 성장세가 높을 것으로 전망됨(출처 : 국민건강보험공    단).</P>
<P>2) 아토피: 2010에서 2015년 아토피 질환으로 진료를 받은 환자수는 621만3762명(출처:        국민건강보험공단)이며, 우리나라 전체 아토피관련 시당 규모는 5000억으로 추산되고 있    음. 또한 세계 시장은 2018년 48억 달러(출처 : 글로벌 데이터)임. </P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="135" HEIGHT="30" USERMARK=" BC0XBEBEBE">10. 기타사항</TD>
<TD WIDTH="622" HEIGHT="30">-</TD>
</TR>
</TBODY>
</TABLE>

<P>&cr;
<SPAN USERMARK="F-GL11"></SPAN>
<SPAN USERMARK="F-GL11"></SPAN>
<SPAN USERMARK="F-GL11 B"></SPAN>
<SPAN USERMARK="F-GL11">2) 연구개발 완</SPAN>
<SPAN USERMARK="F-GL11">료 실적&cr;  당사는 보고서 제출일 현재 완료된 실적 없습니다.&cr;&cr;3) 기타 연구개발 실적</SPAN>
</P>

<P USERMARK="F-GL11">
<SPAN>  </SPAN>
<SPAN>당사는 보고서 제출일 현재 완료된 실적 없습니다.</SPAN>
<SPAN>&cr;&cr;</SPAN>
</P>
<P USERMARK="F-GL16 0XFF0016 B">11. 그 밖에 투자의사결정에 필요한 사항</P>

<P USERMARK="F-GL">&cr;
<SPAN USERMARK="F-11"></SPAN>
<SPAN USERMARK="F-11 B">가. 지적재산권보유현황 등</SPAN>
</P>

<P>
<SPAN USERMARK="F-GL11">&cr;당사는 다음과 같은 특허권을 보유하고 있습니다. 2019년 이후 취득한 특허 외 특허권은 당사가 지배회사인 대화제약(주)로부터의 현물출자를 통한 사업부문이전으로 취득한 내역입니다.</SPAN>
</P>

<TABLE ACLASS="NORMAL" WIDTH="751" BORDER="1" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="352"></COL>
<COL WIDTH="154"></COL>
<COL WIDTH="83"></COL>
<COL WIDTH="126"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH ALIGN="CENTER" VALIGN="BOTTOM" WIDTH="361" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">내용</TH>
<TH ALIGN="CENTER" VALIGN="BOTTOM" WIDTH="163" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">특허번호</TH>

<TH ALIGN="CENTER" VALIGN="BOTTOM" WIDTH="92" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>취득일</P>
</TH>

<TH ALIGN="CENTER" VALIGN="BOTTOM" WIDTH="135" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>보호기간 만료일</P>
</TH>
</TR>
</THEAD>

<TBODY ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="361" HEIGHT="30">디아세레인의 새로운 제조방법</TD>
<TD WIDTH="163" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">특허 제10-0715076호</TD>

<TD WIDTH="92" HEIGHT="30" VALIGN="BOTTOM" ALIGN="CENTER">
<P>2007.04.27</P>
</TD>

<TD WIDTH="135" HEIGHT="30" VALIGN="BOTTOM" ALIGN="CENTER">
<P>2025.06.10</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="361" HEIGHT="30">보글리보스의 제조방법</TD>
<TD WIDTH="163" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">특허 제10-0740458호</TD>

<TD WIDTH="92" HEIGHT="30" VALIGN="BOTTOM" ALIGN="CENTER">
<P>2007.07.11</P>
</TD>

<TD WIDTH="135" HEIGHT="30" VALIGN="BOTTOM" ALIGN="CENTER">
<P>2026.05.08</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="361" HEIGHT="30">덱시부프로펜염의 제조방법</TD>
<TD WIDTH="163" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">특허 제10-0917593호</TD>

<TD WIDTH="92" HEIGHT="30" VALIGN="BOTTOM" ALIGN="CENTER">
<P>2009.09.09</P>
</TD>

<TD WIDTH="135" HEIGHT="30" VALIGN="BOTTOM" ALIGN="CENTER">
<P>2027.08.09</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="361" HEIGHT="30">에스-암로디핀베실레이트 및 그 수화물의 제조방법</TD>
<TD WIDTH="163" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">특허 제10-1313842호</TD>

<TD WIDTH="92" HEIGHT="30" VALIGN="BOTTOM" ALIGN="CENTER">
<P>2013.09.25</P>
</TD>

<TD WIDTH="135" HEIGHT="30" VALIGN="BOTTOM" ALIGN="CENTER">
<P>2030.09.15</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="361" HEIGHT="30">알-라베프라졸, 이의 금속염의 제조방법</TD>
<TD WIDTH="163" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">특허 제10-1459088호</TD>

<TD WIDTH="92" HEIGHT="30" VALIGN="BOTTOM" ALIGN="CENTER">
<P>2014.10.31</P>
</TD>

<TD WIDTH="135" HEIGHT="30" VALIGN="BOTTOM" ALIGN="CENTER">
<P>2032.08.02</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="361" HEIGHT="30">디(뉴클레오시드 5'-)폴리포스페이트의 제조방법</TD>
<TD WIDTH="163" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">특허 제10-1985791호</TD>
<TD WIDTH="92" HEIGHT="30" VALIGN="BOTTOM" ALIGN="CENTER">2019.05.29</TD>
<TD WIDTH="135" HEIGHT="30" VALIGN="BOTTOM" ALIGN="CENTER">2037.07.27</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="361" HEIGHT="53">히알루론산 합성효소 변이 단백질 및 이를 이용한 히알루론산 생산방법</TD>
<TD WIDTH="163" HEIGHT="53" VALIGN="MIDDLE" ALIGN="CENTER">특허 제10-2135044호</TD>
<TD WIDTH="92" HEIGHT="53" VALIGN="MIDDLE" ALIGN="CENTER">2020.07.13</TD>
<TD WIDTH="135" HEIGHT="53" VALIGN="MIDDLE" ALIGN="CENTER">2039.02.12</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="361" HEIGHT="76">비병원성 세균을 이용하여 히알루론산 생산을 위한 발현 시스템 및 상기 발현 시스템을 이용한 히알루론산 생산방법</TD>
<TD WIDTH="163" HEIGHT="76" VALIGN="MIDDLE" ALIGN="CENTER">특허 제10-2152625호</TD>
<TD WIDTH="92" HEIGHT="76" VALIGN="MIDDLE" ALIGN="CENTER">2020.09.01</TD>
<TD WIDTH="135" HEIGHT="76" VALIGN="MIDDLE" ALIGN="CENTER">2039.02.12</TD>
</TR>
</TBODY>
</TABLE>

<INSERTION ABASISNUMBER="SE1" AFREQUENCY="0" ADUPLICATION="N">
<COMMENT>◆click◆『수주상황』 삽입</COMMENT>
<LIBRARYLIST>11011#*_수주상황.dsl</LIBRARYLIST>
</INSERTION>
<PGBRK></PGBRK>
</SECTION-1>

<SECTION-1 ACLASS="MANDATORY" APARTSOURCE="SOURCE">
<TITLE ATOC="Y" AASSOCNOTE="D-0-3-0-0">III. 재무에 관한 사항</TITLE>
<P></P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="627">

<COLGROUP>
<COL WIDTH="618"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD USERMARK=" B" WIDTH="627" HEIGHT="59">다음의 재무제표는 일반기업회계기준에 따라 작성되었으며 
<SPAN>제11기 당기</SPAN> 재무제표는 회계감사인으로 부터 감사받은 재무제표 입니다.
</TD>
</TR>
</TBODY>
</TABLE>

<SECTION-2 ACLASS="MANDATORY">
<TITLE ATOC="Y" AASSOCNOTE="D-0-3-1-0">1. 요약재무정보</TITLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="626">

<COLGROUP>
<COL WIDTH="617"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="626" HEIGHT="30" ALIGN="RIGHT">(단위 : 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="624">

<COLGROUP>
<COL WIDTH="209"></COL>
<COL WIDTH="127"></COL>
<COL WIDTH="126"></COL>
<COL WIDTH="126"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="218" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구분</TH>
<TH WIDTH="136" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">제 11 기</TH>
<TH WIDTH="135" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">제 10 기</TH>
<TH WIDTH="135" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">제 9 기</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="218" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE"></TD>
<TD WIDTH="136" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">(2020년 12월말)</TD>
<TD WIDTH="135" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">(2019년 12월말)</TD>
<TD WIDTH="135" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">(2018년 12월말)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="218" HEIGHT="30">[유동자산]</TD>
<TD WIDTH="136" HEIGHT="30" ALIGN="RIGHT">3,723,536</TD>
<TD WIDTH="135" HEIGHT="30" ALIGN="RIGHT">4,648,848</TD>
<TD WIDTH="135" HEIGHT="30" ALIGN="RIGHT">7,107,577</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="218" HEIGHT="30">  ㆍ현금및현금성자산</TD>
<TD WIDTH="136" HEIGHT="30" ALIGN="RIGHT">362,824</TD>
<TD WIDTH="135" HEIGHT="30" ALIGN="RIGHT">414,545</TD>
<TD WIDTH="135" HEIGHT="30" ALIGN="RIGHT">2,332,397</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="218" HEIGHT="30">  ㆍ매출채권 및 기타유동채권</TD>
<TD WIDTH="136" HEIGHT="30" ALIGN="RIGHT">536,276</TD>
<TD WIDTH="135" HEIGHT="30" ALIGN="RIGHT">2,273,023</TD>
<TD WIDTH="135" HEIGHT="30" ALIGN="RIGHT">2,289,799</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="218" HEIGHT="30">  ㆍ재고자산</TD>
<TD WIDTH="136" HEIGHT="30" ALIGN="RIGHT">2,824,436</TD>
<TD WIDTH="135" HEIGHT="30" ALIGN="RIGHT">1,961,280</TD>
<TD WIDTH="135" HEIGHT="30" ALIGN="RIGHT">2,485,381</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="218" HEIGHT="30">[비유동자산]</TD>
<TD WIDTH="136" HEIGHT="30" ALIGN="RIGHT">19,516,350</TD>
<TD WIDTH="135" HEIGHT="30" ALIGN="RIGHT">19,772,260</TD>
<TD WIDTH="135" HEIGHT="30" ALIGN="RIGHT">10,533,871</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="218" HEIGHT="30">  ㆍ투자자산</TD>
<TD WIDTH="136" HEIGHT="30" ALIGN="RIGHT">2,913,453</TD>
<TD WIDTH="135" HEIGHT="30" ALIGN="RIGHT">2,996,351</TD>
<TD WIDTH="135" HEIGHT="30" ALIGN="RIGHT">3,409,366</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="218" HEIGHT="30">  ㆍ유형자산</TD>
<TD WIDTH="136" HEIGHT="30" ALIGN="RIGHT">16,557,991</TD>
<TD WIDTH="135" HEIGHT="30" ALIGN="RIGHT">16,725,632</TD>
<TD WIDTH="135" HEIGHT="30" ALIGN="RIGHT">7,082,253</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="218" HEIGHT="30">  ㆍ무형자산</TD>
<TD WIDTH="136" HEIGHT="30" ALIGN="RIGHT">16,197</TD>
<TD WIDTH="135" HEIGHT="30" ALIGN="RIGHT">21,568</TD>
<TD WIDTH="135" HEIGHT="30" ALIGN="RIGHT">23,543</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="218" HEIGHT="30">  ㆍ기타비유동자산</TD>
<TD WIDTH="136" HEIGHT="30" ALIGN="RIGHT">28,709</TD>
<TD WIDTH="135" HEIGHT="30" ALIGN="RIGHT">28,709</TD>
<TD WIDTH="135" HEIGHT="30" ALIGN="RIGHT">18,709</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" B" WIDTH="218" HEIGHT="30" ALIGN="CENTER">자산총계</TD>
<TD USERMARK=" B" WIDTH="136" HEIGHT="30" ALIGN="RIGHT">23,239,886</TD>
<TD USERMARK=" B" WIDTH="135" HEIGHT="30" ALIGN="RIGHT">24,421,108</TD>
<TD USERMARK=" B" WIDTH="135" HEIGHT="30" ALIGN="RIGHT">17,641,448</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="218" HEIGHT="30">[유동부채]</TD>
<TD WIDTH="136" HEIGHT="30" ALIGN="RIGHT">3,119,955</TD>
<TD WIDTH="135" HEIGHT="30" ALIGN="RIGHT">2,481,615</TD>
<TD WIDTH="135" HEIGHT="30" ALIGN="RIGHT">862,497</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="218" HEIGHT="30">[비유동부채]</TD>
<TD WIDTH="136" HEIGHT="30" ALIGN="RIGHT">5,731,355</TD>
<TD WIDTH="135" HEIGHT="30" ALIGN="RIGHT">6,460,491</TD>
<TD WIDTH="135" HEIGHT="30" ALIGN="RIGHT">458,594</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" B" WIDTH="218" HEIGHT="30" ALIGN="CENTER">부채총계</TD>
<TD USERMARK=" B" WIDTH="136" HEIGHT="30" ALIGN="RIGHT">8,851,310</TD>
<TD USERMARK=" B" WIDTH="135" HEIGHT="30" ALIGN="RIGHT">8,942,106</TD>
<TD USERMARK=" B" WIDTH="135" HEIGHT="30" ALIGN="RIGHT">1,321,091</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="218" HEIGHT="30">[자본금]</TD>
<TD WIDTH="136" HEIGHT="30" ALIGN="RIGHT">12,305,935</TD>
<TD WIDTH="135" HEIGHT="30" ALIGN="RIGHT">12,305,935</TD>
<TD WIDTH="135" HEIGHT="30" ALIGN="RIGHT">12,305,935</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="218" HEIGHT="30">[자본잉여금]</TD>
<TD WIDTH="136" HEIGHT="30" ALIGN="RIGHT">4,973,250</TD>
<TD WIDTH="135" HEIGHT="30" ALIGN="RIGHT">4,973,250</TD>

<TD WIDTH="135" HEIGHT="30" ALIGN="RIGHT">
<SPAN>4,973,250</SPAN>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="218" HEIGHT="30">[기타포괄손익누계액]</TD>
<TD WIDTH="136" HEIGHT="30" ALIGN="RIGHT">35,366</TD>
<TD WIDTH="135" HEIGHT="30" ALIGN="RIGHT">(87,696)</TD>
<TD WIDTH="135" HEIGHT="30" ALIGN="RIGHT">(147,016)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="218" HEIGHT="30">[이익잉여금]</TD>
<TD WIDTH="136" HEIGHT="30" ALIGN="RIGHT">(2,925,975)</TD>
<TD WIDTH="135" HEIGHT="30" ALIGN="RIGHT">(1,712,487)</TD>
<TD WIDTH="135" HEIGHT="30" ALIGN="RIGHT">(811,812)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" B" WIDTH="218" HEIGHT="30" ALIGN="CENTER">자본총계</TD>
<TD USERMARK=" B" WIDTH="136" HEIGHT="30" ALIGN="RIGHT">14,388,576</TD>
<TD USERMARK=" B" WIDTH="135" HEIGHT="30" ALIGN="RIGHT">15,479,002</TD>
<TD USERMARK=" B" WIDTH="135" HEIGHT="30" ALIGN="RIGHT">16,320,357</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="218" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE">종속·관계·공동기업 &cr;투자주식의 평가방법</TD>
<TD USERMARK="F-10" WIDTH="136" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE">관계회사 : 지분법</TD>

<TD USERMARK="F-10" WIDTH="135" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE">
<SPAN>관계회사 : 지분법</SPAN>
</TD>
<TD WIDTH="135" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE" USERMARK="F-10">관계회사 : 지분법</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="218" HEIGHT="53">
<SPAN USERMARK=" B">【손익계산정보】</SPAN>
</TD>
<TD WIDTH="136" HEIGHT="53" ALIGN="CENTER">(2020.01.01~&cr;2020.12.31)</TD>
<TD WIDTH="135" HEIGHT="53" ALIGN="CENTER">(2019.01.01~&cr;2019.12.31)</TD>
<TD WIDTH="135" HEIGHT="53" ALIGN="CENTER">(2018.01.01~&cr;2018.12.31)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="218" HEIGHT="30">매출액</TD>
<TD WIDTH="136" HEIGHT="30" ALIGN="RIGHT">7,467,276</TD>
<TD WIDTH="135" HEIGHT="30" ALIGN="RIGHT">10,679,061</TD>
<TD WIDTH="135" HEIGHT="30" ALIGN="RIGHT">10,380,582</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="218" HEIGHT="30">영업이익</TD>
<TD WIDTH="136" HEIGHT="30" ALIGN="RIGHT">(424,393)</TD>
<TD WIDTH="135" HEIGHT="30" ALIGN="RIGHT">(12,181)</TD>
<TD WIDTH="135" HEIGHT="30" ALIGN="RIGHT">1,244,746</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="218" HEIGHT="30">당기순이익</TD>
<TD WIDTH="136" HEIGHT="30" ALIGN="RIGHT">(1,213,488)</TD>
<TD WIDTH="135" HEIGHT="30" ALIGN="RIGHT">(900,674)</TD>
<TD WIDTH="135" HEIGHT="30" ALIGN="RIGHT">86,863</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="218" HEIGHT="30">주당순이익(손실)(단위 : 원)</TD>
<TD WIDTH="136" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="135" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="135" HEIGHT="30" ALIGN="RIGHT"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="218" HEIGHT="30"> ㆍ기본주당순이익(손실)</TD>
<TD WIDTH="136" HEIGHT="30" ALIGN="RIGHT">(49)</TD>
<TD WIDTH="135" HEIGHT="30" ALIGN="RIGHT">(37)</TD>
<TD WIDTH="135" HEIGHT="30" ALIGN="RIGHT">4</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="218" HEIGHT="30"> ㆍ희석주당순이익(손실)</TD>
<TD WIDTH="136" HEIGHT="30" ALIGN="RIGHT">(49)</TD>
<TD WIDTH="135" HEIGHT="30" ALIGN="RIGHT">(37)</TD>
<TD WIDTH="135" HEIGHT="30" ALIGN="RIGHT">4</TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK="F-GL11">※상기 재무제표는 주주총회 승인전 재무제표이며 향후 정기주주총회에서 재무제표 승인 관련 안건이 부결되거나 수정이 발생한 경우 정정보고서를 통해 그 내용 및 사유 등을 반영할 예정 입니다. </P>
<WARNING>※ 아래 『재무제표』단위서식을 클릭하여 해당사항을 선택하면,&cr;    2.연결재무제표 ~ 5.재무제표주석 항목을 삽입할 수 있습니다.</WARNING>
</SECTION-2>

<INSERTION ABASISNUMBER="E1" AFREQUENCY="1" ADUPLICATION="N">
<COMMENT>◆click◆『재무제표』 삽입</COMMENT>
<LIBRARYLIST>11011#*재무제표_*.*</LIBRARYLIST>

<LIBRARY>
<FILENAME ATYPE="dsl">재무제표_직접작성</FILENAME>

<SECTION-2 ACLASS="MANDATORY">
<TITLE ATOC="Y" AASSOCNOTE="D-0-3-2-0">2. 연결재무제표</TITLE>
<P USERMARK="F-GL11">해당사항없음</P>
<P></P>
</SECTION-2>

<SECTION-2 ACLASS="MANDATORY">
<TITLE ATOC="Y" AASSOCNOTE="D-0-3-3-0">3. 연결재무제표 주석</TITLE>
<P USERMARK="F-GL11">해당사항없음</P>
<P></P>
</SECTION-2>

<SECTION-2 ACLASS="MANDATORY">
<TITLE ATOC="Y" AASSOCNOTE="D-0-3-4-0">4. 재무제표</TITLE>
<P></P>

<P>
<SPAN USERMARK="F-GL11 B">가. 재무상태표 </SPAN>
<SPAN USERMARK="F-GL11 B">&cr;</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" WIDTH="670" BORDER="0">

<COLGROUP>
<COL WIDTH="291"></COL>
<COL WIDTH="361"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD COLSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="670" HEIGHT="30">제 11 기말                 2020년 12월 31일 현재</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD COLSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="670" HEIGHT="30">제 10 기말                 2019년 12월 31일 현재</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD COLSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="670" HEIGHT="30">제 9 기말                   2018년 12월 31일 현재</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="BOTTOM" WIDTH="300" HEIGHT="30">주식회사 리독스바이오</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="370" HEIGHT="30">(단위 : 원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="674">

<COLGROUP>
<COL WIDTH="235"></COL>
<COL WIDTH="134"></COL>
<COL WIDTH="134"></COL>
<COL WIDTH="135"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="244" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">과 목</TH>
<TH WIDTH="143" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">제 11 기</TH>
<TH WIDTH="143" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">제 10 기</TH>
<TH WIDTH="144" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">제 9 기</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="244" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">자                          산</TD>
<TD WIDTH="143" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="143" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="144" HEIGHT="30" ALIGN="RIGHT"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="244" HEIGHT="30" VALIGN="MIDDLE">Ⅰ. 유동자산</TD>
<TD WIDTH="143" HEIGHT="30" ALIGN="RIGHT">3,723,536,676</TD>
<TD WIDTH="143" HEIGHT="30" ALIGN="RIGHT">4,648,847,528</TD>
<TD WIDTH="144" HEIGHT="30" ALIGN="RIGHT">7,107,576,731</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD USERMARK=" P16" WIDTH="244" HEIGHT="30" VALIGN="MIDDLE">
<SPAN>(1) 당좌자산 (</SPAN>
<SPAN>주석3</SPAN>
<SPAN></SPAN>
<SPAN>)</SPAN>
</TD>
<TD WIDTH="143" HEIGHT="30" ALIGN="RIGHT">899,101,106</TD>
<TD WIDTH="143" HEIGHT="30" ALIGN="RIGHT">2,687,567,194</TD>
<TD WIDTH="144" HEIGHT="30" ALIGN="RIGHT">4,622,195,881</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" P32" WIDTH="244" HEIGHT="30" VALIGN="MIDDLE">1.현금및현금성자산</TD>
<TD WIDTH="143" HEIGHT="30" ALIGN="RIGHT">362,824,855</TD>
<TD WIDTH="143" HEIGHT="30" ALIGN="RIGHT">414,544,602</TD>
<TD WIDTH="144" HEIGHT="30" ALIGN="RIGHT">2,332,396,720</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" P32" WIDTH="244" HEIGHT="30" VALIGN="MIDDLE">2.매출채권 (주석11)</TD>
<TD WIDTH="143" HEIGHT="30" ALIGN="RIGHT">518,207,347</TD>
<TD WIDTH="143" HEIGHT="30" ALIGN="RIGHT">2,260,111,888</TD>
<TD WIDTH="144" HEIGHT="30" ALIGN="RIGHT">1,650,041,012</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" P32" WIDTH="244" HEIGHT="30" VALIGN="MIDDLE">3.미수금</TD>
<TD WIDTH="143" HEIGHT="30" ALIGN="RIGHT">13,012,438</TD>
<TD WIDTH="143" HEIGHT="30" ALIGN="RIGHT">7,612,998</TD>
<TD WIDTH="144" HEIGHT="30" ALIGN="RIGHT">226,130,141</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" P32" WIDTH="244" HEIGHT="30" VALIGN="MIDDLE">4.선급비용</TD>
<TD WIDTH="143" HEIGHT="30" ALIGN="RIGHT">5,006,996</TD>
<TD WIDTH="143" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="144" HEIGHT="30" ALIGN="RIGHT">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" P32" WIDTH="244" HEIGHT="30" VALIGN="MIDDLE">5.선급금</TD>
<TD WIDTH="143" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="143" HEIGHT="30" ALIGN="RIGHT">5,137,996</TD>
<TD WIDTH="144" HEIGHT="30" ALIGN="RIGHT">413,628,008</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" P16" WIDTH="244" HEIGHT="30" VALIGN="MIDDLE">   6.당기법인세자산</TD>
<TD WIDTH="143" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">49,470</TD>
<TD WIDTH="143" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">159,710</TD>
<TD WIDTH="144" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="244" HEIGHT="30" VALIGN="MIDDLE">   (2) 재고자산</TD>
<TD WIDTH="143" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">2,824,435,570</TD>
<TD WIDTH="143" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">1,961,280,334</TD>
<TD WIDTH="144" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">2,485,380,850</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" P32" WIDTH="244" HEIGHT="30" VALIGN="MIDDLE">1.상품</TD>
<TD WIDTH="143" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="143" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="144" HEIGHT="30" ALIGN="RIGHT">425,531,526</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" P32" WIDTH="244" HEIGHT="30" VALIGN="MIDDLE">2.제품</TD>
<TD WIDTH="143" HEIGHT="30" ALIGN="RIGHT">2,316,337,008</TD>
<TD WIDTH="143" HEIGHT="30" ALIGN="RIGHT">1,086,343,564</TD>
<TD WIDTH="144" HEIGHT="30" ALIGN="RIGHT">1,315,996,413</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" P32" WIDTH="244" HEIGHT="30" VALIGN="MIDDLE">3.원재료</TD>
<TD WIDTH="143" HEIGHT="30" ALIGN="RIGHT">453,140,395</TD>
<TD WIDTH="143" HEIGHT="30" ALIGN="RIGHT">809,673,579</TD>
<TD WIDTH="144" HEIGHT="30" ALIGN="RIGHT">600,362,719</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" P16" WIDTH="244" HEIGHT="30" VALIGN="MIDDLE">   4.재공품</TD>
<TD WIDTH="143" HEIGHT="30" ALIGN="RIGHT">54,958,167</TD>
<TD WIDTH="143" HEIGHT="30" ALIGN="RIGHT">65,263,191</TD>
<TD WIDTH="144" HEIGHT="30" ALIGN="RIGHT">143,490,192</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="244" HEIGHT="30" VALIGN="MIDDLE">
<SPAN>Ⅱ. 비유동자산</SPAN>
</TD>
<TD WIDTH="143" HEIGHT="30" ALIGN="RIGHT">19,516,349,872</TD>
<TD WIDTH="143" HEIGHT="30" ALIGN="RIGHT">19,772,260,232</TD>
<TD WIDTH="144" HEIGHT="30" ALIGN="RIGHT">10,533,871,011</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="244" HEIGHT="30" VALIGN="MIDDLE">
<SPAN>   (1) 투자자산</SPAN>
</TD>
<TD WIDTH="143" HEIGHT="30" ALIGN="RIGHT">2,913,452,750</TD>
<TD WIDTH="143" HEIGHT="30" ALIGN="RIGHT">2,996,351,009</TD>
<TD WIDTH="144" HEIGHT="30" ALIGN="RIGHT">3,409,366,122</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD USERMARK=" P32" WIDTH="244" HEIGHT="30" VALIGN="MIDDLE">매도가능증권 
<SPAN></SPAN>
<SPAN>(</SPAN>
<SPAN>주석4)</SPAN>
</TD>
<TD WIDTH="143" HEIGHT="30" ALIGN="RIGHT">100,000,000</TD>
<TD WIDTH="143" HEIGHT="30" ALIGN="RIGHT">100,000,000</TD>
<TD WIDTH="144" HEIGHT="30" ALIGN="RIGHT">100,000,000</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="244" HEIGHT="30" VALIGN="MIDDLE">
<SPAN>      지</SPAN>
<SPAN>분법적용투자주식 (주석5)</SPAN>
</TD>
<TD WIDTH="143" HEIGHT="30" ALIGN="RIGHT">2,813,452,750</TD>
<TD WIDTH="143" HEIGHT="30" ALIGN="RIGHT">2,896,351,009</TD>
<TD WIDTH="144" HEIGHT="30" ALIGN="RIGHT">3,309,366,122</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="244" HEIGHT="30" VALIGN="MIDDLE">
<SPAN>   (2) 유형자산 (</SPAN>
<SPAN>주석6</SPAN>
<SPAN>)</SPAN>
</TD>
<TD WIDTH="143" HEIGHT="30" ALIGN="RIGHT">16,557,990,857</TD>
<TD WIDTH="143" HEIGHT="30" ALIGN="RIGHT">16,725,631,948</TD>
<TD WIDTH="144" HEIGHT="30" ALIGN="RIGHT">7,082,253,031</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" P32" WIDTH="244" HEIGHT="30" VALIGN="MIDDLE">1.토지</TD>
<TD WIDTH="143" HEIGHT="30" ALIGN="RIGHT">2,593,482,000</TD>
<TD WIDTH="143" HEIGHT="30" ALIGN="RIGHT">2,593,482,000</TD>
<TD WIDTH="144" HEIGHT="30" ALIGN="RIGHT">2,593,482,000</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" P32" WIDTH="244" HEIGHT="30" VALIGN="MIDDLE">2.건물</TD>
<TD WIDTH="143" HEIGHT="30" ALIGN="RIGHT">9,595,654,695</TD>
<TD WIDTH="143" HEIGHT="30" ALIGN="RIGHT">9,079,912,995</TD>
<TD WIDTH="144" HEIGHT="30" ALIGN="RIGHT">1,193,031,300</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" P32" WIDTH="244" HEIGHT="30" VALIGN="MIDDLE">  건물감가상각누계액</TD>
<TD WIDTH="143" HEIGHT="30" ALIGN="RIGHT">(416,842,450)</TD>
<TD WIDTH="143" HEIGHT="30" ALIGN="RIGHT">(180,712,765)</TD>
<TD WIDTH="144" HEIGHT="30" ALIGN="RIGHT">(97,106,473)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" P32" WIDTH="244" HEIGHT="30" VALIGN="MIDDLE">3.기계장치</TD>
<TD WIDTH="143" HEIGHT="30" ALIGN="RIGHT">7,365,350,435</TD>
<TD WIDTH="143" HEIGHT="30" ALIGN="RIGHT">2,563,442,052</TD>
<TD WIDTH="144" HEIGHT="30" ALIGN="RIGHT">2,392,942,052</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" P32" WIDTH="244" HEIGHT="30" VALIGN="MIDDLE">  기계장치감가상각누계액</TD>
<TD WIDTH="143" HEIGHT="30" ALIGN="RIGHT">(2,623,120,587)</TD>
<TD WIDTH="143" HEIGHT="30" ALIGN="RIGHT">(2,089,849,621)</TD>
<TD WIDTH="144" HEIGHT="30" ALIGN="RIGHT">(1,778,340,436)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" P32" WIDTH="244" HEIGHT="30" VALIGN="MIDDLE">  정부보조금</TD>
<TD WIDTH="143" HEIGHT="30" ALIGN="RIGHT">(30,773,111)</TD>
<TD WIDTH="143" HEIGHT="30" ALIGN="RIGHT">(15,557,929)</TD>
<TD WIDTH="144" HEIGHT="30" ALIGN="RIGHT">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" P32" WIDTH="244" HEIGHT="30" VALIGN="MIDDLE">4.차량운반구</TD>
<TD WIDTH="143" HEIGHT="30" ALIGN="RIGHT">1,425,001</TD>
<TD WIDTH="143" HEIGHT="30" ALIGN="RIGHT">1,425,001</TD>
<TD WIDTH="144" HEIGHT="30" ALIGN="RIGHT">10,226,001</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" P32" WIDTH="244" HEIGHT="30" VALIGN="MIDDLE">  차량운반구감가상각누계액</TD>
<TD WIDTH="143" HEIGHT="30" ALIGN="RIGHT">(1,319,875)</TD>
<TD WIDTH="143" HEIGHT="30" ALIGN="RIGHT">(1,233,516)</TD>
<TD WIDTH="144" HEIGHT="30" ALIGN="RIGHT">(4,714,279)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" P32" WIDTH="244" HEIGHT="30" VALIGN="MIDDLE">5.비품</TD>
<TD WIDTH="143" HEIGHT="30" ALIGN="RIGHT">401,377,293</TD>
<TD WIDTH="143" HEIGHT="30" ALIGN="RIGHT">380,109,657</TD>
<TD WIDTH="144" HEIGHT="30" ALIGN="RIGHT">270,646,657</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" P16" WIDTH="244" HEIGHT="30" VALIGN="MIDDLE">     비품감가상각누계액</TD>
<TD WIDTH="143" HEIGHT="30" ALIGN="RIGHT">(327,242,544)</TD>
<TD WIDTH="143" HEIGHT="30" ALIGN="RIGHT">(271,385,926)</TD>
<TD WIDTH="144" HEIGHT="30" ALIGN="RIGHT">(243,413,791)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" P32" WIDTH="244" HEIGHT="30" VALIGN="MIDDLE">6.건설중인자산</TD>
<TD WIDTH="143" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="143" HEIGHT="30" ALIGN="RIGHT">4,666,000,000</TD>
<TD WIDTH="144" HEIGHT="30" ALIGN="RIGHT">2,745,500,000</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="244" HEIGHT="30" VALIGN="MIDDLE">
<SPAN>   (3) 무형자산 (</SPAN>
<SPAN>주석7)</SPAN>
</TD>
<TD WIDTH="143" HEIGHT="30" ALIGN="RIGHT">16,197,465</TD>
<TD WIDTH="143" HEIGHT="30" ALIGN="RIGHT">21,568,475</TD>
<TD WIDTH="144" HEIGHT="30" ALIGN="RIGHT">23,543,058</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" P16" WIDTH="244" HEIGHT="30" VALIGN="MIDDLE">   1.특허권</TD>
<TD WIDTH="143" HEIGHT="30" ALIGN="RIGHT">3,086,031</TD>
<TD WIDTH="143" HEIGHT="30" ALIGN="RIGHT">4,947,741</TD>
<TD WIDTH="144" HEIGHT="30" ALIGN="RIGHT">2,930,624</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" P32" WIDTH="244" HEIGHT="30" VALIGN="MIDDLE">2.소프트웨어</TD>
<TD WIDTH="143" HEIGHT="30" ALIGN="RIGHT">13,111,434</TD>
<TD WIDTH="143" HEIGHT="30" ALIGN="RIGHT">16,620,734</TD>
<TD WIDTH="144" HEIGHT="30" ALIGN="RIGHT">20,612,434</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" P16" WIDTH="244" HEIGHT="30" VALIGN="MIDDLE">(4) 기타비유동자산</TD>
<TD WIDTH="143" HEIGHT="30" ALIGN="RIGHT">28,708,800</TD>
<TD WIDTH="143" HEIGHT="30" ALIGN="RIGHT">28,708,800</TD>
<TD WIDTH="144" HEIGHT="30" ALIGN="RIGHT">18,708,800</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" P32" WIDTH="244" HEIGHT="30" VALIGN="MIDDLE">1.임차보증금</TD>
<TD WIDTH="143" HEIGHT="30" ALIGN="RIGHT">28,408,800</TD>
<TD WIDTH="143" HEIGHT="30" ALIGN="RIGHT">28,408,800</TD>
<TD WIDTH="144" HEIGHT="30" ALIGN="RIGHT">18,408,800</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" P32" WIDTH="244" HEIGHT="30" VALIGN="MIDDLE">2.기타보증금</TD>
<TD WIDTH="143" HEIGHT="30" ALIGN="RIGHT">300,000</TD>
<TD WIDTH="143" HEIGHT="30" ALIGN="RIGHT">300,000</TD>
<TD WIDTH="144" HEIGHT="30" ALIGN="RIGHT">300,000</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="244" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">자       산       총     계</TD>
<TD WIDTH="143" HEIGHT="30" ALIGN="RIGHT">23,239,886,548</TD>
<TD WIDTH="143" HEIGHT="30" ALIGN="RIGHT">24,421,107,760</TD>
<TD WIDTH="144" HEIGHT="30" ALIGN="RIGHT">17,641,447,742</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" P32" WIDTH="244" HEIGHT="30" VALIGN="MIDDLE">부                         채</TD>
<TD WIDTH="143" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="143" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="144" HEIGHT="30" ALIGN="RIGHT"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="244" HEIGHT="30" VALIGN="MIDDLE">
<SPAN>Ⅰ. 유동부채</SPAN>
</TD>
<TD WIDTH="143" HEIGHT="30" ALIGN="RIGHT">3,119,955,181</TD>
<TD WIDTH="143" HEIGHT="30" ALIGN="RIGHT">2,481,615,028</TD>
<TD WIDTH="144" HEIGHT="30" ALIGN="RIGHT">862,496,705</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" P32" WIDTH="244" HEIGHT="30" VALIGN="MIDDLE">1.매입채무 (주석11, 19)</TD>
<TD WIDTH="143" HEIGHT="30" ALIGN="RIGHT">70,484,970</TD>
<TD WIDTH="143" HEIGHT="30" ALIGN="RIGHT">1,451,119,828</TD>
<TD WIDTH="144" HEIGHT="30" ALIGN="RIGHT">613,762,085</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD USERMARK=" P32" WIDTH="244" HEIGHT="30" VALIGN="MIDDLE">2.미지급금
<SPAN> (주석11, 19)</SPAN>
</TD>
<TD WIDTH="143" HEIGHT="30" ALIGN="RIGHT">67,959,425</TD>
<TD WIDTH="143" HEIGHT="30" ALIGN="RIGHT">87,486,237</TD>
<TD WIDTH="144" HEIGHT="30" ALIGN="RIGHT">107,684,550</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" P32" WIDTH="244" HEIGHT="30" VALIGN="MIDDLE">3.예수금</TD>
<TD WIDTH="143" HEIGHT="30" ALIGN="RIGHT">31,171,860</TD>
<TD WIDTH="143" HEIGHT="30" ALIGN="RIGHT">9,484,000</TD>
<TD WIDTH="144" HEIGHT="30" ALIGN="RIGHT">693,520</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" P32" WIDTH="244" HEIGHT="30" VALIGN="MIDDLE">4.부가세예수금</TD>
<TD WIDTH="143" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="143" HEIGHT="30" ALIGN="RIGHT">40,020,966</TD>
<TD WIDTH="144" HEIGHT="30" ALIGN="RIGHT">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" P32" WIDTH="244" HEIGHT="30" VALIGN="MIDDLE">5.미지급비용 (주석19)</TD>
<TD WIDTH="143" HEIGHT="30" ALIGN="RIGHT">149,708,926</TD>
<TD WIDTH="143" HEIGHT="30" ALIGN="RIGHT">183,503,997</TD>
<TD WIDTH="144" HEIGHT="30" ALIGN="RIGHT">140,356,550</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD USERMARK=" P32" WIDTH="244" HEIGHT="30" VALIGN="MIDDLE">6.단기차입금 
<SPAN>(주석8)</SPAN>
</TD>
<TD WIDTH="143" HEIGHT="30" ALIGN="RIGHT">2,050,000,000</TD>
<TD WIDTH="143" HEIGHT="30" ALIGN="RIGHT">710,000,000</TD>
<TD WIDTH="144" HEIGHT="30" ALIGN="RIGHT">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD USERMARK=" P32" WIDTH="244" HEIGHT="30" VALIGN="MIDDLE">7.유동성장기부채
<SPAN> (주석8)</SPAN>
</TD>
<TD WIDTH="143" HEIGHT="30" ALIGN="RIGHT">750,630,000</TD>
<TD WIDTH="143" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="144" HEIGHT="30" ALIGN="RIGHT">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="244" HEIGHT="30" VALIGN="MIDDLE">
<SPAN>Ⅱ. 비유동부채</SPAN>
</TD>
<TD WIDTH="143" HEIGHT="30" ALIGN="RIGHT">5,731,355,044</TD>
<TD WIDTH="143" HEIGHT="30" ALIGN="RIGHT">6,460,490,606</TD>
<TD WIDTH="144" HEIGHT="30" ALIGN="RIGHT">458,594,269</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD USERMARK=" P32" WIDTH="244" HEIGHT="30" VALIGN="MIDDLE">1.장기차입금
<SPAN> (</SPAN>
<SPAN>주석8</SPAN>
<SPAN></SPAN>
<SPAN></SPAN>
<SPAN></SPAN>
<SPAN>)</SPAN>
</TD>
<TD WIDTH="143" HEIGHT="30" ALIGN="RIGHT">5,249,370,000</TD>
<TD WIDTH="143" HEIGHT="30" ALIGN="RIGHT">6,000,000,000</TD>
<TD WIDTH="144" HEIGHT="30" ALIGN="RIGHT">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD USERMARK=" P32" WIDTH="244" HEIGHT="30" VALIGN="MIDDLE">2.퇴직급여충당부채 
<SPAN>(</SPAN>
<SPAN>주석</SPAN>
<SPAN>9</SPAN>
<SPAN></SPAN>
<SPAN></SPAN>
<SPAN>)</SPAN>
</TD>
<TD WIDTH="143" HEIGHT="30" ALIGN="RIGHT">536,096,857</TD>
<TD WIDTH="143" HEIGHT="30" ALIGN="RIGHT">515,210,923</TD>
<TD WIDTH="144" HEIGHT="30" ALIGN="RIGHT">458,594,269</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD USERMARK=" P32" WIDTH="244" HEIGHT="30" VALIGN="MIDDLE">3.퇴직연금운용자산 
<SPAN>(</SPAN>
<SPAN>주석</SPAN>
<SPAN>9</SPAN>
<SPAN></SPAN>
<SPAN></SPAN>
<SPAN>)</SPAN>
</TD>
<TD WIDTH="143" HEIGHT="30" ALIGN="RIGHT">(54,111,813)</TD>
<TD WIDTH="143" HEIGHT="30" ALIGN="RIGHT">(54,720,317)</TD>
<TD WIDTH="144" HEIGHT="30" ALIGN="RIGHT">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" P32" WIDTH="244" HEIGHT="30" VALIGN="MIDDLE">부       채       총       계</TD>
<TD WIDTH="143" HEIGHT="30" ALIGN="RIGHT">8,851,310,225</TD>
<TD WIDTH="143" HEIGHT="30" ALIGN="RIGHT">8,942,105,634</TD>
<TD WIDTH="144" HEIGHT="30" ALIGN="RIGHT">1,321,090,974</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="244" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">자                         본</TD>
<TD WIDTH="143" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="143" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="144" HEIGHT="30" ALIGN="RIGHT"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="244" HEIGHT="30" VALIGN="MIDDLE">
<SPAN>Ⅰ. 자본금 (</SPAN>
<SPAN>주석1,12</SPAN>
<SPAN>)</SPAN>
</TD>
<TD WIDTH="143" HEIGHT="30" ALIGN="RIGHT">12,305,935,000</TD>
<TD WIDTH="143" HEIGHT="30" ALIGN="RIGHT">12,305,935,000</TD>
<TD WIDTH="144" HEIGHT="30" ALIGN="RIGHT">12,305,935,000</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" P32" WIDTH="244" HEIGHT="30" VALIGN="MIDDLE">1.보통주자본금</TD>
<TD WIDTH="143" HEIGHT="30" ALIGN="RIGHT">12,305,935,000</TD>
<TD WIDTH="143" HEIGHT="30" ALIGN="RIGHT">12,305,935,000</TD>
<TD WIDTH="144" HEIGHT="30" ALIGN="RIGHT">12,305,935,000</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="244" HEIGHT="30" VALIGN="MIDDLE">
<SPAN>Ⅱ. 자본잉여금 (</SPAN>
<SPAN>주석12</SPAN>
<SPAN>)</SPAN>
</TD>
<TD WIDTH="143" HEIGHT="30" ALIGN="RIGHT">4,973,250,000</TD>
<TD WIDTH="143" HEIGHT="30" ALIGN="RIGHT">4,973,250,000</TD>
<TD WIDTH="144" HEIGHT="30" ALIGN="RIGHT">4,973,250,000</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" P32" WIDTH="244" HEIGHT="30" VALIGN="MIDDLE">1.주식발행초과금</TD>
<TD WIDTH="143" HEIGHT="30" ALIGN="RIGHT">4,973,250,000</TD>
<TD WIDTH="143" HEIGHT="30" ALIGN="RIGHT">4,973,250,000</TD>
<TD WIDTH="144" HEIGHT="30" ALIGN="RIGHT">4,973,250,000</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="244" HEIGHT="30" VALIGN="MIDDLE">
<SPAN>Ⅲ. 기타포괄손익누계액 (</SPAN>
<SPAN>주석</SPAN>
<SPAN>14)</SPAN>
</TD>
<TD WIDTH="143" HEIGHT="30" ALIGN="RIGHT">35,366,058</TD>
<TD WIDTH="143" HEIGHT="30" ALIGN="RIGHT">(87,696,276)</TD>
<TD WIDTH="144" HEIGHT="30" ALIGN="RIGHT">(147,015,905)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="244" HEIGHT="30" VALIGN="MIDDLE">      1.지분법자본변동</TD>
<TD WIDTH="143" HEIGHT="30" ALIGN="RIGHT">35,366,058</TD>
<TD WIDTH="143" HEIGHT="30" ALIGN="RIGHT">(87,696,276)</TD>
<TD WIDTH="144" HEIGHT="30" ALIGN="RIGHT">(147,015,905)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="244" HEIGHT="30" VALIGN="MIDDLE">Ⅳ. 결손금
<SPAN> (</SPAN>
<SPAN>주석</SPAN>
<SPAN>13)</SPAN>
</TD>
<TD WIDTH="143" HEIGHT="30" ALIGN="RIGHT">(2,925,974,735)</TD>
<TD WIDTH="143" HEIGHT="30" ALIGN="RIGHT">(1,712,486,598)</TD>
<TD WIDTH="144" HEIGHT="30" ALIGN="RIGHT">(811,812,327)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" P32" WIDTH="244" HEIGHT="30" VALIGN="MIDDLE">1.미처리결손금</TD>
<TD WIDTH="143" HEIGHT="30" ALIGN="RIGHT">(2,925,974,735)</TD>
<TD WIDTH="143" HEIGHT="30" ALIGN="RIGHT">(1,712,486,598)</TD>
<TD WIDTH="144" HEIGHT="30" ALIGN="RIGHT">(811,812,327)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="244" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">자       본       총       계</TD>
<TD WIDTH="143" HEIGHT="30" ALIGN="RIGHT">14,388,576,323</TD>
<TD WIDTH="143" HEIGHT="30" ALIGN="RIGHT">15,479,002,126</TD>
<TD WIDTH="144" HEIGHT="30" ALIGN="RIGHT">16,320,356,768</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="244" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">부  채  와  자  본  총  계</TD>
<TD WIDTH="143" HEIGHT="30" ALIGN="RIGHT">23,239,886,548</TD>
<TD WIDTH="143" HEIGHT="30" ALIGN="RIGHT">24,421,107,760</TD>
<TD WIDTH="144" HEIGHT="30" ALIGN="RIGHT">17,641,447,742</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK="F-GL11 B">&cr;나. 손익계산서</SPAN>
</P>
<P USERMARK="F-GL11">                                                                                             </P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" WIDTH="676" BORDER="0">

<COLGROUP>
<COL WIDTH="291"></COL>
<COL WIDTH="367"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD COLSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="676" HEIGHT="30">제 11 기          2020년 1월 1일부터  2020년   12월 31일까지</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD COLSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="676" HEIGHT="30">제 10 기          2019년 1월 1일부터  2019년   12월 31일까지</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD COLSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="676" HEIGHT="30">제 9 기            2018년 1월 1일부터  2018년   12월 31일까지</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="BOTTOM" WIDTH="300" HEIGHT="30">주식회사 리독스바이오</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="376" HEIGHT="30">(단위 : 원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="677">

<COLGROUP>
<COL WIDTH="236"></COL>
<COL WIDTH="135"></COL>
<COL WIDTH="135"></COL>
<COL WIDTH="135"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="245" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">과 목</TH>
<TH WIDTH="144" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">제 11 기</TH>
<TH WIDTH="144" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">제 10 기</TH>
<TH WIDTH="144" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">제 9 기</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="245" HEIGHT="30">Ⅰ. 매출액 (주석11)</TD>
<TD WIDTH="144" HEIGHT="30" ALIGN="RIGHT">7,467,275,679</TD>
<TD WIDTH="144" HEIGHT="30" ALIGN="RIGHT">10,679,060,838</TD>
<TD WIDTH="144" HEIGHT="30" ALIGN="RIGHT">10,380,582,323</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" P16" WIDTH="245" HEIGHT="30">1.상품매출액</TD>
<TD WIDTH="144" HEIGHT="30" ALIGN="RIGHT">1,709,070,129</TD>
<TD WIDTH="144" HEIGHT="30" ALIGN="RIGHT">2,460,874,181</TD>
<TD WIDTH="144" HEIGHT="30" ALIGN="RIGHT">1,553,819,526</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" P16" WIDTH="245" HEIGHT="30">2.제품매출액</TD>
<TD WIDTH="144" HEIGHT="30" ALIGN="RIGHT">5,758,205,550</TD>
<TD WIDTH="144" HEIGHT="30" ALIGN="RIGHT">8,218,186,657</TD>
<TD WIDTH="144" HEIGHT="30" ALIGN="RIGHT">8,826,762,797</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="245" HEIGHT="30">Ⅱ. 매출원가(주석11)</TD>
<TD WIDTH="144" HEIGHT="30" ALIGN="RIGHT">6,591,384,872</TD>
<TD WIDTH="144" HEIGHT="30" ALIGN="RIGHT">9,586,413,584</TD>
<TD WIDTH="144" HEIGHT="30" ALIGN="RIGHT">8,031,210,990</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" P16" WIDTH="245" HEIGHT="30">1. 상품매출원가</TD>
<TD WIDTH="144" HEIGHT="30" ALIGN="RIGHT">1,554,732,508</TD>
<TD WIDTH="144" HEIGHT="30" ALIGN="RIGHT">2,241,646,293</TD>
<TD WIDTH="144" HEIGHT="30" ALIGN="RIGHT">1,423,351,404</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" P32" WIDTH="245" HEIGHT="30">기초상품재고액</TD>
<TD WIDTH="144" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="144" HEIGHT="30" ALIGN="RIGHT">425,531,526</TD>
<TD WIDTH="144" HEIGHT="30" ALIGN="RIGHT">62,932,831</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" P32" WIDTH="245" HEIGHT="30">당기상품매입액</TD>
<TD WIDTH="144" HEIGHT="30" ALIGN="RIGHT">1,555,060,757</TD>
<TD WIDTH="144" HEIGHT="30" ALIGN="RIGHT">1,816,476,424</TD>
<TD WIDTH="144" HEIGHT="30" ALIGN="RIGHT">1,849,613,102</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" P32" WIDTH="245" HEIGHT="30">타계정대체</TD>
<TD WIDTH="144" HEIGHT="30" ALIGN="RIGHT">(328,249)</TD>
<TD WIDTH="144" HEIGHT="30" ALIGN="RIGHT">(361,657)</TD>
<TD WIDTH="144" HEIGHT="30" ALIGN="RIGHT">(63,663,003)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" P32" WIDTH="245" HEIGHT="30">기말상품재고액</TD>
<TD WIDTH="144" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="144" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="144" HEIGHT="30" ALIGN="RIGHT">(425,531,526)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" P16" WIDTH="245" HEIGHT="30">2. 제품매출원가</TD>
<TD WIDTH="144" HEIGHT="30" ALIGN="RIGHT">5,036,652,364</TD>
<TD WIDTH="144" HEIGHT="30" ALIGN="RIGHT">7,344,767,291</TD>
<TD WIDTH="144" HEIGHT="30" ALIGN="RIGHT">6,607,859,586</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" P32" WIDTH="245" HEIGHT="30">기초제품재고액</TD>
<TD WIDTH="144" HEIGHT="30" ALIGN="RIGHT">1,086,343,564</TD>
<TD WIDTH="144" HEIGHT="30" ALIGN="RIGHT">1,315,996,413</TD>
<TD WIDTH="144" HEIGHT="30" ALIGN="RIGHT">1,434,086,547</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" P32" WIDTH="245" HEIGHT="30">당기제품제조원가</TD>
<TD WIDTH="144" HEIGHT="30" ALIGN="RIGHT">6,691,218,444</TD>
<TD WIDTH="144" HEIGHT="30" ALIGN="RIGHT">7,151,519,269</TD>
<TD WIDTH="144" HEIGHT="30" ALIGN="RIGHT">6,625,153,580</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" P32" WIDTH="245" HEIGHT="30">타계정대체</TD>
<TD WIDTH="144" HEIGHT="30" ALIGN="RIGHT">(424,572,636)</TD>
<TD WIDTH="144" HEIGHT="30" ALIGN="RIGHT">(36,404,827)</TD>
<TD WIDTH="144" HEIGHT="30" ALIGN="RIGHT">(135,384,128)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" P32" WIDTH="245" HEIGHT="30">기말제품재고액</TD>
<TD WIDTH="144" HEIGHT="30" ALIGN="RIGHT">(2,316,337,008)</TD>
<TD WIDTH="144" HEIGHT="30" ALIGN="RIGHT">(1,086,343,564)</TD>
<TD WIDTH="144" HEIGHT="30" ALIGN="RIGHT">(1,315,996,413)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="245" HEIGHT="30">Ⅲ. 매출총이익</TD>
<TD WIDTH="144" HEIGHT="30" ALIGN="RIGHT">875,890,807</TD>
<TD WIDTH="144" HEIGHT="30" ALIGN="RIGHT">1,092,647,254</TD>
<TD WIDTH="144" HEIGHT="30" ALIGN="RIGHT">2,349,371,333</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="245" HEIGHT="30">Ⅳ. 판매비와관리비(주석11,18)</TD>
<TD WIDTH="144" HEIGHT="30" ALIGN="RIGHT">1,300,283,776</TD>
<TD WIDTH="144" HEIGHT="30" ALIGN="RIGHT">1,104,827,854</TD>
<TD WIDTH="144" HEIGHT="30" ALIGN="RIGHT">1,104,625,217</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" P16" WIDTH="245" HEIGHT="30">1.급여</TD>
<TD WIDTH="144" HEIGHT="30" ALIGN="RIGHT">412,009,135</TD>
<TD WIDTH="144" HEIGHT="30" ALIGN="RIGHT">344,883,485</TD>
<TD WIDTH="144" HEIGHT="30" ALIGN="RIGHT">231,084,920</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" P16" WIDTH="245" HEIGHT="30">2.퇴직급여</TD>
<TD WIDTH="144" HEIGHT="30" ALIGN="RIGHT">38,956,987</TD>
<TD WIDTH="144" HEIGHT="30" ALIGN="RIGHT">28,447,738</TD>
<TD WIDTH="144" HEIGHT="30" ALIGN="RIGHT">38,545,628</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" P16" WIDTH="245" HEIGHT="30">3.복리후생비</TD>
<TD WIDTH="144" HEIGHT="30" ALIGN="RIGHT">51,722,014</TD>
<TD WIDTH="144" HEIGHT="30" ALIGN="RIGHT">44,702,536</TD>
<TD WIDTH="144" HEIGHT="30" ALIGN="RIGHT">45,300,118</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" P16" WIDTH="245" HEIGHT="30">4.보험료</TD>
<TD WIDTH="144" HEIGHT="30" ALIGN="RIGHT">12,083,232</TD>
<TD WIDTH="144" HEIGHT="30" ALIGN="RIGHT">5,570,031</TD>
<TD WIDTH="144" HEIGHT="30" ALIGN="RIGHT">6,799,071</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" P16" WIDTH="245" HEIGHT="30">5.감가상각비</TD>
<TD WIDTH="144" HEIGHT="30" ALIGN="RIGHT">18,700,534</TD>
<TD WIDTH="144" HEIGHT="30" ALIGN="RIGHT">11,305,797</TD>
<TD WIDTH="144" HEIGHT="30" ALIGN="RIGHT">12,960,930</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" P16" WIDTH="245" HEIGHT="30">6.무형자산상각비</TD>
<TD WIDTH="144" HEIGHT="30" ALIGN="RIGHT">6,345,010</TD>
<TD WIDTH="144" HEIGHT="30" ALIGN="RIGHT">6,410,983</TD>
<TD WIDTH="144" HEIGHT="30" ALIGN="RIGHT">3,164,130</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" P16" WIDTH="245" HEIGHT="30">7.지급수수료</TD>
<TD WIDTH="144" HEIGHT="30" ALIGN="RIGHT">121,972,682</TD>
<TD WIDTH="144" HEIGHT="30" ALIGN="RIGHT">86,563,592</TD>
<TD WIDTH="144" HEIGHT="30" ALIGN="RIGHT">113,969,471</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" P16" WIDTH="245" HEIGHT="30">8.광고선전비</TD>
<TD WIDTH="144" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="144" HEIGHT="30" ALIGN="RIGHT">2,506,000</TD>
<TD WIDTH="144" HEIGHT="30" ALIGN="RIGHT">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" P16" WIDTH="245" HEIGHT="30">9.교육훈련비</TD>
<TD WIDTH="144" HEIGHT="30" ALIGN="RIGHT">9,001,480</TD>
<TD WIDTH="144" HEIGHT="30" ALIGN="RIGHT">3,439,012</TD>
<TD WIDTH="144" HEIGHT="30" ALIGN="RIGHT">130,000</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" P16" WIDTH="245" HEIGHT="30">10.차량유지비</TD>
<TD WIDTH="144" HEIGHT="30" ALIGN="RIGHT">5,891,043</TD>
<TD WIDTH="144" HEIGHT="30" ALIGN="RIGHT">4,557,611</TD>
<TD WIDTH="144" HEIGHT="30" ALIGN="RIGHT">2,173,346</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" P16" WIDTH="245" HEIGHT="30">11.도서인쇄비</TD>
<TD WIDTH="144" HEIGHT="30" ALIGN="RIGHT">1,817,100</TD>
<TD WIDTH="144" HEIGHT="30" ALIGN="RIGHT">293,000</TD>
<TD WIDTH="144" HEIGHT="30" ALIGN="RIGHT">87,000</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" P16" WIDTH="245" HEIGHT="30">12.접대비</TD>
<TD WIDTH="144" HEIGHT="30" ALIGN="RIGHT">7,842,120</TD>
<TD WIDTH="144" HEIGHT="30" ALIGN="RIGHT">5,686,735</TD>
<TD WIDTH="144" HEIGHT="30" ALIGN="RIGHT">5,984,700</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" P16" WIDTH="245" HEIGHT="30">13.지급임차료</TD>
<TD WIDTH="144" HEIGHT="30" ALIGN="RIGHT">49,929,540</TD>
<TD WIDTH="144" HEIGHT="30" ALIGN="RIGHT">30,779,452</TD>
<TD WIDTH="144" HEIGHT="30" ALIGN="RIGHT">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" P16" WIDTH="245" HEIGHT="30">14.통신비</TD>
<TD WIDTH="144" HEIGHT="30" ALIGN="RIGHT">3,882,901</TD>
<TD WIDTH="144" HEIGHT="30" ALIGN="RIGHT">3,895,171</TD>
<TD WIDTH="144" HEIGHT="30" ALIGN="RIGHT">2,685,631</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" P16" WIDTH="245" HEIGHT="30">15.운반비</TD>
<TD WIDTH="144" HEIGHT="30" ALIGN="RIGHT">1,869,340</TD>
<TD WIDTH="144" HEIGHT="30" ALIGN="RIGHT">917,360</TD>
<TD WIDTH="144" HEIGHT="30" ALIGN="RIGHT">1,185,724</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" P16" WIDTH="245" HEIGHT="30">16.세금과공과</TD>
<TD WIDTH="144" HEIGHT="30" ALIGN="RIGHT">27,474,840</TD>
<TD WIDTH="144" HEIGHT="30" ALIGN="RIGHT">30,968,462</TD>
<TD WIDTH="144" HEIGHT="30" ALIGN="RIGHT">20,808,340</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="245" HEIGHT="30">   17.회의비</TD>
<TD WIDTH="144" HEIGHT="30" ALIGN="RIGHT">35,850</TD>
<TD WIDTH="144" HEIGHT="30" ALIGN="RIGHT">52,080</TD>
<TD WIDTH="144" HEIGHT="30" ALIGN="RIGHT">351,870</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" P16" WIDTH="245" HEIGHT="30">18.소모품비</TD>
<TD WIDTH="144" HEIGHT="30" ALIGN="RIGHT">4,122,764</TD>
<TD WIDTH="144" HEIGHT="30" ALIGN="RIGHT">23,569,778</TD>
<TD WIDTH="144" HEIGHT="30" ALIGN="RIGHT">1,712,177</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" P16" WIDTH="245" HEIGHT="30">19.수선비</TD>
<TD WIDTH="144" HEIGHT="30" ALIGN="RIGHT">28,231,600</TD>
<TD WIDTH="144" HEIGHT="30" ALIGN="RIGHT">228,882</TD>
<TD WIDTH="144" HEIGHT="30" ALIGN="RIGHT">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" P16" WIDTH="245" HEIGHT="30">20.경상연구개발비</TD>
<TD WIDTH="144" HEIGHT="30" ALIGN="RIGHT">451,037,196</TD>
<TD WIDTH="144" HEIGHT="30" ALIGN="RIGHT">407,472,171</TD>
<TD WIDTH="144" HEIGHT="30" ALIGN="RIGHT">548,134,334</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" P16" WIDTH="245" HEIGHT="30">21.여비교통비</TD>
<TD WIDTH="144" HEIGHT="30" ALIGN="RIGHT">14,759,940</TD>
<TD WIDTH="144" HEIGHT="30" ALIGN="RIGHT">24,206,689</TD>
<TD WIDTH="144" HEIGHT="30" ALIGN="RIGHT">29,555,404</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" P16" WIDTH="245" HEIGHT="30">22.견본비</TD>
<TD WIDTH="144" HEIGHT="30" ALIGN="RIGHT">4,722,095</TD>
<TD WIDTH="144" HEIGHT="30" ALIGN="RIGHT">9,738,130</TD>
<TD WIDTH="144" HEIGHT="30" ALIGN="RIGHT">39,422,423</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" P16" WIDTH="245" HEIGHT="30">23.시험비</TD>
<TD WIDTH="144" HEIGHT="30" ALIGN="RIGHT">27,876,373</TD>
<TD WIDTH="144" HEIGHT="30" ALIGN="RIGHT">26,632,159</TD>
<TD WIDTH="144" HEIGHT="30" ALIGN="RIGHT">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" P16" WIDTH="245" HEIGHT="30">24.잡비</TD>
<TD WIDTH="144" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="144" HEIGHT="30" ALIGN="RIGHT">2,001,000</TD>
<TD WIDTH="144" HEIGHT="30" ALIGN="RIGHT">570,000</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="245" HEIGHT="30">Ⅴ. 영업이익</TD>
<TD WIDTH="144" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(424,392,969)</TD>
<TD WIDTH="144" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(12,180,600)</TD>
<TD WIDTH="144" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">1,244,746,116</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="245" HEIGHT="30">Ⅵ. 영업외수익</TD>
<TD WIDTH="144" HEIGHT="30" ALIGN="RIGHT">42,688,460</TD>
<TD WIDTH="144" HEIGHT="30" ALIGN="RIGHT">66,515,187</TD>
<TD WIDTH="144" HEIGHT="30" ALIGN="RIGHT">176,660,938</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" P16" WIDTH="245" HEIGHT="30">1.이자수익</TD>
<TD WIDTH="144" HEIGHT="30" ALIGN="RIGHT">928,951</TD>
<TD WIDTH="144" HEIGHT="30" ALIGN="RIGHT">1,725,419</TD>
<TD WIDTH="144" HEIGHT="30" ALIGN="RIGHT">108,704,161</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" P16" WIDTH="245" HEIGHT="30">2.외화환산이익</TD>
<TD WIDTH="144" HEIGHT="30" ALIGN="RIGHT">4,205,869</TD>
<TD WIDTH="144" HEIGHT="30" ALIGN="RIGHT">4,506,113</TD>
<TD WIDTH="144" HEIGHT="30" ALIGN="RIGHT">2,421,333</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" P16" WIDTH="245" HEIGHT="30">3.외환차익</TD>
<TD WIDTH="144" HEIGHT="30" ALIGN="RIGHT">17,510,515</TD>
<TD WIDTH="144" HEIGHT="30" ALIGN="RIGHT">6,824,205</TD>
<TD WIDTH="144" HEIGHT="30" ALIGN="RIGHT">29,469,147</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" P16" WIDTH="245" HEIGHT="30">4.유형자산처분이익</TD>
<TD WIDTH="144" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="144" HEIGHT="30" ALIGN="RIGHT">722,834</TD>
<TD WIDTH="144" HEIGHT="30" ALIGN="RIGHT">24,983,000</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" P16" WIDTH="245" HEIGHT="30">5.잡이익</TD>
<TD WIDTH="144" HEIGHT="30" ALIGN="RIGHT">20,043,125</TD>
<TD WIDTH="144" HEIGHT="30" ALIGN="RIGHT">52,736,616</TD>
<TD WIDTH="144" HEIGHT="30" ALIGN="RIGHT">11,083,297</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="245" HEIGHT="30">Ⅶ. 영업외비용</TD>
<TD WIDTH="144" HEIGHT="30" ALIGN="RIGHT">831,783,628</TD>
<TD WIDTH="144" HEIGHT="30" ALIGN="RIGHT">955,008,858</TD>
<TD WIDTH="144" HEIGHT="30" ALIGN="RIGHT">1,333,891,743</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" P16" WIDTH="245" HEIGHT="30">1.이자비용</TD>
<TD WIDTH="144" HEIGHT="30" ALIGN="RIGHT">195,670,134</TD>
<TD WIDTH="144" HEIGHT="30" ALIGN="RIGHT">104,296,825</TD>
<TD WIDTH="144" HEIGHT="30" ALIGN="RIGHT">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" P16" WIDTH="245" HEIGHT="30">2.외환차손</TD>
<TD WIDTH="144" HEIGHT="30" ALIGN="RIGHT">13,572,409</TD>
<TD WIDTH="144" HEIGHT="30" ALIGN="RIGHT">14,163,145</TD>
<TD WIDTH="144" HEIGHT="30" ALIGN="RIGHT">5,288,375</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="245" HEIGHT="30">   3.외화환산손실 </TD>
<TD WIDTH="144" HEIGHT="30" ALIGN="RIGHT">7</TD>
<TD WIDTH="144" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="144" HEIGHT="30" ALIGN="RIGHT">1,128,326</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" P16" WIDTH="245" HEIGHT="30">4.기타의 대손상각비</TD>
<TD WIDTH="144" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="144" HEIGHT="30" ALIGN="RIGHT">364,074,670</TD>
<TD WIDTH="144" HEIGHT="30" ALIGN="RIGHT">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" P16" WIDTH="245" HEIGHT="30">5.재고자산감모손실</TD>
<TD WIDTH="144" HEIGHT="30" ALIGN="RIGHT">392,302,417</TD>
<TD WIDTH="144" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="144" HEIGHT="30" ALIGN="RIGHT">61,988,911</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" P16" WIDTH="245" HEIGHT="30">6.지분법손실</TD>
<TD WIDTH="144" HEIGHT="30" ALIGN="RIGHT">205,960,593</TD>
<TD WIDTH="144" HEIGHT="30" ALIGN="RIGHT">472,334,742</TD>
<TD WIDTH="144" HEIGHT="30" ALIGN="RIGHT">95,481,769</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" P16" WIDTH="245" HEIGHT="30">7.유형자산처분손실</TD>
<TD WIDTH="144" HEIGHT="30" ALIGN="RIGHT">6,597,049</TD>
<TD WIDTH="144" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="144" HEIGHT="30" ALIGN="RIGHT">1,106,848,992</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" P16" WIDTH="245" HEIGHT="30">8.재고자산폐기손실</TD>
<TD WIDTH="144" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="144" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="144" HEIGHT="30" ALIGN="RIGHT">63,155,361</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" P16" WIDTH="245" HEIGHT="30">9.잡손실</TD>
<TD WIDTH="144" HEIGHT="30" ALIGN="RIGHT">17,681,019</TD>
<TD WIDTH="144" HEIGHT="30" ALIGN="RIGHT">139,476</TD>
<TD WIDTH="144" HEIGHT="30" ALIGN="RIGHT">9</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="245" HEIGHT="30">Ⅷ. 법인세차감전순이익</TD>
<TD WIDTH="144" HEIGHT="30" ALIGN="RIGHT">(1,213,488,137)</TD>
<TD WIDTH="144" HEIGHT="30" ALIGN="RIGHT">(900,674,271)</TD>
<TD WIDTH="144" HEIGHT="30" ALIGN="RIGHT">87,515,311</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="245" HEIGHT="30">Ⅸ. 법인세비용 (주석15)</TD>
<TD WIDTH="144" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="144" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="144" HEIGHT="30" ALIGN="RIGHT">651,921</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="245" HEIGHT="30">Ⅹ. 당기순이익</TD>
<TD WIDTH="144" HEIGHT="30" ALIGN="RIGHT">(1,213,488,137)</TD>
<TD WIDTH="144" HEIGHT="30" ALIGN="RIGHT">(900,674,271)</TD>
<TD WIDTH="144" HEIGHT="30" ALIGN="RIGHT">86,863,390</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="245" HEIGHT="30">XI. 주당손익 (주석17)</TD>
<TD WIDTH="144" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="144" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="144" HEIGHT="30" ALIGN="RIGHT"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" P16" WIDTH="245" HEIGHT="30">기본및희석주당이익</TD>
<TD WIDTH="144" HEIGHT="30" ALIGN="RIGHT">(49)</TD>
<TD WIDTH="144" HEIGHT="30" ALIGN="RIGHT">(37)</TD>
<TD WIDTH="144" HEIGHT="30" ALIGN="RIGHT">4</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK="F-GL11 B">&cr;다. 자본변동표</SPAN>
</P>
<P USERMARK="F-GL11">                                                                </P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" WIDTH="889" BORDER="0">

<COLGROUP>
<COL WIDTH="291"></COL>
<COL WIDTH="580"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD COLSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="889" HEIGHT="30">제 11 기          2020년 1월 1일부터  2020년   12월 31일까지</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD COLSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="889" HEIGHT="30">제 10 기          2019년 1월 1일부터  2019년   12월 31일까지</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD COLSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="889" HEIGHT="30">제 9 기            2018년 1월 1일부터  2018년   12월 31일까지</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="BOTTOM" WIDTH="300" HEIGHT="30">주식회사 리독스바이오</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="589" HEIGHT="30">(단위 : 원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="889">

<COLGROUP>
<COL WIDTH="199"></COL>
<COL WIDTH="122"></COL>
<COL WIDTH="126"></COL>
<COL WIDTH="117"></COL>
<COL WIDTH="132"></COL>
<COL WIDTH="139"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="208" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">과     목</TH>
<TH WIDTH="131" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">자 본 금</TH>
<TH WIDTH="135" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">자  본&cr;잉여금</TH>
<TH WIDTH="126" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">기타포괄&cr;손익누계액</TH>
<TH WIDTH="141" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">이  익&cr;잉여금</TH>
<TH WIDTH="148" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">총   계</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="208" HEIGHT="30" VALIGN="MIDDLE">2018년01월01일(전전기초)</TD>
<TD WIDTH="131" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">12,305,935,000</TD>
<TD WIDTH="135" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">4,973,250,000</TD>
<TD WIDTH="126" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="141" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(898,675,717)</TD>
<TD WIDTH="148" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">16,380,509,283</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="208" HEIGHT="30" VALIGN="MIDDLE"> 당기순이익</TD>
<TD WIDTH="131" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="135" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="126" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="141" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">86,863,390</TD>
<TD WIDTH="148" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">86,863,390</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="208" HEIGHT="30" VALIGN="MIDDLE"> 지분법자본변동</TD>
<TD WIDTH="131" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="135" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="126" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(147,015,905)</TD>
<TD WIDTH="141" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>

<TD USERMARK=" 0XBD6F00" WIDTH="148" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">
<SPAN USERMARK=" 0X000000">(147,015,905)</SPAN>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="208" HEIGHT="30" VALIGN="MIDDLE">2018년12월31일(전전기말)</TD>
<TD WIDTH="131" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">12,305,935,000</TD>
<TD WIDTH="135" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">4,973,250,000</TD>
<TD WIDTH="126" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(147,015,905)</TD>
<TD WIDTH="141" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(811,812,327)</TD>
<TD WIDTH="148" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">16,320,356,768</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="208" HEIGHT="30" VALIGN="MIDDLE">2019년01월01일(전기초)</TD>
<TD WIDTH="131" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">12,305,935,000</TD>
<TD WIDTH="135" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">4,973,250,000</TD>
<TD WIDTH="126" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(147,015,905)</TD>
<TD WIDTH="141" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(811,812,327)</TD>
<TD WIDTH="148" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">16,320,356,768</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="208" HEIGHT="30" VALIGN="MIDDLE"> 당기순이익</TD>
<TD WIDTH="131" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="135" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="126" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="141" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(900,674,271)</TD>
<TD WIDTH="148" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(900,674,271)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="208" HEIGHT="30" VALIGN="MIDDLE"> 지분법자본변동</TD>
<TD WIDTH="131" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="135" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="126" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">59,319,629</TD>
<TD WIDTH="141" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="148" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">59,319,629</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="208" HEIGHT="30" VALIGN="MIDDLE">2019년12월31일(전기말)</TD>
<TD WIDTH="131" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">12,305,935,000</TD>
<TD WIDTH="135" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">4,973,250,000</TD>
<TD WIDTH="126" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(87,696,276)</TD>
<TD WIDTH="141" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(1,712,486,598)</TD>
<TD WIDTH="148" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">15,479,002,126</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="208" HEIGHT="30" VALIGN="MIDDLE">2020년01월01일(당기초)</TD>
<TD WIDTH="131" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">12,305,935,000</TD>
<TD WIDTH="135" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">4,973,250,000</TD>
<TD WIDTH="126" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(87,696,276)</TD>
<TD WIDTH="141" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(1,712,486,598)</TD>
<TD WIDTH="148" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">15,479,002,126</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="208" HEIGHT="30" VALIGN="MIDDLE"> 당기순이익</TD>
<TD WIDTH="131" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="135" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="126" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="141" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(1,213,488,137)</TD>
<TD WIDTH="148" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(1,213,488,137)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="208" HEIGHT="30" VALIGN="MIDDLE"> 지분법자본변동</TD>
<TD WIDTH="131" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="135" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="126" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">123,062,334</TD>
<TD WIDTH="141" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="148" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">123,062,334</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="208" HEIGHT="30" VALIGN="MIDDLE">2020년12월31일(당기말)</TD>
<TD WIDTH="131" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">12,305,935,000</TD>
<TD WIDTH="135" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">4,973,250,000</TD>
<TD WIDTH="126" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">35,366,058</TD>
<TD WIDTH="141" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(2,925,974,735)</TD>
<TD WIDTH="148" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">14,388,576,323</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK="F-GL11 B">&cr;라. 현금흐름표</SPAN>
</P>
<P USERMARK="F-11">                                                                                      </P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" WIDTH="673" BORDER="0">

<COLGROUP>
<COL WIDTH="291"></COL>
<COL WIDTH="364"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD COLSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="673" HEIGHT="30">제 11 기           2020년 1월 1일부터  2020년   12월 31일까지</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD COLSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="673" HEIGHT="30">제 10 기           2019년 1월 1일부터  2019년   12월 31일까지</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD COLSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="673" HEIGHT="30">제 9 기            2018년 1월 1일부터  2018년   12월 31일까지</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="BOTTOM" WIDTH="300" HEIGHT="30">주식회사 리독스바이오</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="373" HEIGHT="30">(단위 : 원)</TD>
</TR>
</TBODY>
</TABLE>
<P></P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="672">

<COLGROUP>
<COL WIDTH="277"></COL>
<COL WIDTH="120"></COL>
<COL WIDTH="120"></COL>
<COL WIDTH="119"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="286" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">과                        목</TH>
<TH WIDTH="129" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">제 11 기</TH>
<TH WIDTH="129" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">제 10 기</TH>
<TH WIDTH="128" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">제 9 기</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="286" HEIGHT="30">Ⅰ.영업활동으로 인한 현금흐름</TD>
<TD WIDTH="129" HEIGHT="30" ALIGN="RIGHT">(727,749,528)</TD>
<TD WIDTH="129" HEIGHT="30" ALIGN="RIGHT">1,441,478,222</TD>
<TD WIDTH="128" HEIGHT="30" ALIGN="RIGHT">640,287,548</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" P16" WIDTH="286" HEIGHT="30">1.당분기순이익</TD>
<TD WIDTH="129" HEIGHT="30" ALIGN="RIGHT">(1,213,488,137)</TD>
<TD WIDTH="129" HEIGHT="30" ALIGN="RIGHT">(900,674,271)</TD>
<TD WIDTH="128" HEIGHT="30" ALIGN="RIGHT">86,863,390</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" P16" WIDTH="286" HEIGHT="30">2.현금의 유출이 없는 비용 등의 가산</TD>
<TD WIDTH="129" HEIGHT="30" ALIGN="RIGHT">1,569,413,144</TD>
<TD WIDTH="129" HEIGHT="30" ALIGN="RIGHT">1,015,917,464</TD>
<TD WIDTH="128" HEIGHT="30" ALIGN="RIGHT">1,593,269,343</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" P32" WIDTH="286" HEIGHT="30">퇴직급여</TD>
<TD WIDTH="129" HEIGHT="30" ALIGN="RIGHT">134,167,814</TD>
<TD WIDTH="129" HEIGHT="30" ALIGN="RIGHT">114,933,882</TD>
<TD WIDTH="128" HEIGHT="30" ALIGN="RIGHT">146,908,858</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" P32" WIDTH="286" HEIGHT="30">감가상각비</TD>
<TD WIDTH="129" HEIGHT="30" ALIGN="RIGHT">824,040,261</TD>
<TD WIDTH="129" HEIGHT="30" ALIGN="RIGHT">422,237,857</TD>
<TD WIDTH="128" HEIGHT="30" ALIGN="RIGHT">326,581,907</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" P32" WIDTH="286" HEIGHT="30">무형자산상각비</TD>
<TD WIDTH="129" HEIGHT="30" ALIGN="RIGHT">6,345,010</TD>
<TD WIDTH="129" HEIGHT="30" ALIGN="RIGHT">6,410,983</TD>
<TD WIDTH="128" HEIGHT="30" ALIGN="RIGHT">3,164,130</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" P32" WIDTH="286" HEIGHT="30">외화환산손실</TD>
<TD WIDTH="129" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="129" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="128" HEIGHT="30" ALIGN="RIGHT">1,128,326</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" P32" WIDTH="286" HEIGHT="30">유형자산처분손실</TD>
<TD WIDTH="129" HEIGHT="30" ALIGN="RIGHT">6,597,049</TD>
<TD WIDTH="129" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="128" HEIGHT="30" ALIGN="RIGHT">956,848,992</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" P32" WIDTH="286" HEIGHT="30">재고자산감모손실</TD>
<TD WIDTH="129" HEIGHT="30" ALIGN="RIGHT">392,302,417</TD>
<TD WIDTH="129" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="128" HEIGHT="30" ALIGN="RIGHT">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" P32" WIDTH="286" HEIGHT="30">재고자산폐기손실</TD>
<TD WIDTH="129" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="129" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="128" HEIGHT="30" ALIGN="RIGHT">63,155,361</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" P32" WIDTH="286" HEIGHT="30">지분법손실</TD>
<TD WIDTH="129" HEIGHT="30" ALIGN="RIGHT">205,960,593</TD>
<TD WIDTH="129" HEIGHT="30" ALIGN="RIGHT">472,334,742</TD>
<TD WIDTH="128" HEIGHT="30" ALIGN="RIGHT">95,481,769</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" P16" WIDTH="286" HEIGHT="30">3.현금의 유입이 없는 수익 등의 차감</TD>
<TD WIDTH="129" HEIGHT="30" ALIGN="RIGHT">(4,205,839)</TD>
<TD WIDTH="129" HEIGHT="30" ALIGN="RIGHT">(5,228,929)</TD>
<TD WIDTH="128" HEIGHT="30" ALIGN="RIGHT">(27,404,333)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" P32" WIDTH="286" HEIGHT="30">외화환산이익</TD>
<TD WIDTH="129" HEIGHT="30" ALIGN="RIGHT">4,205,839</TD>
<TD WIDTH="129" HEIGHT="30" ALIGN="RIGHT">4,506,095</TD>
<TD WIDTH="128" HEIGHT="30" ALIGN="RIGHT">2,421,333</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" P32" WIDTH="286" HEIGHT="30">유형자산처분이익</TD>
<TD WIDTH="129" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="129" HEIGHT="30" ALIGN="RIGHT">722,834</TD>
<TD WIDTH="128" HEIGHT="30" ALIGN="RIGHT">24,983,000</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" P16" WIDTH="286" HEIGHT="30">4.영업활동으로 인한 자산부채의 변동</TD>
<TD WIDTH="129" HEIGHT="30" ALIGN="RIGHT">(1,079,468,696)</TD>
<TD WIDTH="129" HEIGHT="30" ALIGN="RIGHT">1,331,463,958</TD>
<TD WIDTH="128" HEIGHT="30" ALIGN="RIGHT">(1,012,440,852)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" P32" WIDTH="286" HEIGHT="30">매출채권의 증가</TD>
<TD WIDTH="129" HEIGHT="30" ALIGN="RIGHT">1,745,822,695</TD>
<TD WIDTH="129" HEIGHT="30" ALIGN="RIGHT">(608,592,312)</TD>
<TD WIDTH="128" HEIGHT="30" ALIGN="RIGHT">(285,142,108)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" P32" WIDTH="286" HEIGHT="30">미수금의 감소(증가)</TD>
<TD WIDTH="129" HEIGHT="30" ALIGN="RIGHT">(5,399,440)</TD>
<TD WIDTH="129" HEIGHT="30" ALIGN="RIGHT">218,517,143</TD>
<TD WIDTH="128" HEIGHT="30" ALIGN="RIGHT">(219,122,143)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" P32" WIDTH="286" HEIGHT="30">미수수익의 증가</TD>
<TD WIDTH="129" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="129" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="128" HEIGHT="30" ALIGN="RIGHT">5,424,657</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" P32" WIDTH="286" HEIGHT="30">선급금의 감소(증가)</TD>
<TD WIDTH="129" HEIGHT="30" ALIGN="RIGHT">5,137,996</TD>
<TD WIDTH="129" HEIGHT="30" ALIGN="RIGHT">408,490,012</TD>
<TD WIDTH="128" HEIGHT="30" ALIGN="RIGHT">(43,283,692)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" P32" WIDTH="286" HEIGHT="30">당기법인세자산의 감소(증가)</TD>
<TD WIDTH="129" HEIGHT="30" ALIGN="RIGHT">110,240</TD>
<TD WIDTH="129" HEIGHT="30" ALIGN="RIGHT">(159,710)</TD>
<TD WIDTH="128" HEIGHT="30" ALIGN="RIGHT">51,973,570</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" P32" WIDTH="286" HEIGHT="30">재고자산의 감소(증가)</TD>
<TD WIDTH="129" HEIGHT="30" ALIGN="RIGHT">(1,255,457,653)</TD>
<TD WIDTH="129" HEIGHT="30" ALIGN="RIGHT">524,100,516</TD>
<TD WIDTH="128" HEIGHT="30" ALIGN="RIGHT">(496,819,263)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" P32" WIDTH="286" HEIGHT="30">보증금의 증가</TD>
<TD WIDTH="129" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="129" HEIGHT="30" ALIGN="RIGHT">(10,000,000)</TD>
<TD WIDTH="128" HEIGHT="30" ALIGN="RIGHT">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" P32" WIDTH="286" HEIGHT="30">매입채무의 증가(감소)</TD>
<TD WIDTH="129" HEIGHT="30" ALIGN="RIGHT">(1,380,347,173)</TD>
<TD WIDTH="129" HEIGHT="30" ALIGN="RIGHT">840,385,274</TD>
<TD WIDTH="128" HEIGHT="30" ALIGN="RIGHT">(41,360,189)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD USERMARK=" P32" WIDTH="286" HEIGHT="30">미지급금의 증가
<SPAN>(감소)</SPAN>
</TD>
<TD WIDTH="129" HEIGHT="30" ALIGN="RIGHT">(19,526,812)</TD>
<TD WIDTH="129" HEIGHT="30" ALIGN="RIGHT">(20,198,313)</TD>
<TD WIDTH="128" HEIGHT="30" ALIGN="RIGHT">78,879,845</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD USERMARK=" P32" WIDTH="286" HEIGHT="30">예수금의 증가
<SPAN>(감소)</SPAN>
</TD>
<TD WIDTH="129" HEIGHT="30" ALIGN="RIGHT">21,687,860</TD>
<TD WIDTH="129" HEIGHT="30" ALIGN="RIGHT">8,790,480</TD>
<TD WIDTH="128" HEIGHT="30" ALIGN="RIGHT">(5,008,830)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" P32" WIDTH="286" HEIGHT="30">선급비용의 감소</TD>
<TD WIDTH="129" HEIGHT="30" ALIGN="RIGHT">(5,006,996)</TD>
<TD WIDTH="129" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="128" HEIGHT="30" ALIGN="RIGHT">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" P32" WIDTH="286" HEIGHT="30">부가세예수금의 감소</TD>
<TD WIDTH="129" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="129" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="128" HEIGHT="30" ALIGN="RIGHT">(38,133,712)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" P32" WIDTH="286" HEIGHT="30">미지급비용의 증가</TD>
<TD WIDTH="129" HEIGHT="30" ALIGN="RIGHT">(33,795,071)</TD>
<TD WIDTH="129" HEIGHT="30" ALIGN="RIGHT">43,147,447</TD>
<TD WIDTH="128" HEIGHT="30" ALIGN="RIGHT">31,194,222</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" P32" WIDTH="286" HEIGHT="30">당기법인세부채의 증가</TD>
<TD WIDTH="129" HEIGHT="30" ALIGN="RIGHT">(40,020,966)</TD>
<TD WIDTH="129" HEIGHT="30" ALIGN="RIGHT">40,020,966</TD>
<TD WIDTH="128" HEIGHT="30" ALIGN="RIGHT">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" P32" WIDTH="286" HEIGHT="30">퇴직금의 지급</TD>
<TD WIDTH="129" HEIGHT="30" ALIGN="RIGHT">(113,281,880)</TD>
<TD WIDTH="129" HEIGHT="30" ALIGN="RIGHT">(58,317,228)</TD>
<TD WIDTH="128" HEIGHT="30" ALIGN="RIGHT">(51,043,209)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" P32" WIDTH="286" HEIGHT="30">퇴직연금운용자산의 증가</TD>
<TD WIDTH="129" HEIGHT="30" ALIGN="RIGHT">608,504</TD>
<TD WIDTH="129" HEIGHT="30" ALIGN="RIGHT">(54,720,317)</TD>
<TD WIDTH="128" HEIGHT="30" ALIGN="RIGHT">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="286" HEIGHT="30">Ⅱ.투자활동으로 인한 현금흐름</TD>
<TD WIDTH="129" HEIGHT="30" ALIGN="RIGHT">(663,970,219)</TD>
<TD WIDTH="129" HEIGHT="30" ALIGN="RIGHT">(10,069,330,340)</TD>
<TD WIDTH="128" HEIGHT="30" ALIGN="RIGHT">910,160,000</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" P16" WIDTH="286" HEIGHT="30">1.투자활동으로 인한 현금유입액</TD>
<TD WIDTH="129" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="129" HEIGHT="30" ALIGN="RIGHT">4,915,755</TD>
<TD WIDTH="128" HEIGHT="30" ALIGN="RIGHT">4,425,000,000</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" P32" WIDTH="286" HEIGHT="30">단기대여금의 감소</TD>
<TD WIDTH="129" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="129" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="128" HEIGHT="30" ALIGN="RIGHT">4,400,000,000</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" P32" WIDTH="286" HEIGHT="30">기계장치의 처분</TD>
<TD WIDTH="129" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="129" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="128" HEIGHT="30" ALIGN="RIGHT">25,000,000</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" P32" WIDTH="286" HEIGHT="30">차량운반구의 처분</TD>
<TD WIDTH="129" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="129" HEIGHT="30" ALIGN="RIGHT">4,915,755</TD>
<TD WIDTH="128" HEIGHT="30" ALIGN="RIGHT">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" P16" WIDTH="286" HEIGHT="30">2.투자활동으로 인한 현금유출액</TD>
<TD WIDTH="129" HEIGHT="30" ALIGN="RIGHT">(663,970,219)</TD>
<TD WIDTH="129" HEIGHT="30" ALIGN="RIGHT">(10,074,246,095)</TD>
<TD WIDTH="128" HEIGHT="30" ALIGN="RIGHT">(3,514,840,000)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" P32" WIDTH="286" HEIGHT="30">건물의 취득</TD>
<TD WIDTH="129" HEIGHT="30" ALIGN="RIGHT">517,021,200</TD>
<TD WIDTH="129" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="128" HEIGHT="30" ALIGN="RIGHT">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" P32" WIDTH="286" HEIGHT="30">기계장치의 취득</TD>
<TD WIDTH="129" HEIGHT="30" ALIGN="RIGHT">124,707,383</TD>
<TD WIDTH="129" HEIGHT="30" ALIGN="RIGHT">152,965,000</TD>
<TD WIDTH="128" HEIGHT="30" ALIGN="RIGHT">13,000,000</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" P32" WIDTH="286" HEIGHT="30">비품의 취득</TD>
<TD WIDTH="129" HEIGHT="30" ALIGN="RIGHT">21,267,636</TD>
<TD WIDTH="129" HEIGHT="30" ALIGN="RIGHT">109,463,000</TD>
<TD WIDTH="128" HEIGHT="30" ALIGN="RIGHT">16,540,000</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" P32" WIDTH="286" HEIGHT="30">차량운반구의 취득</TD>
<TD WIDTH="129" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="129" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="128" HEIGHT="30" ALIGN="RIGHT">8,800,000</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" P32" WIDTH="286" HEIGHT="30">건설중인자산의 취득</TD>
<TD WIDTH="129" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="129" HEIGHT="30" ALIGN="RIGHT">9,807,381,695</TD>
<TD WIDTH="128" HEIGHT="30" ALIGN="RIGHT">3,456,400,000</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD USERMARK=" P32" WIDTH="286" HEIGHT="30">
<SPAN>무형자산의 취득</SPAN>
</TD>
<TD WIDTH="129" HEIGHT="30" ALIGN="RIGHT">974,000</TD>
<TD WIDTH="129" HEIGHT="30" ALIGN="RIGHT">4,436,400</TD>
<TD WIDTH="128" HEIGHT="30" ALIGN="RIGHT">20,100,000</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="286" HEIGHT="30">Ⅲ.재무활동으로 인한 현금흐름</TD>
<TD WIDTH="129" HEIGHT="30" ALIGN="RIGHT">1,340,000,000</TD>
<TD WIDTH="129" HEIGHT="30" ALIGN="RIGHT">6,710,000,000</TD>
<TD WIDTH="128" HEIGHT="30" ALIGN="RIGHT">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" P16" WIDTH="286" HEIGHT="30">1.재무활동으로 인한 현금유입액</TD>
<TD WIDTH="129" HEIGHT="30" ALIGN="RIGHT">2,050,000,000</TD>
<TD WIDTH="129" HEIGHT="30" ALIGN="RIGHT">7,910,000,000</TD>
<TD WIDTH="128" HEIGHT="30" ALIGN="RIGHT">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" P32" WIDTH="286" HEIGHT="30">단기차입금의 증가</TD>
<TD WIDTH="129" HEIGHT="30" ALIGN="RIGHT">2,050,000,000</TD>
<TD WIDTH="129" HEIGHT="30" ALIGN="RIGHT">1,910,000,000</TD>
<TD WIDTH="128" HEIGHT="30" ALIGN="RIGHT">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" P32" WIDTH="286" HEIGHT="30">장기차입금의 증가</TD>
<TD WIDTH="129" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="129" HEIGHT="30" ALIGN="RIGHT">6,000,000,000</TD>
<TD WIDTH="128" HEIGHT="30" ALIGN="RIGHT"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" P16" WIDTH="286" HEIGHT="30">2.재무활동으로 인한 현금유출액</TD>
<TD WIDTH="129" HEIGHT="30" ALIGN="RIGHT">(710,000,000)</TD>
<TD WIDTH="129" HEIGHT="30" ALIGN="RIGHT">(1,200,000,000)</TD>
<TD WIDTH="128" HEIGHT="30" ALIGN="RIGHT">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" P32" WIDTH="286" HEIGHT="30">단기차입금의 상환</TD>
<TD WIDTH="129" HEIGHT="30" ALIGN="RIGHT">710,000,000</TD>
<TD WIDTH="129" HEIGHT="30" ALIGN="RIGHT">1,200,000,000</TD>
<TD WIDTH="128" HEIGHT="30" ALIGN="RIGHT">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="286" HEIGHT="30">Ⅳ.현금의 증가(감소) (Ⅰ+Ⅱ+Ⅲ)</TD>
<TD WIDTH="129" HEIGHT="30" ALIGN="RIGHT">(51,719,747)</TD>
<TD WIDTH="129" HEIGHT="30" ALIGN="RIGHT">(1,917,852,118)</TD>
<TD WIDTH="128" HEIGHT="30" ALIGN="RIGHT">1,550,447,548</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="286" HEIGHT="30">Ⅴ.기초의 현금</TD>
<TD WIDTH="129" HEIGHT="30" ALIGN="RIGHT">414,544,602</TD>
<TD WIDTH="129" HEIGHT="30" ALIGN="RIGHT">2,332,396,720</TD>
<TD WIDTH="128" HEIGHT="30" ALIGN="RIGHT">781,949,172</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="286" HEIGHT="30">Ⅵ.기말의 현금</TD>
<TD WIDTH="129" HEIGHT="30" ALIGN="RIGHT">362,824,855</TD>
<TD WIDTH="129" HEIGHT="30" ALIGN="RIGHT">414,544,602</TD>
<TD WIDTH="128" HEIGHT="30" ALIGN="RIGHT">2,332,396,720</TD>
</TR>
</TBODY>
</TABLE>
<P></P>
</SECTION-2>

<SECTION-2 ACLASS="MANDATORY">
<TITLE ATOC="Y" AASSOCNOTE="D-0-3-5-0">5. 재무제표 주석</TITLE>
<P USERMARK="F-16 0XFF0000 B"></P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" WIDTH="600" BORDER="0">

<COLGROUP>
<COL WIDTH="591"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" WIDTH="600" HEIGHT="30">제 11(당) 기 2020년 1월 1일부터 2020년 12월 31일까지</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" WIDTH="600" HEIGHT="30">제 10(전) 기 2019년 1월 1일부터 2019년 12월 31일까지</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="600" HEIGHT="53">&cr;주식회사 리독스바이오</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN>&cr;1. 회사의 개요&cr;&cr;</SPAN>
<SPAN>주식회사 리독스바이오(이하 "회사")는 2010년 8월 26일에 설립되어 본사와 공장을 경기도 화성시 향남읍에 두고 원료의약품 제조 및 의료기기 판매 등을 주된 영업으로하고 있습니다.&cr;&cr;</SPAN>
<SPAN></SPAN>
<SPAN></SPAN>
<SPAN>당사의 설립시 자본금은 100백만원이었으나 설립 후 수차례의 유상증자 등을 통하여당기말 현재의 자본금은 12,306백만원입니다. 보고기간종료일 현재 주주의 현황은 다음과 같습니다.</SPAN>
</P>

<TABLE BORDER="1" WIDTH="603" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="194"></COL>
<COL WIDTH="191"></COL>
<COL WIDTH="191"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="203" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE">주주명</TH>
<TH WIDTH="200" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">소유주식수(주)</TH>
<TH WIDTH="200" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">지분율(%)</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="203" HEIGHT="30" VALIGN="MIDDLE">대화제약(주)</TD>
<TD WIDTH="200" ALIGN="RIGHT" HEIGHT="30">14,810,770</TD>
<TD WIDTH="200" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">60.18%</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="203" HEIGHT="30" VALIGN="MIDDLE">기타</TD>
<TD WIDTH="200" ALIGN="RIGHT" HEIGHT="30">9,801,100</TD>
<TD WIDTH="200" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">39.82%</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="203" ALIGN="CENTER" HEIGHT="30" VALIGN="MIDDLE">합   계</TD>
<TD WIDTH="200" ALIGN="RIGHT" HEIGHT="30">24,611,870</TD>
<TD WIDTH="200" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">100.00%</TD>
</TR>
</TBODY>
</TABLE>
<P>&cr;&cr;2. 재무제표 작성기준 및 유의적인 회계정책&cr;&cr;회사는 2011년 1월 1일 이후 최초로 개시하는 회계연도부터 시행되는 일반기업회계기준에 따라 당기의 재무제표를 작성하였습니다. &cr;</P>
<P>회사가 채택하고 있는 중요한 회계정책은 다음과 같습니다.&cr;&cr;(1) 현금및현금성자산&cr;회사는 통화 및 타인발행수표 등 통화대용증권과 당좌예금, 보통예금 및 큰 거래비용없이 현금으로 전환이 용이하고 이자율 변동에 따른 가치변동이 중요하지 않은 금융상품으로서 취득 당시 만기일(또는 상환일)이 3개월 이내인 것을 현금 및 현금성자산으로 분류하고 있습니다.&cr;</P>
<P>(2) 수익의 인식</P>
<P>회사는 재화의 판매로 인한 수익을 다음 조건이 모두 충족될 때 인식하고 있습니다. </P>
<P></P>
<P>(가) 재화의 소유에 따른 위험과 효익이 대부분 구매자에게 이전한 경우</P>
<P>(나) 판매한 재화에 대하여 소유권이 있을 때 통상적으로 행사하는 정도의 관리나 효  과적인 통제가 불가능한 경우</P>
<P>(다) 수익금액 및 거래와 관련하여 발생했거나 발생할 거래원가와 관련비용을 신뢰성 있게 측정 가능한 경우 </P>
<P>(라) 경제적 효익의 유입가능성이 매우 높은 경우 </P>
<P></P>
<P>이자, 배당금 및 로열티는 수익금액을 신뢰성 있게 측정할 수 있으며 경제적 효익의 유입 가능성이 매우 높은 경우에 수익으로 인식하고 있습니다.</P>
<P>&cr;(3) 금융상품&cr;회사는 단기적 자금운용을 목적으로 소유하거나 기한이 1년내에 도래하는 금융기관의 정기예금, 정기적금을 단기금융상품으로, 유동자산에 속하지 아니하는 금융상품은 장기금융상품으로 분류하고 있습니다.&cr;</P>
<P>(4) 대손충당금&cr;회사는 재무상태표일 현재 매출채권, 대여금, 미수금 등 받을채권 잔액의 회수가능성에 대한 개별분석 및 장래의 대손예상액을 기초로 대손충당금을 설정하고 있습니다.&cr;</P>
<P>(5) 유가증권 및 투자유가증권&cr;회사는 유가증권을 통제할 수 있는 때에 재무상태표에 자산으로 인식하며, 보유의도와 능력에 따라 단기매매증권, 매도가능증권 또는 만기보유증권으로 분류하고 있습니다. 다만, 유가증권 중 중대한 영향력을 행사할 수 있는 지분증권은 지분법적용투자주식으로 분류하고 있습니다.</P>
<P></P>
<P>단기매매증권은 유동자산으로 분류하고, 매도가능증권 및 만기보유증권은 투자자산으로 분류하고 있으며 보고기간 종료일로부터 1년 이내에 만기가 도래하거나 또는 매도 등에 의하여 처분할 것이 거의 확실한 경우 유동자산(단기투자자산)으로 분류하고 있습니다.</P>
<P></P>
<P>유가증권의 취득원가는 유가증권 취득을 위하여 제공한 대가의 시장가격에 취득부대비용을 포함한 가액으로 산정하고 있습니다.</P>
<P> </P>
<P>만기보유증권은 만기가 확정된 채무증권으로서 상환금액이 확정되었거나 확정이 가능한 채무증권을 만기까지 보유할 적극적인 의도와 능력이 있는 경우에 분류하며, 취득원가와 만기액면가액의 차이를 상환기간에 걸쳐 유효이자율법에 의하여 상각한 후의 금액으로 평가하고 있습니다.  </P>
<P>&cr;단기매매증권은 단기간 내의 매매차익을 목적으로 취득한 유가증권으로서 매수와 매도가 적극적이고 빈번하게 이루어지는 것을 말하며, 공정가액으로 평가하고 미실현보유손익은 당기손익에 반영하고 있습니다.&cr;</P>
<P>매도가능증권은 공정가액으로 평가하되, 매도가능증권 중 시장성이 없는 지분증권의공정가액을 신뢰성 있게 측정할 수 없는 경우에는 취득원가로 평가하고 있습니다.  </P>

<P>
<SPAN>&cr;매도가능증권에 대한 미실현보유손익은 매도가능증권평가이익(또는 손실)의 과목으로 하여 기타포괄손익누계액으로 처리하고 있습니다. 또한, 공정가액이 하락하여 회복할 가능성이 없는 경우에는 당해 매도가능증권의 장부가액과 공정가액의 차액을 매도가능증권손상차손의 과목으로 하여 기간손실로 처리하고 있으며, 동 매도가능증권과 관련된 매도가능증권평가이익(또는 손실)은 매도가능증권손상차손에서 차감(또는 부가)하고 있습니다. 다만, 매도가능증권의 손상차손의 회복이 손상차손을 인식한기간 후에 발생한 사건과 객관적으로 관련된 경우에는 이전에 인식하였던 손상차손금액을 한도로 하여 회복된 금액을 매도가능증권손상차손환입의 과목으로 하여 기간이익으로 처리하고 있습니다.</SPAN>
</P>
<P></P>

<P>
<SPAN>유가증권의 회수가능가액이 채무증권의 상각후취득원가 또는 지분증권의 취득원가보다 작은 경우에는 손상차손을 인식하고 당기손익에 반영하고 있습니다.</SPAN>
</P>
<PGBRK></PGBRK>

<P>
<SPAN>(6) 재고자산&cr;회사는 재고자산의 수량을 계속기록법에 따라 기록한 수량을 실지재고조사에 의하여확정하고, 매입가격에 부대비용을 가산하여 산정한 취득원가를 재무상태표가액으로 계상하고 있습니다. 재고자산의 재고단가 및 매출원가 산정을 위해서 선입선출법을 적용하고 있습니다. 재고자산의 진부화, 손상, 품질저하 등의 사유로 재고자산의 순실현가능가액이 취득원가보다 하락하여 발생한 평가손실은 재고자산에서 직접 차감하여 표시하고 매출원가에 가산하고 있습니다.&cr;&cr;(7) 유형자산의 평가 및 감가상각방법&cr;유형자산은 취득가액에 부대비용을 가산한 취득원가로 계상하고 있으며, 유형자산의제조, </SPAN>
<SPAN></SPAN>
<SPAN>매입 또는 건설에 사용된 차입금에 대하여 당해 자산의 제조, 매입 또는 건설 완료시까지 발생된 이자비용과 기타 유사한 금융비용은 당기손익에 반영하고 있습니다.</SPAN>
<SPAN> 또한 유형자산의 내용연수를 연장시키거나 가치를 실질적으로 증가시키는 지출은 자</SPAN>
<SPAN>본적지출로 하고, 당해 유형자산의 원상을 회복시키거나 능률유지를 위한 지출은 수익적지출로 처리하고 있습니다.</SPAN>
</P>

<P>
<SPAN>&cr;또한, 회사는 유형자산의 진부화 또는 시장가치의 급격한 하락 등으로 인하여 유형자산의 미래 경제적 효익이 장부가액에 현저하게 미달할 가능성이 있는 경우에는 손상차손의 인식여부를 검토하여 장부가액을 회수가능액으로 조정하고 그 차액을 손상차손으로 처리하고 있습니다. 다만, 차기 이후에 손상처리된 자산의 회수가능액이 장부가액을 초과하는 경우에는 그 자산이 손상처리되기 전의 장부가액의 감가상각 후 잔액을 한도로 하여 그 초과액이 손상차손환입으로 처리되고 있습니다.</SPAN>
</P>
<P></P>

<P>
<SPAN>회사의 유형자산은 취득원가에서 아래의 추정내용연수와 감가상각방법에 따라 산정된 감가상각누계액과 손상차손누계액을 차감하는 형식으로 재무상태표에 표시하고 있습니다.</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="600">

<COLGROUP>
<COL WIDTH="191"></COL>
<COL WIDTH="191"></COL>
<COL WIDTH="191"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="200" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">구분 </TH>
<TH WIDTH="200" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">내용연수 </TH>
<TH WIDTH="200" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">감가상각방법</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="200" ALIGN="CENTER" HEIGHT="30">건물</TD>
<TD WIDTH="200" ALIGN="CENTER" HEIGHT="30">20, 40년</TD>
<TD WIDTH="200" ALIGN="CENTER" HEIGHT="30">정액법</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="200" ALIGN="CENTER" HEIGHT="30">기계장치</TD>
<TD WIDTH="200" ALIGN="CENTER" HEIGHT="30">10년</TD>
<TD WIDTH="200" ALIGN="CENTER" HEIGHT="30">정액법</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="200" ALIGN="CENTER" HEIGHT="30">비품 </TD>
<TD WIDTH="200" ALIGN="CENTER" HEIGHT="30">5년 </TD>
<TD WIDTH="200" ALIGN="CENTER" HEIGHT="30">정률법</TD>
</TR>
</TBODY>
</TABLE>
<P>&cr;(8) 무형자산&cr;회사는 개별취득한 무형자산을 최초로 인식할 때에는 취득원가(당해 무형자산의 구입가격과 자산을 의도한 목적에 사용할 수 있도록 준비하는데 직접 관련되는 원가)로측정하고 있으며 사업결합으로 취득한 무형자산의 원가는 사업결합에 관한 기업회계기준에 따라 취득일의 공정가치로 측정하고 있습니다. 한편, 내부적으로 창출한 무형자산 중 연구단계에서 발생한 지출은 발생한 기간의 비용으로 인식하고 개발단계에서 발생한 지출은 다음의 조건을 모두 충족하는 경우에만 무형자산으로 인식하고 있습니다.</P>

<TABLE WIDTH="657" BORDER="1" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="20"></COL>
<COL WIDTH="619"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="29" HEIGHT="53">①</TD>
<TD WIDTH="628" HEIGHT="53">무형자산을 사용 또는 판매하기 위해 그 자산을 완성시킬 수 있는 기술적 실현가능성을제시할 수 있음</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="29" HEIGHT="30">②</TD>
<TD WIDTH="628" HEIGHT="30">무형자산을 완성해 그것을 사용하거나 판매하려는 기업의 의도가 있음</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="29" HEIGHT="30">③</TD>
<TD WIDTH="628" HEIGHT="30">완성된 무형자산을 사용하거나 판매할 수 있는 기업의 능력을 제시할 수 있음</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="29" HEIGHT="30">④</TD>
<TD WIDTH="628" HEIGHT="30">무형자산이 어떻게 미래경제적효익을 창출할 것인가를 보여줄 수 있음</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="29" HEIGHT="53">⑤</TD>
<TD WIDTH="628" HEIGHT="53">무형자산의 개발을 완료하고 그것을 판매 또는 사용하는데 필요한 기술적, 금전적 자원을 충분히 확보하고 있다는 사실을 제시할 수 있음</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="29" HEIGHT="30">⑥</TD>
<TD WIDTH="628" HEIGHT="30">개발단계에서 발생한 무형자산 관련 지출을 신뢰성 있게 구분하여 측정할 수 있음</TD>
</TR>
</TBODY>
</TABLE>
<P></P>
<P>소프트웨어는 관련 제품의 판매 또는 사용이 가능한 시점부터 5년의 내용연수를 적용하여 정액법에 의하여 산정된 상각액을 직접 차감한 잔액으로 표시하고 있으며, 무형자산의 상각이 다른 자산의 제조와 관련된 경우에는 관련 자산의 제조원가로, 그 밖의 경우에는 판매비와관리비로 계상하고 있습니다.</P>
<P></P>
<P>(9) 퇴직급여충당부채&cr;회사는 임직원 퇴직금지급규정에 따라 기말 현재 1년이상 근속한 전직원이 일시에 퇴직할 경우 지급하여야 할 퇴직금추계액을 퇴직급여충당부채로 설정하고 있습니다.</P>
<P>확정급여형 퇴직연금은 수급요건을 갖춘 종업원이 퇴직시에 확정된 연금을 수령하게됩니다. 퇴직연금제도에서 운용되는 자산은 퇴직연금운용자산의 과목으로 하여 퇴직급여관련 부채, 즉 퇴직급여충당부채와 퇴직연금미지급금에서 차감하는 형식으로 표시하고있습니다. 다만 퇴직연금운용자산이 퇴직급여관련 부채의 합계액을 초과하는 경우에는 초과액을 투자자산으로 처리하고 있습니다. </P>

<P>
<SPAN USERMARK=" 0X0000FF"></SPAN>
<SPAN></SPAN>
<SPAN>&cr;(10) 법인세비용&cr;법인세비용은 법인세법 등의 법령에 의한 법인세부담액에 이연법인세 변동액을 가감하여 계상하고 있습니다. 자산, 부채의 장부금액과 세무기준액의 차이인 일시적차이중 미래기간의 과세소득을 증가시키는 가산할 일시적차이에 대한 법인세효과는 예외항목에 해당되지 않는 경우 전액 이연법인세부채로 인식하고 있습니다. 미래기간의 과세소득을 감소시키는 차감할 일시적차이 및 결손금 등에 대한 법인세효과는 향후 과세소득의 발생가능성이 매우 높아 미래의 법인세 절감효과가 실현될 수 있을 것으로 기대되는 경우에 이연법인세자산으로 인식하고 있습니다. 또한, 자본계정에 직접 가감되는 항목과 관련된 법인세부담액과 이연법인세는 자본계정에 직접 가감하고 있습니다.&cr;&cr;(11) 회계추정&cr;</SPAN>
<SPAN>일반기업회계기준</SPAN>
<SPAN>에 따라 재무제표를 작성하기 위해서 회사는 자산 및 부채의 금액, 충당부채 등에 대한 공시, 수익 및 비용의 측정과 관련하여 많은 합리적인 추정과 가정을 사용합니다. 여기에는 유형자산의 장부금액, 매출채권에 대한 평가 등이 포함됩니다. 이러한 평가금액은 실제와 다를 수 있으며 차기에 유의적으로 조정될 가능성이있습니다.&cr;</SPAN>
</P>
<PGBRK></PGBRK>

<P>
<SPAN>3. 현금및현금성자산 &cr;</SPAN>
<SPAN>&cr;보고기간종료일 현재 회사의 현금및현금성자산의 내역은 다음과 같습니다.</SPAN>
</P>

<TABLE ACLASS="NORMAL" WIDTH="618" BORDER="0" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="609"></COL>
</COLGROUP>

<TBODY ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="RIGHT" WIDTH="618" HEIGHT="30">(단위 : 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" WIDTH="619" BORDER="1">

<COLGROUP>
<COL WIDTH="146"></COL>
<COL WIDTH="146"></COL>
<COL WIDTH="146"></COL>
<COL WIDTH="145"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="155" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">계정과목</TH>
<TH ALIGN="CENTER" WIDTH="155" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE">당 기</TH>
<TH ALIGN="CENTER" WIDTH="155" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE">전 기</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="154" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">사용제한여부</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="155" HEIGHT="30" VALIGN="MIDDLE">현금</TD>
<TD ALIGN="RIGHT" WIDTH="155" HEIGHT="30">99</TD>
<TD ALIGN="RIGHT" WIDTH="155" HEIGHT="30">7</TD>
<TD ALIGN="CENTER" WIDTH="154" HEIGHT="30" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="155" HEIGHT="30" VALIGN="MIDDLE">보통예금</TD>
<TD ALIGN="RIGHT" WIDTH="155" HEIGHT="30">362,725</TD>
<TD ALIGN="RIGHT" WIDTH="155" HEIGHT="30">414,538</TD>
<TD ALIGN="CENTER" WIDTH="154" HEIGHT="30" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" WIDTH="155" HEIGHT="30" VALIGN="MIDDLE">합     계</TD>
<TD ALIGN="RIGHT" WIDTH="155" HEIGHT="30">362,824</TD>
<TD ALIGN="RIGHT" WIDTH="155" HEIGHT="30">414,545</TD>
<TD ALIGN="CENTER" WIDTH="154" HEIGHT="30" VALIGN="MIDDLE">-</TD>
</TR>
</TBODY>
</TABLE>
<P>&cr;&cr;4. 매도가능증권&cr;보고기간종료일 현재 회사의 매도가능증권의 내역은 다음과 같습니다.</P>

<TABLE ACLASS="NORMAL" WIDTH="696" BORDER="0" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="687"></COL>
</COLGROUP>

<TBODY ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="RIGHT" WIDTH="696" HEIGHT="30">(단위 : 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" WIDTH="696" BORDER="1">

<COLGROUP>
<COL WIDTH="146"></COL>
<COL WIDTH="63"></COL>
<COL WIDTH="109"></COL>
<COL WIDTH="108"></COL>
<COL WIDTH="108"></COL>
<COL WIDTH="108"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="155" HEIGHT="60" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ROWSPAN="2">구 분</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="72" HEIGHT="60" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ROWSPAN="2">지분율</TH>
<TH ALIGN="CENTER" WIDTH="235" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE" COLSPAN="2">당기말</TH>
<TH ALIGN="CENTER" WIDTH="234" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE" COLSPAN="2">전기말</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH ALIGN="CENTER" WIDTH="118" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE">취득원가</TH>
<TH ALIGN="CENTER" WIDTH="117" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE">장부금액</TH>
<TH ALIGN="CENTER" WIDTH="117" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE">취득원가</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="117" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">장부금액</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="155" HEIGHT="30" VALIGN="MIDDLE">KINGO투자파트너스</TD>
<TD WIDTH="72" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">0.98%</TD>
<TD ALIGN="RIGHT" WIDTH="118" HEIGHT="30" VALIGN="MIDDLE">100,000</TD>
<TD ALIGN="RIGHT" WIDTH="117" HEIGHT="30" VALIGN="MIDDLE">100,000</TD>
<TD ALIGN="RIGHT" WIDTH="117" HEIGHT="30" VALIGN="MIDDLE">100,000</TD>
<TD ALIGN="RIGHT" WIDTH="117" HEIGHT="30" VALIGN="MIDDLE">100,000</TD>
</TR>
</TBODY>
</TABLE>
<P>&cr;&cr;5. 지분법적용투자주식&cr;</P>
<P>(1) 당기말 및 전기말 현재 회사의 지분법적용투자주식의 내역은 다음과 같습니다.</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="621">

<COLGROUP>
<COL WIDTH="302"></COL>
<COL WIDTH="301"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="311" HEIGHT="30"><당기말></TD>
<TD WIDTH="310" HEIGHT="30" ALIGN="RIGHT">(단위 : 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="804">

<COLGROUP>
<COL WIDTH="229"></COL>
<COL WIDTH="56"></COL>
<COL WIDTH="63"></COL>
<COL WIDTH="99"></COL>
<COL WIDTH="98"></COL>
<COL WIDTH="98"></COL>
<COL WIDTH="98"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="238" HEIGHT="60" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ROWSPAN="2">구 분</TH>
<TH WIDTH="65" HEIGHT="60" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ROWSPAN="2">지분율</TH>
<TH WIDTH="72" HEIGHT="60" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ROWSPAN="2">취득일</TH>
<TH WIDTH="322" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" COLSPAN="3">당기말</TH>
<TH WIDTH="107" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">전기말</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="108" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">취득원가</TH>
<TH WIDTH="107" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">순자산가액(*)</TH>
<TH WIDTH="107" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">장부금액</TH>
<TH WIDTH="107" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">장부금액</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="238" HEIGHT="30" VALIGN="MIDDLE">BSC Medical Devices GmbH</TD>
<TD WIDTH="65" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">40%</TD>
<TD WIDTH="72" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">2017.10</TD>
<TD WIDTH="108" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">241,319</TD>
<TD WIDTH="107" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(34,715)</TD>
<TD WIDTH="107" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">100,638</TD>
<TD WIDTH="107" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">225,437</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="238" HEIGHT="30" VALIGN="MIDDLE">S&V Technologies GmbH</TD>
<TD WIDTH="65" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">40%</TD>
<TD WIDTH="72" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">2017.10</TD>
<TD WIDTH="108" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">3,310,545</TD>
<TD WIDTH="107" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">2,615,772</TD>
<TD WIDTH="107" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">2,712,815</TD>
<TD WIDTH="107" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">2,670,914</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="238" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">합 계</TD>
<TD WIDTH="65" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE"></TD>
<TD WIDTH="72" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE"></TD>
<TD WIDTH="108" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">3,551,864</TD>
<TD WIDTH="107" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">2,581,057</TD>
<TD WIDTH="107" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">2,813,453</TD>
<TD WIDTH="107" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">2,896,351</TD>
</TR>
</TBODY>
</TABLE>
<P>(*) 지분율이 고려된 후의 가액입니다. &cr;&cr;(2) 당기와 전기 중 현재 지분법피투자회사의 요약재무정보는 다음과 같습니다.</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="698">

<COLGROUP>
<COL WIDTH="291"></COL>
<COL WIDTH="389"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="300" HEIGHT="30"><당기></TD>
<TD WIDTH="398" HEIGHT="30" ALIGN="RIGHT">(단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE BORDER="1" WIDTH="701" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="232"></COL>
<COL WIDTH="106"></COL>
<COL WIDTH="106"></COL>
<COL WIDTH="106"></COL>
<COL WIDTH="106"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="241" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">회사명</TH>
<TH WIDTH="115" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">자산총액</TH>
<TH WIDTH="115" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">부채총액</TH>
<TH WIDTH="115" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">매출액</TH>
<TH WIDTH="115" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당기순이익</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="241" HEIGHT="30">BSC Medical Devices GmbH</TD>
<TD WIDTH="115" ALIGN="RIGHT" HEIGHT="30">151,066</TD>
<TD WIDTH="115" ALIGN="RIGHT" HEIGHT="30">237,853</TD>
<TD WIDTH="115" ALIGN="RIGHT" HEIGHT="30">518,896</TD>
<TD WIDTH="115" ALIGN="RIGHT" HEIGHT="30">(126,335)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="241" HEIGHT="30">S&V Technologies GmbH</TD>
<TD WIDTH="115" ALIGN="RIGHT" HEIGHT="30">8,533,383</TD>
<TD WIDTH="115" ALIGN="RIGHT" HEIGHT="30">1,993,953</TD>
<TD WIDTH="115" ALIGN="RIGHT" HEIGHT="30">5,247,201</TD>
<TD WIDTH="115" ALIGN="RIGHT" HEIGHT="30">(56,572)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="241" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">합 계</TD>
<TD WIDTH="115" ALIGN="RIGHT" HEIGHT="30">8,684,449</TD>
<TD WIDTH="115" ALIGN="RIGHT" HEIGHT="30">2,231,806</TD>
<TD WIDTH="115" ALIGN="RIGHT" HEIGHT="30">5,766,097</TD>
<TD WIDTH="115" ALIGN="RIGHT" HEIGHT="30">(182,907)</TD>
</TR>
</TBODY>
</TABLE>
<P></P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="698">

<COLGROUP>
<COL WIDTH="291"></COL>
<COL WIDTH="389"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="300" HEIGHT="30"><전기></TD>
<TD WIDTH="398" HEIGHT="30" ALIGN="RIGHT">(단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE BORDER="1" WIDTH="701" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="232"></COL>
<COL WIDTH="106"></COL>
<COL WIDTH="106"></COL>
<COL WIDTH="106"></COL>
<COL WIDTH="106"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="241" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">회사명</TH>
<TH WIDTH="115" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">자산총액</TH>
<TH WIDTH="115" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">부채총액</TH>
<TH WIDTH="115" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">매출액</TH>
<TH WIDTH="115" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당기순이익</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="241" HEIGHT="30">BSC Medical Devices GmbH</TD>
<TD WIDTH="115" ALIGN="RIGHT" HEIGHT="30">253,446</TD>
<TD WIDTH="115" ALIGN="RIGHT" HEIGHT="30">221,598</TD>
<TD WIDTH="115" ALIGN="RIGHT" HEIGHT="30">1,057,441</TD>
<TD WIDTH="115" ALIGN="RIGHT" HEIGHT="30">268,610</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="241" HEIGHT="30">S&V Technologies GmbH</TD>
<TD WIDTH="115" ALIGN="RIGHT" HEIGHT="30">7,553,282</TD>
<TD WIDTH="115" ALIGN="RIGHT" HEIGHT="30">1,257,235</TD>
<TD WIDTH="115" ALIGN="RIGHT" HEIGHT="30">6,759,820</TD>
<TD WIDTH="115" ALIGN="RIGHT" HEIGHT="30">(1,117,453)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="241" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">합 계</TD>
<TD WIDTH="115" ALIGN="RIGHT" HEIGHT="30">7,806,728</TD>
<TD WIDTH="115" ALIGN="RIGHT" HEIGHT="30">1,478,833</TD>
<TD WIDTH="115" ALIGN="RIGHT" HEIGHT="30">7,817,261</TD>
<TD WIDTH="115" ALIGN="RIGHT" HEIGHT="30">(848,843)</TD>
</TR>
</TBODY>
</TABLE>
<P>&cr;(3) 보고기간종료일 현재 지분법적용투자주식의 평가내역은 다음과 같습니다.</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="622">

<COLGROUP>
<COL WIDTH="291"></COL>
<COL WIDTH="313"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="300" HEIGHT="30"></TD>
<TD WIDTH="322" HEIGHT="30" ALIGN="RIGHT">(단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="620">

<COLGROUP>
<COL WIDTH="106"></COL>
<COL WIDTH="118"></COL>
<COL WIDTH="117"></COL>
<COL WIDTH="117"></COL>
<COL WIDTH="117"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="115" HEIGHT="83" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ROWSPAN="2">구분</TH>
<TH WIDTH="253" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" COLSPAN="2">당기</TH>
<TH WIDTH="252" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" COLSPAN="2">전기</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="127" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" USERMARK="F-10">S&V Technologies GmbH</TH>

<TH WIDTH="126" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" USERMARK="F-10">
<P>BSC Medical </P>
<P>Devices GmbH</P>
</TH>
<TH WIDTH="126" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" USERMARK="F-10">S&V Technologies GmbH</TH>
<TH WIDTH="126" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" USERMARK="F-10">BSC Medical &cr;Devices GmbH</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="115" HEIGHT="30" VALIGN="MIDDLE">기초</TD>
<TD WIDTH="127" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">2,670,914</TD>
<TD WIDTH="126" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">225,437</TD>
<TD WIDTH="126" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">3,126,923</TD>
<TD WIDTH="126" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">182,443</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="115" HEIGHT="30" VALIGN="MIDDLE">지분법자본변동</TD>
<TD WIDTH="127" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">119,983</TD>
<TD WIDTH="126" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">3,080</TD>
<TD WIDTH="126" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">46,425</TD>
<TD WIDTH="126" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">12,895</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="115" HEIGHT="30" VALIGN="MIDDLE">지분법손익</TD>
<TD WIDTH="127" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(78,082)</TD>
<TD WIDTH="126" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(127,879)</TD>
<TD WIDTH="126" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(502,434)</TD>
<TD WIDTH="126" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">30,099</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="115" HEIGHT="30" VALIGN="MIDDLE">기말</TD>
<TD WIDTH="127" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">2,712,815</TD>
<TD WIDTH="126" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">100,638</TD>
<TD WIDTH="126" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">2,670,914</TD>
<TD WIDTH="126" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">225,437</TD>
</TR>
</TBODY>
</TABLE>
<P>&cr;(4) 당기 및 전기 중 투자제거차액의 변동 내역은 다음과 같습니다. </P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="622">

<COLGROUP>
<COL WIDTH="291"></COL>
<COL WIDTH="313"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="300" HEIGHT="30"></TD>
<TD WIDTH="322" HEIGHT="30" ALIGN="RIGHT">(단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="620">

<COLGROUP>
<COL WIDTH="106"></COL>
<COL WIDTH="118"></COL>
<COL WIDTH="117"></COL>
<COL WIDTH="117"></COL>
<COL WIDTH="117"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="115" HEIGHT="83" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ROWSPAN="2">구분</TH>
<TH WIDTH="253" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" COLSPAN="2">당기</TH>
<TH WIDTH="252" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" COLSPAN="2">전기</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="127" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" USERMARK="F-10">S&V Technologies GmbH</TH>

<TH WIDTH="126" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" USERMARK="F-10">
<P>BSC Medical </P>
<P>Devices GmbH</P>
</TH>
<TH WIDTH="126" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" USERMARK="F-10">S&V Technologies GmbH</TH>
<TH WIDTH="126" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" USERMARK="F-10">BSC Medical &cr;Devices GmbH</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="115" HEIGHT="30" VALIGN="MIDDLE">기초</TD>
<TD WIDTH="127" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">152,493</TD>
<TD WIDTH="126" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">212,698</TD>
<TD WIDTH="126" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">207,946</TD>
<TD WIDTH="126" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">290,043</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="115" HEIGHT="30" VALIGN="MIDDLE">상각</TD>
<TD WIDTH="127" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(55,453)</TD>
<TD WIDTH="126" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(77,345)</TD>
<TD WIDTH="126" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(55,453)</TD>
<TD WIDTH="126" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(77,345)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="115" HEIGHT="30" VALIGN="MIDDLE">기말</TD>
<TD WIDTH="127" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">97,040</TD>
<TD WIDTH="126" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">135,353</TD>
<TD WIDTH="126" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">152,493</TD>
<TD WIDTH="126" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">212,698</TD>
</TR>
</TBODY>
</TABLE>
<P>&cr;&cr;6. 유형자산&cr;&cr;(1) 당기와 전기 중 회사의 유형자산 변동내역은 다음과 같습니다. </P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="861">

<COLGROUP>
<COL WIDTH="302"></COL>
<COL WIDTH="541"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="311" HEIGHT="30"><당기></TD>
<TD WIDTH="550" HEIGHT="30" ALIGN="RIGHT">(단위 : 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="864">

<COLGROUP>
<COL WIDTH="115"></COL>
<COL WIDTH="115"></COL>
<COL WIDTH="115"></COL>
<COL WIDTH="114"></COL>
<COL WIDTH="114"></COL>
<COL WIDTH="114"></COL>
<COL WIDTH="114"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="124" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구 분</TH>
<TH WIDTH="124" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">기초</TH>
<TH WIDTH="124" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">취득</TH>
<TH WIDTH="123" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">처분</TH>
<TH WIDTH="123" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">감가상각비</TH>
<TH WIDTH="123" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">대체</TH>
<TH WIDTH="123" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">기말</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="124" HEIGHT="30" VALIGN="MIDDLE">토지</TD>
<TD WIDTH="124" HEIGHT="30" ALIGN="RIGHT">2,593,482</TD>
<TD WIDTH="124" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="123" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="123" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="123" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="123" HEIGHT="30" ALIGN="RIGHT">2,593,482</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="124" HEIGHT="30" VALIGN="MIDDLE">건물</TD>
<TD WIDTH="124" HEIGHT="30" ALIGN="RIGHT">8,899,201</TD>
<TD WIDTH="124" HEIGHT="30" ALIGN="RIGHT">517,021</TD>
<TD WIDTH="123" HEIGHT="30" ALIGN="RIGHT">(6,597)</TD>
<TD WIDTH="123" HEIGHT="30" ALIGN="RIGHT">(236,812)</TD>
<TD WIDTH="123" HEIGHT="30" ALIGN="RIGHT">6,000</TD>
<TD WIDTH="123" HEIGHT="30" ALIGN="RIGHT">9,178,812</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="124" HEIGHT="30" VALIGN="MIDDLE">기계장치</TD>
<TD WIDTH="124" HEIGHT="30" ALIGN="RIGHT">458,035</TD>
<TD WIDTH="124" HEIGHT="30" ALIGN="RIGHT">126,693</TD>
<TD WIDTH="123" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="123" HEIGHT="30" ALIGN="RIGHT">(533,271)</TD>
<TD WIDTH="123" HEIGHT="30" ALIGN="RIGHT">4,660,000</TD>
<TD WIDTH="123" HEIGHT="30" ALIGN="RIGHT">4,711,457</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="124" HEIGHT="30" VALIGN="MIDDLE">차량운반구</TD>
<TD WIDTH="124" HEIGHT="30" ALIGN="RIGHT">192</TD>
<TD WIDTH="124" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="123" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="123" HEIGHT="30" ALIGN="RIGHT">(86)</TD>
<TD WIDTH="123" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="123" HEIGHT="30" ALIGN="RIGHT">105</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="124" HEIGHT="30" VALIGN="MIDDLE">비품</TD>
<TD WIDTH="124" HEIGHT="30" ALIGN="RIGHT">108,724</TD>
<TD WIDTH="124" HEIGHT="30" ALIGN="RIGHT">21,268</TD>
<TD WIDTH="123" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="123" HEIGHT="30" ALIGN="RIGHT">(55,857)</TD>
<TD WIDTH="123" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="123" HEIGHT="30" ALIGN="RIGHT">74,135</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="124" HEIGHT="30" VALIGN="MIDDLE">건설중인자산</TD>
<TD WIDTH="124" HEIGHT="30" ALIGN="RIGHT">4,666,000</TD>
<TD WIDTH="124" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="123" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="123" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="123" HEIGHT="30" ALIGN="RIGHT">(4,666,000)</TD>
<TD WIDTH="123" HEIGHT="30" ALIGN="RIGHT">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="124" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">합 계</TD>
<TD WIDTH="124" HEIGHT="30" ALIGN="RIGHT">16,725,634</TD>
<TD WIDTH="124" HEIGHT="30" ALIGN="RIGHT">664,982</TD>
<TD WIDTH="123" HEIGHT="30" ALIGN="RIGHT">(6,597)</TD>
<TD WIDTH="123" HEIGHT="30" ALIGN="RIGHT">(826,026)</TD>
<TD WIDTH="123" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="123" HEIGHT="30" ALIGN="RIGHT">16,557,991</TD>
</TR>
</TBODY>
</TABLE>
<P></P>

<TABLE BORDER="0" WIDTH="865" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="335"></COL>
<COL WIDTH="512"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="344" HEIGHT="30"><전기></TD>
<TD WIDTH="521" HEIGHT="30" ALIGN="RIGHT">(단위 : 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="864">

<COLGROUP>
<COL WIDTH="115"></COL>
<COL WIDTH="115"></COL>
<COL WIDTH="115"></COL>
<COL WIDTH="114"></COL>
<COL WIDTH="114"></COL>
<COL WIDTH="114"></COL>
<COL WIDTH="114"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="124" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구 분</TH>
<TH WIDTH="124" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">기초</TH>
<TH WIDTH="124" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">취득</TH>
<TH WIDTH="123" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">처분</TH>
<TH WIDTH="123" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">감가상각비</TH>
<TH WIDTH="123" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">대체</TH>
<TH WIDTH="123" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">기말</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="124" HEIGHT="30" VALIGN="MIDDLE">토지</TD>
<TD WIDTH="124" HEIGHT="30" ALIGN="RIGHT">2,593,482</TD>
<TD WIDTH="124" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="123" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="123" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="123" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="123" HEIGHT="30" ALIGN="RIGHT">2,593,482</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="124" HEIGHT="30" VALIGN="MIDDLE">건물</TD>
<TD WIDTH="124" HEIGHT="30" ALIGN="RIGHT">1,095,925</TD>
<TD WIDTH="124" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="123" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="123" HEIGHT="30" ALIGN="RIGHT">(83,606)</TD>
<TD WIDTH="123" HEIGHT="30" ALIGN="RIGHT">7,886,882</TD>
<TD WIDTH="123" HEIGHT="30" ALIGN="RIGHT">8,899,201</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="124" HEIGHT="30" VALIGN="MIDDLE">기계장치</TD>
<TD WIDTH="124" HEIGHT="30" ALIGN="RIGHT">614,602</TD>
<TD WIDTH="124" HEIGHT="30" ALIGN="RIGHT">152,965</TD>
<TD WIDTH="123" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="123" HEIGHT="30" ALIGN="RIGHT">(309,532)</TD>
<TD WIDTH="123" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="123" HEIGHT="30" ALIGN="RIGHT">458,035</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="124" HEIGHT="30" VALIGN="MIDDLE">차량운반구</TD>
<TD WIDTH="124" HEIGHT="30" ALIGN="RIGHT">5,512</TD>
<TD WIDTH="124" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="123" HEIGHT="30" ALIGN="RIGHT">(4,193)</TD>
<TD WIDTH="123" HEIGHT="30" ALIGN="RIGHT">(1,127)</TD>
<TD WIDTH="123" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="123" HEIGHT="30" ALIGN="RIGHT">192</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="124" HEIGHT="30" VALIGN="MIDDLE">비품</TD>
<TD WIDTH="124" HEIGHT="30" ALIGN="RIGHT">27,233</TD>
<TD WIDTH="124" HEIGHT="30" ALIGN="RIGHT">109,463</TD>
<TD WIDTH="123" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="123" HEIGHT="30" ALIGN="RIGHT">(27,972)</TD>
<TD WIDTH="123" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="123" HEIGHT="30" ALIGN="RIGHT">108,724</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="124" HEIGHT="30" VALIGN="MIDDLE">건설중인자산</TD>
<TD WIDTH="124" HEIGHT="30" ALIGN="RIGHT">2,745,500</TD>
<TD WIDTH="124" HEIGHT="30" ALIGN="RIGHT">9,807,382</TD>
<TD WIDTH="123" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="123" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="123" HEIGHT="30" ALIGN="RIGHT">(7,886,882)</TD>
<TD WIDTH="123" HEIGHT="30" ALIGN="RIGHT">4,666,000</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="124" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">합 계</TD>
<TD WIDTH="124" HEIGHT="30" ALIGN="RIGHT">7,082,254</TD>
<TD WIDTH="124" HEIGHT="30" ALIGN="RIGHT">10,069,810</TD>
<TD WIDTH="123" HEIGHT="30" ALIGN="RIGHT">(4,193)</TD>
<TD WIDTH="123" HEIGHT="30" ALIGN="RIGHT">(422,237)</TD>
<TD WIDTH="123" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="123" HEIGHT="30" ALIGN="RIGHT">16,725,634</TD>
</TR>
</TBODY>
</TABLE>
<P>&cr;(2) 당기말 현재 당사 자산에 대한 보험가입내역은 다음과 같습니다.</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="622">

<COLGROUP>
<COL WIDTH="335"></COL>
<COL WIDTH="269"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="344" HEIGHT="30"></TD>
<TD WIDTH="278" HEIGHT="30" ALIGN="RIGHT">(단위 : 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="750">

<COLGROUP>
<COL WIDTH="136"></COL>
<COL WIDTH="157"></COL>
<COL WIDTH="161"></COL>
<COL WIDTH="131"></COL>
<COL WIDTH="120"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="145" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">보험종류</TH>
<TH WIDTH="166" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">자산</TH>
<TH WIDTH="170" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">장부금액</TH>
<TH WIDTH="140" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">부보금액</TH>
<TH WIDTH="129" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">보험회사명</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="145" VALIGN="MIDDLE" HEIGHT="120" ROWSPAN="4" ALIGN="CENTER">화재보험 등</TD>
<TD WIDTH="166" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">건물</TD>
<TD WIDTH="170" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">9,178,812</TD>
<TD WIDTH="140" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">10,402,772</TD>
<TD WIDTH="129" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="120" ROWSPAN="4">DB손해보험</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="166" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">기계장치</TD>
<TD WIDTH="170" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">4,711,457</TD>
<TD WIDTH="140" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">5,597,604</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="166" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">비품</TD>
<TD WIDTH="170" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">74,135</TD>
<TD WIDTH="140" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">216,967</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="166" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">차량운반구</TD>
<TD WIDTH="170" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">105</TD>
<TD WIDTH="140" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">678</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="311" VALIGN="MIDDLE" HEIGHT="30" COLSPAN="2" ALIGN="CENTER">합계</TD>
<TD WIDTH="170" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">13,964,509</TD>
<TD WIDTH="140" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">16,218,021</TD>
<TD WIDTH="129" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30"></TD>
</TR>
</TBODY>
</TABLE>
<P>상기 보험 이외에 승강기 사고배상책임보험, 가스사고배상보험 및 환경책임보험에 가입하고있습니다.</P>
<PGBRK></PGBRK>
<P>(3) 당기말 현재 회사가 보유하고 있는 토지의 공시지가는 다음과 같습니다. </P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="586">

<COLGROUP>
<COL WIDTH="335"></COL>
<COL WIDTH="233"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="344" HEIGHT="30"></TD>
<TD WIDTH="242" HEIGHT="30" ALIGN="RIGHT">(단위 : 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="585">

<COLGROUP>
<COL WIDTH="249"></COL>
<COL WIDTH="66"></COL>
<COL WIDTH="75"></COL>
<COL WIDTH="75"></COL>
<COL WIDTH="75"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH ROWSPAN="2" WIDTH="258" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="60">소재지번</TH>
<TH ROWSPAN="2" WIDTH="75" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="60">면적(㎡)</TH>
<TH ROWSPAN="2" WIDTH="84" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="60">장부가액</TH>
<TH COLSPAN="2" WIDTH="168" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">공시지가</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="84" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">당기</TH>
<TH WIDTH="84" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">전기</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="258" VALIGN="MIDDLE" HEIGHT="30">경기도 파주시 적성면 장현리 253-1</TD>
<TD WIDTH="75" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">1,643</TD>
<TD WIDTH="84" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">75,510</TD>
<TD WIDTH="84" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">193,217</TD>
<TD WIDTH="84" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">193,217</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="258" VALIGN="MIDDLE" HEIGHT="30">경기도 화성시 향남읍 상신리 907</TD>
<TD WIDTH="75" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">4,937.2</TD>
<TD WIDTH="84" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">2,517,972</TD>
<TD WIDTH="84" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">2,029,189</TD>
<TD WIDTH="84" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,854,906</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="333" VALIGN="MIDDLE" COLSPAN="2" ALIGN="CENTER" HEIGHT="30">합     계</TD>
<TD WIDTH="84" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">2,593,482</TD>
<TD WIDTH="84" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">2,222,406</TD>
<TD WIDTH="84" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">2,048,123</TD>
</TR>
</TBODY>
</TABLE>
<P>&cr;(4) 보고기간종료일 현재 회사의 유형자산이 담보로 제공되어 있는 내용은 다음과 같습니다.</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="620">

<COLGROUP>
<COL WIDTH="335"></COL>
<COL WIDTH="267"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="344" HEIGHT="30"></TD>
<TD WIDTH="276" HEIGHT="30" ALIGN="RIGHT">(단위 : 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="617">

<COLGROUP>
<COL WIDTH="146"></COL>
<COL WIDTH="145"></COL>
<COL WIDTH="145"></COL>
<COL WIDTH="145"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="155" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">담보제공내역</TH>
<TH WIDTH="154" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">장부금액</TH>
<TH WIDTH="154" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">채권최고액</TH>
<TH WIDTH="154" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">담보권자</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="155" VALIGN="MIDDLE" HEIGHT="30">토지</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="154" HEIGHT="30">2,593,482</TD>
<TD ROWSPAN="4" WIDTH="154" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="120">9,252,000</TD>
<TD ROWSPAN="4" WIDTH="154" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="120">기업은행</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="155" VALIGN="MIDDLE" HEIGHT="30">건물</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="154" HEIGHT="30">9,178,812</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="155" VALIGN="MIDDLE" HEIGHT="30">기계장치</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="154" HEIGHT="30">4,711,457</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="155" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">합   계</TD>
<TD WIDTH="154" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">16,483,751</TD>
</TR>
</TBODY>
</TABLE>
<P>&cr;</P>
<P>7. 무형자산&cr;&cr;당기와 전기 중 회사의 유형자산 변동내역은 다음과 같습니다.</P>

<TABLE BORDER="0" WIDTH="661" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="335"></COL>
<COL WIDTH="308"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="344" HEIGHT="30"><당기></TD>
<TD WIDTH="317" HEIGHT="30" ALIGN="RIGHT">(단위 : 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="659">

<COLGROUP>
<COL WIDTH="129"></COL>
<COL WIDTH="122"></COL>
<COL WIDTH="121"></COL>
<COL WIDTH="121"></COL>
<COL WIDTH="121"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="138" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구 분</TH>
<TH WIDTH="131" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">기초</TH>
<TH WIDTH="130" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">취득</TH>
<TH WIDTH="130" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">감가상각비</TH>
<TH WIDTH="130" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">기말</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="138" HEIGHT="30" VALIGN="MIDDLE">특허권</TD>
<TD WIDTH="131" HEIGHT="30" ALIGN="RIGHT">4,948</TD>
<TD WIDTH="130" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="130" HEIGHT="30" ALIGN="RIGHT">(1,862)</TD>
<TD WIDTH="130" HEIGHT="30" ALIGN="RIGHT">3,086</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="138" HEIGHT="30" VALIGN="MIDDLE">소프트웨어</TD>
<TD WIDTH="131" HEIGHT="30" ALIGN="RIGHT">16,620</TD>
<TD WIDTH="130" HEIGHT="30" ALIGN="RIGHT">974</TD>
<TD WIDTH="130" HEIGHT="30" ALIGN="RIGHT">(4,483)</TD>
<TD WIDTH="130" HEIGHT="30" ALIGN="RIGHT">13,111</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="138" HEIGHT="30" ALIGN="CENTER">합   계</TD>
<TD WIDTH="131" HEIGHT="30" ALIGN="RIGHT">21,568</TD>
<TD WIDTH="130" HEIGHT="30" ALIGN="RIGHT">974</TD>
<TD WIDTH="130" HEIGHT="30" ALIGN="RIGHT">(6,345)</TD>
<TD WIDTH="130" HEIGHT="30" ALIGN="RIGHT">16,197</TD>
</TR>
</TBODY>
</TABLE>
<P></P>

<TABLE BORDER="0" WIDTH="661" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="335"></COL>
<COL WIDTH="308"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="344" HEIGHT="30"><전기></TD>
<TD WIDTH="317" HEIGHT="30" ALIGN="RIGHT">(단위 : 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="657">

<COLGROUP>
<COL WIDTH="129"></COL>
<COL WIDTH="121"></COL>
<COL WIDTH="121"></COL>
<COL WIDTH="121"></COL>
<COL WIDTH="120"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="138" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구 분</TH>
<TH WIDTH="130" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">기초</TH>
<TH WIDTH="130" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">취득</TH>
<TH WIDTH="130" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">감가상각비</TH>
<TH WIDTH="129" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">기말</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="138" HEIGHT="30" VALIGN="MIDDLE">특허권</TD>
<TD WIDTH="130" HEIGHT="30" ALIGN="RIGHT">2,931</TD>
<TD WIDTH="130" HEIGHT="30" ALIGN="RIGHT">3,636</TD>
<TD WIDTH="130" HEIGHT="30" ALIGN="RIGHT">(1,619)</TD>
<TD WIDTH="129" HEIGHT="30" ALIGN="RIGHT">4,948</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="138" HEIGHT="30" VALIGN="MIDDLE">소프트웨어</TD>
<TD WIDTH="130" HEIGHT="30" ALIGN="RIGHT">20,612</TD>
<TD WIDTH="130" HEIGHT="30" ALIGN="RIGHT">800</TD>
<TD WIDTH="130" HEIGHT="30" ALIGN="RIGHT">(4,792)</TD>
<TD WIDTH="129" HEIGHT="30" ALIGN="RIGHT">16,620</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="138" HEIGHT="30" ALIGN="CENTER">합   계</TD>
<TD WIDTH="130" HEIGHT="30" ALIGN="RIGHT">23,543</TD>
<TD WIDTH="130" HEIGHT="30" ALIGN="RIGHT">4,436</TD>
<TD WIDTH="130" HEIGHT="30" ALIGN="RIGHT">(6,411)</TD>
<TD WIDTH="129" HEIGHT="30" ALIGN="RIGHT">21,568</TD>
</TR>
</TBODY>
</TABLE>
<PGBRK></PGBRK>
<P>8. 차입금&cr;&cr;(1) 보고기간종료일 현재 회사의 차입금 내용은 다음과 같습니다.&cr;&cr;가. 단기차입금</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="688">

<COLGROUP>
<COL WIDTH="335"></COL>
<COL WIDTH="335"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="344" HEIGHT="30"></TD>
<TD WIDTH="344" HEIGHT="30" ALIGN="RIGHT">(단위 : 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="689">

<COLGROUP>
<COL WIDTH="176"></COL>
<COL WIDTH="117"></COL>
<COL WIDTH="117"></COL>
<COL WIDTH="117"></COL>
<COL WIDTH="117"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="185" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">종 류</TH>
<TH WIDTH="126" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">차입처</TH>
<TH WIDTH="126" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">연이자율(%)</TH>
<TH WIDTH="126" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">당기말</TH>
<TH WIDTH="126" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">전기말</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="185" VALIGN="MIDDLE" HEIGHT="30">중소기업 시설자금대출</TD>
<TD WIDTH="126" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">기업은행</TD>
<TD WIDTH="126" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">1.62</TD>
<TD WIDTH="126" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">710,000</TD>
<TD WIDTH="126" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">710,000</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="185" VALIGN="MIDDLE" HEIGHT="30">중소기업 회전자금대출</TD>
<TD WIDTH="126" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">기업은행</TD>
<TD WIDTH="126" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">3.54</TD>
<TD WIDTH="126" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">340,000</TD>
<TD WIDTH="126" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="185" VALIGN="MIDDLE" HEIGHT="30">중소기업 운전자금대출</TD>
<TD WIDTH="126" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">기업은행</TD>
<TD WIDTH="126" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2.73</TD>
<TD WIDTH="126" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,000,000</TD>
<TD WIDTH="126" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="185" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">합계</TD>
<TD WIDTH="126" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30"></TD>
<TD WIDTH="126" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30"></TD>
<TD WIDTH="126" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">2,050,000</TD>
<TD WIDTH="126" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">710,000</TD>
</TR>
</TBODY>
</TABLE>
<P>&cr;나. 장기차입금</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="688">

<COLGROUP>
<COL WIDTH="335"></COL>
<COL WIDTH="335"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="344" HEIGHT="30"></TD>
<TD WIDTH="344" HEIGHT="30" ALIGN="RIGHT">(단위 : 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="682">

<COLGROUP>
<COL WIDTH="174"></COL>
<COL WIDTH="116"></COL>
<COL WIDTH="116"></COL>
<COL WIDTH="116"></COL>
<COL WIDTH="115"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="183" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">종 류</TH>
<TH WIDTH="125" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">차입처</TH>
<TH WIDTH="125" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">연이자율(%)</TH>
<TH WIDTH="125" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당기말</TH>
<TH WIDTH="124" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">전기말</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="183" VALIGN="MIDDLE" HEIGHT="30">시설자금대출</TD>
<TD WIDTH="125" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">기업은행</TD>
<TD WIDTH="125" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2.83</TD>
<TD WIDTH="125" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">6,000,000</TD>
<TD WIDTH="124" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">6,000,000</TD>
</TR>
</TBODY>
</TABLE>
<P>&cr;(2) 장기차입금의 연도별 상환계획은 다음과 같습니다.</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="618">

<COLGROUP>
<COL WIDTH="335"></COL>
<COL WIDTH="265"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="344" HEIGHT="30"></TD>
<TD WIDTH="274" HEIGHT="30" ALIGN="RIGHT">(단위 : 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="615">

<COLGROUP>
<COL WIDTH="299"></COL>
<COL WIDTH="298"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="308" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">연 도</TH>
<TH WIDTH="307" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">상환금액</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="308" VALIGN="MIDDLE" HEIGHT="30">2021년</TD>
<TD WIDTH="307" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">750,630</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="308" VALIGN="MIDDLE" HEIGHT="30">2022년</TD>
<TD WIDTH="307" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">999,880</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="308" VALIGN="MIDDLE" HEIGHT="30">2023년</TD>
<TD WIDTH="307" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">999,880</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="308" VALIGN="MIDDLE" HEIGHT="30">2024년 이후 도래분</TD>
<TD WIDTH="307" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">3,249,610</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="308" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">합    계</TD>
<TD WIDTH="307" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">6,000,000</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="308" VALIGN="MIDDLE" HEIGHT="30">1년이내 만기도래분 유동성대체</TD>
<TD WIDTH="307" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(750,630)</TD>
</TR>
</TBODY>
</TABLE>
<P>&cr;&cr;9. 퇴직급여부채    &cr;&cr;당기와 전기 중 퇴직급여부채의 변동내역은 다음과 같습니다.</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="618">

<COLGROUP>
<COL WIDTH="335"></COL>
<COL WIDTH="265"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="344" HEIGHT="30"></TD>
<TD WIDTH="274" HEIGHT="30" ALIGN="RIGHT">(단위 : 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE BORDER="1" WIDTH="628" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="225"></COL>
<COL WIDTH="188"></COL>
<COL WIDTH="188"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="234" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">구    분</TH>
<TH WIDTH="197" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">당기</TH>
<TH WIDTH="197" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">전기</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="628" HEIGHT="30" VALIGN="MIDDLE" COLSPAN="3">퇴직급여충당금</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="234" HEIGHT="30" VALIGN="MIDDLE">  기초</TD>
<TD WIDTH="197" ALIGN="RIGHT" HEIGHT="30">515,211</TD>
<TD WIDTH="197" ALIGN="RIGHT" HEIGHT="30">458,594</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="234" HEIGHT="30" VALIGN="MIDDLE">  충당금 설정액</TD>
<TD WIDTH="197" ALIGN="RIGHT" HEIGHT="30">134,168</TD>
<TD WIDTH="197" ALIGN="RIGHT" HEIGHT="30">114,934</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="234" HEIGHT="30" VALIGN="MIDDLE">  퇴직급여 지급액</TD>
<TD WIDTH="197" ALIGN="RIGHT" HEIGHT="30">(113,282)</TD>
<TD WIDTH="197" ALIGN="RIGHT" HEIGHT="30">(58,317)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="234" HEIGHT="30" VALIGN="MIDDLE">  기말</TD>
<TD WIDTH="197" ALIGN="RIGHT" HEIGHT="30">536,097</TD>
<TD WIDTH="197" ALIGN="RIGHT" HEIGHT="30">515,211</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="234" HEIGHT="30" VALIGN="MIDDLE">퇴직연금운용자산</TD>
<TD WIDTH="197" ALIGN="RIGHT" HEIGHT="30">(54,112)</TD>
<TD WIDTH="197" ALIGN="RIGHT" HEIGHT="30">(54,720)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="234" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">차감후 잔액</TD>
<TD WIDTH="197" ALIGN="RIGHT" HEIGHT="30">481,985</TD>
<TD WIDTH="197" ALIGN="RIGHT" HEIGHT="30">460,491</TD>
</TR>
</TBODY>
</TABLE>
<P></P>
<P>&cr;10. 우발채무와 약정사항&cr;    &cr;보고기간종료일 현재 회사가 금융기관과 체결한 주요 약정사항은 다음과 같습니다.</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="620">

<COLGROUP>
<COL WIDTH="335"></COL>
<COL WIDTH="267"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="344" HEIGHT="30"></TD>
<TD WIDTH="276" HEIGHT="30" ALIGN="RIGHT">(단위 : USD, 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE BORDER="1" WIDTH="619" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="146"></COL>
<COL WIDTH="146"></COL>
<COL WIDTH="146"></COL>
<COL WIDTH="145"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="155" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">약정사항</TH>
<TH WIDTH="155" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">약정금융기관</TH>
<TH WIDTH="155" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">한도액</TH>
<TH WIDTH="154" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">실행금액</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="155" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">시설자금대출</TD>
<TD WIDTH="155" ALIGN="CENTER" HEIGHT="30" VALIGN="MIDDLE">기업은행</TD>
<TD WIDTH="155" ALIGN="RIGHT" HEIGHT="30">6,710,000</TD>
<TD WIDTH="154" ALIGN="RIGHT" HEIGHT="30">6,710,000</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="155" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">회전자금대출</TD>
<TD WIDTH="155" ALIGN="CENTER" HEIGHT="30" VALIGN="MIDDLE">기업은행</TD>
<TD WIDTH="155" ALIGN="RIGHT" HEIGHT="30">400,000</TD>
<TD WIDTH="154" ALIGN="RIGHT" HEIGHT="30">340,000</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="155" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">기업자금대출</TD>
<TD WIDTH="155" ALIGN="CENTER" HEIGHT="30" VALIGN="MIDDLE">기업은행</TD>
<TD WIDTH="155" ALIGN="RIGHT" HEIGHT="30">1,000,000</TD>
<TD WIDTH="154" ALIGN="RIGHT" HEIGHT="30">1,000,000</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN>&cr;</SPAN>
</P>

<P>
<SPAN></SPAN>
<SPAN></SPAN>
<SPAN>11. 특수관계자와의 거래&cr;&cr;(1) 당기말 현재 회사의 특수관계자 현황은 다음과 같습니다.</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="617">

<COLGROUP>
<COL WIDTH="254"></COL>
<COL WIDTH="345"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="263" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">구 분</TH>
<TH WIDTH="354" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">특수관계자의 명칭</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="263" VALIGN="MIDDLE" HEIGHT="30">최상위지배기업</TD>
<TD WIDTH="354" VALIGN="MIDDLE" HEIGHT="30">대화제약(주)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="263" VALIGN="MIDDLE" HEIGHT="30">기타의 특수관계자</TD>
<TD WIDTH="354" VALIGN="MIDDLE" HEIGHT="30">디에이치호림(주), (주)스페셜라이즈드메드, </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="263" VALIGN="MIDDLE" HEIGHT="53">관계기업</TD>
<TD WIDTH="354" VALIGN="MIDDLE" HEIGHT="53">S&V Technologies GmbH, &cr;BSC Medical Devices GmbH</TD>
</TR>
</TBODY>
</TABLE>
<P>&cr;(2) 당기와 전기 중 특수관계자와의 거래 내역은 다음과 같습니다.                  </P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="624">

<COLGROUP>
<COL WIDTH="335"></COL>
<COL WIDTH="271"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="344" HEIGHT="30"></TD>
<TD WIDTH="280" HEIGHT="30" ALIGN="RIGHT">(단위 : 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="625">

<COLGROUP>
<COL WIDTH="223"></COL>
<COL WIDTH="106"></COL>
<COL WIDTH="130"></COL>
<COL WIDTH="130"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="232" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">회사명</TH>
<TH WIDTH="115" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">거래내역</TH>
<TH WIDTH="139" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">당기</TH>
<TH WIDTH="139" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30"> 전기</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="232" VALIGN="MIDDLE" ROWSPAN="2" HEIGHT="60">대화제약㈜　</TD>
<TD WIDTH="115" VALIGN="MIDDLE" HEIGHT="30">매출 등</TD>
<TD WIDTH="139" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">4,767,983</TD>
<TD WIDTH="139" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">8,195,138</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="115" VALIGN="MIDDLE" HEIGHT="30">매입 등</TD>
<TD WIDTH="139" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="139" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="232" VALIGN="MIDDLE" HEIGHT="60" ROWSPAN="2">S&V Technologies GmbH</TD>
<TD WIDTH="115" VALIGN="MIDDLE" HEIGHT="30">매출 등</TD>
<TD WIDTH="139" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">18,804</TD>
<TD WIDTH="139" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">5,571</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="115" VALIGN="MIDDLE" HEIGHT="30">매입 등</TD>
<TD WIDTH="139" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,510,292</TD>
<TD WIDTH="139" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,755,256</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="232" VALIGN="MIDDLE" HEIGHT="30">디에이치호림(주)</TD>
<TD WIDTH="115" VALIGN="MIDDLE" HEIGHT="30">매입 등</TD>
<TD WIDTH="139" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">3,960</TD>
<TD WIDTH="139" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">2,134</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="232" VALIGN="MIDDLE" ROWSPAN="2" ALIGN="CENTER" HEIGHT="60">합     계</TD>
<TD WIDTH="115" VALIGN="MIDDLE" HEIGHT="30">매출액 등 소계</TD>
<TD WIDTH="139" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">4,786,787</TD>
<TD WIDTH="139" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">8,200,709</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="115" VALIGN="MIDDLE" HEIGHT="30">매입액 등 소계</TD>
<TD WIDTH="139" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,514,252</TD>
<TD WIDTH="139" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,757,390</TD>
</TR>
</TBODY>
</TABLE>
<P>&cr;(3) 당기말과 전기말 현재 동 특수관계자에 대한 채권ㆍ채무의 내역은 다음과 같습니다</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="624">

<COLGROUP>
<COL WIDTH="335"></COL>
<COL WIDTH="271"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="344" HEIGHT="30"></TD>
<TD WIDTH="280" HEIGHT="30" ALIGN="RIGHT">(단위 : 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="621">

<COLGROUP>
<COL WIDTH="254"></COL>
<COL WIDTH="111"></COL>
<COL WIDTH="110"></COL>
<COL WIDTH="110"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="263" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">회사명</TH>
<TH WIDTH="120" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">거래내역</TH>
<TH WIDTH="119" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">당기</TH>
<TH WIDTH="119" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">전기</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="263" VALIGN="MIDDLE" ROWSPAN="2" HEIGHT="60">대화제약㈜　</TD>
<TD WIDTH="120" VALIGN="MIDDLE" HEIGHT="30">외상매출금</TD>
<TD WIDTH="119" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">347,336</TD>
<TD WIDTH="119" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,426,062</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="120" VALIGN="MIDDLE" HEIGHT="30">미지급금</TD>
<TD WIDTH="119" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="119" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="263" VALIGN="MIDDLE" HEIGHT="60" ROWSPAN="2">S&V Technologies GmbH</TD>
<TD WIDTH="120" VALIGN="MIDDLE" HEIGHT="30">외상매출금</TD>
<TD WIDTH="119" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">128,203</TD>
<TD WIDTH="119" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">105,481</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="120" VALIGN="MIDDLE" HEIGHT="30">외상매입금</TD>
<TD WIDTH="119" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="119" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">340,382</TD>
</TR>
</TBODY>
</TABLE>
<PGBRK></PGBRK>
<P>(4) 당기 중 회사의 특수관계자와의 자금거래내역은 없습니다. </P>
<P>&cr;(5) 당기와 전기 중 회사가 주요 경영진에 지급한  보상 내역은 다음과 같습니다.</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="619">

<COLGROUP>
<COL WIDTH="335"></COL>
<COL WIDTH="266"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="344" HEIGHT="30"></TD>
<TD WIDTH="275" HEIGHT="30" ALIGN="RIGHT">(단위 : 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" WIDTH="620" BORDER="1" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="191"></COL>
<COL WIDTH="201"></COL>
<COL WIDTH="201"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH ALIGN="CENTER" WIDTH="200" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구분</TH>
<TH ALIGN="CENTER" WIDTH="210" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당기</TH>
<TH ALIGN="CENTER" WIDTH="210" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">전기</TH>
</TR>
</THEAD>

<TBODY ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="200" HEIGHT="30" VALIGN="MIDDLE">단기급여</TD>
<TD ALIGN="RIGHT" WIDTH="210" HEIGHT="30">319,320</TD>
<TD ALIGN="RIGHT" WIDTH="210" HEIGHT="30">264,960</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="200" HEIGHT="30" VALIGN="MIDDLE">퇴직급여</TD>
<TD ALIGN="RIGHT" WIDTH="210" HEIGHT="30">141,870</TD>
<TD ALIGN="RIGHT" WIDTH="210" HEIGHT="30">111,257</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" WIDTH="200" HEIGHT="30">합   계</TD>
<TD ALIGN="RIGHT" WIDTH="210" HEIGHT="30">461,190</TD>
<TD ALIGN="RIGHT" WIDTH="210" HEIGHT="30">376,217</TD>
</TR>
</TBODY>
</TABLE>
<P>&cr;</P>
<P>12. 자본금 및 자본잉여금&cr;&cr;(1) 당기말과 전기말 현재 회사의 자본금에 관련된 사항은 다음과 같습니다.</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="620">

<COLGROUP>
<COL WIDTH="254"></COL>
<COL WIDTH="170"></COL>
<COL WIDTH="169"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="263" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">구분</TH>
<TH WIDTH="179" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">당기</TH>
<TH WIDTH="178" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">전기</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="263" VALIGN="MIDDLE" HEIGHT="30">수권주식수</TD>
<TD WIDTH="179" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">50,000,000 주</TD>
<TD WIDTH="178" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">50,000,000 주</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="263" VALIGN="MIDDLE" HEIGHT="30">1주당 액면금액</TD>
<TD WIDTH="179" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">500원</TD>
<TD WIDTH="178" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">500원</TD>
</TR>
</TBODY>
</TABLE>
<P>&cr;(2) 당기와 전기 중 자본금의 변동내역은 없습니다.</P>
<P>&cr;(3) 당기말과 전기말 현재 자본잉여금의 내역은 다음과 같습니다. </P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="619">

<COLGROUP>
<COL WIDTH="335"></COL>
<COL WIDTH="266"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="344" HEIGHT="30"></TD>
<TD WIDTH="275" HEIGHT="30" ALIGN="RIGHT">(단위 : 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="618">

<COLGROUP>
<COL WIDTH="254"></COL>
<COL WIDTH="169"></COL>
<COL WIDTH="168"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="263" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">구분</TH>
<TH WIDTH="178" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">당기</TH>
<TH WIDTH="177" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">전기</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="263" VALIGN="MIDDLE" HEIGHT="30">주식발행초과금</TD>
<TD WIDTH="178" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">4,973,250</TD>
<TD WIDTH="177" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">4,973,250</TD>
</TR>
</TBODY>
</TABLE>
<PGBRK></PGBRK>
<P>13. 결손금처리계산서&cr;&cr;회사의 당기 및 전기의 결손금처리계산서의 내역은 다음과 같습니다.</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" WIDTH="610" BORDER="0">

<COLGROUP>
<COL WIDTH="601"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" WIDTH="610" HEIGHT="30" VALIGN="MIDDLE">결손금처리계산서(안)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" WIDTH="610" BORDER="0">

<COLGROUP>
<COL WIDTH="105"></COL>
<COL WIDTH="183"></COL>
<COL WIDTH="111"></COL>
<COL WIDTH="175"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="114" HEIGHT="53" VALIGN="MIDDLE" ALIGN="CENTER">제 11(당) 기 </TD>
<TD WIDTH="192" HEIGHT="53">2020년   1월  1일부터&cr;2020년 12월 31일까지</TD>
<TD ALIGN="CENTER" WIDTH="120" HEIGHT="53" VALIGN="MIDDLE">제 10(전) 기 </TD>
<TD WIDTH="184" HEIGHT="53">2019년   1월  1일부터&cr;2019년 12월 31일까지</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="114" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">처리예정일</TD>
<TD WIDTH="192" HEIGHT="30">2021년 3월  26일</TD>
<TD ALIGN="CENTER" WIDTH="120" HEIGHT="30" VALIGN="MIDDLE">처리확정일</TD>
<TD WIDTH="184" HEIGHT="30">2020년 3월  26일</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" WIDTH="610" BORDER="0">

<COLGROUP>
<COL WIDTH="296"></COL>
<COL WIDTH="296"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="305" HEIGHT="30">주식회사 리독스바이오</TD>
<TD ALIGN="RIGHT" WIDTH="305" HEIGHT="30">(단위 : 원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="740">

<COLGROUP>
<COL WIDTH="229"></COL>
<COL WIDTH="117"></COL>
<COL WIDTH="117"></COL>
<COL WIDTH="116"></COL>
<COL WIDTH="116"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="238" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구   분</TH>
<TH WIDTH="252" HEIGHT="30" COLSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">제 11(당) 기</TH>
<TH WIDTH="250" HEIGHT="30" COLSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">제 10(전) 기</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="238" HEIGHT="30">Ⅰ.미처리결손금</TD>
<TD WIDTH="126" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="126" HEIGHT="30" ALIGN="RIGHT">2,925,974,735</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">1,712,486,598</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="238" HEIGHT="30">   1.전기이월미처리결손금</TD>
<TD WIDTH="126" HEIGHT="30" ALIGN="RIGHT">1,712,486,598</TD>
<TD WIDTH="126" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">811,812,327</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="238" HEIGHT="30">   2.당기순손실</TD>
<TD WIDTH="126" HEIGHT="30" ALIGN="RIGHT">1,213,488,137</TD>
<TD WIDTH="126" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">900,674,271</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="238" HEIGHT="30">Ⅱ.차기이월미처리결손금</TD>
<TD WIDTH="126" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="126" HEIGHT="30" ALIGN="RIGHT">2,925,974,735</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">1,712,486,598</TD>
</TR>
</TBODY>
</TABLE>
<P>&cr;</P>
<P>14. 포괄손익계산서   &cr;&cr;당기 및 전기의 포괄손익계산서의 내역은 다음과 같습니다</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" WIDTH="610" BORDER="0">

<COLGROUP>
<COL WIDTH="601"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" WIDTH="610" HEIGHT="30" VALIGN="MIDDLE">포괄손익계산서</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" WIDTH="610" BORDER="0">

<COLGROUP>
<COL WIDTH="601"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="610" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">제 11(당) 기 : 2020년 1월 1일부터 2020년 12월 31일까지</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="610" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">제 10(전) 기 : 2019년 1월 1일부터 2019년 12월 31일까지</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" WIDTH="610" BORDER="0">

<COLGROUP>
<COL WIDTH="296"></COL>
<COL WIDTH="296"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="305" HEIGHT="30">주식회사 리독스바이오 </TD>
<TD ALIGN="RIGHT" WIDTH="305" HEIGHT="30">(단위 : 원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" WIDTH="610" BORDER="1">

<COLGROUP>
<COL WIDTH="195"></COL>
<COL WIDTH="194"></COL>
<COL WIDTH="194"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="204" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구분</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="203" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">제 11(당) 기</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="203" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">제 10(전) 기</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="204" HEIGHT="30" VALIGN="MIDDLE">당기순손실</TD>
<TD ALIGN="RIGHT" WIDTH="203" HEIGHT="30">1,213,488,137</TD>
<TD ALIGN="RIGHT" WIDTH="203" HEIGHT="30">900,674,271</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="204" HEIGHT="30" VALIGN="MIDDLE">기타포괄손실(이익)</TD>
<TD ALIGN="RIGHT" WIDTH="203" HEIGHT="30">(123,062,334)</TD>
<TD ALIGN="RIGHT" WIDTH="203" HEIGHT="30">87,696,276</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="204" HEIGHT="30" VALIGN="MIDDLE">총포괄손실</TD>
<TD ALIGN="RIGHT" WIDTH="203" HEIGHT="30">1,090,425,803</TD>
<TD ALIGN="RIGHT" WIDTH="203" HEIGHT="30">988,370,547</TD>
</TR>
</TBODY>
</TABLE>
<PGBRK></PGBRK>

<P>15. 법인세비용  &cr;&cr;회사는 당기와 전기에 법인세 부담액 및 이연법인세자산(부채)의 변동에 따른 법인세비용이 없습니다. 또한, 보고기간종료일 현재 세무상 이월결손금에 대한 법인세효과는 미래실현가능성이 불확실하여 계상하지 아니하였습니다.
<SPAN USERMARK=" 0X120FC8"></SPAN>&cr;&cr;
</P>
<P>16. 현금흐름표&cr;&cr;회사의 현금흐름표는 간접법에 의해 작성되었으며, 당기 및 전기 중 현금의 유입과 유출이 없는 주요한 거래는 다음과 같습니다.</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="619">

<COLGROUP>
<COL WIDTH="335"></COL>
<COL WIDTH="266"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="344" HEIGHT="30"></TD>
<TD WIDTH="275" HEIGHT="30" ALIGN="RIGHT">(단위 : 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="618">

<COLGROUP>
<COL WIDTH="254"></COL>
<COL WIDTH="169"></COL>
<COL WIDTH="168"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="263" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">구분</TH>
<TH WIDTH="178" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">당기</TH>
<TH WIDTH="177" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">전기</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="263" VALIGN="MIDDLE" HEIGHT="30">건설중인자산의 본계정 대체 </TD>
<TD WIDTH="178" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">4,660,000</TD>
<TD WIDTH="177" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">7,886,882</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="263" VALIGN="MIDDLE" HEIGHT="30">장기차입금의 유동성 대체</TD>
<TD WIDTH="178" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">750,630</TD>
<TD WIDTH="177" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN>&cr;&cr;17. 주당순손실&cr;&cr;(1) 당기와 전기 중 기본주당순손실 산정내역은 다음과 같습니다.</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="624">

<COLGROUP>
<COL WIDTH="335"></COL>
<COL WIDTH="271"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="344" HEIGHT="30"></TD>
<TD WIDTH="280" HEIGHT="30" ALIGN="RIGHT">(단위 : 원, 주)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE BORDER="1" WIDTH="622" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="199"></COL>
<COL WIDTH="198"></COL>
<COL WIDTH="198"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="208" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구   분</TH>
<TH WIDTH="207" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당기</TH>
<TH WIDTH="207" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">전기</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="208" HEIGHT="30">당기순손실</TD>
<TD WIDTH="207" ALIGN="RIGHT" HEIGHT="30">1,213,488,137</TD>
<TD WIDTH="207" ALIGN="RIGHT" HEIGHT="30">900,674,271</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="208" HEIGHT="30">가중평균유통보통주식수</TD>
<TD WIDTH="207" ALIGN="RIGHT" HEIGHT="30">24,611,870</TD>
<TD WIDTH="207" ALIGN="RIGHT" HEIGHT="30">24,611,870</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="208" HEIGHT="30">기본주당순손실</TD>
<TD WIDTH="207" ALIGN="RIGHT" HEIGHT="30">49</TD>
<TD WIDTH="207" ALIGN="RIGHT" HEIGHT="30">37</TD>
</TR>
</TBODY>
</TABLE>
<P>&cr;(2) 회사는 희석증권을 발행하지 않아 기본주당순이익과 희석주당순이익은 동일 합니다. </P>
<PGBRK></PGBRK>

<P>
<SPAN>18. 부가가치 계산에 필요한 자료&cr;&cr;</SPAN>
<SPAN>당기와 전기 중 부가가치 계산에 필요한 계정과목의 내용은 다음과 같습니다</SPAN>
<SPAN USERMARK=" I">.</SPAN>
<SPAN></SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="607">

<COLGROUP>
<COL WIDTH="335"></COL>
<COL WIDTH="254"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="344" HEIGHT="30"></TD>
<TD WIDTH="263" HEIGHT="30" ALIGN="RIGHT">(단위 : 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE BORDER="1" WIDTH="608" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="194"></COL>
<COL WIDTH="194"></COL>
<COL WIDTH="193"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="203" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE">계정과목</TH>
<TH WIDTH="203" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당기</TH>
<TH WIDTH="202" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">전기</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="203" HEIGHT="30" VALIGN="MIDDLE">급여</TD>
<TD WIDTH="203" ALIGN="RIGHT" HEIGHT="30">1,535,114</TD>
<TD WIDTH="202" ALIGN="RIGHT" HEIGHT="30">1,349,738</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="203" HEIGHT="30" VALIGN="MIDDLE">퇴직급여</TD>
<TD WIDTH="203" ALIGN="RIGHT" HEIGHT="30">134,168</TD>
<TD WIDTH="202" ALIGN="RIGHT" HEIGHT="30">114,933</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="203" HEIGHT="30" VALIGN="MIDDLE">경상연구비</TD>
<TD WIDTH="203" ALIGN="RIGHT" HEIGHT="30">157,738</TD>
<TD WIDTH="202" ALIGN="RIGHT" HEIGHT="30">110,588</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="203" HEIGHT="30" VALIGN="MIDDLE">복리후생비</TD>
<TD WIDTH="203" ALIGN="RIGHT" HEIGHT="30">165,791</TD>
<TD WIDTH="202" ALIGN="RIGHT" HEIGHT="30">144,399</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="203" HEIGHT="30" VALIGN="MIDDLE">감가상각비</TD>
<TD WIDTH="203" ALIGN="RIGHT" HEIGHT="30">824,041</TD>
<TD WIDTH="202" ALIGN="RIGHT" HEIGHT="30">422,238</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="203" HEIGHT="30" VALIGN="MIDDLE">세금과공과</TD>
<TD WIDTH="203" ALIGN="RIGHT" HEIGHT="30">27,475</TD>
<TD WIDTH="202" ALIGN="RIGHT" HEIGHT="30">31,364</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="203" HEIGHT="30" VALIGN="MIDDLE">지급임차료</TD>
<TD WIDTH="203" ALIGN="RIGHT" HEIGHT="30">57,752</TD>
<TD WIDTH="202" ALIGN="RIGHT" HEIGHT="30">37,919</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="203" ALIGN="CENTER" HEIGHT="30">합 계</TD>
<TD WIDTH="203" ALIGN="RIGHT" HEIGHT="30">2,902,079</TD>
<TD WIDTH="202" ALIGN="RIGHT" HEIGHT="30">2,211,179</TD>
</TR>
</TBODY>
</TABLE>
<P>&cr;</P>
<P>19. 금융부채의 만기분석 및 유동성위험관리&cr;&cr;(1) 금융부채의 만기분석&cr;현금 등 금융자산을 인도하여 결제하는 금융부채의 종류별 만기분석 내역은 다음과 같습니다.</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="605">

<COLGROUP>
<COL WIDTH="335"></COL>
<COL WIDTH="252"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="344" HEIGHT="30"><당기></TD>
<TD WIDTH="261" HEIGHT="30" ALIGN="RIGHT">(단위 : 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="606">

<COLGROUP>
<COL WIDTH="136"></COL>
<COL WIDTH="107"></COL>
<COL WIDTH="106"></COL>
<COL WIDTH="106"></COL>
<COL WIDTH="106"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="145" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구  분</TH>
<TH WIDTH="116" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">6개월 미만</TH>
<TH WIDTH="115" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">6개월~1년</TH>
<TH WIDTH="115" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">1년 이상</TH>
<TH WIDTH="115" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">합  계</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="145" HEIGHT="30">매입채무</TD>
<TD WIDTH="116" HEIGHT="30" ALIGN="RIGHT">70,485</TD>
<TD WIDTH="115" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="115" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="115" HEIGHT="30" ALIGN="RIGHT">70,485</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="145" HEIGHT="30">미지급금</TD>
<TD WIDTH="116" HEIGHT="30" ALIGN="RIGHT">67,959</TD>
<TD WIDTH="115" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="115" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="115" HEIGHT="30" ALIGN="RIGHT">67,959</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="145" HEIGHT="30">단기차입금</TD>
<TD WIDTH="116" HEIGHT="30" ALIGN="RIGHT">340,000</TD>
<TD WIDTH="115" HEIGHT="30" ALIGN="RIGHT">1,710,000</TD>
<TD WIDTH="115" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="115" HEIGHT="30" ALIGN="RIGHT">2,050,000</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="145" HEIGHT="30">유동성장기부채</TD>
<TD WIDTH="116" HEIGHT="30" ALIGN="RIGHT">750,630</TD>
<TD WIDTH="115" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="115" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="115" HEIGHT="30" ALIGN="RIGHT">750,630</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="145" HEIGHT="30">장기차입금</TD>
<TD WIDTH="116" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="115" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="115" HEIGHT="30" ALIGN="RIGHT">5,249,370</TD>
<TD WIDTH="115" HEIGHT="30" ALIGN="RIGHT">5,249,370</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="145" HEIGHT="30" ALIGN="CENTER">합 계</TD>
<TD WIDTH="116" HEIGHT="30" ALIGN="RIGHT">1,229,074</TD>
<TD WIDTH="115" HEIGHT="30" ALIGN="RIGHT">1,710,000</TD>
<TD WIDTH="115" HEIGHT="30" ALIGN="RIGHT">5,249,370</TD>
<TD WIDTH="115" HEIGHT="30" ALIGN="RIGHT">8,188,444</TD>
</TR>
</TBODY>
</TABLE>
<P></P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="605">

<COLGROUP>
<COL WIDTH="335"></COL>
<COL WIDTH="252"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="344" HEIGHT="30"><전기></TD>
<TD WIDTH="261" HEIGHT="30" ALIGN="RIGHT">(단위 : 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="606">

<COLGROUP>
<COL WIDTH="136"></COL>
<COL WIDTH="107"></COL>
<COL WIDTH="106"></COL>
<COL WIDTH="106"></COL>
<COL WIDTH="106"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="145" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구  분</TH>
<TH WIDTH="116" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">6개월 미만</TH>
<TH WIDTH="115" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">6개월~1년</TH>
<TH WIDTH="115" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">1년 이상</TH>
<TH WIDTH="115" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">합  계</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="145" HEIGHT="30">매입채무</TD>
<TD WIDTH="116" HEIGHT="30" ALIGN="RIGHT">1,451,120</TD>
<TD WIDTH="115" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="115" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="115" HEIGHT="30" ALIGN="RIGHT">1,451,120</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="145" HEIGHT="30">미지급금</TD>
<TD WIDTH="116" HEIGHT="30" ALIGN="RIGHT">87,486</TD>
<TD WIDTH="115" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="115" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="115" HEIGHT="30" ALIGN="RIGHT">87,486</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="145" HEIGHT="30">단기차입금</TD>
<TD WIDTH="116" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="115" HEIGHT="30" ALIGN="RIGHT">710,000</TD>
<TD WIDTH="115" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="115" HEIGHT="30" ALIGN="RIGHT">710,000</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="145" HEIGHT="30">장기차입금</TD>
<TD WIDTH="116" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="115" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="115" HEIGHT="30" ALIGN="RIGHT">6,000,000</TD>
<TD WIDTH="115" HEIGHT="30" ALIGN="RIGHT">6,000,000</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="145" HEIGHT="30">미지급세금</TD>
<TD WIDTH="116" HEIGHT="30" ALIGN="RIGHT">40,021</TD>
<TD WIDTH="115" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="115" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="115" HEIGHT="30" ALIGN="RIGHT">40,021</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="145" HEIGHT="30" VALIGN="MIDDLE">미지급비용</TD>
<TD WIDTH="116" HEIGHT="30" ALIGN="RIGHT">183,504</TD>
<TD WIDTH="115" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="115" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="115" HEIGHT="30" ALIGN="RIGHT">183,504</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="145" HEIGHT="30" ALIGN="CENTER">합 계</TD>
<TD WIDTH="116" HEIGHT="30" ALIGN="RIGHT">1,762,131</TD>
<TD WIDTH="115" HEIGHT="30" ALIGN="RIGHT">710,000</TD>
<TD WIDTH="115" HEIGHT="30" ALIGN="RIGHT">6,000,000</TD>
<TD WIDTH="115" HEIGHT="30" ALIGN="RIGHT">8,472,131</TD>
</TR>
</TBODY>
</TABLE>
<P>&cr;(2) 유동성위험관리&cr;회사의 유동성위험관리에 대한 궁극적인 책임은 단기 및 중장기 자금조달과 유동성관리규정을 적절하게 관리하기 위한 기본정책을 수립하는 이사회에 있습니다. 회사는 충분한 적립금과 차입한도를 유지하고 예측현금흐름과 실제현금흐름을 계속하여 관찰하고 금융자산과 금융부채의 만기구조를 대응시키면서 유동성위험을 관리하고 있습니다.&cr;&cr;</P>

<P>
<SPAN>20. 재무제표의 승인          &cr;&cr;</SPAN>
<SPAN>회사의 재무제표는 </SPAN>
<SPAN>2021년 3월 26일자주주총회에서 최종 승인될 예정입니다.</SPAN>
</P>
<PGBRK></PGBRK>
<P></P>
</SECTION-2>
</LIBRARY>
</INSERTION>

<SECTION-2 ACLASS="MANDATORY">
<TITLE ATOC="Y" AASSOCNOTE="D-0-3-6-0">6. 기타 재무에 관한 사항</TITLE>
<P></P>

<P>
<SPAN USERMARK="F-GL11 B">가. 한국채택국제회계기준으로의 전환&cr;</SPAN>
<SPAN USERMARK="F-GL11">해당사항이 없습니다.&cr;&cr;</SPAN>
<SPAN USERMARK="F-GL11 B">나. 대손충당금 설정현황&cr;</SPAN>
<SPAN USERMARK="F-GL11"></SPAN>
<SPAN USERMARK="F-GL11 B"></SPAN>
<SPAN USERMARK="F-GL11"></SPAN>
<SPAN USERMARK="F-GL11">당사는 현재 매출채권 등에 대한 대손위험이 현저히 낮아 설정하지 않았습니다. 추후에 합리적인 추정과정을 통해 기준을 마련하여 설정 할 예정입니다.&cr;</SPAN>
<SPAN USERMARK="F-GL11">&cr;</SPAN>
<SPAN USERMARK="F-GL11 B">다. 재고자산 현황 등&cr;</SPAN>
<SPAN USERMARK="F-GL11">&cr;1) 재고자산의 사업부문별 보유현황  </SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="618">

<COLGROUP>
<COL WIDTH="335"></COL>
<COL WIDTH="265"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="344" HEIGHT="31"></TD>
<TD WIDTH="274" HEIGHT="31" ALIGN="RIGHT">(단위 : 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" WIDTH="623" BORDER="1" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="319"></COL>
<COL WIDTH="102"></COL>
<COL WIDTH="86"></COL>
<COL WIDTH="80"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH ALIGN="CENTER" WIDTH="328" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE">구 분</TH>
<TH ALIGN="CENTER" WIDTH="111" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE">제 11 기말</TH>
<TH ALIGN="CENTER" WIDTH="95" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE">제 10 기말</TH>
<TH ALIGN="CENTER" WIDTH="89" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE">제 9 기말</TH>
</TR>
</THEAD>

<TBODY ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" WIDTH="328" HEIGHT="30">원 재 료</TD>
<TD ALIGN="RIGHT" WIDTH="111" HEIGHT="30">453,140</TD>
<TD ALIGN="RIGHT" WIDTH="95" HEIGHT="30">809,673</TD>
<TD ALIGN="RIGHT" WIDTH="89" HEIGHT="30">600,363</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" WIDTH="328" HEIGHT="30">상     품</TD>
<TD ALIGN="RIGHT" WIDTH="111" HEIGHT="30">-</TD>
<TD ALIGN="RIGHT" WIDTH="95" HEIGHT="30">-</TD>
<TD ALIGN="RIGHT" WIDTH="89" HEIGHT="30" VALIGN="MIDDLE">425,532</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" WIDTH="328" HEIGHT="30">재 공 품</TD>
<TD ALIGN="RIGHT" WIDTH="111" HEIGHT="30">54,958</TD>
<TD ALIGN="RIGHT" WIDTH="95" HEIGHT="30">65,263</TD>
<TD ALIGN="RIGHT" WIDTH="89" HEIGHT="30" VALIGN="MIDDLE">143,490</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" WIDTH="328" HEIGHT="30">제     품</TD>
<TD ALIGN="RIGHT" WIDTH="111" HEIGHT="30">2,316,337</TD>
<TD ALIGN="RIGHT" WIDTH="95" HEIGHT="30">1,086,344</TD>
<TD ALIGN="RIGHT" WIDTH="89" HEIGHT="30" VALIGN="MIDDLE">1,315,996</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" WIDTH="328" HEIGHT="30">합     계</TD>
<TD ALIGN="RIGHT" WIDTH="111" HEIGHT="30">2,824,435</TD>
<TD ALIGN="RIGHT" WIDTH="95" HEIGHT="30">1,961,280</TD>

<TD ALIGN="RIGHT" WIDTH="89" HEIGHT="30" VALIGN="MIDDLE">
<SPAN>2,485,381</SPAN>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD ALIGN="CENTER" WIDTH="328" HEIGHT="53">
<P>총자산대비 재고자산 구성비율(%)</P>
<P>[재고자산합계÷기말자산총계×100]</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="111" HEIGHT="53">12.15%</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="95" HEIGHT="53">8.03%</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="89" HEIGHT="53">14.09%</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD ALIGN="CENTER" WIDTH="328" HEIGHT="53">
<P>재고자산회전율(회수)</P>
<P>[연환산 매출원가÷{(기초재고+기말재고)÷2}]</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="111" HEIGHT="53">2.75회</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="95" HEIGHT="53">4.31회</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="89" HEIGHT="53">3.54 회</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK="F-GL11">&cr;2) 재고자산의 실사내용&cr;&cr;회사는 재고자산의 실사를 통하여 취득원가와 순실현가능가치 중 낮은 금액으로 측정하고있습니다. 원가는 선입선출법에 따라 결정하고 있습니다. &cr;</SPAN>
</P>

<P USERMARK="F-GL11">① 실사일자 : 당사는 재고실사를
<SPAN> </SPAN>
<SPAN></SPAN>
<SPAN>2021년 1월 6일</SPAN>
<SPAN>에</SPAN> 실재고실사를 시행 하였습니다.&cr;
</P>

<P USERMARK="F-GL11">② 재고실사시 독립적인 전문가 또는 전문기관, 감사인 등의 참여 및 입회여부 :&cr;재고실사시 당사 내부회계관리담당,각 재고자산별 담당자가 입회하여 재고자산 실사를 시행 하였습니다. &cr;&cr;③ 실사 방법:  당사
<SPAN>는 </SPAN>
<SPAN>2020년 12월 31일</SPAN>
<SPAN USERMARK=" 0X0000FF"> </SPAN>기준 장부상 재고수량과 실지재고수량을 확인하였으며, 그에 대한 중요한 차이가 발생되지 않았습니다.
</P>

<P>
<SPAN USERMARK="F-GL11">&cr;</SPAN>
<SPAN USERMARK="F-GL11">3) 장기체화재고 등 내역&cr;                                                                                                     (단위 : 천원)</SPAN>
</P>

<TABLE ACLASS="NORMAL" WIDTH="602" BORDER="1" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="54"></COL>
<COL WIDTH="99"></COL>
<COL WIDTH="99"></COL>
<COL WIDTH="99"></COL>
<COL WIDTH="99"></COL>
<COL WIDTH="98"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구  분</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="108" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">취득원가</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="108" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">보유금액</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="108" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당기평가손실</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="108" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">기말잔액</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="107" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">비 고</TH>
</TR>
</THEAD>

<TBODY ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="30">원재료</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="108" HEIGHT="30">453,140</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="108" HEIGHT="30">453,140</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="108" HEIGHT="30">-</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="108" HEIGHT="30">453,140</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="107" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="30">상   품</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="108" HEIGHT="30">-</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="108" HEIGHT="30">-</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="108" HEIGHT="30">-</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="108" HEIGHT="30">-</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="107" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="30">재공품</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="108" HEIGHT="30">54,958</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="108" HEIGHT="30">54,958</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="108" HEIGHT="30">-</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="108" HEIGHT="30">54,958</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="107" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="30">제   품</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="108" HEIGHT="30">2,316,337</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="108" HEIGHT="30">2,316,337</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="108" HEIGHT="30">-</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="108" HEIGHT="30">2,316,337</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="107" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="30">합   계</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="108" HEIGHT="30">2,824,435</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="108" HEIGHT="30">2,824,435</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="108" HEIGHT="30">-</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="108" HEIGHT="30">2,824,435</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="107" HEIGHT="30">-</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK="F-GL11">&cr;</SPAN>
<SPAN USERMARK="F-GL11 B">라. 공정가치평가 내역</SPAN>
<SPAN USERMARK="F-GL11">&cr;&cr;1) 3사업년기말 및 전환일 현재 회사의 금융자산 장부금액과 공정가치는 다음과같습니다.</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="791">

<COLGROUP>
<COL WIDTH="335"></COL>
<COL WIDTH="438"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="344" HEIGHT="30"></TD>
<TD WIDTH="447" HEIGHT="30" ALIGN="RIGHT">(단위 : 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" WIDTH="790" BORDER="1" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="139"></COL>
<COL WIDTH="129"></COL>
<COL WIDTH="75"></COL>
<COL WIDTH="75"></COL>
<COL WIDTH="75"></COL>
<COL WIDTH="75"></COL>
<COL WIDTH="75"></COL>
<COL WIDTH="75"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="148" HEIGHT="60" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구     분</TH>
<TH ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="138" HEIGHT="60" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">재무상태표</TH>
<TH COLSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="168" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">2020년 말</TH>
<TH COLSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="168" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">2019년 말</TH>
<TH COLSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="168" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">2018년 말</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="84" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">장부금액</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="84" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">공정가치</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="84" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">장부금액</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="84" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">공정가치</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="84" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">장부금액</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="84" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">공정가치</TH>
</TR>
</THEAD>

<TBODY ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TD ROWSPAN="3" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="148" HEIGHT="90">대여금 및 수취채권</TD>
<TD WIDTH="138" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">현금및현금성자산</TD>
<TD ALIGN="RIGHT" WIDTH="84" HEIGHT="30">362,825</TD>
<TD ALIGN="RIGHT" WIDTH="84" HEIGHT="30">362,825</TD>
<TD ALIGN="RIGHT" WIDTH="84" HEIGHT="30">414,545</TD>
<TD ALIGN="RIGHT" WIDTH="84" HEIGHT="30">414,545</TD>

<TD ALIGN="RIGHT" WIDTH="84" HEIGHT="30">
<SPAN>2,332,397</SPAN>
</TD>

<TD ALIGN="RIGHT" WIDTH="84" HEIGHT="30">
<SPAN>2,332,397</SPAN>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="138" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">매출채권</TD>
<TD ALIGN="RIGHT" WIDTH="84" HEIGHT="30">518,207</TD>
<TD ALIGN="RIGHT" WIDTH="84" HEIGHT="30">518,207</TD>
<TD ALIGN="RIGHT" WIDTH="84" HEIGHT="30">2,260,112</TD>
<TD ALIGN="RIGHT" WIDTH="84" HEIGHT="30">2,260,112</TD>
<TD ALIGN="RIGHT" WIDTH="84" HEIGHT="30">1,650,041</TD>
<TD ALIGN="RIGHT" WIDTH="84" HEIGHT="30">1,650,041</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="138" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">기타유동채권</TD>
<TD ALIGN="RIGHT" WIDTH="84" HEIGHT="30">13,012</TD>
<TD ALIGN="RIGHT" WIDTH="84" HEIGHT="30">13,012</TD>
<TD ALIGN="RIGHT" WIDTH="84" HEIGHT="30">7,613</TD>
<TD ALIGN="RIGHT" WIDTH="84" HEIGHT="30">7,613</TD>
<TD ALIGN="RIGHT" WIDTH="84" HEIGHT="30">226,130</TD>
<TD ALIGN="RIGHT" WIDTH="84" HEIGHT="30">226,130</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD COLSPAN="2" ALIGN="CENTER" WIDTH="286" HEIGHT="30">합     계</TD>
<TD ALIGN="RIGHT" WIDTH="84" HEIGHT="30">894,044</TD>
<TD ALIGN="RIGHT" WIDTH="84" HEIGHT="30">894,044</TD>
<TD ALIGN="RIGHT" WIDTH="84" HEIGHT="30">2,682,270</TD>
<TD ALIGN="RIGHT" WIDTH="84" HEIGHT="30">2,682,270</TD>
<TD ALIGN="RIGHT" WIDTH="84" HEIGHT="30">4,208,568</TD>
<TD ALIGN="RIGHT" WIDTH="84" HEIGHT="30">4,208,568</TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK="F-GL11">&cr;2) 3사업년기말 및 전환일 현재 회사의 금융부채 장부금액과 공정가치는 다음과같습니다.</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="738">

<COLGROUP>
<COL WIDTH="335"></COL>
<COL WIDTH="385"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="344" HEIGHT="30"></TD>
<TD WIDTH="394" HEIGHT="30" ALIGN="RIGHT">(단위 : 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="741">

<COLGROUP>
<COL WIDTH="134"></COL>
<COL WIDTH="99"></COL>
<COL WIDTH="69"></COL>
<COL WIDTH="69"></COL>
<COL WIDTH="69"></COL>
<COL WIDTH="69"></COL>
<COL WIDTH="80"></COL>
<COL WIDTH="80"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="143" HEIGHT="60" ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구     분</TH>
<TH WIDTH="108" HEIGHT="60" ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">재무상태표</TH>
<TH WIDTH="156" HEIGHT="30" COLSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">2020년 말</TH>
<TH WIDTH="156" HEIGHT="30" COLSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">2019년 말</TH>
<TH WIDTH="178" HEIGHT="30" COLSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">2018년 말</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="78" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">장부금액</TH>
<TH WIDTH="78" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">공정가치</TH>
<TH WIDTH="78" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">장부금액</TH>
<TH WIDTH="78" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">공정가치</TH>
<TH WIDTH="89" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">장부금액</TH>
<TH WIDTH="89" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">공정가치</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="143" HEIGHT="120" ROWSPAN="4" ALIGN="CENTER" VALIGN="MIDDLE">상각후원가로 &cr;측정하는 금융부채</TD>
<TD WIDTH="108" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">매입채무</TD>
<TD WIDTH="78" HEIGHT="30" ALIGN="RIGHT">70,485</TD>
<TD WIDTH="78" HEIGHT="30" ALIGN="RIGHT">70,485</TD>
<TD WIDTH="78" HEIGHT="30" ALIGN="RIGHT">1,451,120</TD>
<TD WIDTH="78" HEIGHT="30" ALIGN="RIGHT">1,451,120</TD>
<TD WIDTH="89" HEIGHT="30" ALIGN="RIGHT">613,762</TD>
<TD WIDTH="89" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">613,762</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="108" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">기타유동채무</TD>
<TD WIDTH="78" HEIGHT="30" ALIGN="RIGHT">248,840</TD>
<TD WIDTH="78" HEIGHT="30" ALIGN="RIGHT">248,840</TD>
<TD WIDTH="78" HEIGHT="30" ALIGN="RIGHT">320,495</TD>
<TD WIDTH="78" HEIGHT="30" ALIGN="RIGHT">320,495</TD>
<TD WIDTH="89" HEIGHT="30" ALIGN="RIGHT">248,735</TD>
<TD WIDTH="89" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">248,735</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="108" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">단기차입금</TD>
<TD WIDTH="78" HEIGHT="30" ALIGN="RIGHT">2,050,000</TD>
<TD WIDTH="78" HEIGHT="30" ALIGN="RIGHT">2,050,000</TD>
<TD WIDTH="78" HEIGHT="30" ALIGN="RIGHT">710,000</TD>
<TD WIDTH="78" HEIGHT="30" ALIGN="RIGHT">710,000</TD>
<TD WIDTH="89" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="89" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="108" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">장기차입금</TD>
<TD WIDTH="78" HEIGHT="30" ALIGN="RIGHT">6,000,000</TD>
<TD WIDTH="78" HEIGHT="30" ALIGN="RIGHT">6,000,000</TD>
<TD WIDTH="78" HEIGHT="30" ALIGN="RIGHT">6,000,000</TD>
<TD WIDTH="78" HEIGHT="30" ALIGN="RIGHT">6,000,000</TD>
<TD WIDTH="89" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="89" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="251" HEIGHT="30" COLSPAN="2" ALIGN="CENTER">합     계</TD>
<TD WIDTH="78" HEIGHT="30" ALIGN="RIGHT">8,369,325</TD>
<TD WIDTH="78" HEIGHT="30" ALIGN="RIGHT">8,369,325</TD>
<TD WIDTH="78" HEIGHT="30" ALIGN="RIGHT">8,481,615</TD>
<TD WIDTH="78" HEIGHT="30" ALIGN="RIGHT">8,481,615</TD>
<TD WIDTH="89" HEIGHT="30" ALIGN="RIGHT">862,497</TD>
<TD WIDTH="89" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">862,497</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK="F-GL11">&cr;</SPAN>
<SPAN USERMARK="F-GL11 B">마. 채무증권 발행실적 등</SPAN>&cr; 
<SPAN USERMARK="F-GL11">해당사항없음.</SPAN>
</P>

<INSERTION ABASISNUMBER="SE2" AFREQUENCY="0" ADUPLICATION="N">
<COMMENT>◆click◆『진행률적용 수주계약 현황』 삽입</COMMENT>
<LIBRARYLIST>11011#*진행률적용수주계약현황*.dsl</LIBRARYLIST>
</INSERTION>

<TABLE-GROUP ACLASS="SUB_PIS" ADELETETABLE="N">
<TITLE ATOC="N">채무증권 발행실적</TITLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="Y" WIDTH="747" BORDER="0">

<COLGROUP>
<COL WIDTH="70"></COL>
<COL WIDTH="138"></COL>
<COL WIDTH="58"></COL>
<COL WIDTH="445"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD VALIGN="BOTTOM" WIDTH="79" HEIGHT="30" AUPDATECONT="N">(기준일 : </TD>
<TU ALIGN="CENTER" VALIGN="BOTTOM" WIDTH="147" HEIGHT="30" AUNIT="BASE_DT" AUNITVALUE="-">-</TU>
<TD VALIGN="BOTTOM" WIDTH="67" HEIGHT="30" AUPDATECONT="N">)</TD>
<TU ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="454" HEIGHT="30" AUNIT="WONPERCENT" AUNITVALUE="1">(단위 : 원, %)</TU>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="748" BORDER="1">

<COLGROUP>
<COL WIDTH="60"></COL>
<COL WIDTH="60"></COL>
<COL WIDTH="61"></COL>
<COL WIDTH="61"></COL>
<COL WIDTH="71"></COL>
<COL WIDTH="64"></COL>
<COL WIDTH="80"></COL>
<COL WIDTH="75"></COL>
<COL WIDTH="59"></COL>
<COL WIDTH="67"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="N" ADELETE="N">
<TH WIDTH="69" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53">발행회사</TH>
<TH WIDTH="69" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53">증권종류</TH>
<TH WIDTH="70" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53">발행방법</TH>
<TH WIDTH="70" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53">발행일자</TH>
<TH WIDTH="80" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53">권면(전자등록)총액</TH>
<TH WIDTH="73" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53">이자율</TH>
<TH WIDTH="89" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53">평가등급&cr;(평가기관)</TH>
<TH WIDTH="84" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53">만기일</TH>
<TH WIDTH="68" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53">상환&cr;여부</TH>
<TH WIDTH="76" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53">주관회사</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="N">
<TE WIDTH="69" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="BSS_PIS_CMPY">-</TE>
<TU WIDTH="69" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUNIT="BSS_PIS_KNN" AUNITVALUE="-">-</TU>
<TU WIDTH="70" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUNIT="BSS_PIS_STC" AUNITVALUE="-">-</TU>
<TU WIDTH="70" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUNIT="BSS_PIS_DAT" AUNITVALUE="-">-</TU>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_PIS_MON">-</TE>
<TE WIDTH="73" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_PIS_RATE">-</TE>
<TE WIDTH="89" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="BSS_PIS_LEV">-</TE>
<TU WIDTH="84" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUNIT="BSS_PIS_LAS" AUNITVALUE="-">-</TU>
<TE WIDTH="68" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="BSS_PIS_REC">-</TE>
<TE WIDTH="76" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="BSS_PIS_SUC">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE WIDTH="69" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="BSS_PIS_CMPY">-</TE>
<TU WIDTH="69" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUNIT="BSS_PIS_KNN" AUNITVALUE="-">-</TU>
<TU WIDTH="70" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUNIT="BSS_PIS_STC" AUNITVALUE="-">-</TU>
<TU WIDTH="70" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUNIT="BSS_PIS_DAT" AUNITVALUE="-">-</TU>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_PIS_MON">-</TE>
<TE WIDTH="73" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_PIS_RATE">-</TE>
<TE WIDTH="89" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="BSS_PIS_LEV">-</TE>
<TU WIDTH="84" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUNIT="BSS_PIS_LAS" AUNITVALUE="-">-</TU>
<TE WIDTH="68" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="BSS_PIS_REC">-</TE>
<TE WIDTH="76" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="BSS_PIS_SUC">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="69" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUPDATECONT="N">합  계</TD>
<TD WIDTH="69" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUPDATECONT="N">-</TD>
<TD WIDTH="70" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUPDATECONT="N">-</TD>
<TD WIDTH="70" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUPDATECONT="N">-</TD>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_PIS_MONT">-</TE>
<TE WIDTH="73" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_PIS_RATET">-</TE>
<TE WIDTH="89" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="BSS_PIS_LEVT">-</TE>
<TD WIDTH="84" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUPDATECONT="N">-</TD>
<TE WIDTH="68" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="BSS_PIS_RECT">-</TE>
<TE WIDTH="76" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="BSS_PIS_SUCT">-</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>

<INSERTION ABASISNUMBER="LE0" AFREQUENCY="0" ADUPLICATION="Y">
<COMMENT>◆click◆ 『사채관리계약 주요내용 및 충족여부 등』 삽입</COMMENT>
<LIBRARYLIST>11011#*사채관리계약주요내용.dsl</LIBRARYLIST>
</INSERTION>

<TABLE-GROUP ACLASS="SUB_BLC" ADELETETABLE="N">
<TITLE ATOC="N">기업어음증권 미상환 잔액</TITLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="Y" WIDTH="820" BORDER="0">

<COLGROUP>
<COL WIDTH="70"></COL>
<COL WIDTH="142"></COL>
<COL WIDTH="58"></COL>
<COL WIDTH="514"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD VALIGN="BOTTOM" WIDTH="79" HEIGHT="30" AUPDATECONT="N">(기준일 : </TD>
<TU ALIGN="CENTER" VALIGN="BOTTOM" WIDTH="151" HEIGHT="30" AUNIT="BASE_DT" AUNITVALUE="-">-</TU>
<TD VALIGN="BOTTOM" WIDTH="67" HEIGHT="30" AUPDATECONT="N">)</TD>
<TU ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="523" HEIGHT="30" AUNIT="WON" AUNITVALUE="1">(단위 : 원)</TU>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="820" BORDER="1">

<COLGROUP>
<COL WIDTH="45"></COL>
<COL WIDTH="43"></COL>
<COL WIDTH="71"></COL>
<COL WIDTH="71"></COL>
<COL WIDTH="71"></COL>
<COL WIDTH="70"></COL>
<COL WIDTH="70"></COL>
<COL WIDTH="70"></COL>
<COL WIDTH="70"></COL>
<COL WIDTH="70"></COL>
<COL WIDTH="70"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="N" ADELETE="N">
<TH WIDTH="106" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" COLSPAN="2">잔여만기</TH>
<TH WIDTH="80" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">10일 이하</TH>
<TH WIDTH="80" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">10일초과&cr;30일이하</TH>
<TH WIDTH="80" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">30일초과&cr;90일이하</TH>
<TH WIDTH="79" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">90일초과&cr;180일이하</TH>
<TH WIDTH="79" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">180일초과&cr;1년이하</TH>
<TH WIDTH="79" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">1년초과&cr;2년이하</TH>
<TH WIDTH="79" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">2년초과&cr;3년이하</TH>
<TH WIDTH="79" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">3년 초과</TH>
<TH WIDTH="79" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">합 계</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="54" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="90" AUPDATECONT="N" ROWSPAN="3">미상환 잔액</TD>
<TD WIDTH="52" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUPDATECONT="N">공모</TD>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_BL_DA10">-</TE>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_BL_DA30">-</TE>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_BL_DA90">-</TE>
<TE WIDTH="79" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_BL_DA180">-</TE>
<TE WIDTH="79" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_BL_DA365">-</TE>
<TE WIDTH="79" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_BL_DA730">-</TE>
<TE WIDTH="79" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_BL_DA1095">-</TE>
<TE WIDTH="79" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_BL_DA1111">-</TE>
<TE WIDTH="79" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_BL_DATT">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="52" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUPDATECONT="N">사모</TD>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_BC_DA10">-</TE>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_BC_DA30">-</TE>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_BC_DA90">-</TE>
<TE WIDTH="79" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_BC_DA180">-</TE>
<TE WIDTH="79" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_BC_DA365">-</TE>
<TE WIDTH="79" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_BC_DA730">-</TE>
<TE WIDTH="79" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_BC_DA1095">-</TE>
<TE WIDTH="79" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_BC_DA1111">-</TE>
<TE WIDTH="79" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_BC_DATT">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="52" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUPDATECONT="N">합계</TD>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_BLC_DA10">-</TE>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_BLC_DA30">-</TE>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_BLC_DA90">-</TE>
<TE WIDTH="79" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_BLC_DA180">-</TE>
<TE WIDTH="79" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_BLC_DA365">-</TE>
<TE WIDTH="79" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_BLC_DA730">-</TE>
<TE WIDTH="79" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_BLC_DA1095">-</TE>
<TE WIDTH="79" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_BLC_DA1111">-</TE>
<TE WIDTH="79" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_BLC_DATT">-</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>

<TABLE-GROUP ACLASS="SUB_ELPN" ADELETETABLE="N">
<TITLE ATOC="N">단기사채 미상환 잔액</TITLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="Y" WIDTH="759" BORDER="0">

<COLGROUP>
<COL WIDTH="70"></COL>
<COL WIDTH="142"></COL>
<COL WIDTH="58"></COL>
<COL WIDTH="453"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD VALIGN="BOTTOM" WIDTH="79" HEIGHT="30" AUPDATECONT="N">(기준일 : </TD>
<TU ALIGN="CENTER" VALIGN="BOTTOM" WIDTH="151" HEIGHT="30" AUNIT="BASE_DT" AUNITVALUE="-">-</TU>
<TD VALIGN="BOTTOM" WIDTH="67" HEIGHT="30" AUPDATECONT="N">)</TD>
<TU ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="462" HEIGHT="30" AUNIT="WON" AUNITVALUE="1">(단위 : 원)</TU>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="760" BORDER="1">

<COLGROUP>
<COL WIDTH="45"></COL>
<COL WIDTH="46"></COL>
<COL WIDTH="73"></COL>
<COL WIDTH="73"></COL>
<COL WIDTH="73"></COL>
<COL WIDTH="72"></COL>
<COL WIDTH="72"></COL>
<COL WIDTH="72"></COL>
<COL WIDTH="72"></COL>
<COL WIDTH="72"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="N" ADELETE="N">
<TH WIDTH="109" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" COLSPAN="2">잔여만기</TH>
<TH WIDTH="82" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">10일 이하</TH>
<TH WIDTH="82" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">10일초과&cr;30일이하</TH>
<TH WIDTH="82" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">30일초과&cr;90일이하</TH>
<TH WIDTH="81" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">90일초과&cr;180일이하</TH>
<TH WIDTH="81" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">180일초과&cr;1년이하</TH>
<TH WIDTH="81" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">합 계</TH>
<TH WIDTH="81" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">발행 한도</TH>
<TH WIDTH="81" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">잔여 한도</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="54" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="90" AUPDATECONT="N" ROWSPAN="3">미상환 잔액</TD>
<TD WIDTH="55" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUPDATECONT="N">공모</TD>
<TE WIDTH="82" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_EL_DA10">-</TE>
<TE WIDTH="82" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_EL_DA30">-</TE>
<TE WIDTH="82" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_EL_DA90">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_EL_DA180">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_EL_DA365">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_EL_DATT">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_EL_PUB">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_EL_REM">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="55" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUPDATECONT="N">사모</TD>
<TE WIDTH="82" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_EP_DA10">-</TE>
<TE WIDTH="82" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_EP_DA30">-</TE>
<TE WIDTH="82" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_EP_DA90">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_EP_DA180">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_EP_DA365">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_EP_DATT">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_EP_PUB">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_EP_REM">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="55" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUPDATECONT="N">합계</TD>
<TE WIDTH="82" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_ELP_DA10">-</TE>
<TE WIDTH="82" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_ELP_DA30">-</TE>
<TE WIDTH="82" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_ELP_DA90">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_ELP_DA180">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_ELP_DA365">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_ELP_DATT">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_ELP_PUB">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_ELP_REM">-</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>

<TABLE-GROUP ACLASS="SUB_CNC" ADELETETABLE="N">
<TITLE ATOC="N">회사채 미상환 잔액</TITLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="Y" WIDTH="762" BORDER="0">

<COLGROUP>
<COL WIDTH="70"></COL>
<COL WIDTH="142"></COL>
<COL WIDTH="58"></COL>
<COL WIDTH="456"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD VALIGN="BOTTOM" WIDTH="79" HEIGHT="30" AUPDATECONT="N">(기준일 : </TD>
<TU ALIGN="CENTER" VALIGN="BOTTOM" WIDTH="151" HEIGHT="30" AUNIT="BASE_DT" AUNITVALUE="-">-</TU>
<TD VALIGN="BOTTOM" WIDTH="67" HEIGHT="30" AUPDATECONT="N">)</TD>
<TU ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="465" HEIGHT="30" AUNIT="WON" AUNITVALUE="1">(단위 : 원)</TU>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="761" BORDER="1">

<COLGROUP>
<COL WIDTH="45"></COL>
<COL WIDTH="46"></COL>
<COL WIDTH="73"></COL>
<COL WIDTH="73"></COL>
<COL WIDTH="73"></COL>
<COL WIDTH="73"></COL>
<COL WIDTH="72"></COL>
<COL WIDTH="72"></COL>
<COL WIDTH="72"></COL>
<COL WIDTH="72"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="N" ADELETE="N">
<TH WIDTH="109" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" COLSPAN="2">잔여만기</TH>
<TH WIDTH="82" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">1년 이하</TH>
<TH WIDTH="82" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">1년초과&cr;2년이하</TH>
<TH WIDTH="82" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">2년초과&cr;3년이하</TH>
<TH WIDTH="82" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">3년초과&cr;4년이하</TH>
<TH WIDTH="81" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">4년초과&cr;5년이하</TH>
<TH WIDTH="81" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">5년초과&cr;10년이하</TH>
<TH WIDTH="81" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">10년초과</TH>
<TH WIDTH="81" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">합 계</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="54" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="90" AUPDATECONT="N" ROWSPAN="3">미상환 잔액</TD>
<TD WIDTH="55" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUPDATECONT="N">공모</TD>
<TE WIDTH="82" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CN_DA1">-</TE>
<TE WIDTH="82" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CN_DA2">-</TE>
<TE WIDTH="82" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CN_DA3">-</TE>
<TE WIDTH="82" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CN_DA4">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CN_DA5">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CN_DA10">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CN_DA11">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CN_DATT">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="55" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUPDATECONT="N">사모</TD>
<TE WIDTH="82" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CC_DA1">-</TE>
<TE WIDTH="82" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CC_DA2">-</TE>
<TE WIDTH="82" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CC_DA3">-</TE>
<TE WIDTH="82" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CC_DA4">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CC_DA5">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CC_DA10">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CC_DA11">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CC_DATT">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="55" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUPDATECONT="N">합계</TD>
<TE WIDTH="82" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CNC_DA1">-</TE>
<TE WIDTH="82" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CNC_DA2">-</TE>
<TE WIDTH="82" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CNC_DA3">-</TE>
<TE WIDTH="82" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CNC_DA4">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CNC_DA5">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CNC_DA10">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CNC_DA11">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CNC_DATT">-</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>

<TABLE-GROUP ACLASS="SUB_NEF" ADELETETABLE="N">
<TITLE ATOC="N">신종자본증권 미상환 잔액</TITLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="Y" WIDTH="757" BORDER="0">

<COLGROUP>
<COL WIDTH="70"></COL>
<COL WIDTH="142"></COL>
<COL WIDTH="58"></COL>
<COL WIDTH="451"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD VALIGN="BOTTOM" WIDTH="79" HEIGHT="30" AUPDATECONT="N">(기준일 : </TD>
<TU ALIGN="CENTER" VALIGN="BOTTOM" WIDTH="151" HEIGHT="30" AUNIT="BASE_DT" AUNITVALUE="-">-</TU>
<TD VALIGN="BOTTOM" WIDTH="67" HEIGHT="30" AUPDATECONT="N">)</TD>
<TU ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="460" HEIGHT="30" AUNIT="WON" AUNITVALUE="1">(단위 : 원)</TU>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="758" BORDER="1">

<COLGROUP>
<COL WIDTH="45"></COL>
<COL WIDTH="46"></COL>
<COL WIDTH="73"></COL>
<COL WIDTH="72"></COL>
<COL WIDTH="72"></COL>
<COL WIDTH="72"></COL>
<COL WIDTH="72"></COL>
<COL WIDTH="72"></COL>
<COL WIDTH="72"></COL>
<COL WIDTH="72"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="N" ADELETE="N">
<TH WIDTH="109" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" COLSPAN="2">잔여만기</TH>
<TH WIDTH="82" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">1년 이하</TH>
<TH WIDTH="81" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">1년초과&cr;5년이하</TH>
<TH WIDTH="81" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">5년초과&cr;10년이하</TH>
<TH WIDTH="81" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">10년초과&cr;15년이하</TH>
<TH WIDTH="81" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">15년초과&cr;20년이하</TH>
<TH WIDTH="81" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">20년초과&cr;30년이하</TH>
<TH WIDTH="81" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">30년초과</TH>
<TH WIDTH="81" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">합 계</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="54" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="90" AUPDATECONT="N" ROWSPAN="3">미상환 잔액</TD>
<TD WIDTH="55" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUPDATECONT="N">공모</TD>
<TE WIDTH="82" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_NE_DA1">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_NE_DA5">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_NE_DA10">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_NE_DA15">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_NE_DA20">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_NE_DA30">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_NE_DA31">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_NE_DATT">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="55" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUPDATECONT="N">사모</TD>
<TE WIDTH="82" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_NF_DA1">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_NF_DA5">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_NF_DA10">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_NF_DA15">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_NF_DA20">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_NF_DA30">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_NF_DA31">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_NF_DATT">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="55" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUPDATECONT="N">합계</TD>
<TE WIDTH="82" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_NEF_DA1">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_NEF_DA5">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_NEF_DA10">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_NEF_DA15">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_NEF_DA20">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_NEF_DA30">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_NEF_DA31">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_NEF_DATT">-</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>

<TABLE-GROUP ACLASS="SUB_CEF" ADELETETABLE="N">
<TITLE ATOC="N">조건부자본증권 미상환 잔액</TITLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="Y" WIDTH="912" BORDER="0">

<COLGROUP>
<COL WIDTH="70"></COL>
<COL WIDTH="142"></COL>
<COL WIDTH="58"></COL>
<COL WIDTH="606"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD VALIGN="BOTTOM" WIDTH="79" HEIGHT="30" AUPDATECONT="N">(기준일 : </TD>
<TU ALIGN="CENTER" VALIGN="BOTTOM" WIDTH="151" HEIGHT="30" AUNIT="BASE_DT" AUNITVALUE="-">-</TU>
<TD VALIGN="BOTTOM" WIDTH="67" HEIGHT="30" AUPDATECONT="N">)</TD>
<TU ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="615" HEIGHT="30" AUNIT="WON" AUNITVALUE="1">(단위 : 원)</TU>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="912" BORDER="1">

<COLGROUP>
<COL WIDTH="45"></COL>
<COL WIDTH="46"></COL>
<COL WIDTH="72"></COL>
<COL WIDTH="72"></COL>
<COL WIDTH="72"></COL>
<COL WIDTH="71"></COL>
<COL WIDTH="71"></COL>
<COL WIDTH="71"></COL>
<COL WIDTH="71"></COL>
<COL WIDTH="71"></COL>
<COL WIDTH="71"></COL>
<COL WIDTH="71"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="N" ADELETE="N">
<TH WIDTH="109" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" COLSPAN="2">잔여만기</TH>
<TH WIDTH="81" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">1년 이하</TH>
<TH WIDTH="81" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">1년초과&cr;2년이하</TH>
<TH WIDTH="81" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">2년초과&cr;3년이하</TH>
<TH WIDTH="80" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">3년초과&cr;4년이하</TH>
<TH WIDTH="80" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">4년초과&cr;5년이하</TH>
<TH WIDTH="80" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">5년초과&cr;10년이하</TH>
<TH WIDTH="80" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">10년초과&cr;20년이하</TH>
<TH WIDTH="80" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">20년초과&cr;30년이하</TH>
<TH WIDTH="80" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">30년초과</TH>
<TH WIDTH="80" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">합 계</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="54" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="90" AUPDATECONT="N" ROWSPAN="3">미상환 잔액</TD>
<TD WIDTH="55" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUPDATECONT="N">공모</TD>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CE_DA1">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CE_DA2">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CE_DA3">-</TE>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CE_DA4">-</TE>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CE_DA5">-</TE>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CE_DA10">-</TE>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CE_DA20">-</TE>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CE_DA30">-</TE>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CE_DA31">-</TE>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CE_DATT">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="55" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUPDATECONT="N">사모</TD>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CF_DA1">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CF_DA2">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CF_DA3">-</TE>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CF_DA4">-</TE>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CF_DA5">-</TE>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CF_DA10">-</TE>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CF_DA20">-</TE>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CF_DA30">-</TE>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CF_DA31">-</TE>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CF_DATT">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="55" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUPDATECONT="N">합계</TD>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CEF_DA1">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CEF_DA2">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CEF_DA3">-</TE>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CEF_DA4">-</TE>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CEF_DA5">-</TE>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CEF_DA10">-</TE>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CEF_DA20">-</TE>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CEF_DA30">-</TE>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CEF_DA31">-</TE>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CEF_DATT">-</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
<P></P>
<P></P>
<PGBRK></PGBRK>
</SECTION-2>
</SECTION-1>

<SECTION-1 ACLASS="MANDATORY" APARTSOURCE="SOURCE">
<TITLE ATOC="Y" AASSOCNOTE="D-0-4-0-0">IV. 이사의 경영진단 및 분석의견</TITLE>
<P></P>

<P>
<SPAN USERMARK="F-GL16 0XC00000 B">1. 예측정보에 대한 주의사항&cr;</SPAN>
<SPAN USERMARK="F-GL">&cr;</SPAN>
<SPAN USERMARK="F-GL11">당사가 동 사업보고서에서 미래에 발생 할 것으로 예상ㆍ예측한 활동, 사건 또는 현상은 당해 공시서류 작성시점의 사건 및 재무성과를 기반으로 회사의 견해를 반영한 것입니다. 동 예측정보는 미래 사업환경과 관련된 다양한 가정에 기초하고 있으며, 동 가정들은 결과적으로 부정확한 것으로 판명될 수도 있습니다. 또한, 이러한 가정들에는 예측정보에서 기재한 예상치와 실제 결과 간에 중요한 차이를 초래 할 수 있는위험, 불확실성 및 기타 요인을 포함하고 있습니다. 이러한 중요한 차이를 초래 할 수있는 요인에는 회사 내적요인과 외적요인이 포함되어 있으며, 이에 한하지 않습니다. 당사는 동 예측정보 작성시점 이후에 발생하는 위험 또는 불확실성을 반영하기 위하여 예측정보에 기재한 사항을 수정하는 정정보고서를 공시할의무는 없습니다. 결론적으로, 동 사업보고서상에 회사가 예상한 결과 또는 사항이 실현되거나 회사가 당초에 예상한 영향이 발생한다는 확신을 제공 할 수 없습니다. 동보고서에 기재된 예측정보는 동 보고서 작성시점을 기준으로 작성한 것이며, 회사가 이러한 위험요인이나 예측정보를 업데이트할 예정이 없음을 유의하시기 바랍니다.&cr;</SPAN>
<SPAN USERMARK="F-GL">&cr;</SPAN>
<SPAN USERMARK="F-GL 0XC00000"></SPAN>
<SPAN USERMARK="F-GL16 0XC00000"></SPAN>
<SPAN USERMARK="F-GL16 0XC00000 B">2. 경영진단의 개요&cr;</SPAN>
<SPAN USERMARK="F-GL 0XC00000 B"></SPAN>
<SPAN USERMARK="F-GL11"></SPAN>
</P>

<P>
<SPAN USERMARK="F-GL11">급성장 하고있는 필러시장에서 당사의 특화된 기술력으로 생산원가 절감 및 고품질의 히알루론산 원료를 생산하여 지속적인 성장을 이끌것으로 판단하고 있으며, </SPAN>
<SPAN USERMARK="F-GL11"></SPAN>
<SPAN USERMARK="F-GL11">향</SPAN>
<SPAN USERMARK="F-GL11">후 유착방지제, 슬관절 주사제, 항산화 전문 화장품 제조로 영역을 확장할 계획 입니다.&cr;</SPAN>
<SPAN USERMARK="F-GL11">또한, 의약품 케미칼 합성원료 생산 부문은 과거 지배회사의 안정적인 매출을 기반으로 안정적인 재무기여를 할 것으로 예상하고 있으며 원료의약품 제조 전문 기업으로 의 한축을 담당할 것으로 예상 됩니다. 당사는 꾸준한 기술 개발과 고품질의 제품을 생산하기 위하여전사적으로 전력을 다할 것입니다.&cr;</SPAN>
<SPAN USERMARK="F-GL 0X120FC8">&cr;</SPAN>
<SPAN USERMARK="F-GL16 0X120FC8"></SPAN>
<SPAN USERMARK="F-GL16 0XC00000"></SPAN>
<SPAN USERMARK="F-GL16 0XC00000 B">3. 재무상태 및 영업실적</SPAN>
<SPAN USERMARK="F-GL16 B">&cr;&cr;</SPAN>
<SPAN USERMARK="F-GL B">가. 재무상태&cr;&cr;</SPAN>
<SPAN USERMARK="F-GL11">2020년말 </SPAN>
<SPAN USERMARK="F-GL11"></SPAN>
<SPAN USERMARK="F-GL11">현재 총자산은 </SPAN>
<SPAN USERMARK="F-GL11">전기대비 4.84% 감소한 232억원 입니다. 그 중 유</SPAN>
<SPAN USERMARK="F-GL11">동자산은 전기대비 19.9% 감소한 </SPAN>
<SPAN USERMARK="F-GL11"> 37억원, </SPAN>
<SPAN USERMARK="F-GL11"> 비유동자산 </SPAN>
<SPAN USERMARK="F-GL11"></SPAN>
<SPAN USERMARK="F-GL11">1.29% </SPAN>
<SPAN USERMARK="F-GL11">감</SPAN>
<SPAN USERMARK="F-GL11">소한 19.5억원 입니다.  </SPAN>
<SPAN USERMARK="F-GL11"></SPAN>
<SPAN USERMARK="F-GL11">유동자산의 감소는 매출채권의 감소가 주된 요인입니다. 부채는 88억원으로 전기대비 1.02% 감소 하였습니다</SPAN>
<SPAN USERMARK="F-GL11">.</SPAN>
<SPAN USERMARK="F-GL B"></SPAN>
<SPAN USERMARK="F-GL11">.</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="694">

<COLGROUP>
<COL WIDTH="685"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="694" HEIGHT="30" ALIGN="RIGHT">단위: 천원,%)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="695">

<COLGROUP>
<COL WIDTH="174"></COL>
<COL WIDTH="119"></COL>
<COL WIDTH="119"></COL>
<COL WIDTH="119"></COL>
<COL WIDTH="119"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="183" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구분</TH>
<TH WIDTH="128" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">2020년(제 11 기)</TH>
<TH WIDTH="128" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">2019년(제 10 기)</TH>
<TH WIDTH="128" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">차 이</TH>
<TH WIDTH="128" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">증감율</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="183" HEIGHT="30">유동자산</TD>
<TD WIDTH="128" HEIGHT="30" ALIGN="RIGHT">3,723,536</TD>
<TD WIDTH="128" HEIGHT="30" ALIGN="RIGHT">4,648,848</TD>
<TD WIDTH="128" HEIGHT="30" ALIGN="RIGHT">-925,312</TD>
<TD WIDTH="128" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">-19.90</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="183" HEIGHT="30"> 현금및현금성자산</TD>
<TD WIDTH="128" HEIGHT="30" ALIGN="RIGHT">362,824</TD>
<TD WIDTH="128" HEIGHT="30" ALIGN="RIGHT">414,545</TD>
<TD WIDTH="128" HEIGHT="30" ALIGN="RIGHT">-51,721</TD>
<TD WIDTH="128" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">-12.48</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="183" HEIGHT="30"> 매출채권및기타유동자산</TD>
<TD WIDTH="128" HEIGHT="30" ALIGN="RIGHT">536,276</TD>
<TD WIDTH="128" HEIGHT="30" ALIGN="RIGHT">2,273,023</TD>
<TD WIDTH="128" HEIGHT="30" ALIGN="RIGHT">-1,736,747</TD>
<TD WIDTH="128" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">-76.41</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="183" HEIGHT="30"> 재고자산</TD>
<TD WIDTH="128" HEIGHT="30" ALIGN="RIGHT">2,824,436</TD>
<TD WIDTH="128" HEIGHT="30" ALIGN="RIGHT">1,961,280</TD>
<TD WIDTH="128" HEIGHT="30" ALIGN="RIGHT">863,156</TD>
<TD WIDTH="128" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">44.01</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="183" HEIGHT="30">비유동자산</TD>
<TD WIDTH="128" HEIGHT="30" ALIGN="RIGHT">19,516,350</TD>
<TD WIDTH="128" HEIGHT="30" ALIGN="RIGHT">19,772,260</TD>
<TD WIDTH="128" HEIGHT="30" ALIGN="RIGHT">-255,910</TD>
<TD WIDTH="128" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">-1.29</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="183" HEIGHT="30"> 투자자산</TD>
<TD WIDTH="128" HEIGHT="30" ALIGN="RIGHT">2,913,453</TD>
<TD WIDTH="128" HEIGHT="30" ALIGN="RIGHT">2,996,351</TD>
<TD WIDTH="128" HEIGHT="30" ALIGN="RIGHT">-82,898</TD>
<TD WIDTH="128" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">-2.77</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="183" HEIGHT="30"> 유형자산</TD>
<TD WIDTH="128" HEIGHT="30" ALIGN="RIGHT">16,557,991</TD>
<TD WIDTH="128" HEIGHT="30" ALIGN="RIGHT">16,725,632</TD>
<TD WIDTH="128" HEIGHT="30" ALIGN="RIGHT">-167,641</TD>
<TD WIDTH="128" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">-1.00</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="183" HEIGHT="30"> 무형자산</TD>
<TD WIDTH="128" HEIGHT="30" ALIGN="RIGHT">16,197</TD>
<TD WIDTH="128" HEIGHT="30" ALIGN="RIGHT">21,568</TD>
<TD WIDTH="128" HEIGHT="30" ALIGN="RIGHT">-5,371</TD>
<TD WIDTH="128" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">-24.90</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="183" HEIGHT="30"> 기타비유동자산</TD>
<TD WIDTH="128" HEIGHT="30" ALIGN="RIGHT">28,709</TD>
<TD WIDTH="128" HEIGHT="30" ALIGN="RIGHT">28,709</TD>
<TD WIDTH="128" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="128" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="183" HEIGHT="30" VALIGN="MIDDLE">자 산 총 계</TD>
<TD WIDTH="128" HEIGHT="30" ALIGN="RIGHT">23,239,886</TD>
<TD WIDTH="128" HEIGHT="30" ALIGN="RIGHT">24,421,108</TD>
<TD WIDTH="128" HEIGHT="30" ALIGN="RIGHT">-1,181,222</TD>
<TD WIDTH="128" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">-4.84</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="183" HEIGHT="30">유동부채</TD>
<TD WIDTH="128" HEIGHT="30" ALIGN="RIGHT">3,119,955</TD>
<TD WIDTH="128" HEIGHT="30" ALIGN="RIGHT">2,481,615</TD>
<TD WIDTH="128" HEIGHT="30" ALIGN="RIGHT">638,340</TD>
<TD WIDTH="128" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">25.72</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="183" HEIGHT="30">비유동부채</TD>
<TD WIDTH="128" HEIGHT="30" ALIGN="RIGHT">5,731,355</TD>
<TD WIDTH="128" HEIGHT="30" ALIGN="RIGHT">6,460,491</TD>
<TD WIDTH="128" HEIGHT="30" ALIGN="RIGHT">-729,136</TD>
<TD WIDTH="128" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">-11.29</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="183" HEIGHT="30" VALIGN="MIDDLE">부 채 총 계</TD>
<TD WIDTH="128" HEIGHT="30" ALIGN="RIGHT">8,851,310</TD>
<TD WIDTH="128" HEIGHT="30" ALIGN="RIGHT">8,942,106</TD>
<TD WIDTH="128" HEIGHT="30" ALIGN="RIGHT">-90,796</TD>
<TD WIDTH="128" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">-1.02</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="183" HEIGHT="30">자본금</TD>
<TD WIDTH="128" HEIGHT="30" ALIGN="RIGHT">12,305,935</TD>
<TD WIDTH="128" HEIGHT="30" ALIGN="RIGHT">12,305,935</TD>
<TD WIDTH="128" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="128" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="183" HEIGHT="30">자본잉여금</TD>
<TD WIDTH="128" HEIGHT="30" ALIGN="RIGHT">4,973,250</TD>
<TD WIDTH="128" HEIGHT="30" ALIGN="RIGHT">4,973,250</TD>
<TD WIDTH="128" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="128" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="183" HEIGHT="30">이익잉여금</TD>
<TD WIDTH="128" HEIGHT="30" ALIGN="RIGHT">-2,925,975</TD>
<TD WIDTH="128" HEIGHT="30" ALIGN="RIGHT">-1,712,487</TD>
<TD WIDTH="128" HEIGHT="30" ALIGN="RIGHT">-1,213,488</TD>
<TD WIDTH="128" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">70.86</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="183" HEIGHT="30">기타포괄손익누계액</TD>
<TD WIDTH="128" HEIGHT="30" ALIGN="RIGHT">35,366</TD>
<TD WIDTH="128" HEIGHT="30" ALIGN="RIGHT">-87,696</TD>
<TD WIDTH="128" HEIGHT="30" ALIGN="RIGHT">123,062</TD>
<TD WIDTH="128" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">-140.33</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="183" HEIGHT="30" VALIGN="MIDDLE">자 본 총 계</TD>
<TD WIDTH="128" HEIGHT="30" ALIGN="RIGHT">14,388,576</TD>
<TD WIDTH="128" HEIGHT="30" ALIGN="RIGHT">15,479,002</TD>
<TD WIDTH="128" HEIGHT="30" ALIGN="RIGHT">-1,090,426</TD>
<TD WIDTH="128" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">-7.04</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="183" HEIGHT="30" VALIGN="MIDDLE">부 채 와 자 본 총 계</TD>
<TD WIDTH="128" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">23,239,886</TD>
<TD WIDTH="128" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">24,421,108</TD>
<TD WIDTH="128" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-1,181,222</TD>
<TD WIDTH="128" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">-4.84</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK="F-GL">&cr;&cr;</SPAN>
<SPAN USERMARK="F-GL B">나. 영업실적&cr;&cr;</SPAN>
<SPAN USERMARK="F-GL B"></SPAN>
<SPAN USERMARK="F-GL 0X0000FF B"></SPAN>
<SPAN USERMARK="F-GL 0X0000FF B"></SPAN>
<SPAN USERMARK="F-GL 0X0000FF"></SPAN>
<SPAN USERMARK="F-GL11">당사의 매출은 전기대비 30.08% 감소하였습니다. 상품 및 제품 매출 동일하게 30% 감소하였으며, COVID-19로 인한 병원진료 감소로 주된 제품인 항생제 원료가 직접적인 영향을 받았습니다.</SPAN>
<SPAN USERMARK="F-GL11"></SPAN>
<SPAN USERMARK="F-GL11"></SPAN>
<SPAN USERMARK="F-GL11"> 판매비와 관리비용은 인건비성 비용의 증가, 영업외비용은 전년대비 12.9% 감소한 8억원으로 이중 이자비용이 전년대비 87.6% 증가한 1.9억원, 재고자산에대한 손실이 3.9억원, 지분법손실 2억원 입니다. 따라서 2020년 당기순손실은 전년대비 3억 증가하여 12억원 입니다.</SPAN>
<SPAN USERMARK="F-GL11"> &cr;</SPAN>
<SPAN USERMARK="F-GL B"></SPAN>
<SPAN USERMARK="F-GL11"></SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="600">

<COLGROUP>
<COL WIDTH="591"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="600" HEIGHT="30" ALIGN="RIGHT">단위: 천원,%)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="601">

<COLGROUP>
<COL WIDTH="144"></COL>
<COL WIDTH="116"></COL>
<COL WIDTH="116"></COL>
<COL WIDTH="104"></COL>
<COL WIDTH="76"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="153" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구 분</TH>
<TH WIDTH="125" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">2020년(제 11 기)</TH>
<TH WIDTH="125" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">2019년(제 10 기)</TH>
<TH WIDTH="113" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">차 이</TH>
<TH WIDTH="85" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">증감율</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="153" HEIGHT="30">매출액</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">7,467,276</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">10,679,061</TD>
<TD WIDTH="113" HEIGHT="30" ALIGN="RIGHT">-3,211,785</TD>
<TD WIDTH="85" HEIGHT="30" ALIGN="RIGHT">-30.08</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="153" HEIGHT="30">매출원가</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">6,591,385</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">9,586,414</TD>
<TD WIDTH="113" HEIGHT="30" ALIGN="RIGHT">-2,995,029</TD>
<TD WIDTH="85" HEIGHT="30" ALIGN="RIGHT">-31.24</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="153" HEIGHT="30">매출총이익</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">875,891</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">1,092,647</TD>
<TD WIDTH="113" HEIGHT="30" ALIGN="RIGHT">-216,756</TD>
<TD WIDTH="85" HEIGHT="30" ALIGN="RIGHT">-19.84</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="153" HEIGHT="30">판매비와관리비</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">1,300,284</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">1,104,828</TD>
<TD WIDTH="113" HEIGHT="30" ALIGN="RIGHT">195,456</TD>
<TD WIDTH="85" HEIGHT="30" ALIGN="RIGHT">17.69</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="153" HEIGHT="30">영업이익</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-424,393</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-12,181</TD>
<TD WIDTH="113" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-412,212</TD>
<TD WIDTH="85" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">3384.06</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="153" HEIGHT="30">영업외수익</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">42,688</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">66,515</TD>
<TD WIDTH="113" HEIGHT="30" ALIGN="RIGHT">-23,827</TD>
<TD WIDTH="85" HEIGHT="30" ALIGN="RIGHT">-35.82</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="153" HEIGHT="30">영업외비용</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">831,783</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">955,008</TD>
<TD WIDTH="113" HEIGHT="30" ALIGN="RIGHT">-123,225</TD>
<TD WIDTH="85" HEIGHT="30" ALIGN="RIGHT">-12.90</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="153" HEIGHT="30">법인세차감전순이익</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">-1,213,488</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">-900,674</TD>
<TD WIDTH="113" HEIGHT="30" ALIGN="RIGHT">-312,814</TD>
<TD WIDTH="85" HEIGHT="30" ALIGN="RIGHT">34.73</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="153" HEIGHT="30">법인세비용</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="113" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="85" HEIGHT="30" ALIGN="RIGHT">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="153" HEIGHT="30">당기순이익</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">-1,213,488</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">-900,674</TD>
<TD WIDTH="113" HEIGHT="30" ALIGN="RIGHT">-312,814</TD>
<TD WIDTH="85" HEIGHT="30" ALIGN="RIGHT">34.73</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK="F-GL">&cr;</SPAN>
<SPAN USERMARK="F-GL16"></SPAN>
<SPAN USERMARK="F-GL16 B"></SPAN>
<SPAN USERMARK="F-GL16 0XC00000 B"></SPAN>
<SPAN USERMARK="F-GL16 0XC00000 B"></SPAN>
<SPAN USERMARK="F-GL16 0XC00000 B">4. 유동성 및 자금조달 지출&cr;</SPAN>
<SPAN USERMARK="F-GL16 B">&cr;</SPAN>
<SPAN USERMARK="F-GL16 0X0000FF B"></SPAN>
<SPAN USERMARK="F-GL11 B">가. 유동성</SPAN>
<SPAN USERMARK="F-GL11 B"></SPAN>
<SPAN USERMARK="F-GL11"></SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="591">

<COLGROUP>
<COL WIDTH="582"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="591" HEIGHT="30" ALIGN="RIGHT">(단위: 원,%)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="589">

<COLGROUP>
<COL WIDTH="217"></COL>
<COL WIDTH="116"></COL>
<COL WIDTH="116"></COL>
<COL WIDTH="104"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="226" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구  분</TH>
<TH WIDTH="125" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">2020년(제 11 기)</TH>
<TH WIDTH="125" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">2019년(제 10 기)</TH>
<TH WIDTH="113" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">증감율</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="226" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">현금및현금성자산</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">362,824,855</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">414,544,602</TD>
<TD WIDTH="113" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-12.48</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="226" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">매출채권</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">518,207,347</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">2,260,111,888</TD>
<TD WIDTH="113" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-77.07</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="226" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">미수금</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">13,012,438</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">7,612,998</TD>
<TD WIDTH="113" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">70.92</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="226" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">선급금</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">5,137,996</TD>
<TD WIDTH="113" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="226" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">선급비용</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">5,006,996</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="113" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="226" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">당기법인세자산</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">49,470</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">159,710</TD>
<TD WIDTH="113" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-69.03</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="226" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">재고자산</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">2,824,435,570</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">1,961,280,334</TD>
<TD WIDTH="113" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">44.01</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="226" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">합      계</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">3,723,536,676</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">4,648,847,528</TD>
<TD WIDTH="113" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-19.90</TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK="F-GL11">&cr;☞유동성 지표</P>

<TABLE BORDER="1" WIDTH="603" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="106"></COL>
<COL WIDTH="228"></COL>
<COL WIDTH="117"></COL>
<COL WIDTH="116"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH ROWSPAN="2" WIDTH="115" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="60">구   분</TH>
<TH ROWSPAN="2" WIDTH="237" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="60">산   식</TH>
<TH COLSPAN="2" WIDTH="251" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">비   율</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="126" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">2020년(제 11 기)</TH>
<TH WIDTH="125" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">2019년(제 10 기)</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="115" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">유동비율</TD>
<TD WIDTH="237" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">(유동자산/유동부채)×100</TD>
<TD WIDTH="126" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">119.34</TD>
<TD WIDTH="125" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">187.33</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="115" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">부채비율</TD>
<TD WIDTH="237" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">(부채총계/자기자본)×100</TD>
<TD WIDTH="126" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">61.52</TD>
<TD WIDTH="125" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">57.77</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK="F-GL11">&cr;</SPAN>
<SPAN USERMARK="F-GL11 B">나. 자금조달</SPAN>
</P>

<TABLE BORDER="0" WIDTH="621" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="335"></COL>
<COL WIDTH="268"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="344" HEIGHT="30"></TD>
<TD WIDTH="277" HEIGHT="30" ALIGN="RIGHT">(단위 : 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="624">

<COLGROUP>
<COL WIDTH="110"></COL>
<COL WIDTH="145"></COL>
<COL WIDTH="93"></COL>
<COL WIDTH="116"></COL>
<COL WIDTH="115"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="119" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">차입처</TH>
<TH WIDTH="154" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">내역</TH>
<TH WIDTH="102" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">이자율(%)</TH>
<TH WIDTH="125" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당기말</TH>
<TH WIDTH="124" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">전기말</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="119" HEIGHT="120" ROWSPAN="4" ALIGN="CENTER" VALIGN="MIDDLE">기업은행</TD>
<TD WIDTH="154" HEIGHT="30" ALIGN="CENTER">시설자금대출</TD>
<TD WIDTH="102" HEIGHT="30" ALIGN="CENTER">1.62</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">710,000</TD>
<TD WIDTH="124" HEIGHT="30" ALIGN="RIGHT">710,000</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="154" HEIGHT="30" ALIGN="CENTER">시설자금대출</TD>
<TD WIDTH="102" HEIGHT="30" ALIGN="CENTER">2.83</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">6,000,000</TD>
<TD WIDTH="124" HEIGHT="30" ALIGN="RIGHT">6,000,000</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="154" HEIGHT="30" ALIGN="CENTER">운전자금</TD>
<TD WIDTH="102" HEIGHT="30" ALIGN="CENTER">3.54</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">340,000</TD>
<TD WIDTH="124" HEIGHT="30" ALIGN="RIGHT">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="154" HEIGHT="30" ALIGN="CENTER">운전자금</TD>
<TD WIDTH="102" HEIGHT="30" ALIGN="CENTER">2.727</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">1,000,000</TD>
<TD WIDTH="124" HEIGHT="30" ALIGN="RIGHT">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="375" HEIGHT="30" COLSPAN="3" ALIGN="CENTER">합    계</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">8,050,000</TD>
<TD WIDTH="124" HEIGHT="30" ALIGN="RIGHT">6,710,000</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK="F-GL11">&cr;</SPAN>
<SPAN USERMARK="F-11">☞ 직접조달</SPAN>
</P>

<TABLE BORDER="1" WIDTH="785" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="147"></COL>
<COL WIDTH="84"></COL>
<COL WIDTH="123"></COL>
<COL WIDTH="96"></COL>
<COL WIDTH="90"></COL>
<COL WIDTH="91"></COL>
<COL WIDTH="91"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="156" VALIGN="MIDDLE" ALIGN="CENTER" ROWSPAN="2" HEIGHT="60" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">증 자 방 식</TH>
<TH WIDTH="93" VALIGN="MIDDLE" ALIGN="CENTER" ROWSPAN="2" HEIGHT="60" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">발 행 가 액</TH>
<TH WIDTH="132" VALIGN="MIDDLE" ALIGN="CENTER" ROWSPAN="2" HEIGHT="60" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">납 입 일</TH>
<TH WIDTH="105" VALIGN="MIDDLE" ALIGN="CENTER" ROWSPAN="2" HEIGHT="60" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">발행주식수</TH>
<TH WIDTH="99" VALIGN="MIDDLE" ALIGN="CENTER" ROWSPAN="2" HEIGHT="60" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">발 행 총 액</TH>
<TH WIDTH="200" VALIGN="MIDDLE" ALIGN="CENTER" COLSPAN="2" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">자금의 사용목적</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="100" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">운영자금</TH>
<TH WIDTH="100" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">기타</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="156" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">제3자 배정 유상증자</TD>
<TD WIDTH="93" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">1,000원</TD>
<TD WIDTH="132" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2016년12월 15일</TD>
<TD WIDTH="105" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">9,946,500 주</TD>
<TD WIDTH="99" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">9,946백만원</TD>
<TD WIDTH="100" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">5,861백만원</TD>
<TD WIDTH="100" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">4,085백만원</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK="F-GL11">주) 운영자금은 차입금 상환, 연구개발 및 원재료 구매목적으로 소요될 예정이며, 해외 투자금 및 발행비용은 기타로 분류되었습니다.</SPAN>
</P>

<P>
<SPAN USERMARK="F-GL">&cr;&cr;</SPAN>
<SPAN USERMARK="F-GL16"></SPAN>
<SPAN USERMARK="F-GL16 0XC00000"></SPAN>
<SPAN USERMARK="F-GL16 0XC00000 B">5. 부외거래&cr;</SPAN>
<SPAN USERMARK="F-GL11 0XC00000 B"></SPAN>
<SPAN USERMARK="F-GL11">해당사항 없습니다.&cr;&cr;</SPAN>
<SPAN USERMARK="F-GL">&cr;</SPAN>
<SPAN USERMARK="F-GL16 0XC00000 B">6. 그 밖</SPAN>
<SPAN USERMARK="F-GL16 0XC00000 B">에 투자의사결정에 필요한 사항&cr;</SPAN>
<SPAN USERMARK="F-GL 0XC00000 B">&cr;</SPAN>
<SPAN USERMARK="F-GL11 0XC00000 B"></SPAN>
<SPAN USERMARK="F-GL11">당사의 중요한  회계정책 및 추정에 관한 사항은 </SPAN>
<SPAN USERMARK="F-GL11 U">III. 재무에 관한 사항중 5.재무제표 주석 참조하시기 바랍니다. 기타 사항은 XI. 그 밖에 투자자 보호를 위하여 필요한 사항을 참조하시기 바랍니다.</SPAN>
</P>
</SECTION-1>

<SECTION-1 ACLASS="MANDATORY" APARTSOURCE="SOURCE">
<TITLE ATOC="Y" AASSOCNOTE="D-0-5-0-0">V. 감사인의 감사의견 등</TITLE>
<P></P>
<WARNING>※ 회계감사인의 감사(검토)의견, 회계감사인과의 감사/비감사 용역 체결현황이 있을 경우&cr;    아래 『회계감사인의 감사의견』단위서식을 클릭하여 삽입하신 후 입력하세요.</WARNING>

<INSERTION ABASISNUMBER="SE1" AFREQUENCY="1" ADUPLICATION="N">
<COMMENT>◆click◆『회계감사인의 감사의견』 삽입</COMMENT>
<LIBRARYLIST>11011#*회계감사인의감사의견.dsl</LIBRARYLIST>

<LIBRARY>
<FILENAME ATYPE="dsl">25_회계감사인의감사의견</FILENAME>

<P>
<SPAN USERMARK=" B">가. 회</SPAN>
<SPAN USERMARK=" B">계감사인의 명칭 및 감사</SPAN>
</P>

<TABLE-GROUP ACLASS="AUD_OPN" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="575" BORDER="1">

<COLGROUP>
<COL WIDTH="104"></COL>
<COL WIDTH="119"></COL>
<COL WIDTH="99"></COL>
<COL WIDTH="104"></COL>
<COL WIDTH="104"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="N" ADELETE="N">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="113" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">사업연도</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="128" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">감사인</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="108" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">감사의견</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="113" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">강조사항 등</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="113" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">핵심감사사항</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TE ALIGN="CENTER" WIDTH="113" HEIGHT="30" ACODE="OPN_YEAR1" VALIGN="MIDDLE">제11기(당기)</TE>
<TE ALIGN="CENTER" WIDTH="128" HEIGHT="30" ACODE="OPN_AUR1" VALIGN="MIDDLE">광교회계법인</TE>
<TE ALIGN="CENTER" WIDTH="108" HEIGHT="30" ACODE="OPN_CMT1" VALIGN="MIDDLE">적정</TE>
<TE ALIGN="CENTER" WIDTH="113" HEIGHT="30" ACODE="OPN_EMP1" VALIGN="MIDDLE">해당사항 없음</TE>
<TE ALIGN="CENTER" WIDTH="113" HEIGHT="30" ACODE="OPN_POT1" VALIGN="MIDDLE">해당사항 없음</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TE ALIGN="CENTER" WIDTH="113" HEIGHT="30" ACODE="OPN_YEAR2" VALIGN="MIDDLE">제10기(전기)</TE>
<TE ALIGN="CENTER" WIDTH="128" HEIGHT="30" ACODE="OPN_AUR2" VALIGN="MIDDLE">회계법인 새시대</TE>
<TE ALIGN="CENTER" WIDTH="108" HEIGHT="30" ACODE="OPN_CMT2" VALIGN="MIDDLE">적정</TE>
<TE ALIGN="CENTER" WIDTH="113" HEIGHT="30" ACODE="OPN_EMP2" VALIGN="MIDDLE">해당사항 없음</TE>
<TE ALIGN="CENTER" WIDTH="113" HEIGHT="30" ACODE="OPN_POT2" VALIGN="MIDDLE">해당사항 없음</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TE ALIGN="CENTER" WIDTH="113" HEIGHT="30" ACODE="OPN_YEAR3" VALIGN="MIDDLE">제9기(전전기)</TE>
<TE ALIGN="CENTER" WIDTH="128" HEIGHT="30" ACODE="OPN_AUR3" VALIGN="MIDDLE">회계법인 새시대</TE>
<TE ALIGN="CENTER" WIDTH="108" HEIGHT="30" ACODE="OPN_CMT3" VALIGN="MIDDLE">적정</TE>
<TE ALIGN="CENTER" WIDTH="113" HEIGHT="30" ACODE="OPN_EMP3" VALIGN="MIDDLE">해당사항 없음</TE>
<TE ALIGN="CENTER" WIDTH="113" HEIGHT="30" ACODE="OPN_POT3" VALIGN="MIDDLE">해당사항 없음</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
<P></P>

<P>
<SPAN USERMARK="F-GL B">나. </SPAN>
<SPAN USERMARK="F-GL B"></SPAN>
<SPAN USERMARK="F-GL B">감사용역 체결현황</SPAN>
</P>

<TABLE-GROUP ACLASS="AUD_SIGK" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="861" BORDER="1">

<COLGROUP>
<COL WIDTH="112"></COL>
<COL WIDTH="119"></COL>
<COL WIDTH="204"></COL>
<COL WIDTH="98"></COL>
<COL WIDTH="104"></COL>
<COL WIDTH="98"></COL>
<COL WIDTH="63"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="N" ADELETE="N">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="121" HEIGHT="60" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ROWSPAN="2">사업연도</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="128" HEIGHT="60" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ROWSPAN="2">감사인</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="213" HEIGHT="60" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ROWSPAN="2">내 용</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="220" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" COLSPAN="2">감사계약내역</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="179" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" COLSPAN="2">실제수행내역</TH>
</TR>

<TR ACOPY="N" ADELETE="N">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="107" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">보수</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="113" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">시간</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="107" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">보수</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="72" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">시간</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TE ALIGN="CENTER" WIDTH="121" HEIGHT="30" ACODE="SIGK_YEAR1" VALIGN="MIDDLE">제11기(당분기)</TE>
<TE ALIGN="CENTER" WIDTH="128" HEIGHT="30" ACODE="SIGK_AUR1" VALIGN="MIDDLE">광교회계법인</TE>
<TE ALIGN="CENTER" WIDTH="213" HEIGHT="30" ACODE="SIGK_CNT1" VALIGN="MIDDLE">반기검토,중간감사, 기말감사</TE>
<TE ALIGN="RIGHT" WIDTH="107" HEIGHT="30" ACODE="SIGK_CPAY1" VALIGN="MIDDLE">13,000,000원</TE>
<TE ALIGN="RIGHT" WIDTH="113" HEIGHT="30" ACODE="SIGK_CTIM1" VALIGN="MIDDLE">해당사항 없음</TE>
<TE ALIGN="RIGHT" WIDTH="107" HEIGHT="30" ACODE="SIGK_FPAY1" VALIGN="MIDDLE">13,000,000원</TE>
<TE ALIGN="RIGHT" WIDTH="72" HEIGHT="30" ACODE="SIGK_FTIM1" VALIGN="MIDDLE">313시간</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TE ALIGN="CENTER" WIDTH="121" HEIGHT="30" ACODE="SIGK_YEAR2" VALIGN="MIDDLE">제10기(전기)</TE>
<TE ALIGN="CENTER" WIDTH="128" HEIGHT="30" ACODE="SIGK_AUR2" VALIGN="MIDDLE">광교회계법인</TE>
<TE ALIGN="CENTER" WIDTH="213" HEIGHT="30" ACODE="SIGK_CNT2" VALIGN="MIDDLE">반기검토,중간감사, 기말감사</TE>
<TE ALIGN="RIGHT" WIDTH="107" HEIGHT="30" ACODE="SIGK_CPAY2" VALIGN="MIDDLE">10,000,000원</TE>
<TE ALIGN="RIGHT" WIDTH="113" HEIGHT="30" ACODE="SIGK_CTIM2" VALIGN="MIDDLE">해당사항 없음</TE>
<TE ALIGN="RIGHT" WIDTH="107" HEIGHT="30" ACODE="SIGK_FPAY2" VALIGN="MIDDLE">10,000,000원</TE>
<TE ALIGN="RIGHT" WIDTH="72" HEIGHT="30" ACODE="SIGK_FTIM2" VALIGN="MIDDLE">313시간</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TE ALIGN="CENTER" WIDTH="121" HEIGHT="30" ACODE="SIGK_YEAR3" VALIGN="MIDDLE">제9기(전전기)</TE>
<TE ALIGN="CENTER" WIDTH="128" HEIGHT="30" ACODE="SIGK_AUR3" VALIGN="MIDDLE">회계법인 새시대</TE>
<TE ALIGN="CENTER" WIDTH="213" HEIGHT="30" ACODE="SIGK_CNT3" VALIGN="MIDDLE">반기검토,중간감사, 기말감사</TE>
<TE ALIGN="RIGHT" WIDTH="107" HEIGHT="30" ACODE="SIGK_CPAY3" VALIGN="MIDDLE">10,000,000원</TE>
<TE ALIGN="RIGHT" WIDTH="113" HEIGHT="30" ACODE="SIGK_CTIM3" VALIGN="MIDDLE">해당사항 없음</TE>
<TE ALIGN="RIGHT" WIDTH="107" HEIGHT="30" ACODE="SIGK_FPAY3" VALIGN="MIDDLE">10,000,000원</TE>
<TE ALIGN="RIGHT" WIDTH="72" HEIGHT="30" ACODE="SIGK_FTIM3" VALIGN="MIDDLE">296시간</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
<P></P>

<P>
<SPAN USERMARK="F-GL B">다. </SPAN>
<SPAN USERMARK="F-GL B"></SPAN>
<SPAN USERMARK="F-GL B">회계감사인과의 비감사용역 계약체결 현황</SPAN>.
</P>

<TABLE-GROUP ACLASS="AUD_SIGL" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="600" BORDER="1">

<COLGROUP>
<COL WIDTH="138"></COL>
<COL WIDTH="92"></COL>
<COL WIDTH="69"></COL>
<COL WIDTH="106"></COL>
<COL WIDTH="71"></COL>
<COL WIDTH="70"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="N" ADELETE="N">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="147" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">사업연도</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="101" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">계약체결일</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="78" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">용역내용</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="115" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">용역수행기간</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="80" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">용역보수</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="79" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">비고</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TE ALIGN="CENTER" WIDTH="147" HEIGHT="60" ACODE="SIGL_YEAR1" VALIGN="MIDDLE" ROWSPAN="2">제11기(당분기)</TE>
<TE ALIGN="CENTER" WIDTH="101" HEIGHT="30" ACODE="SIGL_CRT1" VALIGN="MIDDLE">-</TE>
<TE ALIGN="CENTER" WIDTH="78" HEIGHT="30" ACODE="SIGL_CNT1" VALIGN="MIDDLE">-</TE>
<TE ALIGN="CENTER" WIDTH="115" HEIGHT="30" ACODE="SIGL_TIM1" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="80" HEIGHT="30" ACODE="SIGL_PAY1" VALIGN="MIDDLE">-</TE>
<TE ALIGN="CENTER" WIDTH="79" HEIGHT="30" ACODE="SIGL_NOTE1" VALIGN="MIDDLE">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" WIDTH="101" HEIGHT="30" ACODE="SIGL_CRT1" VALIGN="MIDDLE">-</TE>
<TE ALIGN="CENTER" WIDTH="78" HEIGHT="30" ACODE="SIGL_CNT1" VALIGN="MIDDLE">-</TE>
<TE ALIGN="CENTER" WIDTH="115" HEIGHT="30" ACODE="SIGL_TIM1" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="80" HEIGHT="30" ACODE="SIGL_PAY1" VALIGN="MIDDLE">-</TE>
<TE ALIGN="CENTER" WIDTH="79" HEIGHT="30" ACODE="SIGL_NOTE1" VALIGN="MIDDLE">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TE ALIGN="CENTER" WIDTH="147" HEIGHT="60" ACODE="SIGL_YEAR2" VALIGN="MIDDLE" ROWSPAN="2">제10기(전기)</TE>
<TE ALIGN="CENTER" WIDTH="101" HEIGHT="30" ACODE="SIGL_CRT2" VALIGN="MIDDLE">-</TE>
<TE ALIGN="CENTER" WIDTH="78" HEIGHT="30" ACODE="SIGL_CNT2" VALIGN="MIDDLE">-</TE>
<TE ALIGN="CENTER" WIDTH="115" HEIGHT="30" ACODE="SIGL_TIM2" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="80" HEIGHT="30" ACODE="SIGL_PAY2" VALIGN="MIDDLE">-</TE>
<TE ALIGN="CENTER" WIDTH="79" HEIGHT="30" ACODE="SIGL_NOTE2" VALIGN="MIDDLE">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" WIDTH="101" HEIGHT="30" ACODE="SIGL_CRT2" VALIGN="MIDDLE">-</TE>
<TE ALIGN="CENTER" WIDTH="78" HEIGHT="30" ACODE="SIGL_CNT2" VALIGN="MIDDLE">-</TE>
<TE ALIGN="CENTER" WIDTH="115" HEIGHT="30" ACODE="SIGL_TIM2" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="80" HEIGHT="30" ACODE="SIGL_PAY2" VALIGN="MIDDLE">-</TE>
<TE ALIGN="CENTER" WIDTH="79" HEIGHT="30" ACODE="SIGL_NOTE2" VALIGN="MIDDLE">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TE ALIGN="CENTER" WIDTH="147" HEIGHT="60" ACODE="SIGL_YEAR3" VALIGN="MIDDLE" ROWSPAN="2">제9기(전전기)</TE>
<TE ALIGN="CENTER" WIDTH="101" HEIGHT="30" ACODE="SIGL_CRT3" VALIGN="MIDDLE">-</TE>
<TE ALIGN="CENTER" WIDTH="78" HEIGHT="30" ACODE="SIGL_CNT3" VALIGN="MIDDLE">-</TE>
<TE ALIGN="CENTER" WIDTH="115" HEIGHT="30" ACODE="SIGL_TIM3" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="80" HEIGHT="30" ACODE="SIGL_PAY3" VALIGN="MIDDLE">-</TE>
<TE ALIGN="CENTER" WIDTH="79" HEIGHT="30" ACODE="SIGL_NOTE3" VALIGN="MIDDLE">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" WIDTH="101" HEIGHT="30" ACODE="SIGL_CRT3" VALIGN="MIDDLE">-</TE>
<TE ALIGN="CENTER" WIDTH="78" HEIGHT="30" ACODE="SIGL_CNT3" VALIGN="MIDDLE">-</TE>
<TE ALIGN="CENTER" WIDTH="115" HEIGHT="30" ACODE="SIGL_TIM3" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="80" HEIGHT="30" ACODE="SIGL_PAY3" VALIGN="MIDDLE">-</TE>
<TE ALIGN="CENTER" WIDTH="79" HEIGHT="30" ACODE="SIGL_NOTE3" VALIGN="MIDDLE">-</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>

<P>
<SPAN USERMARK="F-GL B">&cr;마. </SPAN>
<SPAN USERMARK="F-GL B"></SPAN>
<SPAN USERMARK="F-GL B">회계감사인의 변경&cr;</SPAN>
<SPAN USERMARK="F-GL16 0XC00000 B"></SPAN>
<SPAN USERMARK="F-GL16 B"></SPAN>
<SPAN USERMARK="F-GL11 B"></SPAN>
<SPAN USERMARK="F-GL11"></SPAN>
<SPAN USERMARK="F-GL11"></SPAN>
<SPAN USERMARK="F-GL11"></SPAN>
<SPAN USERMARK="F-GL11">당</SPAN>
<SPAN USERMARK="F-GL11">사는</SPAN>
<SPAN USERMARK="F-GL11"> 당</SPAN>
<SPAN USERMARK="F-GL11">사의 지배회사인 대화제약(주)에 대한 연결실체로서의 관련성을 고려하여 광교회계법인과 감사계약을 체결하고 있으</SPAN>
<SPAN USERMARK="F-GL11">며, 2014년도(제5기) 회계사업연도부터</SPAN>
<SPAN USERMARK="F-GL11"> 감사를 진행하</SPAN>
<SPAN USERMARK="F-GL11">고 있습니다.&cr;</SPAN>
</P>
</LIBRARY>
</INSERTION>

<INSERTION ABASISNUMBER="SE1" AFREQUENCY="1" ADUPLICATION="N">
<COMMENT>◆click◆『내부감사기구가 회계감사인과 논의한 결과』 삽입</COMMENT>
<LIBRARYLIST>11011#*회계감사인과논의한결과.dsl</LIBRARYLIST>

<LIBRARY>
<FILENAME ATYPE="dsl">46_회계감사인과논의한결과</FILENAME>
<P USERMARK="F-GL11 B">바. 재무제표 중 이해관계자의 판단에 상당한 영향을 미칠 수 있는 사항에 대해 내부감사기구가 회계감사인과 논의한 결과</P>

<TABLE-GROUP ACLASS="DIS_CUS" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="713" BORDER="1">

<COLGROUP>
<COL WIDTH="39"></COL>
<COL WIDTH="128"></COL>
<COL WIDTH="253"></COL>
<COL WIDTH="39"></COL>
<COL WIDTH="209"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="N" ADELETE="N">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="48" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">구분</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="137" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">일자</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="262" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">참석자</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="48" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">방식</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="218" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">주요 논의 내용</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="N">
<TE ALIGN="CENTER" WIDTH="48" HEIGHT="53" ACODE="DIS_DIV" VALIGN="MIDDLE">1</TE>
<TU ALIGN="CENTER" WIDTH="137" HEIGHT="53" AUNIT="DIS_DATE" AUNITVALUE="20200214" VALIGN="MIDDLE">2020년 02월 14일</TU>
<TE ALIGN="CENTER" WIDTH="262" HEIGHT="53" ACODE="DIS_ATT" VALIGN="MIDDLE">1. 회사 : 감사/경영지원팀장 및 과장&cr;2. 감사인 : 업무수행이사</TE>
<TE ALIGN="CENTER" WIDTH="48" HEIGHT="53" ACODE="DIS_WAY" VALIGN="MIDDLE">서면</TE>
<TE ALIGN="CENTER" WIDTH="218" HEIGHT="53" ACODE="DIS_CONT" VALIGN="MIDDLE">ㆍ2019년 기말감사</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" WIDTH="48" HEIGHT="53" ACODE="DIS_DIV" VALIGN="MIDDLE">2</TE>
<TU ALIGN="CENTER" WIDTH="137" HEIGHT="53" AUNIT="DIS_DATE" AUNITVALUE="20200724" VALIGN="MIDDLE">2020년 07월 24일</TU>
<TE ALIGN="CENTER" WIDTH="262" HEIGHT="53" ACODE="DIS_ATT" VALIGN="MIDDLE">1. 회사 : 감사&cr;2. 감사인 : 업무수행이사</TE>
<TE ALIGN="CENTER" WIDTH="48" HEIGHT="53" ACODE="DIS_WAY" VALIGN="MIDDLE">서면</TE>
<TE ALIGN="CENTER" WIDTH="218" HEIGHT="53" ACODE="DIS_CONT" VALIGN="MIDDLE">ㆍ반기 검토</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" WIDTH="48" HEIGHT="53" ACODE="DIS_DIV" VALIGN="MIDDLE">3</TE>
<TU ALIGN="CENTER" WIDTH="137" HEIGHT="53" AUNIT="DIS_DATE" AUNITVALUE="20201119" VALIGN="MIDDLE">2020년 11월 19일</TU>
<TE ALIGN="CENTER" WIDTH="262" HEIGHT="53" ACODE="DIS_ATT" VALIGN="MIDDLE">1. 회사 : 감사&cr;2. 감사인 : 업무수행이사 외 1인</TE>
<TE ALIGN="CENTER" WIDTH="48" HEIGHT="53" ACODE="DIS_WAY" VALIGN="MIDDLE">서면</TE>
<TE ALIGN="CENTER" WIDTH="218" HEIGHT="53" ACODE="DIS_CONT" VALIGN="MIDDLE">ㆍ2020년 중간감사</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" WIDTH="48" HEIGHT="53" ACODE="DIS_DIV" VALIGN="MIDDLE">4</TE>
<TU ALIGN="CENTER" WIDTH="137" HEIGHT="53" AUNIT="DIS_DATE" AUNITVALUE="20210205" VALIGN="MIDDLE">2021년 02월 05일</TU>
<TE ALIGN="CENTER" WIDTH="262" HEIGHT="53" ACODE="DIS_ATT" VALIGN="MIDDLE">1. 회사 : 감사&cr;2. 감사인 : 업무수행이사 외 1인</TE>
<TE ALIGN="CENTER" WIDTH="48" HEIGHT="53" ACODE="DIS_WAY" VALIGN="MIDDLE">서면</TE>
<TE ALIGN="CENTER" WIDTH="218" HEIGHT="53" ACODE="DIS_CONT" VALIGN="MIDDLE">ㆍ2020년 기말감사</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
</LIBRARY>
</INSERTION>

<P>
<SPAN USERMARK="F-GL11">&cr;</SPAN>
<SPAN USERMARK="F-GL16 0XC00000 B">2. 내</SPAN>
<SPAN USERMARK="F-GL16 0XC00000 B">부회계관리제도&cr;</SPAN>
<SPAN USERMARK="F-GL11">해당사항없습니다.&cr;</SPAN>
</P>

<INSERTION ABASISNUMBER="SE1" AFREQUENCY="0" ADUPLICATION="N">
<COMMENT>◆click◆『조정협의회내용 및 재무제표 불일치정보』 삽입</COMMENT>
<LIBRARYLIST>11011#*조정협의회내용및재무제표불일치정보.dsl</LIBRARYLIST>
</INSERTION>
<PGBRK></PGBRK>
</SECTION-1>

<SECTION-1 ACLASS="MANDATORY" APARTSOURCE="SOURCE">
<TITLE ATOC="Y">VI. 이사회 등 회사의 기관에 관한 사항</TITLE>
<P></P>

<SECTION-2 ACLASS="MANDATORY">
<TITLE ATOC="Y" AASSOCNOTE="D-0-6-1-0">1. 이사회에 관한 사항</TITLE>
<P></P>

<P>
<SPAN USERMARK="F-GL11 B">가. 이사회의 구성 개요&cr;</SPAN>
<SPAN USERMARK="F-GL11">&cr;당사의 이사회는 이사로 구성되고 법령 또는 정관에 정하여진 사항, 주주총회로부터 위임받은사항, 회사의 기본방침 및 업무집행에 관한 주요사항을 의결하며 이사 및 경영진의 직무집행을 감독하고 있습니다. 보고서 제출일 현재 당사의 이사회는 4명의 사내이사(대표이사포함)로 구성되어 있습니다.&cr;</SPAN>
<SPAN USERMARK="F-GL11 B">&cr;나. 이사회의 중요의결사항&cr;&cr;</SPAN>
<SPAN USERMARK="F-GL11">1) 이사회에서의 사내이사의 주요활동내역&cr;</SPAN>
<SPAN USERMARK="F-GL11 B"></SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="1266">

<COLGROUP>
<COL WIDTH="39"></COL>
<COL WIDTH="83"></COL>
<COL WIDTH="274"></COL>
<COL WIDTH="64"></COL>
<COL WIDTH="107"></COL>
<COL WIDTH="107"></COL>
<COL WIDTH="107"></COL>
<COL WIDTH="107"></COL>
<COL WIDTH="106"></COL>
<COL WIDTH="106"></COL>
<COL WIDTH="67"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="48" HEIGHT="113" ROWSPAN="3" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">회차</TH>
<TH WIDTH="92" HEIGHT="113" ROWSPAN="3" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">개최일자</TH>
<TH WIDTH="283" HEIGHT="113" ROWSPAN="3" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">의 안 내 용</TH>
<TH WIDTH="73" HEIGHT="113" ROWSPAN="3" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">승인&cr;여부</TH>
<TH WIDTH="694" HEIGHT="30" COLSPAN="6" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">이사의 성명</TH>
<TH WIDTH="76" HEIGHT="113" ROWSPAN="3" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">비고</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="116" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">이한구&cr;(출석률 100%)</TH>
<TH WIDTH="116" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">한권석&cr;(출석률 100%)</TH>
<TH WIDTH="116" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">김수지&cr;(출석률 100%)</TH>
<TH WIDTH="116" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">김은석&cr;(출석률 100%)</TH>
<TH WIDTH="115" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">노병태&cr;(출석률 100%)</TH>
<TH WIDTH="115" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">박영택&cr;(출석률 100%)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="694" HEIGHT="30" COLSPAN="6" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">찬반여부</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="48" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">1</TD>
<TD WIDTH="92" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">2020.03.02</TD>
<TD WIDTH="283" HEIGHT="30" VALIGN="MIDDLE">제10기 재무제표 승인의 건</TD>
<TD WIDTH="73" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">가결</TD>
<TD WIDTH="116" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">찬성</TD>
<TD WIDTH="116" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">찬성</TD>
<TD WIDTH="116" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">찬성</TD>
<TD WIDTH="116" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">찬성</TD>
<TD WIDTH="115" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">찬성</TD>
<TD WIDTH="115" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">찬성</TD>
<TD WIDTH="76" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="48" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">2</TD>
<TD WIDTH="92" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">2020.03.10</TD>
<TD WIDTH="283" HEIGHT="30" VALIGN="MIDDLE">제10기 정기주주총회 소집에 관한건</TD>
<TD WIDTH="73" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">가결</TD>
<TD WIDTH="116" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">찬성</TD>
<TD WIDTH="116" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">찬성</TD>
<TD WIDTH="116" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">찬성</TD>
<TD WIDTH="116" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">찬성</TD>
<TD WIDTH="115" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">찬성</TD>
<TD WIDTH="115" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">찬성</TD>
<TD WIDTH="76" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="48" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">3</TD>
<TD WIDTH="92" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">2020.03.26</TD>
<TD WIDTH="283" HEIGHT="30" VALIGN="MIDDLE">사내이사 보수 결정의 건</TD>
<TD WIDTH="73" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">가결</TD>
<TD WIDTH="116" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">찬성</TD>
<TD WIDTH="116" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">찬성</TD>
<TD WIDTH="116" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">찬성</TD>
<TD WIDTH="116" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">찬성</TD>
<TD WIDTH="115" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">찬성</TD>
<TD WIDTH="115" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">찬성</TD>
<TD WIDTH="76" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="48" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">4</TD>
<TD WIDTH="92" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">2020.11.24</TD>
<TD WIDTH="283" HEIGHT="30" VALIGN="MIDDLE">임시주주총회</TD>
<TD WIDTH="73" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">가결</TD>
<TD WIDTH="116" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">찬성</TD>
<TD WIDTH="116" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">찬성</TD>
<TD WIDTH="116" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">찬성</TD>
<TD WIDTH="116" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">찬성</TD>
<TD WIDTH="115" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">사임(임기만료)</TD>
<TD WIDTH="115" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">사임(임기만료)</TD>
<TD WIDTH="76" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">-</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK="F-GL11">주1) 이사회의 의장은 정관 제39조 [이사회의 구성과 소집]에 따라 이한구 대표이사가 맡고 있음.&cr;주2) 이사회의 의장은 대표이사를 겸직하고 있음.&cr;&cr;2) 이사회에서의 사외이사의 주요활동내역&cr;</SPAN>
<SPAN USERMARK="F-GL11 B"></SPAN>
<SPAN USERMARK="F-GL11">해</SPAN>
<SPAN USERMARK="F-GL11">당사항 없습니다.&cr;&cr;</SPAN>
<SPAN USERMARK="F-GL11">3) 사외이사 및 그 변동현황&cr;</SPAN>
</P>

<TABLE-GROUP ACLASS="OUT_DIR" ADELETETABLE="N">

<TABLE ACLASS="NORMAL" AFIXTABLE="Y" WIDTH="600" BORDER="0">

<COLGROUP>
<COL WIDTH="291"></COL>
<COL WIDTH="291"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="300" HEIGHT="30" AUPDATECONT="N" VALIGN="MIDDLE"></TD>
<TD WIDTH="300" HEIGHT="30" AUPDATECONT="N" VALIGN="MIDDLE" ALIGN="RIGHT">(단위 : 명)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="599" BORDER="1">

<COLGROUP>
<COL WIDTH="121"></COL>
<COL WIDTH="120"></COL>
<COL WIDTH="100"></COL>
<COL WIDTH="100"></COL>
<COL WIDTH="113"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="N" ADELETE="N">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="130" HEIGHT="60" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ROWSPAN="2">이사의 수</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="129" HEIGHT="60" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ROWSPAN="2">사외이사 수</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="340" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" COLSPAN="3">사외이사 변동현황</TH>
</TR>

<TR ACOPY="N" ADELETE="N">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="109" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">선임</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="109" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">해임</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="122" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">중도퇴임</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TE ALIGN="RIGHT" WIDTH="130" HEIGHT="30" ACODE="DIR_NUM" VALIGN="MIDDLE">4</TE>
<TE ALIGN="RIGHT" WIDTH="129" HEIGHT="30" ACODE="ODIR_NUM" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="109" HEIGHT="30" ACODE="ODIR_PRE" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="109" HEIGHT="30" ACODE="ODIR_DIS" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="122" HEIGHT="30" ACODE="ODIR_RET" VALIGN="MIDDLE">-</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>

<P>
<SPAN USERMARK="F-GL11 B">&cr;</SPAN>
<SPAN USERMARK="F-GL11"></SPAN>
<SPAN USERMARK="F-GL11 B">다. 이사의 독립성&cr;</SPAN>
<SPAN USERMARK="F-GL11">&cr;당</SPAN>
<SPAN USERMARK="F-GL11">사의 이사회는 대주주 및 경영진으로부터 독립성을 유지하고 있으며, 당사 이사의 선임은 이사회가 선정하여 주주총회 의안으로 제출하고, 주주총회에서 선임하고 있습니다.&cr;이러한 절차를 통해 선임된 이사는 다음과 같습니다.&cr; &cr;1) 이사의 선임&cr;</SPAN>
</P>
<P USERMARK="F-GL11">[2020년 12월 31일 현재]</P>

<TABLE BORDER="1" WIDTH="1186" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="81"></COL>
<COL WIDTH="54"></COL>
<COL WIDTH="126"></COL>
<COL WIDTH="249"></COL>
<COL WIDTH="54"></COL>
<COL WIDTH="69"></COL>
<COL WIDTH="134"></COL>
<COL WIDTH="69"></COL>
<COL WIDTH="269"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="90" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" USERMARK=" BC0XD7D7D7">직  명</TD>
<TD WIDTH="63" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" USERMARK=" BC0XD7D7D7">성   명</TD>
<TD WIDTH="135" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" USERMARK=" BC0XD7D7D7">임기&cr;(연임횟수)</TD>
<TD WIDTH="258" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" USERMARK=" BC0XD7D7D7">선임배경</TD>
<TD WIDTH="63" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" USERMARK=" BC0XD7D7D7">추천인</TD>
<TD WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" USERMARK=" BC0XD7D7D7">활동분야</TD>
<TD WIDTH="143" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" USERMARK=" BC0XD7D7D7">최대주주 또는 &cr;주요주주와의 관계</TD>
<TD WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" USERMARK=" BC0XD7D7D7">회사와의&cr;거래</TD>
<TD WIDTH="278" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" USERMARK=" BC0XD7D7D7">주요경력</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="90" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="168">사내이사&cr;(대표이사)</TD>
<TD WIDTH="63" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="168">이한구</TD>
<TD WIDTH="135" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="168">2020.11~2023.11&cr;(2회)</TD>
<TD WIDTH="258" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="168">당사의 업무 총괄 및 대외적 업무를 &cr;안정적으로 수행하기 위함</TD>
<TD WIDTH="63" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="168">이사회</TD>
<TD WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="168">경영총괄</TD>
<TD WIDTH="143" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="168">-</TD>
<TD WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="168">해당없음</TD>
<TD WIDTH="278" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="168">성균관대학교 약학과 졸&cr; 성균관대학원 약학과 박사 졸&cr; 중외제약 연구소 부소장&cr; 디에스앤지(주) 대표이사 회장&cr; 대화제약(주) 대표이사 회장&cr; 주)씨트리 대표이사&cr; 현)대화제약(주) 대표이사 명예회장</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="90" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">사내이사&cr;(대표이사)</TD>
<TD WIDTH="63" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">한권석</TD>
<TD WIDTH="135" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">2020.11~2023.11&cr;(2회)</TD>
<TD WIDTH="258" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">당사의 업무 총괄 및 대외적 업무를 &cr;안정적으로 수행하기 위함</TD>
<TD WIDTH="63" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">이사회</TD>
<TD WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">경영총괄</TD>
<TD WIDTH="143" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">-</TD>
<TD WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">해당없음</TD>
<TD WIDTH="278" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">대화제약(주) 부사장</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="90" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="145">사내이사</TD>
<TD WIDTH="63" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="145">김수지</TD>
<TD WIDTH="135" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="145">2019.09~2022.09&cr;(2회)</TD>
<TD WIDTH="258" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="145">당사의 대외적 업무를&cr;안정적으로 수행하기 위함</TD>
<TD WIDTH="63" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="145">이사회</TD>
<TD WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="145">경영감독</TD>
<TD WIDTH="143" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="145">-</TD>
<TD WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="145">해당없음</TD>
<TD WIDTH="278" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="145">성균관대학교 약학과 졸&cr; 성균관대학교 대학원 무역학과 졸&cr; 필립무역상사 근무&cr; 대화제약㈜ 대표이사 회장&cr; 현)디에이치호림 대표이사&cr; 현)대화제약(주) 대표이사 명예회장</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="90" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="99">사내이사</TD>
<TD WIDTH="63" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="99">김은석</TD>
<TD WIDTH="135" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="99">2019.09~2022.09&cr;(2회)</TD>
<TD WIDTH="258" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="99">당사의 대외적 업무를&cr;안정적으로 수행하기 위함</TD>
<TD WIDTH="63" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="99">이사회</TD>
<TD WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="99">경영감독</TD>
<TD WIDTH="143" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="99">-</TD>
<TD WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="99">해당없음</TD>
<TD WIDTH="278" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="99">성균관대학교 산업심리학과 졸&cr; 성균관대학교대학원 경영학과 석사 졸&cr; 부광약품(주)근무&cr; 현) 대화제약 대표이사 사장</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK="F-GL11"></SPAN>
<SPAN USERMARK="F-GL11 B"></SPAN>
<SPAN USERMARK="F-GL11">&cr;2) 이사의 구성과 소집&cr;&cr;당사의 정관 제5장 이사ㆍ이사회ㆍ감사  제39조 이사회의 구성과 소집에 관하여 다음과 같이 운영하게 되어 있습니다.&cr;① 이사회는 이사로 구성하며 당 회사 업무의 중요사항을 결의하며 의장은 대표이사가 한다.&cr;② 이사회는 대표이사(사장 또는 대표권 있는 이사) 또는 이사회에서 따로 정한 이사가 있는 경우에는 그 이사가 회의 7일전에 각 이사 및 감사에게 통지하여 소집한다. 그러나 이사 및 감사 전원의 동의가 있을 때에는 소집절차를 생략할 수 있다.&cr;③ 제2항의 규정에 의하여 소집권자로 지정되지 않은 다른 이사는 소집권자인 이사에게 이사회 소집을 요구할 수 있다. 소집권자인 이사가 정당한 이유없이 이사회 소집을 거절하는 경우에는 다른 이사가 이사회를 소집할 수 있다.&cr;④ 이사회의 의장은 제2항 및 제3항의 규정에 의한 이사회의 소집권자로 한다.&cr;&cr;3) 이사회의 결의방법&cr;당사의 정관 제5장 이사ㆍ이사회ㆍ감사 제40조 이사회의 결의방법에 관하여 다음과 같이 운영하게 되어 있습니다.&cr;① 이사회의 결의는 법령과 정관에 다른 정함이 있는 경우를 제외하고는 이사 과반수     의 출석과 출석이사의 과반수로 한다.&cr;② 이사회는 이사의 전부 또는 일부가 직접회의에 출석하지 아니하고 모든 이사가 음성을동시에 송수신하는 원격통신 수단에 의하여 결의에 참가하는 것을 허용할 수 있다. 이 경우 당해 이사는 이사회에 직접 출석한 것으로 본다.&cr;③ 이사회의 결의에 관하여 특별한 이해관계가 있는 자는 의결권을 행사하지 못한다&cr;&cr;4) 이사회의 의사록&cr;</SPAN>
<SPAN USERMARK="F-GL11">당사의 정관 제5장 이사ㆍ이사회ㆍ감사 제41조 이사회의 의사록에 관하여 다음과 같이 운영하게 되어 있습니다.</SPAN>
<SPAN USERMARK="F-GL11">&cr;이사회의 의사에 관하여는 의사록을 작성하고 의장과 출석한 이사 및 감사가 기명날인 또는 서명을 하여 본점에 비치한다.&cr;&cr;</SPAN>
<SPAN USERMARK="F-GL11"></SPAN>
<SPAN USERMARK="F-GL11 B">라. </SPAN>
<SPAN USERMARK="F-GL11 B">사외이사 및 그 변동현황&cr;</SPAN>
<SPAN USERMARK="F-GL11">해당사항 없습니다.</SPAN>
<SPAN USERMARK="F-GL11">&cr;</SPAN>
<SPAN USERMARK="F-GL11 B"></SPAN>
<SPAN USERMARK="F-GL11"></SPAN>
<SPAN USERMARK="F-GL11"></SPAN>
<SPAN USERMARK="F-GL11 B">&cr;마. </SPAN>
<SPAN USERMARK="F-GL11 B">사</SPAN>
<SPAN USERMARK="F-GL11 B">외</SPAN>
<SPAN USERMARK="F-GL11 B">이</SPAN>
<SPAN USERMARK="F-GL11 B">사</SPAN>
<SPAN USERMARK="F-GL11 B">의 전문성</SPAN>
<SPAN USERMARK="F-GL11">&cr;해당사항 없습니다.</SPAN>
</P>
<P></P>

<INSERTION ABASISNUMBER="SE1" AFREQUENCY="0" ADUPLICATION="Y">
<COMMENT>◆click◆『사외이사 교육실시 현황』 삽입</COMMENT>
<LIBRARYLIST>11011#*_사외이사_교육_*.dsl</LIBRARYLIST>
</INSERTION>
<P></P>
</SECTION-2>

<SECTION-2 ACLASS="MANDATORY">
<TITLE ATOC="Y" AASSOCNOTE="D-0-6-2-0">2. 감사제도에 관한 사항</TITLE>
<P></P>

<P>
<SPAN USERMARK="F-GL11 B">가. 감사에 관한 사항&cr;</SPAN>
<SPAN USERMARK="F-GL11">&cr;당사는 보고서 작성 기준일 현재 감사위원회를 별도로 설치하고 있지 아니하며, 상법 제409조 및 정관 제31조에 근거하여 주주총회 결의에 의하여 선임된 비상근감사 1명이 감사업무를 수행하고 있습니다. &cr;</SPAN>
<SPAN USERMARK="F-GL11 B">&cr;</SPAN>
<SPAN USERMARK="F-GL11">1) 감사의 직무&cr;</SPAN>
<SPAN USERMARK="F-GL11">당사의 정관 제5장 이사ㆍ이사회ㆍ감사 제37조 감사의 직무에 관하여 다음과 같이 운영하게 되어 있습니다.</SPAN>
<SPAN USERMARK="F-GL11">&cr;</SPAN>
<SPAN USERMARK="F-GL11">① 감사는 당 회사의 업무 및 회계를 감사한다.&cr;② 감사는 이사회에 출석하여 의견을 진술할 수 있다.&cr;③ 감사는 회의의 목적사항과 소집의 이유를 기재한 서면을 이사회에 제출하여 임시총회의 소집을 청구할 수 있다.&cr;④ 감</SPAN>
<SPAN USERMARK="F-GL11">사는 그 직무를 대행하기 위하여 필요한 떼에는 자회사에 대하여 영업의 보고를 요구할 수 있다. 이 경우 자회사가 지체 없이 보고하지 아니할 때 또는 그 보고 내용을 확인할 필요가 있는 때에는 자회사의 업무와 재산 상태를 조사할 수 있다.&cr;⑤ 감사는 회사의 비용으로 전문가의 도움을 구할 수 있다.&cr;⑥ 감사는 필요하면 회의의 목적사항과 소집이유를 적은 서면을 이사(소집권자가 있는 경우에는 소직권자)에게 제출하여 이사회 소집을 청구할 수 있다.&cr;⑦ 제6항의 청구를 하였는데도 이사가 지체없이 이사회를 소집하지 아니하면 그 청구한 감사가 이사회를 소집할 수 있다.&cr;⑧ 감사의 책임감경은 제35조의 2 이사의 책임감경 조항을 준용한다.&cr;</SPAN>
<SPAN USERMARK="F-GL11">&cr;</SPAN>
<SPAN USERMARK="F-GL11 B"></SPAN>
<SPAN USERMARK="F-GL11 B">나. 감사의 주요활동 내역&cr;</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="610">

<COLGROUP>
<COL WIDTH="39"></COL>
<COL WIDTH="83"></COL>
<COL WIDTH="250"></COL>
<COL WIDTH="39"></COL>
<COL WIDTH="106"></COL>
<COL WIDTH="39"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="48" HEIGHT="113" ROWSPAN="3" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">회차</TH>
<TH WIDTH="92" HEIGHT="113" ROWSPAN="3" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">개최일자</TH>
<TH WIDTH="259" HEIGHT="113" ROWSPAN="3" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">의 안 내 용</TH>
<TH WIDTH="48" HEIGHT="113" ROWSPAN="3" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">승인&cr;여부</TH>
<TH WIDTH="115" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">감사의 성명</TH>
<TH WIDTH="48" HEIGHT="113" ROWSPAN="3" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">비고</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="115" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">강효원&cr;(출석률 100%)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="115" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">찬반여부</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="48" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">1</TD>
<TD WIDTH="92" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">2020.03.02</TD>
<TD WIDTH="259" HEIGHT="30" VALIGN="MIDDLE">제10기 재무제표 승인의 건</TD>
<TD WIDTH="48" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">가결</TD>
<TD WIDTH="115" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">찬성</TD>
<TD WIDTH="48" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="48" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">2</TD>
<TD WIDTH="92" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">2020.03.10</TD>
<TD WIDTH="259" HEIGHT="30" VALIGN="MIDDLE">제10기 정기주주총회 소집에 관한건</TD>
<TD WIDTH="48" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">가결</TD>
<TD WIDTH="115" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">찬성</TD>
<TD WIDTH="48" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="48" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">3</TD>
<TD WIDTH="92" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">2020.03.26</TD>
<TD WIDTH="259" HEIGHT="30" VALIGN="MIDDLE">사내이사 보수 결정의 건</TD>
<TD WIDTH="48" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">가결</TD>
<TD WIDTH="115" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">찬성</TD>
<TD WIDTH="48" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">-</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK="F-GL11">&cr;</SPAN>
<SPAN USERMARK="F-GL11 B">다. 감사의 선임 현황&cr;</SPAN>
<SPAN USERMARK="F-GL11"></SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="1257">

<COLGROUP>
<COL WIDTH="83"></COL>
<COL WIDTH="80"></COL>
<COL WIDTH="283"></COL>
<COL WIDTH="65"></COL>
<COL WIDTH="133"></COL>
<COL WIDTH="133"></COL>
<COL WIDTH="133"></COL>
<COL WIDTH="133"></COL>
<COL WIDTH="133"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD ROWSPAN="2" WIDTH="92" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60" USERMARK=" BC0XD7D7D7">성   명</TD>
<TD WIDTH="89" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">생년월일</TD>
<TD ROWSPAN="2" WIDTH="292" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60" USERMARK=" BC0XD7D7D7">주요직업 및 약력</TD>
<TD ROWSPAN="2" WIDTH="74" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60" USERMARK=" BC0XD7D7D7">회사와의&cr;거래내역</TD>
<TD ROWSPAN="2" WIDTH="142" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60" USERMARK=" BC0XD7D7D7">최대주주와의 관계</TD>
<TD ROWSPAN="2" WIDTH="142" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60" USERMARK=" BC0XD7D7D7">신규선임여부</TD>
<TD ROWSPAN="2" WIDTH="142" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60" USERMARK=" BC0XD7D7D7">체납사실&cr;여부</TD>
<TD ROWSPAN="2" WIDTH="142" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60" USERMARK=" BC0XD7D7D7">부실기업 경영진&cr;여부</TD>
<TD ROWSPAN="2" WIDTH="142" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60" USERMARK=" BC0XD7D7D7">법령상결격사유&cr;유무</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="89" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">추천인</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ROWSPAN="2" WIDTH="92" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="145">강효원&cr;(상근감사)</TD>
<TD WIDTH="89" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">1959.08.10</TD>
<TD ROWSPAN="2" WIDTH="292" HEIGHT="145">(前)국세청 근무&cr;(前)근로복지공단 고문&cr;(前)(주)대우건설 고문&cr;(現)세무법인 드림새시대 대표세무사&cr;(現)학교법인 경희학원 고문&cr;(現)대화제약(주) 상근감사</TD>
<TD ROWSPAN="2" WIDTH="74" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="145">없음</TD>
<TD ROWSPAN="2" WIDTH="142" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="145">없음</TD>
<TD ROWSPAN="2" WIDTH="142" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="145">재선임</TD>
<TD ROWSPAN="2" WIDTH="142" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="145">부</TD>
<TD ROWSPAN="2" WIDTH="142" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="145">부</TD>
<TD ROWSPAN="2" WIDTH="142" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="145">무</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="89" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="115">이사회</TD>
</TR>
</TBODY>
</TABLE>

<INSERTION ABASISNUMBER="SE1" AFREQUENCY="0" ADUPLICATION="Y">
<COMMENT>◆click◆『감사위원회 위원의 인적사항 및 사외이사 여부』 삽입</COMMENT>
<LIBRARYLIST>11011#*감사위원현황.dsl</LIBRARYLIST>
</INSERTION>

<INSERTION ABASISNUMBER="E1" AFREQUENCY="1" ADUPLICATION="Y">
<COMMENT>◆click◆『감사위원회(감사) 교육실시 현황』 삽입</COMMENT>
<LIBRARYLIST>11011#*_감사*_교육_*.dsl</LIBRARYLIST>

<LIBRARY>
<FILENAME ATYPE="dsl">41_02_감사_교육_실시현황</FILENAME>

<P>
<SPAN USERMARK="F-GL11 B">&cr;라. 감사 교육실시 현황</SPAN>
</P>

<TABLE-GROUP ACLASS="ADT_EDU" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="667" BORDER="1">

<COLGROUP>
<COL WIDTH="128"></COL>
<COL WIDTH="161"></COL>
<COL WIDTH="351"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="N" ADELETE="N">
<TH WIDTH="137" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">교육일자</TH>
<TH WIDTH="170" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">교육실시주체</TH>
<TH WIDTH="360" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">주요 교육내용</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="N">
<TU WIDTH="137" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="63" AUNIT="ADT_EDU_DT" AUNITVALUE="20201117">2020년 11월 17일</TU>
<TE WIDTH="170" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="63" ACODE="ADT_EDU_MA">코스닥협회&cr;2020년 내부감사 포럼 </TE>
<TE WIDTH="360" VALIGN="MIDDLE" HEIGHT="63" ACODE="ADT_EDU_DTL">-외감법 내 내부감사의 역할&cr;-내부회계관리제도 모범규준 내 감사의 책임과 역할</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
</LIBRARY>
</INSERTION>

<INSERTION ABASISNUMBER="E1" AFREQUENCY="1" ADUPLICATION="Y">
<COMMENT>◆click◆『감사위원회(감사) 지원조직 현황』 삽입</COMMENT>
<LIBRARYLIST>11011#*_감사*_지원조직_*.dsl</LIBRARYLIST>

<LIBRARY>
<FILENAME ATYPE="dsl">42_02_감사_지원조직_현황</FILENAME>

<P>
<SPAN USERMARK="F-GL11 B">&cr;마. 감사의 지원조직 현황</SPAN>
</P>

<TABLE-GROUP ACLASS="ADT_OGN" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="599" BORDER="1">

<COLGROUP>
<COL WIDTH="141"></COL>
<COL WIDTH="141"></COL>
<COL WIDTH="141"></COL>
<COL WIDTH="140"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="N" ADELETE="N">
<TH WIDTH="150" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">부서(팀)명</TH>
<TH WIDTH="150" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">직원수(명)</TH>
<TH WIDTH="150" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">직위(근속연수)</TH>
<TH WIDTH="149" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">주요 활동내역</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="N">
<TE WIDTH="150" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="99" ACODE="ADT_OGN_NM">경영지원팀</TE>
<TE WIDTH="150" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="99" ACODE="ADT_OGN_CNT">2</TE>
<TE WIDTH="150" VALIGN="MIDDLE" HEIGHT="99" ACODE="ADT_OGN_PST" ALIGN="CENTER">팀장,과장(평균10년)</TE>
<TE WIDTH="149" VALIGN="MIDDLE" HEIGHT="99" ACODE="ADT_OGN_DTL">재무제표,주주총회,이사회 등 경영전반에 관한 감사업무 지원</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>

<P>
<SPAN USERMARK="F-GL11 B">&cr;바. 준법지원인 지원조직 현황&cr;</SPAN>
<SPAN USERMARK="F-GL11">해당사항 없습니다.</SPAN>
</P>
<P></P>
</LIBRARY>
</INSERTION>

<INSERTION ABASISNUMBER="E1" AFREQUENCY="1" ADUPLICATION="Y">
<COMMENT>◆click◆『준법지원인 등 지원조직 현황』 삽입</COMMENT>
<LIBRARYLIST>11011#*_준법지원인등_지원조직_*.dsl</LIBRARYLIST>

<LIBRARY>
<FILENAME ATYPE="dsl">43_02_준법지원인등_지원조직_해당사항없음</FILENAME>

<INSERTION ABASISNUMBER="E0" AFREQUENCY="0" ADUPLICATION="N">
<COMMENT>지원조직이 없는 경우에는 그 사실을 기재한다.</COMMENT>
<LIBRARYLIST></LIBRARYLIST>
</INSERTION>
<P></P>
</LIBRARY>
</INSERTION>
</SECTION-2>

<SECTION-2 ACLASS="MANDATORY">
<TITLE ATOC="Y" AASSOCNOTE="D-0-6-3-0">3. 주주의 의결권 행사에 관한 사항</TITLE>
<P></P>

<P>
<SPAN USERMARK="F-GL11 B">가. 투표제도</SPAN>
<SPAN USERMARK="F-GL11">&cr;당사는 집중투표제를 채택하지 않고 있습니다.&cr;&cr;</SPAN>
<SPAN USERMARK="F-GL11 B">나. 소수주주권</SPAN>
<SPAN USERMARK="F-GL11">&cr;해당사항 업습니다.&cr;&cr;</SPAN>
<SPAN USERMARK="F-GL11 B">다. </SPAN>
<SPAN USERMARK="F-GL11 B">경</SPAN>
<SPAN USERMARK="F-GL11 B">영권 경쟁</SPAN>
<SPAN USERMARK="F-GL11">&cr;</SPAN>
<SPAN USERMARK="F-GL11">해당사항 업습니다.</SPAN>
</P>
<PGBRK></PGBRK>
</SECTION-2>
</SECTION-1>

<SECTION-1 ACLASS="MANDATORY" APARTSOURCE="SOURCE">
<TITLE ATOC="Y" AASSOCNOTE="D-0-7-0-0">VII. 주주에 관한 사항</TITLE>

<P>
<SPAN USERMARK=" 0XC00000 B">&cr;</SPAN>
<SPAN USERMARK="F-16 0XC00000 B">1. 최대주주 및 특수관계인의 주식소유 현황&cr;</SPAN>
<SPAN USERMARK=" 0XC00000 B">&cr;</SPAN>
<SPAN USERMARK="F-GL11 B">가. 최대주주 및 특수관계인의 주식소유 현황&cr;</SPAN>
</P>

<TABLE-GROUP ACLASS="BSH_SPCL" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="Y" WIDTH="639" BORDER="0">

<COLGROUP>
<COL WIDTH="71"></COL>
<COL WIDTH="143"></COL>
<COL WIDTH="70"></COL>
<COL WIDTH="319"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD VALIGN="BOTTOM" WIDTH="80" HEIGHT="30" AUPDATECONT="N">(기준일 : </TD>
<TU ALIGN="CENTER" VALIGN="BOTTOM" WIDTH="152" HEIGHT="30" AUNIT="SH5_CUR_DT" AUNITVALUE="20201231">2020년 12월 31일</TU>
<TD VALIGN="BOTTOM" WIDTH="79" HEIGHT="30" AUPDATECONT="N">)</TD>
<TU ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="328" HEIGHT="30" AUNIT="STOCKPERCENT" AUNITVALUE="1">(단위 : 주, %)</TU>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="686" BORDER="1" FRAME="BORDER" RULES="ALL">

<COLGROUP>
<COL WIDTH="84"></COL>
<COL WIDTH="104"></COL>
<COL WIDTH="54"></COL>
<COL WIDTH="91"></COL>
<COL WIDTH="54"></COL>
<COL WIDTH="88"></COL>
<COL WIDTH="54"></COL>
<COL WIDTH="85"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="N" ADELETE="N">
<TH ROWSPAN="3" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="93" HEIGHT="90" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">성 명</TH>
<TH ROWSPAN="3" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="113" HEIGHT="90" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">관 계</TH>
<TH ROWSPAN="3" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="90" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">주식의&cr;종류</TH>
<TH COLSPAN="4" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="323" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">소유주식수 및 지분율</TH>
<TH ROWSPAN="3" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="94" HEIGHT="90" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">비고</TH>
</TR>

<TR ACOPY="N" ADELETE="N">
<TH COLSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="163" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">기 초</TH>
<TH COLSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="160" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">기 말</TH>
</TR>

<TR ACOPY="N" ADELETE="N">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="100" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">주식수</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">지분율</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="97" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">주식수</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">지분율</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="N">
<TE ALIGN="CENTER" WIDTH="93" HEIGHT="30" ACODE="SH5_NM_T" VALIGN="MIDDLE">대화제약㈜</TE>
<TE ALIGN="CENTER" WIDTH="113" HEIGHT="30" ACODE="SH5_RET" VALIGN="MIDDLE">최대주주</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" ACODE="STK_KND">보통주</TE>
<TE ALIGN="RIGHT" WIDTH="100" HEIGHT="30" ACODE="SH5_BGN_CNT" VALIGN="MIDDLE">14,721,830 </TE>
<TE ALIGN="RIGHT" WIDTH="63" HEIGHT="30" ACODE="SH5_BGN_RT" VALIGN="MIDDLE">59.82 </TE>
<TE ALIGN="RIGHT" WIDTH="97" HEIGHT="30" ACODE="SH5_END_CNT" VALIGN="MIDDLE">14,810,770</TE>
<TE ALIGN="RIGHT" WIDTH="63" HEIGHT="30" ACODE="SH5_END_RT" VALIGN="MIDDLE">60.18</TE>

<TE ALIGN="CENTER" WIDTH="94" HEIGHT="30" ACODE="NOTE5" VALIGN="MIDDLE">
<SPAN>K-OTC매수</SPAN>
</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" WIDTH="93" HEIGHT="30" ACODE="SH5_NM_T" VALIGN="MIDDLE"> 이한구</TE>
<TE ALIGN="CENTER" WIDTH="113" HEIGHT="30" ACODE="SH5_RET" VALIGN="MIDDLE">임원</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" ACODE="STK_KND">보통주</TE>
<TE ALIGN="RIGHT" WIDTH="100" HEIGHT="30" ACODE="SH5_BGN_CNT" VALIGN="MIDDLE">100,000 </TE>
<TE ALIGN="RIGHT" WIDTH="63" HEIGHT="30" ACODE="SH5_BGN_RT" VALIGN="MIDDLE">0.41 </TE>
<TE ALIGN="RIGHT" WIDTH="97" HEIGHT="30" ACODE="SH5_END_CNT" VALIGN="MIDDLE">100,000 </TE>
<TE ALIGN="RIGHT" WIDTH="63" HEIGHT="30" ACODE="SH5_END_RT" VALIGN="MIDDLE">0.41 </TE>
<TE ALIGN="CENTER" WIDTH="94" HEIGHT="30" ACODE="NOTE5" VALIGN="MIDDLE">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" WIDTH="93" HEIGHT="30" ACODE="SH5_NM_T" VALIGN="MIDDLE">한권석</TE>
<TE ALIGN="CENTER" WIDTH="113" HEIGHT="30" ACODE="SH5_RET" VALIGN="MIDDLE">임원</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" ACODE="STK_KND">보통주</TE>
<TE ALIGN="RIGHT" WIDTH="100" HEIGHT="30" ACODE="SH5_BGN_CNT" VALIGN="MIDDLE">250,000 </TE>
<TE ALIGN="RIGHT" WIDTH="63" HEIGHT="30" ACODE="SH5_BGN_RT" VALIGN="MIDDLE">1.02 </TE>
<TE ALIGN="RIGHT" WIDTH="97" HEIGHT="30" ACODE="SH5_END_CNT" VALIGN="MIDDLE">250,000 </TE>
<TE ALIGN="RIGHT" WIDTH="63" HEIGHT="30" ACODE="SH5_END_RT" VALIGN="MIDDLE">1.02 </TE>
<TE ALIGN="CENTER" WIDTH="94" HEIGHT="30" ACODE="NOTE5" VALIGN="MIDDLE">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" WIDTH="93" HEIGHT="30" ACODE="SH5_NM_T" VALIGN="MIDDLE">김수지</TE>
<TE ALIGN="CENTER" WIDTH="113" HEIGHT="30" ACODE="SH5_RET" VALIGN="MIDDLE">임원</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" ACODE="STK_KND">보통주</TE>
<TE ALIGN="RIGHT" WIDTH="100" HEIGHT="30" ACODE="SH5_BGN_CNT" VALIGN="MIDDLE">126,020 </TE>
<TE ALIGN="RIGHT" WIDTH="63" HEIGHT="30" ACODE="SH5_BGN_RT" VALIGN="MIDDLE">0.51 </TE>
<TE ALIGN="RIGHT" WIDTH="97" HEIGHT="30" ACODE="SH5_END_CNT" VALIGN="MIDDLE">138,000</TE>
<TE ALIGN="RIGHT" WIDTH="63" HEIGHT="30" ACODE="SH5_END_RT" VALIGN="MIDDLE">0.56 </TE>
<TE ALIGN="CENTER" WIDTH="94" HEIGHT="30" ACODE="NOTE5" VALIGN="MIDDLE">K-OTC매수</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" WIDTH="93" HEIGHT="30" ACODE="SH5_NM_T" VALIGN="MIDDLE">김은석</TE>
<TE ALIGN="CENTER" WIDTH="113" HEIGHT="30" ACODE="SH5_RET" VALIGN="MIDDLE">임원</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" ACODE="STK_KND">보통주</TE>
<TE ALIGN="RIGHT" WIDTH="100" HEIGHT="30" ACODE="SH5_BGN_CNT" VALIGN="MIDDLE">603,020 </TE>
<TE ALIGN="RIGHT" WIDTH="63" HEIGHT="30" ACODE="SH5_BGN_RT" VALIGN="MIDDLE">2.45 </TE>
<TE ALIGN="RIGHT" WIDTH="97" HEIGHT="30" ACODE="SH5_END_CNT" VALIGN="MIDDLE">611,410</TE>
<TE ALIGN="RIGHT" WIDTH="63" HEIGHT="30" ACODE="SH5_END_RT" VALIGN="MIDDLE">2.48 </TE>
<TE ALIGN="CENTER" WIDTH="94" HEIGHT="30" ACODE="NOTE5" VALIGN="MIDDLE">K-OTC매수</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" WIDTH="93" HEIGHT="30" ACODE="SH5_NM_T" VALIGN="MIDDLE">노병태</TE>
<TE ALIGN="CENTER" WIDTH="113" HEIGHT="30" ACODE="SH5_RET" VALIGN="MIDDLE">임원</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" ACODE="STK_KND">보통주</TE>
<TE ALIGN="RIGHT" WIDTH="100" HEIGHT="30" ACODE="SH5_BGN_CNT" VALIGN="MIDDLE">100,000 </TE>
<TE ALIGN="RIGHT" WIDTH="63" HEIGHT="30" ACODE="SH5_BGN_RT" VALIGN="MIDDLE">0.41 </TE>
<TE ALIGN="RIGHT" WIDTH="97" HEIGHT="30" ACODE="SH5_END_CNT" VALIGN="MIDDLE">100,000 </TE>
<TE ALIGN="RIGHT" WIDTH="63" HEIGHT="30" ACODE="SH5_END_RT" VALIGN="MIDDLE">0.41 </TE>
<TE ALIGN="CENTER" WIDTH="94" HEIGHT="30" ACODE="NOTE5" VALIGN="MIDDLE">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" WIDTH="93" HEIGHT="30" ACODE="SH5_NM_T" VALIGN="MIDDLE">양재권</TE>
<TE ALIGN="CENTER" WIDTH="113" HEIGHT="30" ACODE="SH5_RET" VALIGN="MIDDLE">관계회사 임원</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" ACODE="STK_KND">보통주</TE>
<TE ALIGN="RIGHT" WIDTH="100" HEIGHT="30" ACODE="SH5_BGN_CNT" VALIGN="MIDDLE">2,000 </TE>
<TE ALIGN="RIGHT" WIDTH="63" HEIGHT="30" ACODE="SH5_BGN_RT" VALIGN="MIDDLE">0.01 </TE>
<TE ALIGN="RIGHT" WIDTH="97" HEIGHT="30" ACODE="SH5_END_CNT" VALIGN="MIDDLE">2,000 </TE>
<TE ALIGN="RIGHT" WIDTH="63" HEIGHT="30" ACODE="SH5_END_RT" VALIGN="MIDDLE">0.01 </TE>
<TE ALIGN="CENTER" WIDTH="94" HEIGHT="30" ACODE="NOTE5" VALIGN="MIDDLE">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD ROWSPAN="2" COLSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="206" HEIGHT="60" AUPDATECONT="N">계</TD>
<TE ALIGN="CENTER" WIDTH="63" HEIGHT="30" ACODE="SH5_STK_KNDT" VALIGN="MIDDLE">보통주</TE>
<TE ALIGN="RIGHT" WIDTH="100" HEIGHT="30" ACODE="STK_CNT_BIML" VALIGN="MIDDLE">15,902,870 </TE>
<TE ALIGN="RIGHT" WIDTH="63" HEIGHT="30" ACODE="STK_RATE_BIML" VALIGN="MIDDLE">64.62 </TE>
<TE ALIGN="RIGHT" WIDTH="97" HEIGHT="30" ACODE="STK_CNT_GIML" VALIGN="MIDDLE">16,012,180 </TE>
<TE ALIGN="RIGHT" WIDTH="63" HEIGHT="30" ACODE="STK_RATE_GIML" VALIGN="MIDDLE">65.06 </TE>
<TE ALIGN="CENTER" WIDTH="94" HEIGHT="30" ACODE="NOTE4" VALIGN="MIDDLE">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="N">
<TE ALIGN="CENTER" WIDTH="63" HEIGHT="30" ACODE="SH5_STK_KNDT" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="100" HEIGHT="30" ACODE="STK_CNT_BIML" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="63" HEIGHT="30" ACODE="STK_RATE_BIML" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="97" HEIGHT="30" ACODE="STK_CNT_GIML" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="63" HEIGHT="30" ACODE="STK_RATE_GIML" VALIGN="MIDDLE">-</TE>
<TE ALIGN="CENTER" WIDTH="94" HEIGHT="30" ACODE="NOTE4" VALIGN="MIDDLE">-</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>

<P>
<SPAN USERMARK="F-GL11">주) 최대주주인 대화제약(주)는 K-OTC에서 88,940주를 매수하여 주식수 14,810,770주(60.18%)로 지분율이 변경됨.</SPAN>
<SPAN USERMARK="F-GL11 0X0000FF"> </SPAN>
<SPAN USERMARK="F-GL11 0X0000FF"></SPAN>
<SPAN USERMARK="F-GL11 0X0000FF">&cr;</SPAN>
<SPAN USERMARK="F-GL16 0XC00000 B"></SPAN>
</P>

<INSERTION ABASISNUMBER="LE0" AFREQUENCY="1" ADUPLICATION="Y">
<COMMENT>◆복수click가능◆『최대주주가 법인 또는 투자조합 등 단체인 경우』 삽입</COMMENT>
<LIBRARYLIST>11011#*최대주주가단체인경우.dsl</LIBRARYLIST>

<LIBRARY>
<FILENAME ATYPE="dsl">33_최대주주가단체인경우</FILENAME>

<P>
<SPAN USERMARK="F-GL B">나. 법인 또는 단체의 기본정보&cr;</SPAN>
</P>

<TABLE-GROUP ACLASS="THD_ASN_BAS" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="586" BORDER="1">

<COLGROUP>
<COL WIDTH="96"></COL>
<COL WIDTH="69"></COL>
<COL WIDTH="54"></COL>
<COL WIDTH="62"></COL>
<COL WIDTH="55"></COL>
<COL WIDTH="62"></COL>
<COL WIDTH="54"></COL>
<COL WIDTH="62"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="N" ADELETE="N">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="105" HEIGHT="83" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ROWSPAN="2">명 칭</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="78" HEIGHT="83" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ROWSPAN="2">출자자수&cr;(명)</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="134" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" COLSPAN="2">대표이사&cr;(대표조합원)</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="135" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" COLSPAN="2">업무집행자&cr;(업무집행조합원)</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="134" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" COLSPAN="2">최대주주&cr;(최대출자자)</TH>
</TR>

<TR ACOPY="N" ADELETE="N">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">성명</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="71" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">지분(%)</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="64" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">성명</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="71" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">지분(%)</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">성명</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="71" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">지분(%)</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TE WIDTH="105" HEIGHT="60" ACODE="BAS_NAME" VALIGN="MIDDLE" ALIGN="CENTER" ROWSPAN="2">대화제약(주)</TE>
<TE WIDTH="78" HEIGHT="60" ACODE="BAS_CNT" VALIGN="MIDDLE" ALIGN="RIGHT" ROWSPAN="2">22,046</TE>
<TE WIDTH="63" HEIGHT="30" ACODE="BAS_NAM1" VALIGN="MIDDLE" ALIGN="CENTER">노병태</TE>
<TE WIDTH="71" HEIGHT="30" ACODE="BAS_RAT1" VALIGN="MIDDLE" ALIGN="RIGHT">0.15</TE>
<TE WIDTH="64" HEIGHT="30" ACODE="BAS_NAM2" VALIGN="MIDDLE" ALIGN="CENTER">-</TE>
<TE WIDTH="71" HEIGHT="30" ACODE="BAS_RAT2" VALIGN="MIDDLE" ALIGN="RIGHT">-</TE>
<TE ALIGN="CENTER" WIDTH="63" HEIGHT="30" ACODE="BAS_NAM3" VALIGN="MIDDLE">김수지</TE>
<TE WIDTH="71" HEIGHT="30" ACODE="BAS_RAT3" VALIGN="MIDDLE" ALIGN="RIGHT">9.75</TE>
</TR>

<TR ACOPY="Y" ADELETE="N">
<TE WIDTH="63" HEIGHT="30" ACODE="BAS_NAM1" VALIGN="MIDDLE" ALIGN="CENTER">김은석</TE>
<TE WIDTH="71" HEIGHT="30" ACODE="BAS_RAT1" VALIGN="MIDDLE" ALIGN="RIGHT">0.71</TE>
<TE WIDTH="64" HEIGHT="30" ACODE="BAS_NAM2" VALIGN="MIDDLE" ALIGN="CENTER">-</TE>
<TE WIDTH="71" HEIGHT="30" ACODE="BAS_RAT2" VALIGN="MIDDLE" ALIGN="RIGHT">-</TE>
<TE ALIGN="CENTER" WIDTH="63" HEIGHT="30" ACODE="BAS_NAM3" VALIGN="MIDDLE">-</TE>
<TE WIDTH="71" HEIGHT="30" ACODE="BAS_RAT3" VALIGN="MIDDLE" ALIGN="RIGHT">-</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>

<INSERTION ABASISNUMBER="E0" AFREQUENCY="0" ADUPLICATION="N">
<COMMENT>* 법인 또는 단체의 대표이사, 업무집행자, 최대주주의 지분율을 기재</COMMENT>
<LIBRARYLIST></LIBRARYLIST>
</INSERTION>
<P USERMARK="F-GL11"></P>

<INSERTION ABASISNUMBER="SE1" AFREQUENCY="1" ADUPLICATION="N">
<COMMENT>◆click◆『공시대상기간 중 법인 또는 단체의 대표이사, 업무집행자, 최대주주의 성명 또는&cr; 지분율 변동이 있는경우』 삽입</COMMENT>
<LIBRARYLIST>11011#*성명또는지분율변동인경우.dsl</LIBRARYLIST>

<LIBRARY>
<FILENAME ATYPE="dsl">34_성명또는지분율변동인경우</FILENAME>

<P>
<SPAN USERMARK="F-GL B">다. 법인 또는 단체의 대표이사, 업무집행자,최대주주의 변동내역</SPAN>
</P>

<TABLE-GROUP ACLASS="THD_ASN_BASK" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="540" BORDER="1">

<COLGROUP>
<COL WIDTH="128"></COL>
<COL WIDTH="54"></COL>
<COL WIDTH="62"></COL>
<COL WIDTH="55"></COL>
<COL WIDTH="62"></COL>
<COL WIDTH="54"></COL>
<COL WIDTH="62"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="N" ADELETE="N">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="137" HEIGHT="83" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ROWSPAN="2">변동일</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="134" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" COLSPAN="2">대표이사&cr;(대표조합원)</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="135" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" COLSPAN="2">업무집행자&cr;(업무집행조합원)</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="134" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" COLSPAN="2">최대주주&cr;(최대출자자)</TH>
</TR>

<TR ACOPY="N" ADELETE="N">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">성명</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="71" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">지분(%)</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="64" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">성명</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="71" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">지분(%)</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">성명</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="71" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">지분(%)</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="N">
<TU WIDTH="137" HEIGHT="30" AUNIT="BAS_DATE" AUNITVALUE="20200131" VALIGN="MIDDLE" ALIGN="CENTER">2020년 01월 31일</TU>
<TE WIDTH="63" HEIGHT="30" ACODE="BAS_NAM1" VALIGN="MIDDLE" ALIGN="CENTER">김은석</TE>
<TE WIDTH="71" HEIGHT="30" ACODE="BAS_RAT1" VALIGN="MIDDLE" ALIGN="RIGHT">0.31</TE>
<TE WIDTH="64" HEIGHT="30" ACODE="BAS_NAM2" VALIGN="MIDDLE" ALIGN="CENTER">-</TE>
<TE WIDTH="71" HEIGHT="30" ACODE="BAS_RAT2" VALIGN="MIDDLE" ALIGN="RIGHT">-</TE>
<TE WIDTH="63" HEIGHT="30" ACODE="BAS_NAM3" VALIGN="MIDDLE" ALIGN="CENTER">-</TE>
<TE WIDTH="71" HEIGHT="30" ACODE="BAS_RAT3" VALIGN="MIDDLE" ALIGN="RIGHT">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TU WIDTH="137" HEIGHT="30" AUNIT="BAS_DATE" AUNITVALUE="20200229" VALIGN="MIDDLE" ALIGN="CENTER">2020년 02월 29일</TU>
<TE WIDTH="63" HEIGHT="30" ACODE="BAS_NAM1" VALIGN="MIDDLE" ALIGN="CENTER">김은석</TE>
<TE WIDTH="71" HEIGHT="30" ACODE="BAS_RAT1" VALIGN="MIDDLE" ALIGN="RIGHT">0.32</TE>
<TE WIDTH="64" HEIGHT="30" ACODE="BAS_NAM2" VALIGN="MIDDLE" ALIGN="CENTER">-</TE>
<TE WIDTH="71" HEIGHT="30" ACODE="BAS_RAT2" VALIGN="MIDDLE" ALIGN="RIGHT">-</TE>
<TE WIDTH="63" HEIGHT="30" ACODE="BAS_NAM3" VALIGN="MIDDLE" ALIGN="CENTER">김수지</TE>
<TE WIDTH="71" HEIGHT="30" ACODE="BAS_RAT3" VALIGN="MIDDLE" ALIGN="RIGHT">9.67</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TU WIDTH="137" HEIGHT="30" AUNIT="BAS_DATE" AUNITVALUE="20200331" VALIGN="MIDDLE" ALIGN="CENTER">2020년 03월 31일</TU>
<TE WIDTH="63" HEIGHT="30" ACODE="BAS_NAM1" VALIGN="MIDDLE" ALIGN="CENTER">김은석</TE>
<TE WIDTH="71" HEIGHT="30" ACODE="BAS_RAT1" VALIGN="MIDDLE" ALIGN="RIGHT">0.40</TE>
<TE WIDTH="64" HEIGHT="30" ACODE="BAS_NAM2" VALIGN="MIDDLE" ALIGN="CENTER">-</TE>
<TE WIDTH="71" HEIGHT="30" ACODE="BAS_RAT2" VALIGN="MIDDLE" ALIGN="RIGHT">-</TE>
<TE WIDTH="63" HEIGHT="30" ACODE="BAS_NAM3" VALIGN="MIDDLE" ALIGN="CENTER">김수지</TE>
<TE WIDTH="71" HEIGHT="30" ACODE="BAS_RAT3" VALIGN="MIDDLE" ALIGN="RIGHT">9.82</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TU WIDTH="137" HEIGHT="30" AUNIT="BAS_DATE" AUNITVALUE="20200430" VALIGN="MIDDLE" ALIGN="CENTER">2020년 04월 30일</TU>
<TE WIDTH="63" HEIGHT="30" ACODE="BAS_NAM1" VALIGN="MIDDLE" ALIGN="CENTER">김은석</TE>
<TE WIDTH="71" HEIGHT="30" ACODE="BAS_RAT1" VALIGN="MIDDLE" ALIGN="RIGHT">0.41</TE>
<TE WIDTH="64" HEIGHT="30" ACODE="BAS_NAM2" VALIGN="MIDDLE" ALIGN="CENTER">-</TE>
<TE WIDTH="71" HEIGHT="30" ACODE="BAS_RAT2" VALIGN="MIDDLE" ALIGN="RIGHT">-</TE>
<TE WIDTH="63" HEIGHT="30" ACODE="BAS_NAM3" VALIGN="MIDDLE" ALIGN="CENTER">-</TE>
<TE WIDTH="71" HEIGHT="30" ACODE="BAS_RAT3" VALIGN="MIDDLE" ALIGN="RIGHT">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TU WIDTH="137" HEIGHT="30" AUNIT="BAS_DATE" AUNITVALUE="20200731" VALIGN="MIDDLE" ALIGN="CENTER">2020년 07월 31일</TU>
<TE WIDTH="63" HEIGHT="30" ACODE="BAS_NAM1" VALIGN="MIDDLE" ALIGN="CENTER">김은석</TE>
<TE WIDTH="71" HEIGHT="30" ACODE="BAS_RAT1" VALIGN="MIDDLE" ALIGN="RIGHT">0.43</TE>
<TE WIDTH="64" HEIGHT="30" ACODE="BAS_NAM2" VALIGN="MIDDLE" ALIGN="CENTER">-</TE>
<TE WIDTH="71" HEIGHT="30" ACODE="BAS_RAT2" VALIGN="MIDDLE" ALIGN="RIGHT">-</TE>
<TE WIDTH="63" HEIGHT="30" ACODE="BAS_NAM3" VALIGN="MIDDLE" ALIGN="CENTER">-</TE>
<TE WIDTH="71" HEIGHT="30" ACODE="BAS_RAT3" VALIGN="MIDDLE" ALIGN="RIGHT">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TU WIDTH="137" HEIGHT="30" AUNIT="BAS_DATE" AUNITVALUE="20200831" VALIGN="MIDDLE" ALIGN="CENTER">2020년 08월 31일</TU>
<TE WIDTH="63" HEIGHT="30" ACODE="BAS_NAM1" VALIGN="MIDDLE" ALIGN="CENTER">김은석</TE>
<TE WIDTH="71" HEIGHT="30" ACODE="BAS_RAT1" VALIGN="MIDDLE" ALIGN="RIGHT">0.45</TE>
<TE WIDTH="64" HEIGHT="30" ACODE="BAS_NAM2" VALIGN="MIDDLE" ALIGN="CENTER">-</TE>
<TE WIDTH="71" HEIGHT="30" ACODE="BAS_RAT2" VALIGN="MIDDLE" ALIGN="RIGHT">-</TE>
<TE WIDTH="63" HEIGHT="30" ACODE="BAS_NAM3" VALIGN="MIDDLE" ALIGN="CENTER">-</TE>
<TE WIDTH="71" HEIGHT="30" ACODE="BAS_RAT3" VALIGN="MIDDLE" ALIGN="RIGHT">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TU WIDTH="137" HEIGHT="30" AUNIT="BAS_DATE" AUNITVALUE="20201031" VALIGN="MIDDLE" ALIGN="CENTER">2020년 10월 31일</TU>
<TE WIDTH="63" HEIGHT="30" ACODE="BAS_NAM1" VALIGN="MIDDLE" ALIGN="CENTER">김은석</TE>
<TE WIDTH="71" HEIGHT="30" ACODE="BAS_RAT1" VALIGN="MIDDLE" ALIGN="RIGHT">0.68</TE>
<TE WIDTH="64" HEIGHT="30" ACODE="BAS_NAM2" VALIGN="MIDDLE" ALIGN="CENTER">-</TE>
<TE WIDTH="71" HEIGHT="30" ACODE="BAS_RAT2" VALIGN="MIDDLE" ALIGN="RIGHT">-</TE>
<TE WIDTH="63" HEIGHT="30" ACODE="BAS_NAM3" VALIGN="MIDDLE" ALIGN="CENTER">김수지</TE>
<TE WIDTH="71" HEIGHT="30" ACODE="BAS_RAT3" VALIGN="MIDDLE" ALIGN="RIGHT">9.70</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TU WIDTH="137" HEIGHT="30" AUNIT="BAS_DATE" AUNITVALUE="20201130" VALIGN="MIDDLE" ALIGN="CENTER">2020년 11월 30일</TU>
<TE WIDTH="63" HEIGHT="30" ACODE="BAS_NAM1" VALIGN="MIDDLE" ALIGN="CENTER">김은석</TE>
<TE WIDTH="71" HEIGHT="30" ACODE="BAS_RAT1" VALIGN="MIDDLE" ALIGN="RIGHT">0.70</TE>
<TE WIDTH="64" HEIGHT="30" ACODE="BAS_NAM2" VALIGN="MIDDLE" ALIGN="CENTER">-</TE>
<TE WIDTH="71" HEIGHT="30" ACODE="BAS_RAT2" VALIGN="MIDDLE" ALIGN="RIGHT">-</TE>
<TE WIDTH="63" HEIGHT="30" ACODE="BAS_NAM3" VALIGN="MIDDLE" ALIGN="CENTER">김수지</TE>
<TE WIDTH="71" HEIGHT="30" ACODE="BAS_RAT3" VALIGN="MIDDLE" ALIGN="RIGHT">9.72</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TU WIDTH="137" HEIGHT="30" AUNIT="BAS_DATE" AUNITVALUE="20201231" VALIGN="MIDDLE" ALIGN="CENTER">2020년 12월 31일</TU>
<TE WIDTH="63" HEIGHT="30" ACODE="BAS_NAM1" VALIGN="MIDDLE" ALIGN="CENTER">김은석</TE>
<TE WIDTH="71" HEIGHT="30" ACODE="BAS_RAT1" VALIGN="MIDDLE" ALIGN="RIGHT">0.71</TE>
<TE WIDTH="64" HEIGHT="30" ACODE="BAS_NAM2" VALIGN="MIDDLE" ALIGN="CENTER">-</TE>
<TE WIDTH="71" HEIGHT="30" ACODE="BAS_RAT2" VALIGN="MIDDLE" ALIGN="RIGHT">-</TE>
<TE WIDTH="63" HEIGHT="30" ACODE="BAS_NAM3" VALIGN="MIDDLE" ALIGN="CENTER">김수지</TE>
<TE WIDTH="71" HEIGHT="30" ACODE="BAS_RAT3" VALIGN="MIDDLE" ALIGN="RIGHT">9.75</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
</LIBRARY>
</INSERTION>
<P USERMARK="F-GL11">주) 최대주주인 대화제약주식회사가 2019년 3월 29일 발행한 전환사채 200억원 중 2020년 9월 51억원이 전환청구되어 총 발행주식 총수가 18,224,974주에서 18,569,379주로 변경 되어 상기 지분율은 변경된 발행주식 통수로 산정.&cr;</P>
<P USERMARK="F-GL11 B">라. 최대주주(법인 또는 단체)의 최근 결산기 재무현황</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="Y" WIDTH="600" BORDER="0">

<COLGROUP>
<COL WIDTH="291"></COL>
<COL WIDTH="291"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="300" HEIGHT="30" AUPDATECONT="N" VALIGN="MIDDLE"></TD>
<TD WIDTH="300" HEIGHT="30" AUPDATECONT="N" VALIGN="MIDDLE" ALIGN="RIGHT">(단위 : 백만원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE-GROUP ACLASS="THD_ASN_FIN" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="598" BORDER="1">

<COLGROUP>
<COL WIDTH="290"></COL>
<COL WIDTH="290"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="N" ADELETE="N">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="299" HEIGHT="30" AUPDATECONT="N" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">구    분</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="299" HEIGHT="30" AUPDATECONT="N" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N"></TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="299" HEIGHT="30" AUPDATECONT="N">법인 또는 단체의 명칭</TD>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="299" HEIGHT="30" ACODE="FIN_NAME">대화제약(주)</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="299" HEIGHT="30" AUPDATECONT="N">자산총계</TD>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="299" HEIGHT="30" ACODE="FIN_AST">155,709</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="299" HEIGHT="30" AUPDATECONT="N">부채총계</TD>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="299" HEIGHT="30" ACODE="FIN_DEB">70,214</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="299" HEIGHT="30" AUPDATECONT="N">자본총계</TD>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="299" HEIGHT="30" ACODE="FIN_CAP">85,495</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="299" HEIGHT="30" AUPDATECONT="N">매출액</TD>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="299" HEIGHT="30" ACODE="FIN_SAL">82,325</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="299" HEIGHT="30" AUPDATECONT="N">영업이익</TD>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="299" HEIGHT="30" ACODE="FIN_BUF">4,611</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="299" HEIGHT="30" AUPDATECONT="N">당기순이익</TD>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="299" HEIGHT="30" ACODE="FIN_PRF">-554</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
<P USERMARK="F-GL11">주) 2020년말 별도 재무제표입니다&cr;</P>

<P>
<SPAN USERMARK="F-DU B">마. 최대주주 사업현황&cr;&cr;</SPAN>
<SPAN USERMARK="F-DU">(1) 사업현황 등 회사 경영 안정성에 영향을 미칠 수 있는 주요 내용</SPAN>
<SPAN USERMARK="F-GL11">&cr;&cr;</SPAN>
<SPAN USERMARK="F-GL11">당사 최대주주인 대화제약(주)는 1984년 01월 19일에 설립되었으며, 2003년 2월14일에 코스닥시장에 상장되었습니다. 보고서 작성 기준일 현재 영위하고 있는 주요사업은 의약품 및 의약부외품을 제조 및 판매부문과 완제의약품을 공급받아 유통하는 의약품 도매업 부문으로 구성되어 있습니다. 그리고 경영 안정성에 영향을 미칠 수 있는 주요 내용은 공시일 기준 현재 없습니다.&cr;</SPAN>
</P>

<P>
<SPAN USERMARK="F-11">▶</SPAN>
<SPAN USERMARK="F-11 B">최대주주의 현황</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="635">

<COLGROUP>
<COL WIDTH="113"></COL>
<COL WIDTH="504"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="122" VALIGN="MIDDLE" HEIGHT="30">법인명</TD>
<TD WIDTH="513" VALIGN="MIDDLE" HEIGHT="30">대화제약㈜</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="122" VALIGN="MIDDLE" HEIGHT="30">대표자</TD>
<TD WIDTH="513" VALIGN="MIDDLE" HEIGHT="30">노병태, 김은석(각자 대표)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="122" VALIGN="MIDDLE" HEIGHT="30">설립일</TD>
<TD WIDTH="513" VALIGN="MIDDLE" HEIGHT="30">1984년 1월</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="122" VALIGN="MIDDLE" HEIGHT="30">결산기</TD>
<TD WIDTH="513" VALIGN="MIDDLE" HEIGHT="30">12월</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="122" VALIGN="MIDDLE" HEIGHT="30">업종</TD>
<TD WIDTH="513" VALIGN="MIDDLE" HEIGHT="30">의약품 및 의약부외품 외 제조 및 판매업</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="122" VALIGN="MIDDLE" HEIGHT="30">상장여부</TD>
<TD WIDTH="513" VALIGN="MIDDLE" HEIGHT="30">코스닥증권시장 상장</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="122" VALIGN="MIDDLE" HEIGHT="30">회사와의관계</TD>
<TD WIDTH="513" VALIGN="MIDDLE" HEIGHT="30">최대주주</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="122" VALIGN="MIDDLE" HEIGHT="76">주요사업의 내용</TD>
<TD WIDTH="513" VALIGN="MIDDLE" HEIGHT="76">최대주주는 의약품 및 의약부외품을 제조 및 판매하는 의약품 제조 판매부문과 완제의약품을 공급받아 유통하는 의약품 도매업 부문이 주요 사업부문으로 구성되어 있습니다.</TD>
</TR>
</TBODY>
</TABLE>
<P>&cr;</P>

<P>
<SPAN USERMARK="F-16 0XC00000 B">2. 최대주주 변동내역</SPAN>
<SPAN USERMARK="F-16 0XC00000 B"></SPAN>
</P>
</LIBRARY>
</INSERTION>
<P></P>

<INSERTION ABASISNUMBER="LE0" AFREQUENCY="0" ADUPLICATION="Y">
<COMMENT>◆복수click가능◆『최대주주의 최대주주(최대출자자)가 법인 또는 단체인 경우』 삽입</COMMENT>
<LIBRARYLIST>11011#*최대주주의최대출자자가단체인경우.dsl</LIBRARYLIST>
</INSERTION>

<INSERTION ABASISNUMBER="SE1" AFREQUENCY="1" ADUPLICATION="N">
<COMMENT>◆click◆『최대주주 변동내역』 삽입</COMMENT>
<LIBRARYLIST>11011#*최대주주변동내역.dsl</LIBRARYLIST>

<LIBRARY>
<FILENAME ATYPE="dsl">8_최대주주변동내역</FILENAME>

<TABLE-GROUP ACLASS="BSH_CHA" ADELETETABLE="N">
<TITLE ATOC="N"></TITLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="Y" WIDTH="575" BORDER="0">

<COLGROUP>
<COL WIDTH="69"></COL>
<COL WIDTH="140"></COL>
<COL WIDTH="65"></COL>
<COL WIDTH="265"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD VALIGN="BOTTOM" WIDTH="78" HEIGHT="30" AUPDATECONT="N">(기준일 : </TD>
<TU ALIGN="CENTER" VALIGN="BOTTOM" WIDTH="149" HEIGHT="30" AUNIT="BASE_DT" AUNITVALUE="20201231">2020년 12월 31일</TU>
<TD VALIGN="BOTTOM" WIDTH="74" HEIGHT="30" AUPDATECONT="N">)</TD>
<TU ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="274" HEIGHT="30" AUNIT="STOCKPERCENT" AUNITVALUE="1">(단위 : 주, %)</TU>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="573" BORDER="1">

<COLGROUP>
<COL WIDTH="83"></COL>
<COL WIDTH="84"></COL>
<COL WIDTH="84"></COL>
<COL WIDTH="70"></COL>
<COL WIDTH="154"></COL>
<COL WIDTH="44"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="N" ADELETE="N">
<TH WIDTH="92" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">변동일</TH>
<TH WIDTH="93" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">최대주주명</TH>
<TH WIDTH="93" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">소유주식수</TH>
<TH WIDTH="79" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">지분율</TH>
<TH WIDTH="163" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">변동원인</TH>
<TH WIDTH="53" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">비 고</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="N">
<TU WIDTH="92" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUNIT="BSH_DATE" AUNITVALUE="20100830">2010.08.30</TU>
<TE WIDTH="93" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="BSH_NAME">이광진</TE>
<TE WIDTH="93" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="BSH_CNT">11,200 </TE>
<TE WIDTH="79" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="BSH_RATE">56.00% </TE>
<TE WIDTH="163" VALIGN="MIDDLE" HEIGHT="30" ACODE="BSH_RSN">설립</TE>
<TE WIDTH="53" VALIGN="MIDDLE" HEIGHT="30" ACODE="NOTE">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TU WIDTH="92" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUNIT="BSH_DATE" AUNITVALUE="20101106">2010.11.06</TU>
<TE WIDTH="93" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="BSH_NAME">이광진</TE>
<TE WIDTH="93" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="BSH_CNT">14,600 </TE>
<TE WIDTH="79" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="BSH_RATE">62.39% </TE>
<TE WIDTH="163" VALIGN="MIDDLE" HEIGHT="30" ACODE="BSH_RSN">유상증자</TE>
<TE WIDTH="53" VALIGN="MIDDLE" HEIGHT="30" ACODE="NOTE">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TU WIDTH="92" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUNIT="BSH_DATE" AUNITVALUE="20111231">2011.12.31</TU>
<TE WIDTH="93" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="BSH_NAME">김성호</TE>
<TE WIDTH="93" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="BSH_CNT">29,532 </TE>
<TE WIDTH="79" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="BSH_RATE">35.41% </TE>
<TE WIDTH="163" VALIGN="MIDDLE" HEIGHT="30" ACODE="BSH_RSN">유상증자</TE>
<TE WIDTH="53" VALIGN="MIDDLE" HEIGHT="30" ACODE="NOTE">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TU WIDTH="92" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUNIT="BSH_DATE" AUNITVALUE="20120621">2012.06.21</TU>
<TE WIDTH="93" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="BSH_NAME">김성호</TE>
<TE WIDTH="93" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="BSH_CNT">30,732 </TE>
<TE WIDTH="79" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="BSH_RATE">32.83% </TE>
<TE WIDTH="163" VALIGN="MIDDLE" HEIGHT="30" ACODE="BSH_RSN">유상증자</TE>
<TE WIDTH="53" VALIGN="MIDDLE" HEIGHT="30" ACODE="NOTE">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TU WIDTH="92" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUNIT="BSH_DATE" AUNITVALUE="20130822">2013.08.22</TU>
<TE WIDTH="93" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="BSH_NAME">대화제약㈜</TE>
<TE WIDTH="93" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="BSH_CNT">93,600 </TE>
<TE WIDTH="79" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="BSH_RATE">100.00% </TE>
<TE WIDTH="163" VALIGN="MIDDLE" HEIGHT="30" ACODE="BSH_RSN">주식양수</TE>
<TE WIDTH="53" VALIGN="MIDDLE" HEIGHT="30" ACODE="NOTE">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TU WIDTH="92" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUNIT="BSH_DATE" AUNITVALUE="20141223">2014.12.23</TU>
<TE WIDTH="93" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="BSH_NAME">대화제약㈜</TE>
<TE WIDTH="93" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="BSH_CNT">300,000 </TE>
<TE WIDTH="79" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="BSH_RATE">100.00% </TE>
<TE WIDTH="163" VALIGN="MIDDLE" HEIGHT="30" ACODE="BSH_RSN">유상증자</TE>
<TE WIDTH="53" VALIGN="MIDDLE" HEIGHT="30" ACODE="NOTE">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TU WIDTH="92" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUNIT="BSH_DATE" AUNITVALUE="20160504">2016.05.04</TU>
<TE WIDTH="93" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="BSH_NAME">대화제약㈜</TE>
<TE WIDTH="93" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="BSH_CNT">600,000 </TE>
<TE WIDTH="79" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="BSH_RATE">100.00% </TE>
<TE WIDTH="163" VALIGN="MIDDLE" HEIGHT="30" ACODE="BSH_RSN">유상증자</TE>
<TE WIDTH="53" VALIGN="MIDDLE" HEIGHT="30" ACODE="NOTE">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TU WIDTH="92" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUNIT="BSH_DATE" AUNITVALUE="20160829">2016.08.29</TU>
<TE WIDTH="93" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="BSH_NAME">대화제약㈜</TE>
<TE WIDTH="93" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="BSH_CNT">14,665,370</TE>
<TE WIDTH="79" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="BSH_RATE">100.00% </TE>
<TE WIDTH="163" VALIGN="MIDDLE" HEIGHT="30" ACODE="BSH_RSN">현물출자 및 주식분할</TE>
<TE WIDTH="53" VALIGN="MIDDLE" HEIGHT="30" ACODE="NOTE">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TU WIDTH="92" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUNIT="BSH_DATE" AUNITVALUE="20161216">2016.12.16</TU>
<TE WIDTH="93" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="BSH_NAME">대화제약㈜</TE>
<TE WIDTH="93" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="BSH_CNT">15,507,370</TE>
<TE WIDTH="79" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="BSH_RATE">63.01%</TE>
<TE WIDTH="163" VALIGN="MIDDLE" HEIGHT="30" ACODE="BSH_RSN">유상증자</TE>
<TE WIDTH="53" VALIGN="MIDDLE" HEIGHT="30" ACODE="NOTE">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TU WIDTH="92" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUNIT="BSH_DATE" AUNITVALUE="20171124">2017.11.24</TU>
<TE WIDTH="93" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="BSH_NAME">대화제약㈜</TE>
<TE WIDTH="93" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="BSH_CNT">15,857,370</TE>
<TE WIDTH="79" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="BSH_RATE">64.44%</TE>
<TE WIDTH="163" VALIGN="MIDDLE" HEIGHT="30" ACODE="BSH_RSN">특수관계인증가</TE>
<TE WIDTH="53" VALIGN="MIDDLE" HEIGHT="30" ACODE="NOTE">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TU WIDTH="92" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUNIT="BSH_DATE" AUNITVALUE="20180801">2018.08.01</TU>
<TE WIDTH="93" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="BSH_NAME">대화제약㈜</TE>
<TE WIDTH="93" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="BSH_CNT">15,897,370</TE>
<TE WIDTH="79" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="BSH_RATE">64.60%</TE>
<TE WIDTH="163" VALIGN="MIDDLE" HEIGHT="30" ACODE="BSH_RSN">최대주주인증가</TE>
<TE WIDTH="53" VALIGN="MIDDLE" HEIGHT="30" ACODE="NOTE">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TU WIDTH="92" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUNIT="BSH_DATE" AUNITVALUE="20191231">2019.12.31</TU>
<TE WIDTH="93" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="BSH_NAME">대화제약㈜</TE>
<TE WIDTH="93" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="BSH_CNT">15,932,870</TE>
<TE WIDTH="79" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="BSH_RATE">64.74%</TE>
<TE WIDTH="163" VALIGN="MIDDLE" HEIGHT="30" ACODE="BSH_RSN">최대주주인증가</TE>
<TE WIDTH="53" VALIGN="MIDDLE" HEIGHT="30" ACODE="NOTE">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TU WIDTH="92" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUNIT="BSH_DATE" AUNITVALUE="20200331">2020.03.31</TU>
<TE WIDTH="93" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="BSH_NAME">대화제약㈜</TE>
<TE WIDTH="93" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="BSH_CNT">15,958,290</TE>
<TE WIDTH="79" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="BSH_RATE">64.84%</TE>
<TE WIDTH="163" VALIGN="MIDDLE" HEIGHT="30" ACODE="BSH_RSN">최대주주인증가</TE>
<TE WIDTH="53" VALIGN="MIDDLE" HEIGHT="30" ACODE="NOTE">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TU WIDTH="92" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUNIT="BSH_DATE" AUNITVALUE="20200630">2020.06.30</TU>
<TE WIDTH="93" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="BSH_NAME">대화제약㈜</TE>
<TE WIDTH="93" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="BSH_CNT">15,962,010</TE>
<TE WIDTH="79" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="BSH_RATE">64.85%</TE>
<TE WIDTH="163" VALIGN="MIDDLE" HEIGHT="30" ACODE="BSH_RSN">최대주주인증가</TE>
<TE WIDTH="53" VALIGN="MIDDLE" HEIGHT="30" ACODE="NOTE">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TU WIDTH="92" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUNIT="BSH_DATE" AUNITVALUE="20200930">2020.09.30</TU>
<TE WIDTH="93" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="BSH_NAME">대화제약㈜</TE>
<TE WIDTH="93" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="BSH_CNT">15,981,830</TE>
<TE WIDTH="79" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="BSH_RATE">64.94%</TE>
<TE WIDTH="163" VALIGN="MIDDLE" HEIGHT="30" ACODE="BSH_RSN">최대주주인증가</TE>
<TE WIDTH="53" VALIGN="MIDDLE" HEIGHT="30" ACODE="NOTE">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TU WIDTH="92" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUNIT="BSH_DATE" AUNITVALUE="20201231">2020.12.31</TU>
<TE WIDTH="93" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="BSH_NAME">대화제약㈜</TE>
<TE WIDTH="93" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="BSH_CNT">16,012,180</TE>
<TE WIDTH="79" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="BSH_RATE">65.06%</TE>
<TE WIDTH="163" VALIGN="MIDDLE" HEIGHT="30" ACODE="BSH_RSN">최대주주인증가</TE>
<TE WIDTH="53" VALIGN="MIDDLE" HEIGHT="30" ACODE="NOTE">-</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>

<P>
<SPAN USERMARK="F-GL11">■ 2016년 08월 29일 지배회사인 대화제약(주)의 현물투자로 866,537주가 증가하였으며 주식 분할(액면가 5,000원 -> 500원)하여 14,665,370주로 변경됨.&cr;■ 2016년 12월 16일 제3자배정 유상증자를 통하여 지분율이 63.01% 변경됨.&cr;</SPAN>
<SPAN USERMARK="F-GL11">■ 2017년 11월 24일 특수관계인증가를 통하여 지분율이 64.44% 변경됨</SPAN>
<SPAN USERMARK="F-GL11">.(</SPAN>
<SPAN USERMARK="F-GL11 U">최대주주인 대화제약(주)의 지분 14,665,370주, 59.59%와 특수관계인의 지분 </SPAN>
<SPAN USERMARK="F-GL11 U">1,192,000주, 4.85%</SPAN>
<SPAN USERMARK="F-GL11 U"> 포함</SPAN>
<SPAN USERMARK="F-GL11">), 리독스바이오의 발행 주식 총수는 24,611,870주임.&cr;</SPAN>
<SPAN USERMARK="F-GL11">■ 2018년 08월 01일 최대주주인지분증가를 통하여 지분율이 64.6% 변경됨</SPAN>
<SPAN USERMARK="F-GL11">.(</SPAN>
<SPAN USERMARK="F-GL11 U">최대주주인 대화제약(주)의 지분 14,715,370주, 59.79%와 특수관계인의 지분 </SPAN>
<SPAN USERMARK="F-GL11 U">1,182,000주, 4.81%</SPAN>
<SPAN USERMARK="F-GL11 U"> 포함</SPAN>
<SPAN USERMARK="F-GL11">), 리독스바이오의 발행 주식 총수는 24,611,870주임.&cr;</SPAN>
<SPAN USERMARK="F-GL11"></SPAN>
<SPAN USERMARK="F-GL11"></SPAN>
<SPAN USERMARK="F-GL11"></SPAN>
<SPAN USERMARK="F-GL11">■ 2019년 12월 31일 최대주주인지분증가를 통하여 지분율이 64.74% 변경됨</SPAN>
<SPAN USERMARK="F-GL11"></SPAN>
<SPAN USERMARK="F-GL11">.(</SPAN>
<SPAN USERMARK="F-GL11 U">최대주주인 대화제약(주)의 지분 14,721,830주, 59.82%와 특수관계인의 지분 </SPAN>
<SPAN USERMARK="F-GL11 U">1,211,040주, 4.92%</SPAN>
<SPAN USERMARK="F-GL11 U"> 포함</SPAN>
<SPAN USERMARK="F-GL11">), 리독스바이오의 발행 주식 총수는 24,611,870주임.</SPAN>
<SPAN USERMARK="F-GL11"></SPAN>
<SPAN USERMARK="F-GL11"></SPAN>
<SPAN USERMARK="F-GL11"></SPAN>
<SPAN USERMARK="F-GL11"></SPAN>
<SPAN USERMARK="F-GL11 B"></SPAN>
<SPAN USERMARK="F-GL11"></SPAN>
<SPAN USERMARK="F-GL11">&cr;■ 2020년 12월 31일 최대주주인지분증가를 통하여 지분율이 65.06% 변경됨</SPAN>
<SPAN USERMARK="F-GL11"></SPAN>
<SPAN USERMARK="F-GL11">.(</SPAN>
<SPAN USERMARK="F-GL11 U">최대주주인 대화제약(주)의 지분 14,810,770, 60.18%와 특수관계인의 지분 </SPAN>
<SPAN USERMARK="F-GL11 U">1,201.410주, 4.88%</SPAN>
<SPAN USERMARK="F-GL11 U"> 포함</SPAN>
<SPAN USERMARK="F-GL11">), 리독스바이오의 발행 주식 총수는 24,611,870주임.</SPAN>
<SPAN USERMARK="F-GL11"></SPAN>
<SPAN USERMARK="F-GL11"></SPAN>
<SPAN USERMARK="F-GL11"></SPAN>
<SPAN USERMARK="F-GL11"></SPAN>
<SPAN USERMARK="F-GL11">&cr;</SPAN>
</P>
</LIBRARY>
</INSERTION>

<P>
<SPAN USERMARK="F-16 0XC00000 B">3. 주</SPAN>
<SPAN USERMARK="F-16 0XC00000 B">식의 분포</SPAN>
<SPAN USERMARK="F-16">&cr;</SPAN>&cr;
<SPAN USERMARK="F-GL11 B">가. 주식 소유현황</SPAN>
</P>

<TABLE-GROUP ACLASS="SH5_PRE_STT" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="Y" WIDTH="601" BORDER="0">

<COLGROUP>
<COL WIDTH="70"></COL>
<COL WIDTH="142"></COL>
<COL WIDTH="63"></COL>
<COL WIDTH="290"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD VALIGN="BOTTOM" WIDTH="79" HEIGHT="30" AUPDATECONT="N">(기준일 : </TD>
<TU ALIGN="CENTER" VALIGN="BOTTOM" WIDTH="151" HEIGHT="30" AUNIT="BASE_DT" AUNITVALUE="20201231">2020년 12월 31일</TU>
<TD VALIGN="BOTTOM" WIDTH="72" HEIGHT="30" AUPDATECONT="N">)</TD>
<TU ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="299" HEIGHT="30" AUNIT="STOCK" AUNITVALUE="1">(단위 : 주)</TU>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="602" BORDER="1">

<COLGROUP>
<COL WIDTH="111"></COL>
<COL WIDTH="174"></COL>
<COL WIDTH="114"></COL>
<COL WIDTH="72"></COL>
<COL WIDTH="86"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="N" ADELETE="N">
<TH WIDTH="120" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">구분</TH>
<TH WIDTH="183" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">주주명</TH>
<TH WIDTH="123" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">소유주식수</TH>
<TH WIDTH="81" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">지분율</TH>
<TH WIDTH="95" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">비고</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="120" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60" ROWSPAN="2" AUPDATECONT="N">5% 이상 주주</TD>
<TE WIDTH="183" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="SH5_NM">대화제약(주)</TE>
<TE WIDTH="123" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="SH5_TOT_CNT">14,810,770</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="SH5_TOT_RT">60.18%</TE>
<TD WIDTH="95" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="N">
<TE WIDTH="183" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="SH5_NM">-</TE>
<TE WIDTH="123" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="SH5_TOT_CNT">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="SH5_TOT_RT">-</TE>
<TD WIDTH="95" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="303" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" COLSPAN="2" AUPDATECONT="N">우리사주조합</TD>
<TE WIDTH="123" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="SH5_WOO_CNT">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="SH5_WOO_RT">-</TE>
<TD WIDTH="95" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">-</TD>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>

<P>&cr;
<SPAN USERMARK="F-GL11 B">나. 소액주주현황</SPAN>
</P>

<INSERTION ABASISNUMBER="SE1" AFREQUENCY="1" ADUPLICATION="N">
<COMMENT>◆click◆『소액주주현황』 삽입</COMMENT>
<LIBRARYLIST>11011#*소액주주현황.dsl</LIBRARYLIST>

<LIBRARY>
<FILENAME ATYPE="dsl">10_소액주주현황</FILENAME>

<TABLE-GROUP ACLASS="SH4_PRE_STT" ADELETETABLE="N">
<TITLE ATOC="N"></TITLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="Y" WIDTH="543" BORDER="0">

<COLGROUP>
<COL WIDTH="70"></COL>
<COL WIDTH="142"></COL>
<COL WIDTH="58"></COL>
<COL WIDTH="237"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD VALIGN="BOTTOM" WIDTH="79" HEIGHT="30" AUPDATECONT="N">(기준일 : </TD>
<TU ALIGN="CENTER" VALIGN="BOTTOM" WIDTH="151" HEIGHT="30" AUNIT="BASE_DT" AUNITVALUE="20201231">2020년 12월 31일</TU>
<TD VALIGN="BOTTOM" WIDTH="67" HEIGHT="30" AUPDATECONT="N">)</TD>
<TU ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="246" HEIGHT="30" AUNIT="STOCK" AUNITVALUE="1">(단위 : 주)</TU>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="543" BORDER="1">

<COLGROUP>
<COL WIDTH="69"></COL>
<COL WIDTH="54"></COL>
<COL WIDTH="54"></COL>
<COL WIDTH="46"></COL>
<COL WIDTH="75"></COL>
<COL WIDTH="83"></COL>
<COL WIDTH="46"></COL>
<COL WIDTH="44"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="N" ADELETE="N">
<TH WIDTH="78" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="83" ROWSPAN="2">구 분</TH>
<TH WIDTH="181" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30" COLSPAN="3">주주</TH>
<TH WIDTH="231" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30" COLSPAN="3">소유주식</TH>
<TH WIDTH="53" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="83" ROWSPAN="2">비 고</TH>
</TR>

<TR ACOPY="N" ADELETE="N">
<TH WIDTH="63" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53">소액&cr;주주수</TH>
<TH WIDTH="63" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53">전체&cr;주주수</TH>
<TH WIDTH="55" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53">비율&cr;(%)</TH>
<TH WIDTH="84" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53">소액&cr;주식수</TH>
<TH WIDTH="92" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53">총발행&cr;주식수</TH>
<TH WIDTH="55" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53">비율&cr;(%)</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUPDATECONT="N">소액주주</TD>
<TE WIDTH="63" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="SH4_JJ_CNT">349</TE>
<TE WIDTH="63" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="SH4_JJ_CNTT">356</TE>
<TE WIDTH="55" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="SH4_JJ_RT">98.03</TE>
<TE WIDTH="84" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="SH4_BB_CNT">8,599,690</TE>
<TE WIDTH="92" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="SH4_BB_CNTT">24,611,870</TE>
<TE WIDTH="55" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="SH4_BB_RT">34.94</TE>
<TE WIDTH="53" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="NOTE">-</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>

<P>
<SPAN USERMARK="F-GL11 B">&cr;다. 주식사무</SPAN>
</P>
</LIBRARY>
</INSERTION>

<TABLE BORDER="1" WIDTH="655" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="178"></COL>
<COL WIDTH="122"></COL>
<COL WIDTH="122"></COL>
<COL WIDTH="197"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="187" VALIGN="MIDDLE" HEIGHT="513">정관상 신주인수권의 내용</TD>
<TD COLSPAN="3" WIDTH="468" HEIGHT="513">제10조 (신주인수권)&cr;① 주주는 그가 소유한 주식의 수에 비례하여 신주의 배정을 받을       권리를 가진다.&cr;② 회사는 제1항의 규정에도 불구하고 다음 각 호의 어느 하나에        해 당하는 경우 이사회의 결의로 주주이외의 자에게 신주를 배       정할 수 있다.&cr;   1. 이사회 결의로 일반공모증자방식으로 신주를 발행하는 경우&cr;   2. 우리사주조합원에게 신주를 우선하여 배정하는 경우&cr;   3. 주식매수선택권의 행사로 인하여 신주를 발행하는 경우&cr;   4. 자본시장과 금융투자업에 관한 법률 규정에 의하여 주식예탁&cr;       증서 발행에 따라 신주를 발행하는 경우&cr;   5. 회사의 경영상 필요로 외국의 합작법인에게 신주를 발행하는&cr;       경우&cr;   6. 긴급한 자급의 조달을 위하여 국내외의 금융기관(기간투자가 &cr;      및 각종 연기금 포함) 및 국내, 외국인, 법인, 개인 투자자에게 &cr;      신주를 발행하는 경우&cr;   7. 상법 제418조 제2항의 규정에 따라 신기술의 도입, 재무구조의&cr;      개산등 회사의 경영상 목적을 달성하기 위하여 필요한 경우&cr;   8. 회사가 경영상 긴급자금을 필요로 해 전환사채에 발행에 따른&cr;      신주를 발행하는 경우&cr;③ 주주가 신주인수권을 포기 또는 상실하거나,주주 배정에서 단주&cr;   가 발행하는 경우에는 그 처리방법은 이사회에서 정한다.</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="187" VALIGN="MIDDLE" HEIGHT="53">결 산 일</TD>
<TD WIDTH="131" VALIGN="MIDDLE" HEIGHT="53">12월 31일</TD>
<TD WIDTH="131" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">정기주주총회</TD>
<TD WIDTH="206" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">사업연도 종료 후 3개월 이내</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="187" VALIGN="MIDDLE" HEIGHT="30">주주명부폐쇄시기</TD>
<TD COLSPAN="3" WIDTH="468" VALIGN="MIDDLE" HEIGHT="30">1월 1일 ~ 1월 31일까지(정기주주총회)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="187" VALIGN="MIDDLE" HEIGHT="30">주권의 종류</TD>
<TD COLSPAN="3" WIDTH="468" VALIGN="MIDDLE" HEIGHT="30">보통주</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="187" VALIGN="MIDDLE" HEIGHT="30">명의개서대리인</TD>
<TD COLSPAN="3" WIDTH="468" VALIGN="MIDDLE" HEIGHT="30">하나은행증권대행부(02-368-5850)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="187" VALIGN="MIDDLE" HEIGHT="30">주주의 특전</TD>
<TD WIDTH="131" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">-</TD>
<TD WIDTH="131" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">공고게재</TD>
<TD WIDTH="206" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">www.redoxbio.co.kr</TD>
</TR>
</TBODY>
</TABLE>
<P></P>
<PGBRK></PGBRK>
</SECTION-1>

<SECTION-1 ACLASS="MANDATORY" APARTSOURCE="SOURCE">
<TITLE ATOC="Y">VIII. 임원 및 직원 등에 관한 사항</TITLE>

<SECTION-2 ACLASS="MANDATORY">
<TITLE ATOC="Y" AASSOCNOTE="D-0-8-1-0">1. 임원 및 직원 등의 현황</TITLE>

<P>
<SPAN USERMARK="F-GL11 B">&cr;가. 임원의 현황&cr;</SPAN>
<SPAN USERMARK="F-GL11">당사의 임원은 보고서 작성 기준일 현재 총 10명으로 등기임원은 5명, 미등기임원 5명입니다. 이중 이한구,한권석이 각자 대표를 맡고 있습니다.</SPAN>
</P>

<TABLE-GROUP ACLASS="SH5_DRCT_STT" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="Y" WIDTH="1434" BORDER="0">

<COLGROUP>
<COL WIDTH="71"></COL>
<COL WIDTH="143"></COL>
<COL WIDTH="99"></COL>
<COL WIDTH="1085"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD VALIGN="BOTTOM" WIDTH="80" HEIGHT="30" AUPDATECONT="N">(기준일 : </TD>
<TU ALIGN="CENTER" VALIGN="BOTTOM" WIDTH="152" HEIGHT="30" AUNIT="BASE_DT" AUNITVALUE="20201231">2020년 12월 31일</TU>
<TD VALIGN="BOTTOM" WIDTH="108" HEIGHT="30" AUPDATECONT="N">)</TD>
<TU ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1094" HEIGHT="30" AUNIT="STOCK" AUNITVALUE="1">(단위 : 주)</TU>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="1436" BORDER="1" FRAME="BORDER" RULES="ALL">

<COLGROUP>
<COL WIDTH="54"></COL>
<COL WIDTH="39"></COL>
<COL WIDTH="92"></COL>
<COL WIDTH="99"></COL>
<COL WIDTH="84"></COL>
<COL WIDTH="54"></COL>
<COL WIDTH="170"></COL>
<COL WIDTH="269"></COL>
<COL WIDTH="74"></COL>
<COL WIDTH="74"></COL>
<COL WIDTH="99"></COL>
<COL WIDTH="83"></COL>
<COL WIDTH="128"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="N" ADELETE="N">
<TH ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="83" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">성명</TH>
<TH ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="48" HEIGHT="83" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">성별</TH>
<TH ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="101" HEIGHT="83" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">출생년월</TH>
<TH ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="108" HEIGHT="83" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">직위</TH>
<TH ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="93" HEIGHT="83" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">등기임원&cr;여부</TH>
<TH ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="83" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">상근&cr;여부</TH>
<TH ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="179" HEIGHT="83" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">담당&cr;업무</TH>
<TH ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="278" HEIGHT="83" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">주요경력</TH>
<TH COLSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="166" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">소유주식수</TH>
<TH ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="108" HEIGHT="83" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">최대주주와의&cr;관계</TH>
<TH ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="92" HEIGHT="83" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">재직기간</TH>
<TH ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="137" HEIGHT="83" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">임기&cr;만료일</TH>
</TR>

<TR ACOPY="N" ADELETE="N">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="83" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">의결권&cr;있는 주식</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="83" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">의결권&cr;없는 주식</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="N">
<TE ALIGN="CENTER" WIDTH="63" HEIGHT="168" ACODE="SH5_NM_T" VALIGN="MIDDLE">이한구</TE>
<TU ALIGN="CENTER" WIDTH="48" HEIGHT="168" AUNIT="SH5_SEX" AUNITVALUE="1" VALIGN="MIDDLE">남</TU>
<TU ALIGN="CENTER" WIDTH="101" HEIGHT="168" AUNIT="SH5_BIH" AUNITVALUE="194702" VALIGN="MIDDLE">1947년 02월</TU>
<TE ALIGN="CENTER" WIDTH="108" HEIGHT="168" ACODE="SH5_LEV" VALIGN="MIDDLE">대표이사회장</TE>
<TU ALIGN="CENTER" WIDTH="93" HEIGHT="168" AUNIT="SH5_REG_DRCT" AUNITVALUE="1" VALIGN="MIDDLE">등기임원</TU>
<TU ALIGN="CENTER" WIDTH="63" HEIGHT="168" AUNIT="SH5_FUL" AUNITVALUE="1" VALIGN="MIDDLE">상근</TU>
<TE ALIGN="CENTER" WIDTH="179" HEIGHT="168" ACODE="SH5_OBJ" VALIGN="MIDDLE">경영총괄</TE>
<TE ALIGN="CENTER" WIDTH="278" HEIGHT="168" ACODE="SH5_SKL" VALIGN="MIDDLE">성균관대학교 약학과 졸&cr; 성균관대학원 약학과 박사 졸&cr; 중외제약 연구소 부소장&cr; 디에스앤지(주) 대표이사 회장&cr; 대화제약(주) 대표이사 회장&cr; 주)씨트리 대표이사&cr; 현)대화제약(주) 대표이사 명예회장</TE>
<TE ALIGN="RIGHT" WIDTH="83" HEIGHT="168" ACODE="SH5_STK_VOTY" VALIGN="MIDDLE">100,000</TE>
<TE ALIGN="RIGHT" WIDTH="83" HEIGHT="168" ACODE="SH5_STK_VOTN" VALIGN="MIDDLE">-</TE>
<TE ALIGN="CENTER" WIDTH="108" HEIGHT="168" ACODE="SH5_RLTN" VALIGN="MIDDLE">없음</TE>
<TE ALIGN="CENTER" WIDTH="92" HEIGHT="168" ACODE="SH5_PER" VALIGN="MIDDLE">2017.10.&cr;~ 현재</TE>
<TU ALIGN="CENTER" WIDTH="137" HEIGHT="168" AUNIT="SH5_FIH" AUNITVALUE="20231124" VALIGN="MIDDLE">2023년 11월 24일</TU>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" WIDTH="63" HEIGHT="53" ACODE="SH5_NM_T" VALIGN="MIDDLE">한권석</TE>
<TU ALIGN="CENTER" WIDTH="48" HEIGHT="53" AUNIT="SH5_SEX" AUNITVALUE="1" VALIGN="MIDDLE">남</TU>
<TU ALIGN="CENTER" WIDTH="101" HEIGHT="53" AUNIT="SH5_BIH" AUNITVALUE="195207" VALIGN="MIDDLE">1952년 07월</TU>
<TE ALIGN="CENTER" WIDTH="108" HEIGHT="53" ACODE="SH5_LEV" VALIGN="MIDDLE">대표이사사장</TE>
<TU ALIGN="CENTER" WIDTH="93" HEIGHT="53" AUNIT="SH5_REG_DRCT" AUNITVALUE="1" VALIGN="MIDDLE">등기임원</TU>
<TU ALIGN="CENTER" WIDTH="63" HEIGHT="53" AUNIT="SH5_FUL" AUNITVALUE="1" VALIGN="MIDDLE">상근</TU>
<TE ALIGN="CENTER" WIDTH="179" HEIGHT="53" ACODE="SH5_OBJ" VALIGN="MIDDLE">경영총괄</TE>
<TE ALIGN="CENTER" WIDTH="278" HEIGHT="53" ACODE="SH5_SKL" VALIGN="MIDDLE">대화제약(주) 부사장</TE>
<TE ALIGN="RIGHT" WIDTH="83" HEIGHT="53" ACODE="SH5_STK_VOTY" VALIGN="MIDDLE">250,000</TE>
<TE ALIGN="RIGHT" WIDTH="83" HEIGHT="53" ACODE="SH5_STK_VOTN" VALIGN="MIDDLE">-</TE>
<TE ALIGN="CENTER" WIDTH="108" HEIGHT="53" ACODE="SH5_RLTN" VALIGN="MIDDLE">없음</TE>
<TE ALIGN="CENTER" WIDTH="92" HEIGHT="53" ACODE="SH5_PER" VALIGN="MIDDLE">2017.11.&cr;~ 현재</TE>
<TU ALIGN="CENTER" WIDTH="137" HEIGHT="53" AUNIT="SH5_FIH" AUNITVALUE="20231124" VALIGN="MIDDLE">2023년 11월 24일</TU>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" WIDTH="63" HEIGHT="145" ACODE="SH5_NM_T" VALIGN="MIDDLE">김수지</TE>
<TU ALIGN="CENTER" WIDTH="48" HEIGHT="145" AUNIT="SH5_SEX" AUNITVALUE="1" VALIGN="MIDDLE">남</TU>
<TU ALIGN="CENTER" WIDTH="101" HEIGHT="145" AUNIT="SH5_BIH" AUNITVALUE="194404" VALIGN="MIDDLE">1944년 04월</TU>
<TE ALIGN="CENTER" WIDTH="108" HEIGHT="145" ACODE="SH5_LEV" VALIGN="MIDDLE">사내이사</TE>
<TU ALIGN="CENTER" WIDTH="93" HEIGHT="145" AUNIT="SH5_REG_DRCT" AUNITVALUE="1" VALIGN="MIDDLE">등기임원</TU>
<TU ALIGN="CENTER" WIDTH="63" HEIGHT="145" AUNIT="SH5_FUL" AUNITVALUE="2" VALIGN="MIDDLE">비상근</TU>
<TE ALIGN="CENTER" WIDTH="179" HEIGHT="145" ACODE="SH5_OBJ" VALIGN="MIDDLE">경영감독</TE>
<TE ALIGN="CENTER" WIDTH="278" HEIGHT="145" ACODE="SH5_SKL" VALIGN="MIDDLE">성균관대학교 약학과 졸&cr; 성균관대학교 대학원 무역학과 졸&cr; 필립무역상사 근무&cr; 대화제약㈜ 대표이사 회장&cr; 현)디에이치호림 대표이사&cr; 현)대화제약(주) 대표이사 명예회장</TE>
<TE ALIGN="RIGHT" WIDTH="83" HEIGHT="145" ACODE="SH5_STK_VOTY" VALIGN="MIDDLE">126,020</TE>
<TE ALIGN="RIGHT" WIDTH="83" HEIGHT="145" ACODE="SH5_STK_VOTN" VALIGN="MIDDLE">-</TE>
<TE ALIGN="CENTER" WIDTH="108" HEIGHT="145" ACODE="SH5_RLTN" VALIGN="MIDDLE">없음</TE>
<TE ALIGN="CENTER" WIDTH="92" HEIGHT="145" ACODE="SH5_PER" VALIGN="MIDDLE">2016.09.&cr;~ 현재</TE>
<TU ALIGN="CENTER" WIDTH="137" HEIGHT="145" AUNIT="SH5_FIH" AUNITVALUE="20220926" VALIGN="MIDDLE">2022년 09월 26일</TU>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" WIDTH="63" HEIGHT="99" ACODE="SH5_NM_T" VALIGN="MIDDLE">김은석</TE>
<TU ALIGN="CENTER" WIDTH="48" HEIGHT="99" AUNIT="SH5_SEX" AUNITVALUE="1" VALIGN="MIDDLE">남</TU>
<TU ALIGN="CENTER" WIDTH="101" HEIGHT="99" AUNIT="SH5_BIH" AUNITVALUE="197511" VALIGN="MIDDLE">1975년 11월</TU>
<TE ALIGN="CENTER" WIDTH="108" HEIGHT="99" ACODE="SH5_LEV" VALIGN="MIDDLE">사내이사</TE>
<TU ALIGN="CENTER" WIDTH="93" HEIGHT="99" AUNIT="SH5_REG_DRCT" AUNITVALUE="1" VALIGN="MIDDLE">등기임원</TU>
<TU ALIGN="CENTER" WIDTH="63" HEIGHT="99" AUNIT="SH5_FUL" AUNITVALUE="2" VALIGN="MIDDLE">비상근</TU>
<TE ALIGN="CENTER" WIDTH="179" HEIGHT="99" ACODE="SH5_OBJ" VALIGN="MIDDLE">경영감독</TE>
<TE ALIGN="CENTER" WIDTH="278" HEIGHT="99" ACODE="SH5_SKL" VALIGN="MIDDLE">성균관대학교 산업심리학과 졸&cr; 성균관대학교대학원 경영학과 석사 졸&cr; 부광약품(주)근무&cr; 현) 대화제약 대표이사 사장</TE>
<TE ALIGN="RIGHT" WIDTH="83" HEIGHT="99" ACODE="SH5_STK_VOTY" VALIGN="MIDDLE">603,020</TE>
<TE ALIGN="RIGHT" WIDTH="83" HEIGHT="99" ACODE="SH5_STK_VOTN" VALIGN="MIDDLE">-</TE>
<TE ALIGN="CENTER" WIDTH="108" HEIGHT="99" ACODE="SH5_RLTN" VALIGN="MIDDLE">없음</TE>
<TE ALIGN="CENTER" WIDTH="92" HEIGHT="99" ACODE="SH5_PER" VALIGN="MIDDLE">2016.09.&cr;~ 현재</TE>
<TU ALIGN="CENTER" WIDTH="137" HEIGHT="99" AUNIT="SH5_FIH" AUNITVALUE="20220926" VALIGN="MIDDLE">2022년 09월 26일</TU>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" WIDTH="63" HEIGHT="99" ACODE="SH5_NM_T" VALIGN="MIDDLE">강효원</TE>
<TU ALIGN="CENTER" WIDTH="48" HEIGHT="99" AUNIT="SH5_SEX" AUNITVALUE="1" VALIGN="MIDDLE">남</TU>
<TU ALIGN="CENTER" WIDTH="101" HEIGHT="99" AUNIT="SH5_BIH" AUNITVALUE="195908" VALIGN="MIDDLE">1959년 08월</TU>
<TE ALIGN="CENTER" WIDTH="108" HEIGHT="99" ACODE="SH5_LEV" VALIGN="MIDDLE">감사</TE>
<TU ALIGN="CENTER" WIDTH="93" HEIGHT="99" AUNIT="SH5_REG_DRCT" AUNITVALUE="1" VALIGN="MIDDLE">등기임원</TU>
<TU ALIGN="CENTER" WIDTH="63" HEIGHT="99" AUNIT="SH5_FUL" AUNITVALUE="2" VALIGN="MIDDLE">비상근</TU>
<TE ALIGN="CENTER" WIDTH="179" HEIGHT="99" ACODE="SH5_OBJ" VALIGN="MIDDLE">감사</TE>
<TE ALIGN="CENTER" WIDTH="278" HEIGHT="99" ACODE="SH5_SKL" VALIGN="MIDDLE">순천고 졸&cr; 국세청 근무&cr; 근로복지공단 고문&cr; 현) 대화제약(주) 상근감사</TE>
<TE ALIGN="RIGHT" WIDTH="83" HEIGHT="99" ACODE="SH5_STK_VOTY" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="83" HEIGHT="99" ACODE="SH5_STK_VOTN" VALIGN="MIDDLE">-</TE>
<TE ALIGN="CENTER" WIDTH="108" HEIGHT="99" ACODE="SH5_RLTN" VALIGN="MIDDLE">없음</TE>
<TE ALIGN="CENTER" WIDTH="92" HEIGHT="99" ACODE="SH5_PER" VALIGN="MIDDLE">2013.09.&cr;~ 현재</TE>
<TU ALIGN="CENTER" WIDTH="137" HEIGHT="99" AUNIT="SH5_FIH" AUNITVALUE="20220331" VALIGN="MIDDLE">2022년 03월 31일</TU>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" WIDTH="63" HEIGHT="76" ACODE="SH5_NM_T" VALIGN="MIDDLE">노병태</TE>
<TU ALIGN="CENTER" WIDTH="48" HEIGHT="76" AUNIT="SH5_SEX" AUNITVALUE="1" VALIGN="MIDDLE">남</TU>
<TU ALIGN="CENTER" WIDTH="101" HEIGHT="76" AUNIT="SH5_BIH" AUNITVALUE="196109" VALIGN="MIDDLE">1961년 09월</TU>
<TE ALIGN="CENTER" WIDTH="108" HEIGHT="76" ACODE="SH5_LEV" VALIGN="MIDDLE">사내이사</TE>
<TU ALIGN="CENTER" WIDTH="93" HEIGHT="76" AUNIT="SH5_REG_DRCT" AUNITVALUE="2" VALIGN="MIDDLE">미등기임원</TU>
<TU ALIGN="CENTER" WIDTH="63" HEIGHT="76" AUNIT="SH5_FUL" AUNITVALUE="2" VALIGN="MIDDLE">비상근</TU>
<TE ALIGN="CENTER" WIDTH="179" HEIGHT="76" ACODE="SH5_OBJ" VALIGN="MIDDLE">사내이사</TE>
<TE ALIGN="CENTER" WIDTH="278" HEIGHT="76" ACODE="SH5_SKL" VALIGN="MIDDLE">한사대학교 공업디자인과 졸&cr; (현,대구대학교)&cr; 현) 대화제약(주) 대표이사 회장</TE>
<TE ALIGN="RIGHT" WIDTH="83" HEIGHT="76" ACODE="SH5_STK_VOTY" VALIGN="MIDDLE">100,000</TE>
<TE ALIGN="RIGHT" WIDTH="83" HEIGHT="76" ACODE="SH5_STK_VOTN" VALIGN="MIDDLE">-</TE>
<TE ALIGN="CENTER" WIDTH="108" HEIGHT="76" ACODE="SH5_RLTN" VALIGN="MIDDLE">없음</TE>
<TE ALIGN="CENTER" WIDTH="92" HEIGHT="76" ACODE="SH5_PER" VALIGN="MIDDLE">2013.09.&cr;~ 2020.12.</TE>
<TU ALIGN="CENTER" WIDTH="137" HEIGHT="76" AUNIT="SH5_FIH" AUNITVALUE="20201124" VALIGN="MIDDLE">2020년 11월 24일</TU>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" WIDTH="63" HEIGHT="99" ACODE="SH5_NM_T" VALIGN="MIDDLE">박영택</TE>
<TU ALIGN="CENTER" WIDTH="48" HEIGHT="99" AUNIT="SH5_SEX" AUNITVALUE="1" VALIGN="MIDDLE">남</TU>
<TU ALIGN="CENTER" WIDTH="101" HEIGHT="99" AUNIT="SH5_BIH" AUNITVALUE="195806" VALIGN="MIDDLE">1958년 06월</TU>
<TE ALIGN="CENTER" WIDTH="108" HEIGHT="99" ACODE="SH5_LEV" VALIGN="MIDDLE">사내이사</TE>
<TU ALIGN="CENTER" WIDTH="93" HEIGHT="99" AUNIT="SH5_REG_DRCT" AUNITVALUE="2" VALIGN="MIDDLE">미등기임원</TU>
<TU ALIGN="CENTER" WIDTH="63" HEIGHT="99" AUNIT="SH5_FUL" AUNITVALUE="1" VALIGN="MIDDLE">상근</TU>
<TE ALIGN="CENTER" WIDTH="179" HEIGHT="99" ACODE="SH5_OBJ" VALIGN="MIDDLE">케미칼사업/연구소 총괄</TE>
<TE ALIGN="CENTER" WIDTH="278" HEIGHT="99" ACODE="SH5_SKL" VALIGN="MIDDLE">충남대학교 화학과 졸&cr; 고려대학교 대학원 화학과 졸(박사)&cr; 대화제약(주) 제3공장 공장장&cr; 대화제약㈜향남연구소 소장</TE>
<TE ALIGN="RIGHT" WIDTH="83" HEIGHT="99" ACODE="SH5_STK_VOTY" VALIGN="MIDDLE">30,000</TE>
<TE ALIGN="RIGHT" WIDTH="83" HEIGHT="99" ACODE="SH5_STK_VOTN" VALIGN="MIDDLE">-</TE>
<TE ALIGN="CENTER" WIDTH="108" HEIGHT="99" ACODE="SH5_RLTN" VALIGN="MIDDLE">없음</TE>
<TE ALIGN="CENTER" WIDTH="92" HEIGHT="99" ACODE="SH5_PER" VALIGN="MIDDLE">2016.09.&cr;~ 2020.12.</TE>
<TU ALIGN="CENTER" WIDTH="137" HEIGHT="99" AUNIT="SH5_FIH" AUNITVALUE="20201124" VALIGN="MIDDLE">2020년 11월 24일</TU>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" WIDTH="63" HEIGHT="214" ACODE="SH5_NM_T" VALIGN="MIDDLE">황태섭</TE>
<TU ALIGN="CENTER" WIDTH="48" HEIGHT="214" AUNIT="SH5_SEX" AUNITVALUE="1" VALIGN="MIDDLE">남</TU>
<TU ALIGN="CENTER" WIDTH="101" HEIGHT="214" AUNIT="SH5_BIH" AUNITVALUE="196201" VALIGN="MIDDLE">1962년 01월</TU>
<TE ALIGN="CENTER" WIDTH="108" HEIGHT="214" ACODE="SH5_LEV" VALIGN="MIDDLE">전무</TE>
<TU ALIGN="CENTER" WIDTH="93" HEIGHT="214" AUNIT="SH5_REG_DRCT" AUNITVALUE="2" VALIGN="MIDDLE">미등기임원</TU>
<TU ALIGN="CENTER" WIDTH="63" HEIGHT="214" AUNIT="SH5_FUL" AUNITVALUE="1" VALIGN="MIDDLE">상근</TU>
<TE ALIGN="CENTER" WIDTH="179" HEIGHT="214" ACODE="SH5_OBJ" VALIGN="MIDDLE">공장장 및 연구소장</TE>
<TE ALIGN="CENTER" WIDTH="278" HEIGHT="214" ACODE="SH5_SKL" VALIGN="MIDDLE">성균관대학교 약학과 졸&cr;성균관대학교 대학원 약학과 석사 졸&cr;중외제약 근무&cr;한서캠 근무&cr;명문제약 근무&cr;씨트리 근무&cr;대웅바이오 근무&cr;이니스트 ST 근무&cr;한국 팜바이오제약 근무</TE>
<TE ALIGN="RIGHT" WIDTH="83" HEIGHT="214" ACODE="SH5_STK_VOTY" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="83" HEIGHT="214" ACODE="SH5_STK_VOTN" VALIGN="MIDDLE">-</TE>
<TE ALIGN="CENTER" WIDTH="108" HEIGHT="214" ACODE="SH5_RLTN" VALIGN="MIDDLE">없음</TE>
<TE ALIGN="CENTER" WIDTH="92" HEIGHT="214" ACODE="SH5_PER" VALIGN="MIDDLE">2020.12.&cr;~ 현재</TE>
<TU ALIGN="CENTER" WIDTH="137" HEIGHT="214" AUNIT="SH5_FIH" AUNITVALUE="-" VALIGN="MIDDLE">-</TU>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" WIDTH="63" HEIGHT="76" ACODE="SH5_NM_T" VALIGN="MIDDLE">이성훈</TE>
<TU ALIGN="CENTER" WIDTH="48" HEIGHT="76" AUNIT="SH5_SEX" AUNITVALUE="1" VALIGN="MIDDLE">남</TU>
<TU ALIGN="CENTER" WIDTH="101" HEIGHT="76" AUNIT="SH5_BIH" AUNITVALUE="197110" VALIGN="MIDDLE">1971년 10월</TU>
<TE ALIGN="CENTER" WIDTH="108" HEIGHT="76" ACODE="SH5_LEV" VALIGN="MIDDLE">이사</TE>
<TU ALIGN="CENTER" WIDTH="93" HEIGHT="76" AUNIT="SH5_REG_DRCT" AUNITVALUE="2" VALIGN="MIDDLE">미등기임원</TU>
<TU ALIGN="CENTER" WIDTH="63" HEIGHT="76" AUNIT="SH5_FUL" AUNITVALUE="1" VALIGN="MIDDLE">상근</TU>
<TE ALIGN="CENTER" WIDTH="179" HEIGHT="76" ACODE="SH5_OBJ" VALIGN="MIDDLE">케미칼사업&cr; 팀 장</TE>
<TE ALIGN="CENTER" WIDTH="278" HEIGHT="76" ACODE="SH5_SKL" VALIGN="MIDDLE">고려대학교 화학과 졸&cr; 제일약품 근무&cr; 헥사파마텍 근무</TE>
<TE ALIGN="RIGHT" WIDTH="83" HEIGHT="76" ACODE="SH5_STK_VOTY" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="83" HEIGHT="76" ACODE="SH5_STK_VOTN" VALIGN="MIDDLE">-</TE>
<TE ALIGN="CENTER" WIDTH="108" HEIGHT="76" ACODE="SH5_RLTN" VALIGN="MIDDLE">없음</TE>
<TE ALIGN="CENTER" WIDTH="92" HEIGHT="76" ACODE="SH5_PER" VALIGN="MIDDLE">2018.05.&cr;~ 현재</TE>
<TU ALIGN="CENTER" WIDTH="137" HEIGHT="76" AUNIT="SH5_FIH" AUNITVALUE="-" VALIGN="MIDDLE">-</TU>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" WIDTH="63" HEIGHT="76" ACODE="SH5_NM_T" VALIGN="MIDDLE">신정혜</TE>
<TU ALIGN="CENTER" WIDTH="48" HEIGHT="76" AUNIT="SH5_SEX" AUNITVALUE="2" VALIGN="MIDDLE">여</TU>
<TU ALIGN="CENTER" WIDTH="101" HEIGHT="76" AUNIT="SH5_BIH" AUNITVALUE="197205" VALIGN="MIDDLE">1972년 05월</TU>
<TE ALIGN="CENTER" WIDTH="108" HEIGHT="76" ACODE="SH5_LEV" VALIGN="MIDDLE">이사</TE>
<TU ALIGN="CENTER" WIDTH="93" HEIGHT="76" AUNIT="SH5_REG_DRCT" AUNITVALUE="2" VALIGN="MIDDLE">미등기임원</TU>
<TU ALIGN="CENTER" WIDTH="63" HEIGHT="76" AUNIT="SH5_FUL" AUNITVALUE="1" VALIGN="MIDDLE">상근</TU>
<TE ALIGN="CENTER" WIDTH="179" HEIGHT="76" ACODE="SH5_OBJ" VALIGN="MIDDLE">품질보증팀&cr; 팀 장</TE>
<TE ALIGN="CENTER" WIDTH="278" HEIGHT="76" ACODE="SH5_SKL" VALIGN="MIDDLE">경북대학교 화학과 졸&cr; 제일약품 근무&cr; 헥사파마텍 근무</TE>
<TE ALIGN="RIGHT" WIDTH="83" HEIGHT="76" ACODE="SH5_STK_VOTY" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="83" HEIGHT="76" ACODE="SH5_STK_VOTN" VALIGN="MIDDLE">-</TE>
<TE ALIGN="CENTER" WIDTH="108" HEIGHT="76" ACODE="SH5_RLTN" VALIGN="MIDDLE">없음</TE>
<TE ALIGN="CENTER" WIDTH="92" HEIGHT="76" ACODE="SH5_PER" VALIGN="MIDDLE">2018.08.&cr;~ 현재</TE>
<TU ALIGN="CENTER" WIDTH="137" HEIGHT="76" AUNIT="SH5_FIH" AUNITVALUE="-" VALIGN="MIDDLE">-</TU>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>

<P>
<SPAN USERMARK="F-GL11">주1) 2020년 12월 31일 기준 주주의 수&cr;주2) 2020년 11월 24일 임시주주총회를 통해 이한구, 한권석 대표이사가 재선임 되었으며노병태, </SPAN>
<SPAN USERMARK="F-GL11">박영택 사내이사가 일신상의 사유로 사임 하였습니다.&cr;</SPAN>
</P>

<INSERTION ABASISNUMBER="SE1" AFREQUENCY="1" ADUPLICATION="N">
<COMMENT>◆click◆『등기임원후보자 및 해임대상자』 삽입</COMMENT>
<LIBRARYLIST>11011#*등기임원후보자및해임대상자.dsl</LIBRARYLIST>

<LIBRARY>
<FILENAME ATYPE="dsl">51_등기임원후보자및해임대상자</FILENAME>

<P>
<SPAN USERMARK="F-GL11 B">나. 등기임원 선임 후보자 및 해임 대상자 현황</SPAN>
</P>

<TABLE-GROUP ACLASS="PSN_MBER" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="Y" WIDTH="597" BORDER="0">

<COLGROUP>
<COL WIDTH="71"></COL>
<COL WIDTH="161"></COL>
<COL WIDTH="338"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD VALIGN="BOTTOM" WIDTH="80" HEIGHT="30" AUPDATECONT="N">(기준일 : </TD>
<TU ALIGN="CENTER" VALIGN="BOTTOM" WIDTH="170" HEIGHT="30" AUNIT="BASE_DT" AUNITVALUE="-">-</TU>
<TD VALIGN="BOTTOM" WIDTH="347" HEIGHT="30" AUPDATECONT="N"></TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="599" BORDER="1">

<COLGROUP>
<COL WIDTH="54"></COL>
<COL WIDTH="59"></COL>
<COL WIDTH="33"></COL>
<COL WIDTH="73"></COL>
<COL WIDTH="77"></COL>
<COL WIDTH="75"></COL>
<COL WIDTH="63"></COL>
<COL WIDTH="93"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="N" ADELETE="N">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="76" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">구분</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="68" HEIGHT="76" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">성명</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="42" HEIGHT="76" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">성별</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="82" HEIGHT="76" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">출생년월</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="86" HEIGHT="76" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">사외이사&cr;후보자&cr;해당여부</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="84" HEIGHT="76" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">주요경력</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="72" HEIGHT="76" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">선ㆍ해임&cr;예정일</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="102" HEIGHT="76" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">최대주주와의&cr;관계</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="N">
<TU ALIGN="CENTER" WIDTH="63" HEIGHT="30" AUNIT="PSN_APP" AUNITVALUE="Y" VALIGN="MIDDLE">선임</TU>
<TE ALIGN="CENTER" WIDTH="68" HEIGHT="30" ACODE="PSN_NAM" VALIGN="MIDDLE">-</TE>
<TU ALIGN="CENTER" WIDTH="42" HEIGHT="30" AUNIT="PSN_SEX" AUNITVALUE="1" VALIGN="MIDDLE">남</TU>
<TU ALIGN="CENTER" WIDTH="82" HEIGHT="30" AUNIT="PSN_BIH" AUNITVALUE="-" VALIGN="MIDDLE">-</TU>
<TE ALIGN="CENTER" WIDTH="86" HEIGHT="30" ACODE="PSN_DIR" VALIGN="MIDDLE">-</TE>
<TE ALIGN="CENTER" WIDTH="84" HEIGHT="30" ACODE="PSN_CAR" VALIGN="MIDDLE">-</TE>
<TU ALIGN="CENTER" WIDTH="72" HEIGHT="30" AUNIT="PSN_DAT" AUNITVALUE="-" VALIGN="MIDDLE">-</TU>
<TE ALIGN="CENTER" WIDTH="102" HEIGHT="30" ACODE="PSN_RSP" VALIGN="MIDDLE">-</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
</LIBRARY>
</INSERTION>
<P USERMARK="F-GL11">해당사항 없습니다.</P>

<P>
<SPAN USERMARK="F-GL11 B">&cr;다. 직원의 현황</SPAN>
</P>

<TABLE-GROUP ACLASS="EMPLOYEE" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="Y" WIDTH="796" BORDER="0">

<COLGROUP>
<COL WIDTH="71"></COL>
<COL WIDTH="143"></COL>
<COL WIDTH="117"></COL>
<COL WIDTH="429"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD VALIGN="BOTTOM" WIDTH="80" HEIGHT="30" AUPDATECONT="N">(기준일 : </TD>
<TU ALIGN="CENTER" VALIGN="BOTTOM" WIDTH="152" HEIGHT="30" AUNIT="BASE_DT" AUNITVALUE="20201231">2020년 12월 31일</TU>
<TD VALIGN="BOTTOM" WIDTH="126" HEIGHT="30" AUPDATECONT="N">)</TD>
<TU ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="438" HEIGHT="30" AUNIT="WON" AUNITVALUE="2">(단위 : 천원)</TU>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="793" BORDER="1" FRAME="BORDER" RULES="ALL">

<COLGROUP>
<COL WIDTH="69"></COL>
<COL WIDTH="39"></COL>
<COL WIDTH="39"></COL>
<COL WIDTH="60"></COL>
<COL WIDTH="39"></COL>
<COL WIDTH="60"></COL>
<COL WIDTH="44"></COL>
<COL WIDTH="69"></COL>
<COL WIDTH="75"></COL>
<COL WIDTH="62"></COL>
<COL WIDTH="24"></COL>
<COL WIDTH="24"></COL>
<COL WIDTH="24"></COL>
<COL WIDTH="39"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="N" ADELETE="N">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="646" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" COLSPAN="10">직원</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="99" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" COLSPAN="3">소속 외&cr;근로자</TH>
<TH ROWSPAN="4" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="48" HEIGHT="189" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">비고</TH>
</TR>

<TR ACOPY="N" ADELETE="N">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="78" HEIGHT="136" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ROWSPAN="3">사업부문</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="48" HEIGHT="136" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ROWSPAN="3">성별</TH>
<TH COLSPAN="5" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="287" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">직 원 수</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="78" HEIGHT="136" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ROWSPAN="3">평 균&cr;근속연수</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="84" HEIGHT="136" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ROWSPAN="3">연간급여&cr;총 액</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="71" HEIGHT="136" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ROWSPAN="3">1인평균&cr;급여액</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="33" HEIGHT="136" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ROWSPAN="3">남</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="33" HEIGHT="136" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ROWSPAN="3">여</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="33" HEIGHT="136" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ROWSPAN="3">계</TH>
</TR>

<TR ACOPY="N" ADELETE="N">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="117" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" COLSPAN="2">기간의 정함이&cr;없는 근로자</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="117" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" COLSPAN="2">기간제&cr;근로자</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="53" HEIGHT="106" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ROWSPAN="2">합 계</TH>
</TR>

<TR ACOPY="N" ADELETE="N">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="48" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">전체</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="69" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">(단시간&cr;근로자)</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="48" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">전체</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="69" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">(단시간&cr;근로자)</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="N">
<TE ALIGN="CENTER" WIDTH="78" HEIGHT="30" ACODE="EMP_OPR" VALIGN="MIDDLE">제조부문</TE>
<TU ALIGN="CENTER" WIDTH="48" HEIGHT="30" AUNIT="EMP_SEX" AUNITVALUE="1" VALIGN="MIDDLE">남</TU>
<TE ALIGN="RIGHT" WIDTH="48" HEIGHT="30" ACODE="EMP_REO" VALIGN="MIDDLE">22</TE>
<TE ALIGN="RIGHT" WIDTH="69" HEIGHT="30" ACODE="EMP_REOS" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="48" HEIGHT="30" ACODE="EMP_COC" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="69" HEIGHT="30" ACODE="EMP_COCS" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="53" HEIGHT="30" ACODE="EMP_CN" VALIGN="MIDDLE">22</TE>
<TE ALIGN="RIGHT" WIDTH="78" HEIGHT="30" ACODE="EMP_AVY" VALIGN="MIDDLE">2.9</TE>
<TE ALIGN="RIGHT" WIDTH="84" HEIGHT="30" ACODE="EMP_AIC" VALIGN="MIDDLE">1,041,280</TE>
<TE ALIGN="RIGHT" WIDTH="71" HEIGHT="30" ACODE="EMP_VIC" VALIGN="MIDDLE">47,330</TE>
<TE ALIGN="RIGHT" WIDTH="33" HEIGHT="90" ACODE="EMP_MAN" VALIGN="MIDDLE" ROWSPAN="3">-</TE>
<TE ALIGN="RIGHT" WIDTH="33" HEIGHT="90" ACODE="EMP_WOM" VALIGN="MIDDLE" ROWSPAN="3">-</TE>
<TE ALIGN="RIGHT" WIDTH="33" HEIGHT="90" ACODE="EMP_MW_TOTAL" VALIGN="MIDDLE" ROWSPAN="3">-</TE>
<TE ALIGN="CENTER" WIDTH="48" HEIGHT="30" ACODE="NOTE" VALIGN="MIDDLE">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" WIDTH="78" HEIGHT="30" ACODE="EMP_OPR" VALIGN="MIDDLE">제조부문</TE>
<TU ALIGN="CENTER" WIDTH="48" HEIGHT="30" AUNIT="EMP_SEX" AUNITVALUE="2" VALIGN="MIDDLE">여</TU>
<TE ALIGN="RIGHT" WIDTH="48" HEIGHT="30" ACODE="EMP_REO" VALIGN="MIDDLE">6</TE>
<TE ALIGN="RIGHT" WIDTH="69" HEIGHT="30" ACODE="EMP_REOS" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="48" HEIGHT="30" ACODE="EMP_COC" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="69" HEIGHT="30" ACODE="EMP_COCS" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="53" HEIGHT="30" ACODE="EMP_CN" VALIGN="MIDDLE">6</TE>
<TE ALIGN="RIGHT" WIDTH="78" HEIGHT="30" ACODE="EMP_AVY" VALIGN="MIDDLE">4.2</TE>
<TE ALIGN="RIGHT" WIDTH="84" HEIGHT="30" ACODE="EMP_AIC" VALIGN="MIDDLE">249,580</TE>
<TE ALIGN="RIGHT" WIDTH="71" HEIGHT="30" ACODE="EMP_VIC" VALIGN="MIDDLE">41,596</TE>
<TE ALIGN="CENTER" WIDTH="48" HEIGHT="30" ACODE="NOTE" VALIGN="MIDDLE">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD ALIGN="CENTER" WIDTH="126" HEIGHT="30" AUPDATECONT="N" COLSPAN="2" VALIGN="MIDDLE">합 계</TD>
<TE ALIGN="RIGHT" WIDTH="48" HEIGHT="30" ACODE="EMP_REOT" VALIGN="MIDDLE">28</TE>
<TE ALIGN="RIGHT" WIDTH="69" HEIGHT="30" ACODE="EMP_REOST" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="48" HEIGHT="30" ACODE="EMP_COCT" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="69" HEIGHT="30" ACODE="EMP_COCST" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="53" HEIGHT="30" ACODE="EMP_CNT" VALIGN="MIDDLE">28</TE>
<TE ALIGN="RIGHT" WIDTH="78" HEIGHT="30" ACODE="EMP_AVYT" VALIGN="MIDDLE">3.3</TE>
<TE ALIGN="RIGHT" WIDTH="84" HEIGHT="30" ACODE="EMP_AICT" VALIGN="MIDDLE">1,290,860</TE>
<TE ALIGN="RIGHT" WIDTH="71" HEIGHT="30" ACODE="EMP_VICT" VALIGN="MIDDLE">46,102</TE>
<TE ALIGN="CENTER" WIDTH="48" HEIGHT="30" ACODE="NOTET" VALIGN="MIDDLE">-</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>

<INSERTION ABASISNUMBER="E0" AFREQUENCY="0" ADUPLICATION="N">
<COMMENT>* 직원 현황 표는 미등기임원을 포함하여 작성한다</COMMENT>
<LIBRARYLIST></LIBRARYLIST>
</INSERTION>

<P>
<SPAN USERMARK="F-GL11">주1) 직원수는 2020년 12월말 기준입니다.(등기임원 제외)&cr;주2) 평균근속연수는 2020년 12월말 현재 재직중인 직원의 근무기간을 통산한 근속연수 평균치입니다&cr;주3) 1인평균급여액은 실질평균급여와 차이가 있습니다.&cr;</SPAN>
<SPAN USERMARK="F-GL11"></SPAN>
</P>

<P>
<SPAN USERMARK="F-GL11 B">라. 미등기임원 현황</SPAN>
</P>

<TABLE-GROUP ACLASS="UNRESISTER" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="Y" WIDTH="847" BORDER="0">

<COLGROUP>
<COL WIDTH="71"></COL>
<COL WIDTH="143"></COL>
<COL WIDTH="117"></COL>
<COL WIDTH="480"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD VALIGN="BOTTOM" WIDTH="80" HEIGHT="30" AUPDATECONT="N">(기준일 : </TD>
<TU ALIGN="CENTER" VALIGN="BOTTOM" WIDTH="152" HEIGHT="30" AUNIT="BASE_DT" AUNITVALUE="20201231">2020년 12월 31일</TU>
<TD VALIGN="BOTTOM" WIDTH="126" HEIGHT="30" AUPDATECONT="N">)</TD>
<TU ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="489" HEIGHT="30" AUNIT="WON" AUNITVALUE="2">(단위 : 천원)</TU>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="848" BORDER="1">

<COLGROUP>
<COL WIDTH="84"></COL>
<COL WIDTH="54"></COL>
<COL WIDTH="104"></COL>
<COL WIDTH="112"></COL>
<COL WIDTH="449"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="N" ADELETE="N">
<TH WIDTH="93" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">구 분</TH>
<TH WIDTH="63" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">인원수</TH>
<TH WIDTH="113" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">연간급여 총액</TH>
<TH WIDTH="121" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">1인평균 급여액</TH>
<TH WIDTH="458" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">비고</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="93" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUPDATECONT="N">미등기임원</TD>
<TE WIDTH="63" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="URT_CNT">5</TE>
<TE WIDTH="113" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="URT_PAY_TOT">281,143</TE>
<TE WIDTH="121" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="URT_PAY_AVR">56,228</TE>
<TE WIDTH="458" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="URT_NOTE">전체 미등기임원의 보수총액을 인원수로 단순평균 계산하여 산출.</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
<P></P>
<P></P>
</SECTION-2>

<SECTION-2 ACLASS="MANDATORY">
<TITLE ATOC="Y" AASSOCNOTE="D-0-8-2-0">2. 임원의 보수 등</TITLE>

<P>
<SPAN USERMARK="F-GL B">&cr;가. 이사ㆍ감사 전체의 보수현황</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="Y" WIDTH="600" BORDER="0">

<COLGROUP>
<COL WIDTH="591"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="600" HEIGHT="30" AUPDATECONT="N"><이사ㆍ감사 전체의 보수현황></TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK="F-GL11">1) 주주총회 승인금액</P>

<TABLE-GROUP ACLASS="SUB_CMP" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="Y" WIDTH="602" BORDER="0">

<COLGROUP>
<COL WIDTH="291"></COL>
<COL WIDTH="293"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD VALIGN="BOTTOM" WIDTH="300" HEIGHT="30" AUPDATECONT="N"></TD>
<TU ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="302" HEIGHT="30" AUNIT="WON" AUNITVALUE="2">(단위 : 천원)</TU>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="602" BORDER="1">

<COLGROUP>
<COL WIDTH="169"></COL>
<COL WIDTH="78"></COL>
<COL WIDTH="199"></COL>
<COL WIDTH="120"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="N" ADELETE="N">
<TH WIDTH="178" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">구 분</TH>
<TH WIDTH="87" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">인원수</TH>
<TH WIDTH="208" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">주주총회 승인금액</TH>
<TH WIDTH="129" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">비고</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="N">
<TE WIDTH="178" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="PRT_PAY_SUB">사내(외)이사</TE>
<TE WIDTH="87" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="PRT_PAY_NUM">4</TE>
<TE WIDTH="208" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="PRT_PAY_KMY">500,000</TE>
<TE WIDTH="129" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="NOTE">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE WIDTH="178" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="PRT_PAY_SUB">감사</TE>
<TE WIDTH="87" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="PRT_PAY_NUM">1</TE>
<TE WIDTH="208" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="PRT_PAY_KMY">50,000</TE>
<TE WIDTH="129" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="NOTE">-</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
<P></P>

<P>
<SPAN USERMARK="F-GL11">2) 보수지급금액</SPAN>
<SPAN USERMARK="F-DU11">&cr;① 이사ㆍ감사 전체</SPAN>
</P>

<TABLE-GROUP ACLASS="SUB_CMPT" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="Y" WIDTH="602" BORDER="0">

<COLGROUP>
<COL WIDTH="291"></COL>
<COL WIDTH="293"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD VALIGN="BOTTOM" WIDTH="300" HEIGHT="30" AUPDATECONT="N"></TD>
<TU ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="302" HEIGHT="30" AUNIT="WON" AUNITVALUE="2">(단위 : 천원)</TU>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="602" BORDER="1">

<COLGROUP>
<COL WIDTH="142"></COL>
<COL WIDTH="142"></COL>
<COL WIDTH="141"></COL>
<COL WIDTH="141"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="N" ADELETE="N">
<TH WIDTH="151" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">인원수</TH>
<TH WIDTH="151" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">보수총액</TH>
<TH WIDTH="150" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">1인당 평균보수액</TH>
<TH WIDTH="150" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">비고</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TE WIDTH="151" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="TRT_PAY_NUM">5</TE>
<TE WIDTH="151" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="TRT_PAY_SUM">212,160</TE>
<TE WIDTH="150" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="TRT_PAY_VIC">42,432</TE>
<TE WIDTH="150" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="NOTE5">-</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
<P></P>

<P>
<SPAN USERMARK="F-GL11">② 유형별</SPAN>
</P>

<TABLE-GROUP ACLASS="SUB_CMPP" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="Y" WIDTH="602" BORDER="0">

<COLGROUP>
<COL WIDTH="291"></COL>
<COL WIDTH="293"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD VALIGN="BOTTOM" WIDTH="300" HEIGHT="30" AUPDATECONT="N"></TD>
<TU ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="302" HEIGHT="30" AUNIT="WON" AUNITVALUE="2">(단위 : 천원)</TU>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="602" BORDER="1">

<COLGROUP>
<COL WIDTH="236"></COL>
<COL WIDTH="81"></COL>
<COL WIDTH="80"></COL>
<COL WIDTH="80"></COL>
<COL WIDTH="80"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="N" ADELETE="N">
<TH WIDTH="245" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53">구 분</TH>
<TH WIDTH="90" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53">인원수</TH>
<TH WIDTH="89" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53">보수총액</TH>
<TH WIDTH="89" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53">1인당&cr;평균보수액</TH>
<TH WIDTH="89" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53">비고</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="245" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" AUPDATECONT="N">등기이사&cr;(사외이사, 감사위원회 위원 제외)</TD>
<TE WIDTH="90" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53" ACODE="RRT_PAY_NUM">4</TE>
<TE WIDTH="89" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53" ACODE="RRT_PAY_SUM">212,160</TE>
<TE WIDTH="89" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53" ACODE="RRT_PAY_VIC">53,040</TE>
<TE WIDTH="89" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACODE="NOTE1">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="245" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" AUPDATECONT="N">사외이사&cr;(감사위원회 위원 제외)</TD>
<TE WIDTH="90" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53" ACODE="ORT_PAY_NUM">-</TE>
<TE WIDTH="89" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53" ACODE="ORT_PAY_SUM">-</TE>
<TE WIDTH="89" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53" ACODE="ORT_PAY_VIC">-</TE>
<TE WIDTH="89" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACODE="NOTE2">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="245" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUPDATECONT="N">감사위원회 위원</TD>
<TE WIDTH="90" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="GRT_PAY_NUM">-</TE>
<TE WIDTH="89" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="GRT_PAY_SUM">-</TE>
<TE WIDTH="89" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="GRT_PAY_VIC">-</TE>
<TE WIDTH="89" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="NOTE3">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="245" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUPDATECONT="N">감사</TD>
<TE WIDTH="90" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="AUD_PAY_NUM">1</TE>
<TE WIDTH="89" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="AUD_PAY_SUM">-</TE>
<TE WIDTH="89" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="AUD_PAY_VIC">-</TE>
<TE WIDTH="89" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="NOTE4">-</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>

<P>&cr;
<SPAN USERMARK="F-GL B">나. 이사ㆍ감사의 개인별 보수현황</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="Y" WIDTH="600" BORDER="0">

<COLGROUP>
<COL WIDTH="591"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="600" HEIGHT="30" AUPDATECONT="N"><보수지급금액 5억원 이상인 이사ㆍ감사의 개인별 보수현황></TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK="F-GL11">1) 개인별 보수지급금액</P>

<TABLE-GROUP ACLASS="SUB_CMPK" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="Y" WIDTH="602" BORDER="0">

<COLGROUP>
<COL WIDTH="291"></COL>
<COL WIDTH="293"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD VALIGN="BOTTOM" WIDTH="300" HEIGHT="30" AUPDATECONT="N"></TD>
<TU ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="302" HEIGHT="30" AUNIT="WON" AUNITVALUE="1">(단위 : 원)</TU>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="602" BORDER="1">

<COLGROUP>
<COL WIDTH="85"></COL>
<COL WIDTH="67"></COL>
<COL WIDTH="157"></COL>
<COL WIDTH="257"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="N" ADELETE="N">
<TH WIDTH="94" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">이름</TH>
<TH WIDTH="76" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">직위</TH>
<TH WIDTH="166" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">보수총액</TH>
<TH WIDTH="266" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">보수총액에 포함되지 않는 보수</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="N">
<TE WIDTH="94" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="CMPK_NM">-</TE>
<TE WIDTH="76" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="CMPK_LEV">-</TE>
<TE WIDTH="166" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="CMPK_PAY">-</TE>
<TE WIDTH="266" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="CMPK_NOTPAY">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE WIDTH="94" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="CMPK_NM">-</TE>
<TE WIDTH="76" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="CMPK_LEV">-</TE>
<TE WIDTH="166" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="CMPK_PAY">-</TE>
<TE WIDTH="266" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="CMPK_NOTPAY">-</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>

<P>&cr;
<SPAN USERMARK="F-GL11">2) 산정기준 및 방법</SPAN>
</P>

<TABLE BORDER="0" WIDTH="602" ACLASS="NORMAL">

<COLGROUP>
<COL WIDTH="291"></COL>
<COL WIDTH="293"></COL>
</COLGROUP>

<TBODY>

<TR>
<TD WIDTH="300" HEIGHT="30" VALIGN="BOTTOM"></TD>
<TD WIDTH="302" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">(단위 : 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE BORDER="1" WIDTH="600" ACLASS="NORMAL">

<COLGROUP>
<COL WIDTH="111"></COL>
<COL WIDTH="90"></COL>
<COL WIDTH="106"></COL>
<COL WIDTH="108"></COL>
<COL WIDTH="140"></COL>
</COLGROUP>

<THEAD>

<TR>
<TH VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" WIDTH="120" HEIGHT="30">이름</TH>
<TH COLSPAN="2" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" WIDTH="214" HEIGHT="30">보수의 종류</TH>
<TH VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" WIDTH="117" HEIGHT="30">총액</TH>
<TH VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" WIDTH="149" HEIGHT="30">산정기준 및 방법</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD ROWSPAN="6" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="120" HEIGHT="203">-</TD>
<TD ROWSPAN="4" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="99" HEIGHT="143">근로소득</TD>
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="115" HEIGHT="30">급여</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="117" HEIGHT="30">-</TD>
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="149" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="115" HEIGHT="30">상여</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="117" HEIGHT="30">-</TD>
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="149" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="115" HEIGHT="53">주식매수선택권&cr; 행사이익</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="117" HEIGHT="53">-</TD>
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="149" HEIGHT="53">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="115" HEIGHT="30">기타 근로소득</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="117" HEIGHT="30">-</TD>
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="149" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD COLSPAN="2" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="214" HEIGHT="30">퇴직소득</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="117" HEIGHT="30">-</TD>
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="149" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD COLSPAN="2" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="214" HEIGHT="30">기타소득</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="117" HEIGHT="30">-</TD>
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="149" HEIGHT="30">-</TD>
</TR>
</TBODY>
</TABLE>

<P>&cr;
<SPAN USERMARK="F-GL B">다. </SPAN>
<SPAN USERMARK="F-GL B">보</SPAN>
<SPAN USERMARK="F-GL B">수지급금액 5억원 이상 중 상위 5명의 개인별 보수현황</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="Y" WIDTH="600" BORDER="0">

<COLGROUP>
<COL WIDTH="591"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="600" HEIGHT="30" AUPDATECONT="N"><보수지급금액 5억원 이상 중 상위 5명의 개인별 보수현황></TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK="F-GL11">1) 개인별 보수지급금액</P>

<TABLE-GROUP ACLASS="SUB_CMPK_HIGH" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="Y" WIDTH="602" BORDER="0">

<COLGROUP>
<COL WIDTH="291"></COL>
<COL WIDTH="293"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD VALIGN="BOTTOM" WIDTH="300" HEIGHT="30" AUPDATECONT="N"></TD>
<TU ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="302" HEIGHT="30" AUNIT="WON" AUNITVALUE="2">(단위 : 천원)</TU>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="602" BORDER="1">

<COLGROUP>
<COL WIDTH="85"></COL>
<COL WIDTH="67"></COL>
<COL WIDTH="157"></COL>
<COL WIDTH="257"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="N" ADELETE="N">
<TH WIDTH="94" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">이름</TH>
<TH WIDTH="76" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">직위</TH>
<TH WIDTH="166" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">보수총액</TH>
<TH WIDTH="266" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">보수총액에 포함되지 않는 보수</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="N">
<TE WIDTH="94" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="CMPK_NM">-</TE>
<TE WIDTH="76" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="CMPK_LEV">-</TE>
<TE WIDTH="166" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="CMPK_PAY">-</TE>
<TE WIDTH="266" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="CMPK_NOTPAY">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE WIDTH="94" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="CMPK_NM">-</TE>
<TE WIDTH="76" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="CMPK_LEV">-</TE>
<TE WIDTH="166" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="CMPK_PAY">-</TE>
<TE WIDTH="266" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="CMPK_NOTPAY">-</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>

<P>&cr;
<SPAN USERMARK="F-GL11">2) 산정기준 및 방법</SPAN>
</P>

<TABLE BORDER="0" WIDTH="602" ACLASS="NORMAL">

<COLGROUP>
<COL WIDTH="291"></COL>
<COL WIDTH="293"></COL>
</COLGROUP>

<TBODY>

<TR>
<TD WIDTH="300" HEIGHT="30" VALIGN="BOTTOM"></TD>
<TD WIDTH="302" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">(단위 : ?원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE BORDER="1" WIDTH="600" ACLASS="NORMAL">

<COLGROUP>
<COL WIDTH="111"></COL>
<COL WIDTH="90"></COL>
<COL WIDTH="106"></COL>
<COL WIDTH="108"></COL>
<COL WIDTH="140"></COL>
</COLGROUP>

<THEAD>

<TR>
<TH VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" WIDTH="120" HEIGHT="30">이름</TH>
<TH COLSPAN="2" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" WIDTH="214" HEIGHT="30">보수의 종류</TH>
<TH VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" WIDTH="117" HEIGHT="30">총액</TH>
<TH VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" WIDTH="149" HEIGHT="30">산정기준 및 방법</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD ROWSPAN="6" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="120" HEIGHT="203">-</TD>
<TD ROWSPAN="4" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="99" HEIGHT="143">근로소득</TD>
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="115" HEIGHT="30">급여</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="117" HEIGHT="30">-</TD>
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="149" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="115" HEIGHT="30">상여</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="117" HEIGHT="30">-</TD>
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="149" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="115" HEIGHT="53">주식매수선택권&cr; 행사이익</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="117" HEIGHT="53">-</TD>
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="149" HEIGHT="53">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="115" HEIGHT="30">기타 근로소득</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="117" HEIGHT="30">-</TD>
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="149" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD COLSPAN="2" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="214" HEIGHT="30">퇴직소득</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="117" HEIGHT="30">-</TD>
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="149" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD COLSPAN="2" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="214" HEIGHT="30">기타소득</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="117" HEIGHT="30">-</TD>
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="149" HEIGHT="30">-</TD>
</TR>
</TBODY>
</TABLE>

<INSERTION ABASISNUMBER="SE1" AFREQUENCY="0" ADUPLICATION="N">
<COMMENT>◆click◆『주식매수선택권의 부여 및 행사현황』 삽입</COMMENT>
<LIBRARYLIST>11011#*주식매수선택권의부여및행사현황.dsl</LIBRARYLIST>
</INSERTION>
<PGBRK></PGBRK>
</SECTION-2>
</SECTION-1>

<SECTION-1 ACLASS="MANDATORY" APARTSOURCE="SOURCE">
<TITLE ATOC="Y" AASSOCNOTE="D-0-9-0-0">IX. 계열회사 등에 관한 사항</TITLE>
<P></P>

<P>
<SPAN USERMARK="F-GL16 0XC00000 B">1. 계열회사의 현황&cr;</SPAN>
<SPAN USERMARK=" B">&cr;</SPAN>
<SPAN USERMARK="F-GL11">당사는 보고서 작성기준일 현재 계열회사는 당사를 포함하여 5개사이며, 기업집단의 명칭은 대화제약입니다.</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="695">

<COLGROUP>
<COL WIDTH="171"></COL>
<COL WIDTH="125"></COL>
<COL WIDTH="212"></COL>
<COL WIDTH="151"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="180" VALIGN="BOTTOM" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">회 사 명</TH>
<TH WIDTH="134" VALIGN="BOTTOM" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">법인번호</TH>
<TH WIDTH="221" VALIGN="BOTTOM" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">주 업 종</TH>
<TH WIDTH="160" VALIGN="BOTTOM" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">구   분</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="180" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">대화제약(주)</TD>
<TD WIDTH="134" VALIGN="MIDDLE" HEIGHT="30">211111-0001529</TD>
<TD WIDTH="221" VALIGN="MIDDLE" HEIGHT="30">연구개발, 의약품 제조 판매</TD>
<TD WIDTH="160" VALIGN="MIDDLE" HEIGHT="30">코스닥상장</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="180" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">디에이치호림(주)</TD>
<TD WIDTH="134" VALIGN="MIDDLE" HEIGHT="30">110111-3681362</TD>
<TD WIDTH="221" VALIGN="MIDDLE" HEIGHT="30">완제의약품 도소매</TD>
<TD WIDTH="160" VALIGN="MIDDLE" HEIGHT="30">비상장</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="180" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">(주)스페셜라이즈드메드</TD>
<TD WIDTH="134" VALIGN="MIDDLE" HEIGHT="30">110111-2659245</TD>
<TD WIDTH="221" VALIGN="MIDDLE" HEIGHT="30">의료정보시스템 컨텐츠 서비스</TD>
<TD WIDTH="160" VALIGN="MIDDLE" HEIGHT="30">비상장</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="180" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">S&V Technologies GmbH</TD>
<TD WIDTH="134" VALIGN="MIDDLE" HEIGHT="30">HRB 10630 NP</TD>
<TD WIDTH="221" VALIGN="MIDDLE" HEIGHT="30">화장품 및 의료기기 제조</TD>
<TD WIDTH="160" VALIGN="MIDDLE" HEIGHT="30">비상장(해외법인)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="180" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER" USERMARK="F-9">BSC Medical Devices  GmbH</TD>
<TD WIDTH="134" VALIGN="MIDDLE" HEIGHT="30">HRB 173696</TD>
<TD WIDTH="221" VALIGN="MIDDLE" HEIGHT="30">의료기기제조 및 판매</TD>
<TD WIDTH="160" VALIGN="MIDDLE" HEIGHT="30">비상장(해외법인)</TD>
</TR>
</TBODY>
</TABLE>

<P>&cr;
<SPAN USERMARK="F-16"></SPAN>
<SPAN USERMARK="F-GL16"></SPAN>
<SPAN USERMARK="F-GL16"></SPAN>
<SPAN USERMARK="F-GL16 0XC00000"></SPAN>
<SPAN USERMARK="F-GL16 0XC00000 B">2. 계열회사간 계통도&cr;</SPAN>
</P>

<TABLE ACLASS="NORMAL" WIDTH="1184" BORDER="0" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="1175"></COL>
</COLGROUP>

<TBODY ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="1184" HEIGHT="33">(기준일 : 2020년 12월 31일 현재)                                                                                                                                                                               (단위 : 주)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="1184">

<COLGROUP>
<COL WIDTH="126"></COL>
<COL WIDTH="75"></COL>
<COL WIDTH="77"></COL>
<COL WIDTH="75"></COL>
<COL WIDTH="77"></COL>
<COL WIDTH="85"></COL>
<COL WIDTH="74"></COL>
<COL WIDTH="83"></COL>
<COL WIDTH="77"></COL>
<COL WIDTH="77"></COL>
<COL WIDTH="82"></COL>
<COL WIDTH="77"></COL>
<COL WIDTH="82"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="135" HEIGHT="30" ALIGN="CENTER" VALIGN="BOTTOM" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">피출자회사</TH>
<TH WIDTH="170" HEIGHT="30" COLSPAN="2" ALIGN="CENTER" VALIGN="BOTTOM" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">대화제약(주) </TH>
<TH WIDTH="170" HEIGHT="30" COLSPAN="2" ALIGN="CENTER" VALIGN="BOTTOM" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">디에이치호림(주)</TH>
<TH WIDTH="177" HEIGHT="30" COLSPAN="2" ALIGN="CENTER" VALIGN="BOTTOM" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">(주)스페셜라이즈드메드</TH>
<TH WIDTH="178" HEIGHT="30" COLSPAN="2" ALIGN="CENTER" VALIGN="BOTTOM" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">(주)리독스바이오</TH>
<TH WIDTH="177" HEIGHT="30" COLSPAN="2" ALIGN="CENTER" VALIGN="BOTTOM" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">S&V Technologies GmbH</TH>
<TH WIDTH="177" HEIGHT="30" COLSPAN="2" ALIGN="CENTER" VALIGN="BOTTOM" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" USERMARK="F-9">BSC Medical Devices  GmbH</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="135" HEIGHT="30" ALIGN="CENTER" VALIGN="BOTTOM" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">출자회사</TH>
<TH WIDTH="84" HEIGHT="30" ALIGN="CENTER" VALIGN="BOTTOM" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">소유주식</TH>
<TH WIDTH="86" HEIGHT="30" ALIGN="CENTER" VALIGN="BOTTOM" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">지분율(%)</TH>
<TH WIDTH="84" HEIGHT="30" ALIGN="CENTER" VALIGN="BOTTOM" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">소유주식</TH>
<TH WIDTH="86" HEIGHT="30" ALIGN="CENTER" VALIGN="BOTTOM" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">지분율(%)</TH>
<TH WIDTH="94" HEIGHT="30" ALIGN="CENTER" VALIGN="BOTTOM" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">소유주식</TH>
<TH WIDTH="83" HEIGHT="30" ALIGN="CENTER" VALIGN="BOTTOM" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">지분율(%)</TH>
<TH WIDTH="92" HEIGHT="30" ALIGN="CENTER" VALIGN="BOTTOM" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">소유주식</TH>
<TH WIDTH="86" HEIGHT="30" ALIGN="CENTER" VALIGN="BOTTOM" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">지분율(%)</TH>
<TH WIDTH="86" HEIGHT="30" ALIGN="CENTER" VALIGN="BOTTOM" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">소유주식</TH>
<TH WIDTH="91" HEIGHT="30" ALIGN="CENTER" VALIGN="BOTTOM" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">지분율(%)</TH>
<TH WIDTH="86" HEIGHT="30" ALIGN="CENTER" VALIGN="BOTTOM" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">소유주식</TH>
<TH WIDTH="91" HEIGHT="30" ALIGN="CENTER" VALIGN="BOTTOM" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">지분율(%)</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="135" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">대화제약(주)</TD>
<TD WIDTH="84" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">-</TD>
<TD WIDTH="86" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">-</TD>
<TD WIDTH="84" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">5,435,820</TD>
<TD WIDTH="86" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">63.91</TD>
<TD WIDTH="94" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">136,471 </TD>
<TD WIDTH="83" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">56.86 </TD>
<TD WIDTH="92" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">14,810,770</TD>
<TD WIDTH="86" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">60.18</TD>
<TD WIDTH="86" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">- </TD>
<TD WIDTH="91" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">60.00</TD>
<TD WIDTH="86" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">- </TD>
<TD WIDTH="91" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">60.00</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="135" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">디에이치호림(주)</TD>
<TD WIDTH="84" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">-</TD>
<TD WIDTH="86" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">-</TD>
<TD WIDTH="84" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">- </TD>
<TD WIDTH="86" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">- </TD>
<TD WIDTH="94" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">10,501 </TD>
<TD WIDTH="83" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">4.38 </TD>
<TD WIDTH="92" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">- </TD>
<TD WIDTH="86" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">- </TD>
<TD WIDTH="86" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">- </TD>
<TD WIDTH="91" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">- </TD>
<TD WIDTH="86" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">- </TD>
<TD WIDTH="91" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">- </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="135" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">(주)리독스바이오</TD>
<TD WIDTH="84" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">-</TD>
<TD WIDTH="86" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">-</TD>
<TD WIDTH="84" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">-</TD>
<TD WIDTH="86" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">-</TD>
<TD WIDTH="94" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">-</TD>
<TD WIDTH="83" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">-</TD>
<TD WIDTH="92" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">- </TD>
<TD WIDTH="86" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">- </TD>
<TD WIDTH="86" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">- </TD>
<TD WIDTH="91" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">40.00</TD>
<TD WIDTH="86" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">- </TD>
<TD WIDTH="91" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">40.00</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN></SPAN>&cr;
<SPAN USERMARK="F-GL"></SPAN>
<SPAN USERMARK="F-GL16"></SPAN>
<SPAN USERMARK="F-GL16 0XC00000 B">3. 회사와 계열회사간 임원 겸직 현황&cr;</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="599">

<COLGROUP>
<COL WIDTH="96"></COL>
<COL WIDTH="186"></COL>
<COL WIDTH="170"></COL>
<COL WIDTH="111"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="105" VALIGN="BOTTOM" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">성    명</TH>
<TH WIDTH="195" VALIGN="BOTTOM" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">겸직회사</TH>
<TH WIDTH="179" VALIGN="BOTTOM" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">직    책</TH>
<TH WIDTH="120" VALIGN="BOTTOM" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">비    고</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD ROWSPAN="2" WIDTH="105" VALIGN="MIDDLE" HEIGHT="60" ALIGN="CENTER">이한구</TD>
<TD WIDTH="195" VALIGN="MIDDLE" HEIGHT="30">대화제약(주)</TD>
<TD WIDTH="179" VALIGN="MIDDLE" HEIGHT="30">자문위원(미등기임원)</TD>
<TD WIDTH="120" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">상근</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="195" VALIGN="MIDDLE" HEIGHT="30">(주)리독스바이오</TD>
<TD WIDTH="179" VALIGN="MIDDLE" HEIGHT="30">대표이사(등기임원)</TD>
<TD WIDTH="120" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">상근</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ROWSPAN="4" WIDTH="105" VALIGN="MIDDLE" HEIGHT="120" ALIGN="CENTER">김수지</TD>
<TD WIDTH="195" VALIGN="MIDDLE" HEIGHT="30">대화제약(주)</TD>
<TD WIDTH="179" VALIGN="MIDDLE" HEIGHT="30">자문위원(미등기임원)</TD>
<TD WIDTH="120" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">상근</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="195" VALIGN="MIDDLE" HEIGHT="30">디에이치호림(주)</TD>
<TD WIDTH="179" VALIGN="MIDDLE" HEIGHT="30">대표이사(등기임원)</TD>
<TD WIDTH="120" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">상근</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="195" VALIGN="MIDDLE" HEIGHT="30">(주)스페셜라이즈드메드</TD>
<TD WIDTH="179" VALIGN="MIDDLE" HEIGHT="30">대표이사(등기임원)</TD>
<TD WIDTH="120" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">상근</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="195" VALIGN="MIDDLE" HEIGHT="30">(주)리독스바이오</TD>
<TD WIDTH="179" VALIGN="MIDDLE" HEIGHT="30">대표이사(등기임원)</TD>
<TD WIDTH="120" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">비상근</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="105" VALIGN="MIDDLE" HEIGHT="60" ROWSPAN="2" ALIGN="CENTER">김은석</TD>
<TD WIDTH="195" VALIGN="MIDDLE" HEIGHT="30">대화제약(주)</TD>
<TD WIDTH="179" VALIGN="MIDDLE" HEIGHT="30">대표이사(등기임원)</TD>
<TD WIDTH="120" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">상근</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="195" VALIGN="MIDDLE" HEIGHT="30">(주)리독스바이오</TD>
<TD WIDTH="179" VALIGN="MIDDLE" HEIGHT="30">사내이사(등기임원)</TD>
<TD WIDTH="120" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">비상근</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ROWSPAN="4" WIDTH="105" VALIGN="MIDDLE" HEIGHT="120" ALIGN="CENTER">강효원</TD>
<TD WIDTH="195" VALIGN="MIDDLE" HEIGHT="30">대화제약(주)</TD>
<TD WIDTH="179" VALIGN="MIDDLE" HEIGHT="30">감사(등기임원)</TD>
<TD WIDTH="120" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">상근</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="195" VALIGN="MIDDLE" HEIGHT="30">디에이치호림(주)</TD>
<TD WIDTH="179" VALIGN="MIDDLE" HEIGHT="30">감사(등기임원)</TD>
<TD WIDTH="120" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">비상근</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="195" VALIGN="MIDDLE" HEIGHT="30">(주)스페셜라이즈드메드</TD>
<TD WIDTH="179" VALIGN="MIDDLE" HEIGHT="30">감사(등기임원)</TD>
<TD WIDTH="120" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">비상근</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="195" VALIGN="MIDDLE" HEIGHT="30">(주)리독스바이오</TD>
<TD WIDTH="179" VALIGN="MIDDLE" HEIGHT="30">감사(등기임원)</TD>
<TD WIDTH="120" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">비상근</TD>
</TR>
</TBODY>
</TABLE>

<P>&cr;&cr;
<SPAN USERMARK="F-GL"></SPAN>
<SPAN USERMARK="F-GL16"></SPAN>
<SPAN USERMARK="F-GL16"></SPAN>
<SPAN USERMARK="F-GL16 0XC00000"></SPAN>
<SPAN USERMARK="F-GL16 0XC00000 B">4. 회</SPAN>
<SPAN USERMARK="F-GL16 0XC00000 B">사의 경영에 영향력을 미치는 회사&cr;</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="361">

<COLGROUP>
<COL WIDTH="147"></COL>
<COL WIDTH="196"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="156" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">구 분</TH>
<TH WIDTH="205" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">내 용</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="156" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">법인명</TD>
<TD WIDTH="205" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">대화제약(주)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="156" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>대표자</P>
</TD>
<TD WIDTH="205" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">노병태, 김은석</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="156" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>설립일</P>
</TD>

<TD WIDTH="205" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>1984년 1월 19일</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="156" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>결산기</P>
</TD>

<TD WIDTH="205" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>12월</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="156" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>업종</P>
</TD>
<TD WIDTH="205" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">의약품 제조업</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="156" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>주제품</P>
</TD>
<TD WIDTH="205" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">의약품</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="156" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>회사와의관계</P>
</TD>
<TD WIDTH="205" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">계열회사(지배회사)</TD>
</TR>
</TBODY>
</TABLE>

<INSERTION ABASISNUMBER="SE1" AFREQUENCY="0" ADUPLICATION="N">
<COMMENT>◆click◆『타법인출자 현황』 삽입</COMMENT>
<LIBRARYLIST>11011#*타법인출자현황.dsl</LIBRARYLIST>
</INSERTION>
<PGBRK></PGBRK>
</SECTION-1>

<SECTION-1 ACLASS="MANDATORY" APARTSOURCE="SOURCE">
<TITLE ATOC="Y" AASSOCNOTE="D-0-10-0-0">X. 이해관계자와의 거래내용</TITLE>
<P></P>

<P>
<SPAN USERMARK="F-GL16 0XC00000 B">1. 대주주등에 대한 신용공여등&cr;</SPAN>
<SPAN USERMARK="F-GL11">보고서 작성기준일 현재 대주주 등에 대한 신용공여 등 기타의 거래관계가 없습니다.&cr;</SPAN>&cr;
<SPAN USERMARK="F-16"></SPAN>
<SPAN USERMARK="F-GL16"></SPAN>
<SPAN USERMARK="F-GL16 0XC00000"></SPAN>
<SPAN USERMARK="F-GL16 0XC00000 B">2. 대주주와의 자산양수도 등&cr;</SPAN>
</P>

<P>
<SPAN USERMARK="F-GL11">당사는 2016년 08월 29일자로 포괄적인 현물출자 방식에 의하여 합성원료사업부문에관한일체의 권리와 의무를 대화제약(주)으로부터 양수하였습니다.&cr;- 양수도기준 일자 : 2016년 08월 29일&cr;- 양수도방법 : 합성원료사업에 관한 일체의 권리와 의무를 (주)리독스바이오에게 포괄적으로 현물출자&cr;- 현물출자 가액의 결정&cr;</SPAN>
<SPAN USERMARK="F-GL11">&cr;① 감정평가법인의 감정가액</SPAN>
</P>

<TABLE BORDER="1" WIDTH="445" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="214"></COL>
<COL WIDTH="213"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="223" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">구  분</TH>
<TH WIDTH="222" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">감정가액(천원)</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="223" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">토  지</TD>
<TD WIDTH="222" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">               2,517,972 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="223" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">건  물</TD>
<TD WIDTH="222" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">               1,615,100 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="223" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">기  계</TD>
<TD WIDTH="222" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">                 152,358 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="223" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">계</TD>
<TD WIDTH="222" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">              4,285,430 </TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK="F-GL11">&cr;② 전항 이외의 자산, 부채는 장부가를 기준으로 평가 : 감정인(공인회계사)의 조사보고</P>

<TABLE BORDER="1" WIDTH="447" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="215"></COL>
<COL WIDTH="214"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="224" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">구    분</TH>
<TH WIDTH="223" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">감정가액(천원)</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="224" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">특허권</TD>
<TD WIDTH="223" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">                    5,866 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="224" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">원재료</TD>
<TD WIDTH="223" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">                  41,390 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="224" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">예   금</TD>
<TD WIDTH="223" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">                         1 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="224" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">계</TD>
<TD WIDTH="223" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">                  47,257 </TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK="F-GL11">- 현물출자 인가일자 : 2016년 08월 03일, 수원지방법원&cr;- 현물출자 가액 : 4,332,687천원&cr;</SPAN>
<SPAN USERMARK="F-11">&cr;</SPAN>
<SPAN USERMARK="F-16"></SPAN>
<SPAN USERMARK="F-GL16"></SPAN>
<SPAN USERMARK="F-GL16 0XC00000"></SPAN>
<SPAN USERMARK="F-GL16 0XC00000 B">3. 대주주와의 영업거래&cr;                                                             </SPAN>
<SPAN USERMARK="F-GL">    (단위:천원)</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="600">

<COLGROUP>
<COL WIDTH="119"></COL>
<COL WIDTH="96"></COL>
<COL WIDTH="95"></COL>
<COL WIDTH="80"></COL>
<COL WIDTH="81"></COL>
<COL WIDTH="75"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="128" VALIGN="BOTTOM" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">특수관계자 구분</TH>
<TH WIDTH="105" VALIGN="BOTTOM" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">회사명</TH>
<TH WIDTH="104" VALIGN="BOTTOM" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">구분</TH>
<TH WIDTH="89" VALIGN="BOTTOM" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">당분기말</TH>
<TH WIDTH="90" VALIGN="BOTTOM" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">전기말</TH>
<TH WIDTH="84" VALIGN="BOTTOM" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">관계</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD ROWSPAN="4" VALIGN="MIDDLE" WIDTH="128" HEIGHT="120" ALIGN="CENTER">지배회사</TD>
<TD ROWSPAN="4" WIDTH="105" VALIGN="MIDDLE" HEIGHT="120" ALIGN="CENTER">대화제약(주)</TD>
<TD WIDTH="104" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">매출</TD>
<TD WIDTH="89" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30">4,767,983</TD>
<TD WIDTH="90" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30">8,195,138</TD>
<TD ROWSPAN="4" WIDTH="84" VALIGN="MIDDLE" HEIGHT="120" ALIGN="CENTER">지배주주</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="104" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">매입</TD>
<TD WIDTH="89" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="90" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="104" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">단기대여금</TD>
<TD WIDTH="89" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="90" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="104" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">미수수익</TD>
<TD WIDTH="89" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="90" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30">-</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK=" 0XC00000">&cr;</SPAN>
<SPAN USERMARK="F-GL 0XC00000"></SPAN>
<SPAN USERMARK="F-GL16 0XC00000"></SPAN>
<SPAN USERMARK="F-GL16 0XC00000 B">4. 대주주 이외의 이해관계자의 거래&cr;</SPAN>
<SPAN USERMARK="F-GL16 0XC00000 B">                                                           </SPAN>
<SPAN USERMARK="F-GL">    (단위:천원)</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="572">

<COLGROUP>
<COL WIDTH="119"></COL>
<COL WIDTH="174"></COL>
<COL WIDTH="84"></COL>
<COL WIDTH="75"></COL>
<COL WIDTH="75"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="128" VALIGN="BOTTOM" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">특수관계자 구분</TH>
<TH WIDTH="183" VALIGN="BOTTOM" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">회사명</TH>
<TH WIDTH="93" VALIGN="BOTTOM" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">구분</TH>
<TH WIDTH="84" VALIGN="BOTTOM" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">당분기말</TH>
<TH WIDTH="84" VALIGN="BOTTOM" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">전기말</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD ROWSPAN="3" VALIGN="MIDDLE" WIDTH="128" HEIGHT="90" ALIGN="CENTER">기타</TD>
<TD WIDTH="183" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">디에이치호림(주)</TD>
<TD WIDTH="93" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">매입</TD>
<TD WIDTH="84" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30">3,960</TD>
<TD WIDTH="84" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30">2,134</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="183" VALIGN="MIDDLE" HEIGHT="60" ALIGN="CENTER" ROWSPAN="2">S&V Technologies GmbH</TD>
<TD WIDTH="93" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">매출</TD>
<TD WIDTH="84" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30">18,804</TD>
<TD WIDTH="84" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30">5,571</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="93" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">매입</TD>
<TD WIDTH="84" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">1,510,292</TD>
<TD WIDTH="84" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">1,755,256</TD>
</TR>
</TBODY>
</TABLE>
<PGBRK></PGBRK>
</SECTION-1>

<SECTION-1 ACLASS="MANDATORY" APARTSOURCE="SOURCE">
<TITLE ATOC="Y" AASSOCNOTE="D-0-11-0-0">XI. 그 밖에 투자자 보호를 위하여 필요한 사항</TITLE>

<P>
<SPAN USERMARK="F-GL16 0XFF0016 B">&cr;1</SPAN>
<SPAN USERMARK="F-GL16 0XFF0016 B"></SPAN>
<SPAN USERMARK="F-GL16 0XFF0016 B"></SPAN>
<SPAN USERMARK="F-GL16 0XFF0016 B"></SPAN>
<SPAN USERMARK="F-GL16 0XFF0016 B">. 공</SPAN>
<SPAN USERMARK="F-GL16 0XFF0016 B">시내용의 진행 ·변경 상황&cr;</SPAN>
<SPAN USERMARK="F-DU"></SPAN>
<SPAN USERMARK="F-GL11 B"></SPAN>
<SPAN USERMARK="F-GL11">당사는 보고서 제출일 현재 해당사항 없습니다.&cr;</SPAN>
<SPAN USERMARK="F-GL16 0XFF0016 B"></SPAN>
<SPAN USERMARK="F-GL16 0XFF0016 B"></SPAN>
<SPAN USERMARK="F-GL16 0XFF0016 B"></SPAN>
<SPAN USERMARK="F-GL16 0XFF0016 B">&cr;2. 주주총회 의사록 요약</SPAN>
<SPAN USERMARK="F-GL16 0XFF0016 B">&cr;</SPAN>
<SPAN USERMARK=" B"></SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="727">

<COLGROUP>
<COL WIDTH="83"></COL>
<COL WIDTH="99"></COL>
<COL WIDTH="369"></COL>
<COL WIDTH="140"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="92" VALIGN="BOTTOM" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">개최일자</TH>
<TH WIDTH="108" VALIGN="BOTTOM" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">회차</TH>
<TH WIDTH="378" VALIGN="BOTTOM" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">의 안 내 용</TH>
<TH WIDTH="149" VALIGN="BOTTOM" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">가결 여부</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="92" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="46">2020.11.24</TD>
<TD WIDTH="108" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="46">임시주주총회</TD>
<TD WIDTH="378" VALIGN="MIDDLE" HEIGHT="46">1. 이사 선임의 건</TD>
<TD WIDTH="149" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="46">원안대로 승인 가결</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="92" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">2020.03.26</TD>
<TD WIDTH="108" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">제10기&cr;정기주주총회</TD>
<TD WIDTH="378" VALIGN="MIDDLE" HEIGHT="76">1. 제10기 재무제표 및 결손금처리계산서(안)승인의 건&cr;2. 이사보수한도 승인의 건&cr;3. 감사보수한도 승인의 건</TD>
<TD WIDTH="149" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">원안대로 승인 가결</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="92" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="46">2019.09.26</TD>
<TD WIDTH="108" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="46">임시주주총회</TD>
<TD WIDTH="378" VALIGN="MIDDLE" HEIGHT="46">1. 이사 선임의 건</TD>
<TD WIDTH="149" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="46">원안대로 승인 가결</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="92" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="145">2019.03.22</TD>
<TD WIDTH="108" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="145">제9기&cr;정기주주총회</TD>
<TD WIDTH="378" VALIGN="MIDDLE" HEIGHT="145">1. 제9기 재무제표 및 결손금처리계산서(안)승인의 건&cr;2. 이사 선임의 건&cr;3. 감사 선임의 건&cr;4. 정관 일부 변경의 건&cr;5. 이사보수한도 승인의 건&cr;6. 감사보수한도 승인의 건</TD>
<TD WIDTH="149" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="145">원안대로 승인 가결</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="92" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">2018.03.30</TD>
<TD WIDTH="108" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">제8기&cr;정기주주총회</TD>
<TD WIDTH="378" VALIGN="MIDDLE" HEIGHT="76">1. 제8기 재무제표 승인의 건&cr;2. 이사보수한도 승인의 건&cr;3. 감사보수한도 승인의 건</TD>
<TD WIDTH="149" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">원안대로 승인 가결</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="92" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">2017.11.24</TD>
<TD WIDTH="108" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">임시주주총회</TD>
<TD WIDTH="378" VALIGN="MIDDLE" HEIGHT="53">1. 이사 선임의 건&cr;2. 대표이사 선임의 건</TD>
<TD WIDTH="149" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">원안대로 승인 가결</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="92" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">2017.03.30</TD>
<TD WIDTH="108" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">제7기&cr;정기주주총회</TD>
<TD WIDTH="378" VALIGN="MIDDLE" HEIGHT="76">1. 제7기 재무제표 승인의 건&cr;2. 이사보수한도 승인의 건&cr;3. 감사보수한도 승인의 건</TD>
<TD WIDTH="149" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">원안대로 승인 가결</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="92" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">2016.09.26</TD>
<TD WIDTH="108" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">임시주주총회</TD>
<TD WIDTH="378" VALIGN="MIDDLE" HEIGHT="53">1. 정관 변경의 건&cr;2. 사내이사 선임의 건</TD>
<TD WIDTH="149" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">원안대로 승인 가결</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="92" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="99">2016.07.25</TD>
<TD WIDTH="108" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="99">임시주주총회</TD>
<TD WIDTH="378" VALIGN="MIDDLE" HEIGHT="99">1. 사업목적 추가의 건&cr;2. 공고방법 변경의 건&cr;3. 회사가 발행할 주식 총수 변경의 건&cr;4. 1주의 금액 변경의 건</TD>
<TD WIDTH="149" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="99">원안대로 승인 가결</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="92" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="145">2016.03.31</TD>
<TD WIDTH="108" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="145">제6기&cr;정기주주총회</TD>
<TD WIDTH="378" VALIGN="MIDDLE" HEIGHT="145"> 1. 제6기 재무제표 및 결손금처리계산서 승인의 건&cr; 2. 이사 선임의 건&cr; 3. 감사 선임의 건&cr; 4. 정관 일부 변경의 건&cr; 5. 이사보수한도 승인의 건&cr; 6. 감사보수한도 승인의 건</TD>
<TD WIDTH="149" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="145">원안대로 승인 가결</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="92" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="99">2015.03.31</TD>
<TD WIDTH="108" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="99">제5기&cr;정기주주총회</TD>
<TD WIDTH="378" VALIGN="MIDDLE" HEIGHT="99"> 1. 제5기 재무제표 및 결손금처리계산서 승인의 건&cr; 2. 이사 선임의 건&cr; 3. 이사보수한도 승인의 건&cr; 4. 감사보수한도 승인의 건</TD>
<TD WIDTH="149" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="99">원안대로 승인 가결</TD>
</TR>
</TBODY>
</TABLE>

<P>&cr;&cr;
<SPAN USERMARK="F-GL"></SPAN>
<SPAN USERMARK="F-GL16"></SPAN>
<SPAN USERMARK="F-GL16"></SPAN>
<SPAN USERMARK="F-GL16"></SPAN>
<SPAN USERMARK="F-GL16 0XC00000"></SPAN>
<SPAN USERMARK="F-GL16 0XC00000 B">3. 우발채무 등&cr;</SPAN>&cr;
<SPAN USERMARK="F-GL11"></SPAN>
<SPAN USERMARK="F-GL11 B">가. 중요한 소송사건 등&cr;</SPAN>
<SPAN USERMARK="F-GL11">당사는 보고서 제출일 현재 해당사항 없습니다.&cr;&cr;</SPAN>
<SPAN USERMARK="F-GL11 B">나. 견질 또는 담보용 어음, 수표 현황&cr;</SPAN>
<SPAN USERMARK="F-GL11">당사는 </SPAN>
<SPAN USERMARK="F-GL11"></SPAN>
<SPAN USERMARK="F-GL11">보고서 제출일 현재 해당사항 없습니다.&cr;&cr;</SPAN>
<SPAN USERMARK="F-GL11 B">다. 채무보증 현황&cr;</SPAN>
<SPAN USERMARK="F-GL11">당사는 </SPAN>
<SPAN USERMARK="F-GL11"></SPAN>
<SPAN USERMARK="F-GL11">보고서 제출일 현재 해당사항 없습니다.&cr;&cr;</SPAN>
<SPAN USERMARK="F-GL11 B">라. </SPAN>
<SPAN USERMARK="F-GL11 B">채</SPAN>
<SPAN USERMARK="F-GL11 B">무인수약정 현황</SPAN>
<SPAN USERMARK="F-GL11">&cr;당사는 </SPAN>
<SPAN USERMARK="F-GL11"></SPAN>
<SPAN USERMARK="F-GL11">보고서 제출일 현재 해당사항 없습니다.&cr;&cr;</SPAN>
<SPAN USERMARK="F-GL11 B">마. 기타의 우발채무 등&cr;</SPAN>
<SPAN USERMARK="F-GL11">&cr;(1) 보고기간종료일 현재 회사의 차입금 등과 관련하여 금융기관과 체결한 주요 약정사항은 다음과 같습니다.&cr;                                                                                                       (단위: 천원)</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="685">

<COLGROUP>
<COL WIDTH="201"></COL>
<COL WIDTH="159"></COL>
<COL WIDTH="137"></COL>
<COL WIDTH="152"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="210" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">약정사항</TH>
<TH WIDTH="168" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">약정금융기관</TH>
<TH WIDTH="146" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">한도액</TH>
<TH WIDTH="161" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">실행금액</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="210" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">시설자금대출</TD>
<TD WIDTH="168" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">기업은행</TD>
<TD WIDTH="146" HEIGHT="30" ALIGN="RIGHT">6,710,000</TD>
<TD WIDTH="161" HEIGHT="30" ALIGN="RIGHT">6,710,000</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="210" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">회전자금대출</TD>
<TD WIDTH="168" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">기업은행</TD>
<TD WIDTH="146" HEIGHT="30" ALIGN="RIGHT">400,000</TD>
<TD WIDTH="161" HEIGHT="30" ALIGN="RIGHT">340,000</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="210" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">기업자금대출</TD>
<TD WIDTH="168" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">기업은행</TD>
<TD WIDTH="146" HEIGHT="30" ALIGN="RIGHT">1,000,000</TD>
<TD WIDTH="161" HEIGHT="30" ALIGN="RIGHT">1,000,000</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK="F-GL11">&cr;</SPAN>
<SPAN USERMARK="F-GL11"></SPAN>
<SPAN USERMARK="F-GL11">(2) 타인으로부터 제공받고 있는 담보 및 지급보증의 내역은 없습니다.&cr;</SPAN>
<SPAN USERMARK="F-GL16 0XC00000 B">&cr;</SPAN>
<SPAN USERMARK="F-GL11 B">바. 자본으로 인정되는 채무증권의 발행&cr;</SPAN>
<SPAN USERMARK="F-GL11">당사는 </SPAN>
<SPAN USERMARK="F-GL11"></SPAN>
<SPAN USERMARK="F-GL11">보고서 제출일 현재 해당사항 없습니다.</SPAN>
<SPAN USERMARK="F-GL11 B">&cr;</SPAN>
<SPAN USERMARK="F-GL16 0XC00000 B">&cr;</SPAN>
<SPAN USERMARK="F-GL"></SPAN>
<SPAN USERMARK="F-GL16"></SPAN>
<SPAN USERMARK="F-GL16"></SPAN>
<SPAN USERMARK="F-GL16"></SPAN>
<SPAN USERMARK="F-GL16 0XC00000"></SPAN>
<SPAN USERMARK="F-GL16 0XC00000 B">4. 제재현황 등 그 밖의 사항&cr;&cr;</SPAN>
<SPAN USERMARK="F-GL11 B">가. 제재현황&cr;</SPAN>
<SPAN USERMARK="F-GL11">당사는 </SPAN>
<SPAN USERMARK="F-GL11"></SPAN>
<SPAN USERMARK="F-GL11">보고서 제출일 현재 해당사항 없습니다.</SPAN>
<SPAN USERMARK="F-GL11 B">&cr;</SPAN>
<SPAN USERMARK="F-GL16 0XC00000 B">&cr;</SPAN>
<SPAN USERMARK="F-GL11 B">나. 작성 기준일 이후 발생한 주요사항&cr;</SPAN>
<SPAN USERMARK="F-GL11">당사는 </SPAN>
<SPAN USERMARK="F-GL11"></SPAN>
<SPAN USERMARK="F-GL11">보고서 제출일 현재 해당사항 없습니다.</SPAN>
<SPAN USERMARK="F-GL11 B">&cr;</SPAN>
</P>

<P>
<SPAN USERMARK="F-GL11 B">다. 견질 또는 담보용 어음 ·수표 현황</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" WIDTH="600" BORDER="0">

<COLGROUP>
<COL WIDTH="291"></COL>
<COL WIDTH="291"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="BOTTOM" WIDTH="300" HEIGHT="30">(기준일 : - )</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="300" HEIGHT="30">(단위 : 원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" WIDTH="600" BORDER="1" FRAME="BORDER" RULES="ALL">

<COLGROUP>
<COL WIDTH="141"></COL>
<COL WIDTH="141"></COL>
<COL WIDTH="141"></COL>
<COL WIDTH="141"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="150" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">제 출 처</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="150" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">매 수</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="150" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">금 액</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="150" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">비 고</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" WIDTH="150" HEIGHT="30" VALIGN="MIDDLE">은 행</TD>
<TD ALIGN="RIGHT" WIDTH="150" HEIGHT="30" VALIGN="MIDDLE">-</TD>
<TD ALIGN="RIGHT" WIDTH="150" HEIGHT="30" VALIGN="MIDDLE">-</TD>
<TD ALIGN="CENTER" WIDTH="150" HEIGHT="30" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" WIDTH="150" HEIGHT="30" VALIGN="MIDDLE">금융기관(은행제외)</TD>
<TD ALIGN="RIGHT" WIDTH="150" HEIGHT="30" VALIGN="MIDDLE">-</TD>
<TD ALIGN="RIGHT" WIDTH="150" HEIGHT="30" VALIGN="MIDDLE">-</TD>
<TD ALIGN="CENTER" WIDTH="150" HEIGHT="30" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" WIDTH="150" HEIGHT="30" VALIGN="MIDDLE">법 인</TD>
<TD ALIGN="RIGHT" WIDTH="150" HEIGHT="30" VALIGN="MIDDLE">-</TD>
<TD ALIGN="RIGHT" WIDTH="150" HEIGHT="30" VALIGN="MIDDLE">-</TD>
<TD ALIGN="CENTER" WIDTH="150" HEIGHT="30" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" WIDTH="150" HEIGHT="30" VALIGN="MIDDLE">기타(개인)</TD>
<TD ALIGN="RIGHT" WIDTH="150" HEIGHT="30" VALIGN="MIDDLE">-</TD>
<TD ALIGN="RIGHT" WIDTH="150" HEIGHT="30" VALIGN="MIDDLE">-</TD>
<TD ALIGN="CENTER" WIDTH="150" HEIGHT="30" VALIGN="MIDDLE">-</TD>
</TR>
</TBODY>
</TABLE>

<INSERTION ABASISNUMBER="SE1" AFREQUENCY="0" ADUPLICATION="N">
<COMMENT>◆click◆『신용보강 제공 현황』 삽입</COMMENT>
<LIBRARYLIST>11011#*신용보강제공현황.dsl</LIBRARYLIST>
</INSERTION>

<INSERTION ABASISNUMBER="SE1" AFREQUENCY="0" ADUPLICATION="N">
<COMMENT>◆click◆『장래매출채권 유동화 현황 및 채무비중』 삽입</COMMENT>
<LIBRARYLIST>11011#*장래매출채권유동화현황및채무비중.dsl</LIBRARYLIST>
</INSERTION>

<INSERTION ABASISNUMBER="SE1" AFREQUENCY="0" ADUPLICATION="N">
<COMMENT>◆click◆『단기매매차익 미환수 현황』 삽입</COMMENT>
<LIBRARYLIST>11011#*단기매매차익미환수현황.dsl</LIBRARYLIST>
</INSERTION>

<INSERTION ABASISNUMBER="SE1" AFREQUENCY="1" ADUPLICATION="N">
<COMMENT>◆click◆『공모자금의 사용내역』 삽입</COMMENT>
<LIBRARYLIST>11011#*공모자금의사용내역.dsl</LIBRARYLIST>

<LIBRARY>
<FILENAME ATYPE="dsl">18_공모자금의사용내역</FILENAME>

<P>
<SPAN USERMARK="F-GL11 B">라. </SPAN>
<SPAN USERMARK="F-GL11 B"></SPAN>
<SPAN USERMARK="F-DU11 B">공</SPAN>
<SPAN USERMARK="F-DU B">모자금의 사용내역</SPAN>
</P>

<TABLE-GROUP ACLASS="FUND" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="Y" WIDTH="904" BORDER="0">

<COLGROUP>
<COL WIDTH="71"></COL>
<COL WIDTH="143"></COL>
<COL WIDTH="59"></COL>
<COL WIDTH="595"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD VALIGN="BOTTOM" WIDTH="80" HEIGHT="30" AUPDATECONT="N">(기준일 : </TD>
<TU ALIGN="CENTER" VALIGN="BOTTOM" WIDTH="152" HEIGHT="30" AUNIT="BASE_DT" AUNITVALUE="20201231">2020년 12월 31일</TU>
<TD VALIGN="BOTTOM" WIDTH="68" HEIGHT="30" AUPDATECONT="N">)</TD>
<TU ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="604" HEIGHT="30" AUNIT="WON" AUNITVALUE="2">(단위 : 천원)</TU>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="903" BORDER="1" FRAME="BORDER" RULES="ALL">

<COLGROUP>
<COL WIDTH="137"></COL>
<COL WIDTH="39"></COL>
<COL WIDTH="128"></COL>
<COL WIDTH="69"></COL>
<COL WIDTH="75"></COL>
<COL WIDTH="69"></COL>
<COL WIDTH="75"></COL>
<COL WIDTH="239"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="N" ADELETE="N">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="146" HEIGHT="83" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ROWSPAN="2">구 분</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="48" HEIGHT="83" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ROWSPAN="2">회차</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="137" HEIGHT="83" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ROWSPAN="2">납입일</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="162" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" COLSPAN="2">증권신고서 등의&cr; 자금사용 계획</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="162" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" COLSPAN="2">실제 자금사용&cr; 내역</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="248" HEIGHT="83" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ROWSPAN="2">차이발생 사유 등</TH>
</TR>

<TR ACOPY="N" ADELETE="N">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="78" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">사용용도</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="84" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">조달금액</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="78" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">내용</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="84" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">금액</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="N">
<TE ALIGN="CENTER" WIDTH="146" HEIGHT="30" ACODE="PO_TYPE" VALIGN="MIDDLE">제3자배정유상증자</TE>
<TE ALIGN="CENTER" WIDTH="48" HEIGHT="30" ACODE="MO_SEQ" VALIGN="MIDDLE">-</TE>
<TU ALIGN="CENTER" WIDTH="137" HEIGHT="30" AUNIT="PYM_DT" VALIGN="MIDDLE" AUNITVALUE="20161215">2016년 12월 15일</TU>
<TE ALIGN="RIGHT" WIDTH="78" HEIGHT="30" ACODE="PLA_USE" VALIGN="MIDDLE">운영자금</TE>
<TE ALIGN="RIGHT" WIDTH="84" HEIGHT="30" ACODE="PLA_AMT" VALIGN="MIDDLE">5,861,498</TE>
<TE ALIGN="CENTER" WIDTH="78" HEIGHT="30" ACODE="BRK_CON" VALIGN="MIDDLE">운영자금</TE>
<TE ALIGN="RIGHT" WIDTH="84" HEIGHT="30" ACODE="BRK_AMT" VALIGN="MIDDLE">4,672,944</TE>
<TE ALIGN="CENTER" WIDTH="248" HEIGHT="30" ACODE="PS_AMT_PL" VALIGN="MIDDLE">공모자금 사용 계획에 따라 진행중</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" WIDTH="146" HEIGHT="30" ACODE="PO_TYPE" VALIGN="MIDDLE">제3자배정유상증자</TE>
<TE ALIGN="CENTER" WIDTH="48" HEIGHT="30" ACODE="MO_SEQ" VALIGN="MIDDLE">-</TE>
<TU ALIGN="CENTER" WIDTH="137" HEIGHT="30" AUNIT="PYM_DT" VALIGN="MIDDLE" AUNITVALUE="20161215">2016년 12월 15일</TU>
<TE ALIGN="RIGHT" WIDTH="78" HEIGHT="30" ACODE="PLA_USE" VALIGN="MIDDLE">기타</TE>
<TE ALIGN="RIGHT" WIDTH="84" HEIGHT="30" ACODE="PLA_AMT" VALIGN="MIDDLE">4,085,002</TE>
<TE ALIGN="CENTER" WIDTH="78" HEIGHT="30" ACODE="BRK_CON" VALIGN="MIDDLE">기타</TE>
<TE ALIGN="RIGHT" WIDTH="84" HEIGHT="30" ACODE="BRK_AMT" VALIGN="MIDDLE">3,736,865</TE>
<TE ALIGN="CENTER" WIDTH="248" HEIGHT="30" ACODE="PS_AMT_PL" VALIGN="MIDDLE">공모자금 사용 계획에 따라 진행중</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
</LIBRARY>
</INSERTION>

<INSERTION ABASISNUMBER="SE1" AFREQUENCY="0" ADUPLICATION="N">
<COMMENT>◆click◆『사모자금의 사용내역』 삽입</COMMENT>
<LIBRARYLIST>11011#*사모자금의사용내역.dsl</LIBRARYLIST>
</INSERTION>

<INSERTION ABASISNUMBER="SE1" AFREQUENCY="0" ADUPLICATION="N">
<COMMENT>◆click◆『미사용자금의 운용내역』 삽입</COMMENT>
<LIBRARYLIST>11011#*미사용자금의운용내역.dsl</LIBRARYLIST>
</INSERTION>

<P>
<SPAN USERMARK="F-GL11 B">마. </SPAN>
<SPAN USERMARK="F-GL11 B"></SPAN>
<SPAN USERMARK="F-DU B">외국지주회사의 자회사 현황</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" WIDTH="700" BORDER="0">

<COLGROUP>
<COL WIDTH="291"></COL>
<COL WIDTH="391"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="BOTTOM" WIDTH="300" HEIGHT="30">(기준일 : - )</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="400" HEIGHT="30">(단위 : 원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" WIDTH="701" BORDER="1" FRAME="BORDER" RULES="ALL">

<COLGROUP>
<COL WIDTH="134"></COL>
<COL WIDTH="71"></COL>
<COL WIDTH="71"></COL>
<COL WIDTH="71"></COL>
<COL WIDTH="71"></COL>
<COL WIDTH="71"></COL>
<COL WIDTH="70"></COL>
<COL WIDTH="70"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="143" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구 분</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="80" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">A지주회사</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="80" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">B법인</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="80" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">C법인</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="80" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">D법인</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="80" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">...</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="79" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">연결조정</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="79" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">연결 후&cr;금액</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="143" HEIGHT="30" VALIGN="MIDDLE">매출액</TD>
<TD ALIGN="RIGHT" WIDTH="80" HEIGHT="30" VALIGN="MIDDLE">-</TD>
<TD ALIGN="RIGHT" WIDTH="80" HEIGHT="30" VALIGN="MIDDLE">-</TD>
<TD ALIGN="RIGHT" WIDTH="80" HEIGHT="30" VALIGN="MIDDLE">-</TD>
<TD ALIGN="RIGHT" WIDTH="80" HEIGHT="30" VALIGN="MIDDLE">-</TD>
<TD ALIGN="RIGHT" WIDTH="80" HEIGHT="30" VALIGN="MIDDLE">-</TD>
<TD ALIGN="RIGHT" WIDTH="79" HEIGHT="30" VALIGN="MIDDLE">( -    )</TD>
<TD ALIGN="RIGHT" WIDTH="79" HEIGHT="30" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="143" HEIGHT="30" VALIGN="MIDDLE">  내부 매출액</TD>
<TD ALIGN="RIGHT" WIDTH="80" HEIGHT="30" VALIGN="MIDDLE">(   -  )</TD>
<TD ALIGN="RIGHT" WIDTH="80" HEIGHT="30" VALIGN="MIDDLE">(    - )</TD>
<TD ALIGN="RIGHT" WIDTH="80" HEIGHT="30" VALIGN="MIDDLE">(    - )</TD>
<TD ALIGN="RIGHT" WIDTH="80" HEIGHT="30" VALIGN="MIDDLE">(    - )</TD>
<TD ALIGN="RIGHT" WIDTH="80" HEIGHT="30" VALIGN="MIDDLE">(    - )</TD>
<TD ALIGN="RIGHT" WIDTH="79" HEIGHT="30" VALIGN="MIDDLE">-</TD>
<TD ALIGN="RIGHT" WIDTH="79" HEIGHT="30" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="143" HEIGHT="30" VALIGN="MIDDLE">  순 매출액</TD>
<TD ALIGN="RIGHT" WIDTH="80" HEIGHT="30" VALIGN="MIDDLE">-</TD>
<TD ALIGN="RIGHT" WIDTH="80" HEIGHT="30" VALIGN="MIDDLE">-</TD>
<TD ALIGN="RIGHT" WIDTH="80" HEIGHT="30" VALIGN="MIDDLE">-</TD>
<TD ALIGN="RIGHT" WIDTH="80" HEIGHT="30" VALIGN="MIDDLE">-</TD>
<TD ALIGN="RIGHT" WIDTH="80" HEIGHT="30" VALIGN="MIDDLE">-</TD>
<TD ALIGN="RIGHT" WIDTH="79" HEIGHT="30" VALIGN="MIDDLE">-</TD>
<TD ALIGN="RIGHT" WIDTH="79" HEIGHT="30" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="143" HEIGHT="30" VALIGN="MIDDLE">영업손익</TD>
<TD ALIGN="RIGHT" WIDTH="80" HEIGHT="30" VALIGN="MIDDLE">-</TD>
<TD ALIGN="RIGHT" WIDTH="80" HEIGHT="30" VALIGN="MIDDLE">-</TD>
<TD ALIGN="RIGHT" WIDTH="80" HEIGHT="30" VALIGN="MIDDLE">-</TD>
<TD ALIGN="RIGHT" WIDTH="80" HEIGHT="30" VALIGN="MIDDLE">-</TD>
<TD ALIGN="RIGHT" WIDTH="80" HEIGHT="30" VALIGN="MIDDLE">-</TD>
<TD ALIGN="RIGHT" WIDTH="79" HEIGHT="30" VALIGN="MIDDLE">(  -   )</TD>
<TD ALIGN="RIGHT" WIDTH="79" HEIGHT="30" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="143" HEIGHT="30" VALIGN="MIDDLE">계속사업손익</TD>
<TD ALIGN="RIGHT" WIDTH="80" HEIGHT="30" VALIGN="MIDDLE">-</TD>
<TD ALIGN="RIGHT" WIDTH="80" HEIGHT="30" VALIGN="MIDDLE">-</TD>
<TD ALIGN="RIGHT" WIDTH="80" HEIGHT="30" VALIGN="MIDDLE">-</TD>
<TD ALIGN="RIGHT" WIDTH="80" HEIGHT="30" VALIGN="MIDDLE">-</TD>
<TD ALIGN="RIGHT" WIDTH="80" HEIGHT="30" VALIGN="MIDDLE">-</TD>
<TD ALIGN="RIGHT" WIDTH="79" HEIGHT="30" VALIGN="MIDDLE">(  -   )</TD>
<TD ALIGN="RIGHT" WIDTH="79" HEIGHT="30" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="143" HEIGHT="30" VALIGN="MIDDLE">당기순손익</TD>
<TD ALIGN="RIGHT" WIDTH="80" HEIGHT="30" VALIGN="MIDDLE">-</TD>
<TD ALIGN="RIGHT" WIDTH="80" HEIGHT="30" VALIGN="MIDDLE">-</TD>
<TD ALIGN="RIGHT" WIDTH="80" HEIGHT="30" VALIGN="MIDDLE">-</TD>
<TD ALIGN="RIGHT" WIDTH="80" HEIGHT="30" VALIGN="MIDDLE">-</TD>
<TD ALIGN="RIGHT" WIDTH="80" HEIGHT="30" VALIGN="MIDDLE">-</TD>
<TD ALIGN="RIGHT" WIDTH="79" HEIGHT="30" VALIGN="MIDDLE">(  -   )</TD>
<TD ALIGN="RIGHT" WIDTH="79" HEIGHT="30" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="143" HEIGHT="30" VALIGN="MIDDLE">자산총액</TD>
<TD ALIGN="RIGHT" WIDTH="80" HEIGHT="30" VALIGN="MIDDLE">-</TD>
<TD ALIGN="RIGHT" WIDTH="80" HEIGHT="30" VALIGN="MIDDLE">-</TD>
<TD ALIGN="RIGHT" WIDTH="80" HEIGHT="30" VALIGN="MIDDLE">-</TD>
<TD ALIGN="RIGHT" WIDTH="80" HEIGHT="30" VALIGN="MIDDLE">-</TD>
<TD ALIGN="RIGHT" WIDTH="80" HEIGHT="30" VALIGN="MIDDLE">-</TD>
<TD ALIGN="RIGHT" WIDTH="79" HEIGHT="30" VALIGN="MIDDLE">(  -   )</TD>
<TD ALIGN="RIGHT" WIDTH="79" HEIGHT="30" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="143" HEIGHT="30" VALIGN="MIDDLE">  현금및현금성자산</TD>
<TD ALIGN="RIGHT" WIDTH="80" HEIGHT="30" VALIGN="MIDDLE">-</TD>
<TD ALIGN="RIGHT" WIDTH="80" HEIGHT="30" VALIGN="MIDDLE">-</TD>
<TD ALIGN="RIGHT" WIDTH="80" HEIGHT="30" VALIGN="MIDDLE">-</TD>
<TD ALIGN="RIGHT" WIDTH="80" HEIGHT="30" VALIGN="MIDDLE">-</TD>
<TD ALIGN="RIGHT" WIDTH="80" HEIGHT="30" VALIGN="MIDDLE">-</TD>
<TD ALIGN="RIGHT" WIDTH="79" HEIGHT="30" VALIGN="MIDDLE">-</TD>
<TD ALIGN="RIGHT" WIDTH="79" HEIGHT="30" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="143" HEIGHT="30" VALIGN="MIDDLE">  유동자산</TD>
<TD ALIGN="RIGHT" WIDTH="80" HEIGHT="30" VALIGN="MIDDLE">-</TD>
<TD ALIGN="RIGHT" WIDTH="80" HEIGHT="30" VALIGN="MIDDLE">-</TD>
<TD ALIGN="RIGHT" WIDTH="80" HEIGHT="30" VALIGN="MIDDLE">-</TD>
<TD ALIGN="RIGHT" WIDTH="80" HEIGHT="30" VALIGN="MIDDLE">-</TD>
<TD ALIGN="RIGHT" WIDTH="80" HEIGHT="30" VALIGN="MIDDLE">-</TD>
<TD ALIGN="RIGHT" WIDTH="79" HEIGHT="30" VALIGN="MIDDLE">-</TD>
<TD ALIGN="RIGHT" WIDTH="79" HEIGHT="30" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="143" HEIGHT="30" VALIGN="MIDDLE">  단기금융상품</TD>
<TD ALIGN="RIGHT" WIDTH="80" HEIGHT="30" VALIGN="MIDDLE">-</TD>
<TD ALIGN="RIGHT" WIDTH="80" HEIGHT="30" VALIGN="MIDDLE">-</TD>
<TD ALIGN="RIGHT" WIDTH="80" HEIGHT="30" VALIGN="MIDDLE">-</TD>
<TD ALIGN="RIGHT" WIDTH="80" HEIGHT="30" VALIGN="MIDDLE">-</TD>
<TD ALIGN="RIGHT" WIDTH="80" HEIGHT="30" VALIGN="MIDDLE">-</TD>
<TD ALIGN="RIGHT" WIDTH="79" HEIGHT="30" VALIGN="MIDDLE">-</TD>
<TD ALIGN="RIGHT" WIDTH="79" HEIGHT="30" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="143" HEIGHT="30" VALIGN="MIDDLE">부채총액</TD>
<TD ALIGN="RIGHT" WIDTH="80" HEIGHT="30" VALIGN="MIDDLE">-</TD>
<TD ALIGN="RIGHT" WIDTH="80" HEIGHT="30" VALIGN="MIDDLE">-</TD>
<TD ALIGN="RIGHT" WIDTH="80" HEIGHT="30" VALIGN="MIDDLE">-</TD>
<TD ALIGN="RIGHT" WIDTH="80" HEIGHT="30" VALIGN="MIDDLE">-</TD>
<TD ALIGN="RIGHT" WIDTH="80" HEIGHT="30" VALIGN="MIDDLE">-</TD>
<TD ALIGN="RIGHT" WIDTH="79" HEIGHT="30" VALIGN="MIDDLE">(  -   )</TD>
<TD ALIGN="RIGHT" WIDTH="79" HEIGHT="30" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="143" HEIGHT="30" VALIGN="MIDDLE">자기자본</TD>
<TD ALIGN="RIGHT" WIDTH="80" HEIGHT="30" VALIGN="MIDDLE">-</TD>
<TD ALIGN="RIGHT" WIDTH="80" HEIGHT="30" VALIGN="MIDDLE">-</TD>
<TD ALIGN="RIGHT" WIDTH="80" HEIGHT="30" VALIGN="MIDDLE">-</TD>
<TD ALIGN="RIGHT" WIDTH="80" HEIGHT="30" VALIGN="MIDDLE">-</TD>
<TD ALIGN="RIGHT" WIDTH="80" HEIGHT="30" VALIGN="MIDDLE">-</TD>
<TD ALIGN="RIGHT" WIDTH="79" HEIGHT="30" VALIGN="MIDDLE">(  -   )</TD>
<TD ALIGN="RIGHT" WIDTH="79" HEIGHT="30" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="143" HEIGHT="30" VALIGN="MIDDLE">자본금</TD>
<TD ALIGN="RIGHT" WIDTH="80" HEIGHT="30" VALIGN="MIDDLE">-</TD>
<TD ALIGN="RIGHT" WIDTH="80" HEIGHT="30" VALIGN="MIDDLE">-</TD>
<TD ALIGN="RIGHT" WIDTH="80" HEIGHT="30" VALIGN="MIDDLE">-</TD>
<TD ALIGN="RIGHT" WIDTH="80" HEIGHT="30" VALIGN="MIDDLE">-</TD>
<TD ALIGN="RIGHT" WIDTH="80" HEIGHT="30" VALIGN="MIDDLE">-</TD>
<TD ALIGN="RIGHT" WIDTH="79" HEIGHT="30" VALIGN="MIDDLE">(  -   )</TD>
<TD ALIGN="RIGHT" WIDTH="79" HEIGHT="30" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="143" HEIGHT="30" VALIGN="MIDDLE">감사인</TD>
<TD ALIGN="CENTER" WIDTH="80" HEIGHT="30" VALIGN="MIDDLE">-</TD>
<TD ALIGN="CENTER" WIDTH="80" HEIGHT="30" VALIGN="MIDDLE">-</TD>
<TD ALIGN="CENTER" WIDTH="80" HEIGHT="30" VALIGN="MIDDLE">-</TD>
<TD ALIGN="CENTER" WIDTH="80" HEIGHT="30" VALIGN="MIDDLE">-</TD>
<TD ALIGN="CENTER" WIDTH="80" HEIGHT="30" VALIGN="MIDDLE">-</TD>
<TD ALIGN="CENTER" WIDTH="79" HEIGHT="30" VALIGN="MIDDLE">-</TD>
<TD ALIGN="CENTER" WIDTH="79" HEIGHT="30" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="143" HEIGHT="30" VALIGN="MIDDLE">감사ㆍ검토 의견</TD>
<TD ALIGN="CENTER" WIDTH="80" HEIGHT="30" VALIGN="MIDDLE">-</TD>
<TD ALIGN="CENTER" WIDTH="80" HEIGHT="30" VALIGN="MIDDLE">-</TD>
<TD ALIGN="CENTER" WIDTH="80" HEIGHT="30" VALIGN="MIDDLE">-</TD>
<TD ALIGN="CENTER" WIDTH="80" HEIGHT="30" VALIGN="MIDDLE">-</TD>
<TD ALIGN="CENTER" WIDTH="80" HEIGHT="30" VALIGN="MIDDLE">-</TD>
<TD ALIGN="CENTER" WIDTH="79" HEIGHT="30" VALIGN="MIDDLE">-</TD>
<TD ALIGN="CENTER" WIDTH="79" HEIGHT="30" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="143" HEIGHT="30" VALIGN="MIDDLE">비  고</TD>
<TD ALIGN="CENTER" WIDTH="80" HEIGHT="30" VALIGN="MIDDLE">-</TD>
<TD ALIGN="CENTER" WIDTH="80" HEIGHT="30" VALIGN="MIDDLE">-</TD>
<TD ALIGN="CENTER" WIDTH="80" HEIGHT="30" VALIGN="MIDDLE">-</TD>
<TD ALIGN="CENTER" WIDTH="80" HEIGHT="30" VALIGN="MIDDLE">-</TD>
<TD ALIGN="CENTER" WIDTH="80" HEIGHT="30" VALIGN="MIDDLE">-</TD>
<TD ALIGN="CENTER" WIDTH="79" HEIGHT="30" VALIGN="MIDDLE">-</TD>
<TD ALIGN="CENTER" WIDTH="79" HEIGHT="30" VALIGN="MIDDLE">-</TD>
</TR>
</TBODY>
</TABLE>

<INSERTION ABASISNUMBER="LE0" AFREQUENCY="0" ADUPLICATION="Y">
<COMMENT>◆click◆『합병등 전후의 재무사항 비교표』 삽입</COMMENT>
<LIBRARYLIST>11011#*합병등전후의재무사항비교표.dsl</LIBRARYLIST>
</INSERTION>

<INSERTION ABASISNUMBER="SE1" AFREQUENCY="0" ADUPLICATION="Y">
<COMMENT>◆click◆『보호예수 현황』 삽입</COMMENT>
<LIBRARYLIST>11011#*보호예수현황.dsl</LIBRARYLIST>
</INSERTION>

<INSERTION ABASISNUMBER="SE1" AFREQUENCY="0" ADUPLICATION="Y">
<COMMENT>◆click◆『특례상장기업 관리종목 지정유예 현황』 삽입</COMMENT>
<LIBRARYLIST>11011#*특례상장기업관리종목지정유예현황.dsl</LIBRARYLIST>
</INSERTION>
<P></P>

<P>
<SPAN USERMARK="F-GL B">바. </SPAN>
<SPAN USERMARK="F-GL B"></SPAN>
<SPAN USERMARK="F-DU B">타법인 주식 및 출자증권 양수결정&cr;</SPAN>
</P>

<TABLE BORDER="1" WIDTH="827" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="165"></COL>
<COL WIDTH="158"></COL>
<COL WIDTH="109"></COL>
<COL WIDTH="103"></COL>
<COL WIDTH="86"></COL>
<COL WIDTH="152"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD COLSPAN="2" ROWSPAN="4" WIDTH="341" VALIGN="MIDDLE" HEIGHT="143">1. 발행회사</TD>
<TD WIDTH="118" ALIGN="CENTER" HEIGHT="30">회사명</TD>
<TD COLSPAN="3" WIDTH="368" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">S & V Technologies GmbH</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="118" ALIGN="CENTER" HEIGHT="30">국적</TD>
<TD WIDTH="112" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">독일</TD>
<TD WIDTH="95" ALIGN="CENTER" HEIGHT="30">대표자</TD>
<TD WIDTH="161" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">Dr. Christine F. Kreiner</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="118" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">자본금(원)</TD>
<TD WIDTH="112" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">134,615,000</TD>
<TD WIDTH="95" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">회사와 관계</TD>
<TD WIDTH="161" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="118" ALIGN="CENTER" HEIGHT="53">발행주식&cr;총수(주)</TD>
<TD WIDTH="112" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">-</TD>
<TD WIDTH="95" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">주요사업</TD>
<TD WIDTH="161" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">의약품, 의료용품 및 화장품제조업</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD COLSPAN="2" WIDTH="341" HEIGHT="53">  - 최근 6월 이내 제3자 배정에 의한&cr;    신주취득 여부</TD>
<TD COLSPAN="4" WIDTH="486" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">아니오</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ROWSPAN="6" WIDTH="174" VALIGN="MIDDLE" HEIGHT="180">2. 양수내역</TD>
<TD WIDTH="167" ALIGN="CENTER" HEIGHT="30">양수주식수(주)</TD>
<TD COLSPAN="4" WIDTH="486" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="167" ALIGN="CENTER" HEIGHT="30">양수금액(원)(A)</TD>
<TD COLSPAN="4" WIDTH="486" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">3,324,990,500</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="167" ALIGN="CENTER" HEIGHT="30">총자산(원)(B)</TD>
<TD COLSPAN="4" WIDTH="486" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">17,149,604,636</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="167" ALIGN="CENTER" HEIGHT="30">총자산대비(%)(A/B)</TD>
<TD COLSPAN="4" WIDTH="486" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">19.39</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="167" ALIGN="CENTER" HEIGHT="30">자기자본(원)(C)</TD>
<TD COLSPAN="4" WIDTH="486" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">16,178,666,490</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="167" ALIGN="CENTER" HEIGHT="30">자기자본대비(%)(A/C)</TD>
<TD COLSPAN="4" WIDTH="486" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">20.55</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD COLSPAN="2" ROWSPAN="2" WIDTH="341" VALIGN="MIDDLE" HEIGHT="60">3. 양수후 소유주식수 및 지분비율</TD>
<TD WIDTH="118" ALIGN="CENTER" HEIGHT="30">소유주식수(주)</TD>
<TD COLSPAN="3" WIDTH="368" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="118" ALIGN="CENTER" HEIGHT="30">지분비율(%)</TD>
<TD COLSPAN="3" WIDTH="368" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">40</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD COLSPAN="2" WIDTH="341" HEIGHT="30">4. 양수목적</TD>
<TD COLSPAN="4" WIDTH="486" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">독일 필러생산법인 인수를 통한 안정적인 제품공급과 제품경쟁력 확보</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD COLSPAN="2" WIDTH="341" HEIGHT="30">5. 양수예정일자</TD>
<TD COLSPAN="4" WIDTH="486" ALIGN="CENTER" HEIGHT="30">2017년 09월 15일</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ROWSPAN="5" WIDTH="174" VALIGN="MIDDLE" HEIGHT="150">6. 거래상대방</TD>
<TD WIDTH="167" ALIGN="CENTER" HEIGHT="30">회사명(성명)</TD>
<TD COLSPAN="4" WIDTH="486" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">Dr. Christine F. Kreiner 외6명</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="167" ALIGN="CENTER" HEIGHT="30">자본금(원)</TD>
<TD COLSPAN="4" WIDTH="486" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="167" ALIGN="CENTER" HEIGHT="30">주요사업</TD>
<TD COLSPAN="4" WIDTH="486" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="167" ALIGN="CENTER" HEIGHT="30">본점소재지(주소)</TD>
<TD COLSPAN="4" WIDTH="486" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">독일 베르린외</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="167" ALIGN="CENTER" HEIGHT="30">회사와의 관계</TD>
<TD COLSPAN="4" WIDTH="486" ALIGN="CENTER" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD COLSPAN="2" WIDTH="341" HEIGHT="76">7. 거래대금지급</TD>
<TD COLSPAN="4" WIDTH="486" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">1. 지급형태: 현금&cr;   2. 지급시기 및 조건: 2017.09.15까지 지급완료&cr;3. 자금조달방법: 보유자금</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ROWSPAN="5" WIDTH="174" VALIGN="MIDDLE" HEIGHT="150">8. 외부평가에 관한 사항</TD>
<TD WIDTH="167" HEIGHT="30">외부평가 여부</TD>
<TD COLSPAN="4" WIDTH="486" ALIGN="CENTER" HEIGHT="30">미해당</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="167" HEIGHT="30">- 근거 및 사유</TD>
<TD COLSPAN="4" WIDTH="486" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">비상장</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="167" HEIGHT="30">외부평가기관의 명칭</TD>
<TD COLSPAN="4" WIDTH="486" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="167" HEIGHT="30">외부평가 기간</TD>
<TD COLSPAN="4" WIDTH="486" ALIGN="CENTER" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="167" HEIGHT="30">외부평가 의견</TD>
<TD COLSPAN="4" WIDTH="486" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD COLSPAN="2" WIDTH="341" HEIGHT="30">9. 이사회결의일(결정일)</TD>
<TD COLSPAN="4" WIDTH="486" ALIGN="CENTER" HEIGHT="30">2017년 09월 06일</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ROWSPAN="2" WIDTH="174" VALIGN="MIDDLE" HEIGHT="60">  - 사외이사참석여부</TD>
<TD WIDTH="167" ALIGN="CENTER" HEIGHT="30">참석(명)</TD>
<TD COLSPAN="4" WIDTH="486" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="167" ALIGN="CENTER" HEIGHT="30">불참(명)</TD>
<TD COLSPAN="4" WIDTH="486" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD COLSPAN="2" WIDTH="341" HEIGHT="30">  - 감사(사외이사가 아닌 감사위원) 참석여부</TD>
<TD COLSPAN="4" WIDTH="486" ALIGN="CENTER" HEIGHT="30">참석</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD COLSPAN="2" WIDTH="341" HEIGHT="30">10. 우회상장 해당 여부</TD>
<TD COLSPAN="4" WIDTH="486" ALIGN="CENTER" HEIGHT="30">아니오</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD COLSPAN="2" WIDTH="341" HEIGHT="30">  - 향후 6월이내 제3자배정 증자 등 계획</TD>
<TD COLSPAN="4" WIDTH="486" ALIGN="CENTER" HEIGHT="30">해당사항없음</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD COLSPAN="2" WIDTH="341" HEIGHT="30">11. 발행회사(타법인)의 우회상장 요건 충족여부</TD>
<TD COLSPAN="4" WIDTH="486" ALIGN="CENTER" HEIGHT="30">해당사항없음</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD COLSPAN="2" WIDTH="341" HEIGHT="30">12. 공정거래위원회 신고대상 여부</TD>
<TD COLSPAN="4" WIDTH="486" ALIGN="CENTER" HEIGHT="30">미해당</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD COLSPAN="2" WIDTH="341" HEIGHT="30">13. 풋옵션 등 계약 체결여부</TD>
<TD COLSPAN="4" WIDTH="486" ALIGN="CENTER" HEIGHT="30">아니오</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD COLSPAN="2" WIDTH="341" HEIGHT="30">  - 계약내용</TD>
<TD COLSPAN="4" WIDTH="486" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">-</TD>
</TR>
</TBODY>
</TABLE>

<P USERMARK="F-GL">&cr;
<SPAN USERMARK="F-11">14. 기타 투자판단과 관련한 중요사항&cr;&cr;1) 상기 자산총액 및 자기자본은 최근사업년도(2016.12.31)재무제표 기준입니다. &cr;&cr;2) 총 양수금액: EUR 2,470,000&cr;&cr;3) 상기 발행회사는 독일소재 유한회사로 자본금은 주식으로 나누어지는 것이 아니고(이에 따라 주식수, 액면금액이라는 개념이 없음) 주주는 취득한 실수자본(우리나라 납입자본금)에 대한 지분을 보유하게 됩니다. 따라서 본 건 공시에는 발행주식총수, 양수주식수, 양수후 소유주식수는 기재하지 않았습니다.&cr;&cr;4) 상기 양수금액은 EUR2,470,000이며 적용환율은 이사회결의 전일인 2017.09.05  매매기준율 1,346.15원을 적용함&cr;</SPAN>※ 관련공시 
</P>

<TABLE WIDTH="784" BORDER="1" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="775"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="784" VALIGN="MIDDLE" HEIGHT="30">【 발행회사의 요약 재무상황 】</TD>
</TR>
</TBODY>
</TABLE>

<TABLE WIDTH="784" BORDER="1" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="775"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="784" ALIGN="RIGHT" HEIGHT="30">(단위 : 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE BORDER="1" WIDTH="786" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="79"></COL>
<COL WIDTH="79"></COL>
<COL WIDTH="79"></COL>
<COL WIDTH="78"></COL>
<COL WIDTH="78"></COL>
<COL WIDTH="78"></COL>
<COL WIDTH="78"></COL>
<COL WIDTH="78"></COL>
<COL WIDTH="78"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">구  분</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">자산총계</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">부채총계</TD>
<TD WIDTH="87" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">자본총계</TD>
<TD WIDTH="87" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">자본금</TD>
<TD WIDTH="87" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">매출액</TD>
<TD WIDTH="87" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">당기순이익</TD>
<TD WIDTH="87" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">감사의견</TD>
<TD WIDTH="87" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">외부감사인</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2017년도</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">8,452,370</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">8,368,923</TD>
<TD WIDTH="87" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">83,447</TD>
<TD WIDTH="87" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">125,272</TD>
<TD WIDTH="87" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">5,715,250</TD>
<TD WIDTH="87" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">203,982</TD>
<TD WIDTH="87" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">-</TD>
<TD WIDTH="87" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2016년도</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">9,393,356</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">9,096,400</TD>
<TD WIDTH="87" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">296,956</TD>
<TD WIDTH="87" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">125,272</TD>
<TD WIDTH="87" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">7,528,098</TD>
<TD WIDTH="87" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">2,355,179</TD>
<TD WIDTH="87" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">-</TD>
<TD WIDTH="87" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2015년도</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">11,857,193</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">14,046,312</TD>
<TD WIDTH="87" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-2,189,118</TD>
<TD WIDTH="87" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">125,272</TD>
<TD WIDTH="87" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">7,127,656</TD>
<TD WIDTH="87" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,025,593</TD>
<TD WIDTH="87" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">-</TD>
<TD WIDTH="87" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">-</TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK="F-GL11">- 각 결산기의 환산은 매출 및 당기순이익은 각 결산기의 평균환율을 사용하였으며, 그 외의 사항은 각 결산기의 기말환율을 적용하여 산출하였습니다.</P>
<PGBRK></PGBRK>
</SECTION-1>

<SECTION-1 ACLASS="MANDATORY" APARTSOURCE="SOURCE">
<TITLE ATOC="Y">【 전문가의 확인 】</TITLE>

<SECTION-2 ACLASS="MANDATORY">
<TITLE ATOC="Y" AASSOCNOTE="D-3-0-1-0">1. 전문가의 확인</TITLE>
<P USERMARK="F-GL11">해당사항 없습니다&cr;</P>
</SECTION-2>

<SECTION-2 ACLASS="MANDATORY">
<TITLE ATOC="Y" AASSOCNOTE="D-3-0-2-0">2. 전문가와의 이해관계</TITLE>
<P USERMARK="F-GL11">해당사항 없습니다&cr;</P>
</SECTION-2>
</SECTION-1>
</BODY>
</DOCUMENT>